data_2l4a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l4a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.618 0.723 . . . . 1.83 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 9.6 mmt180 -46.52 -32.02 3.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.93 -0.708 . . . . 3.4 110.631 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.546 HG21 ' CG ' ' A' ' 48' ' ' ARG . 6.6 mm -70.12 -37.24 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 1.2 111.63 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.472 ' HB3' ' CG ' ' A' ' 52' ' ' LEU . 73.3 m-20 -74.67 -54.37 7.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.916 -1.115 . . . . 1.25 111.417 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 1.3 ptm180 -57.08 -46.68 82.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 2.79 111.204 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 2.5 m-20 -65.75 -32.79 74.53 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.124 -1.03 . . . . 2.1 108.689 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 9.1 mt -69.38 -38.04 76.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 1.16 108.548 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.546 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 41.4 mt -67.5 -39.02 85.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.332 -0.988 . . . . 1.47 108.332 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -65.31 -30.97 71.88 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.983 -0.747 . . . . 2.17 108.983 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.524 ' OE1' ' CG1' ' A' ' 38' ' ' VAL . 7.3 mt-10 -79.45 -32.87 42.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.543 -0.723 . . . . 2.07 109.419 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.485 HD21 ' N ' ' A' ' 23' ' ' LEU . 2.5 mm? -69.21 -41.61 76.84 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.365 -0.934 . . . . 2.01 108.666 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.474 ' OE1' ' CA ' ' A' ' 24' ' ' GLN . 2.2 tp60 -64.67 -38.35 90.71 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 2.5 108.909 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -78.08 -20.73 51.71 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.319 -0.993 . . . . 2.59 108.319 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.69 91.02 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.478 -0.889 . . . . 1.52 109.506 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.54 14.11 37.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.351 -1.099 . . . . 1.56 110.351 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 28.19 5.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.293 . . . . 4.22 110.015 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 tt -105.64 137.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 1.17 110.294 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 7.8 t -77.91 -123.45 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.826 -0.749 . . . . 2.14 110.128 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' SER . 14.2 p30 -122.44 -44.48 2.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.056 -1.028 . . . . 3.04 110.086 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.495 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 74.1 t -45.51 -55.45 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.902 -1.124 . . . . 1.2 108.428 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -64.32 -47.11 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.073 -1.454 . . . . 1.77 107.073 177.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.508 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -53.3 -19.17 3.01 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.568 0.699 . . . . 1.52 109.839 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' ASN . 3.7 p -87.45 -31.13 20.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.94 110.586 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -87.19 -31.62 20.25 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.272 -0.893 . . . . 2.64 112.586 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 13.3 mtp180 -68.85 -17.81 64.05 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.507 -1.371 . . . . 2.78 110.759 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.527 ' CG2' ' CD2' ' A' ' 40' ' ' LEU . 1.8 m -104.94 -11.33 9.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 C-N-CA 119.626 -0.83 . . . . 1.5 110.047 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.2 40.11 6.65 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.351 -0.928 . . . . 0.48 111.362 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.527 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -146.09 171.79 14.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.779 -1.424 . . . . 1.95 110.654 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 38.4 m -76.39 158.94 80.85 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.392 -1.336 . . . . 1.3 107.392 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.554 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 55.9 Cg_endo -77.13 -44.61 0.19 Allowed 'Trans proline' 0 C--N 1.282 -2.96 0 O-C-N 124.189 1.626 . . . . 0.32 111.27 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.503 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.34 -52.56 5.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 1.27 109.099 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.0 Cg_endo -79.76 -38.03 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.36 110.107 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.524 ' CB ' HD13 ' A' ' 40' ' ' LEU . 42.1 t -42.93 -46.75 5.51 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.749 -1.204 . . . . 1.03 107.749 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -62.02 -51.7 66.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.328 -1.36 . . . . 1.1 107.328 177.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -44.75 -37.39 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.099 -1.04 . . . . 2.03 108.212 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.546 ' CG ' HG21 ' A' ' 15' ' ' ILE . 2.6 mmt180 -73.64 -46.17 48.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.951 0.881 . . . . 2.34 108.717 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -65.86 -38.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.411 -0.806 . . . . 1.18 109.94 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -56.74 -45.48 81.96 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.389 -0.967 . . . . 2.58 108.389 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -39.45 64.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.138 -1.43 . . . . 2.98 107.138 177.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.546 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 59.3 mt -73.06 -19.97 61.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.584 0.707 . . . . 1.26 109.31 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.33 -51.44 13.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 1.85 109.869 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -52.96 -30.15 33.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.527 -0.733 . . . . 4.17 110.364 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 13.0 mm-40 -84.33 11.05 9.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 2.99 109.843 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.26 48.57 73.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.13 -1.188 . . . . 2.13 110.13 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.521 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 20.8 m-85 -129.15 7.8 5.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.059 -1.259 . . . . 3.22 110.214 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 6.5 mm . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 1.24 109.448 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' HB2' ' NH2' ' A' ' 51' ' ' ARG . 3.7 t70 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.353 0.597 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 7.1 tpp85 -44.68 -33.89 2.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 9.3 mm -73.67 -20.91 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.517 ' OD2' ' CZ ' ' A' ' 51' ' ' ARG . 2.9 m-20 -85.17 -59.53 2.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 0.0 110.142 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -53.99 -40.21 66.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.472 ' OD1' ' HD2' ' A' ' 17' ' ' ARG . 10.1 m120 -69.56 -41.37 75.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.568 HG23 ' CG2' ' A' ' 49' ' ' VAL . 18.6 mt -67.87 -33.75 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.28 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 mt -68.78 -36.47 78.34 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -66.2 -37.62 86.01 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.47 ' OE2' ' O ' ' A' ' 37' ' ' ARG . 98.9 mt-10 -68.78 -39.24 80.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.707 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.7 mt -64.38 -24.93 67.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.351 -0.843 . . . . 0.0 109.592 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -75.97 -39.13 56.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -84.01 -24.56 30.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 1.5 m-20 -133.85 90.57 2.72 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.04 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 9.8 51.88 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -123.07 39.36 3.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -1.131 . . . . 0.0 110.294 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.466 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 7.5 tt -117.86 139.8 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.379 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 31' ' ' ASN . 9.1 t -86.96 -108.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.347 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' SER . 1.8 p-10 -128.58 -45.72 1.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.27 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 31' ' ' ASN . 93.8 t -46.03 -61.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.954 -1.091 . . . . 0.0 109.119 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.6 tp10 -64.05 -28.13 69.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.224 -0.923 . . . . 0.0 108.944 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.55 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -75.09 -15.3 60.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.713 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASN . 28.0 p -86.57 -44.18 12.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.567 -0.708 . . . . 0.0 110.597 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -82.0 -21.86 36.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 31.8 mtt-85 -70.74 -19.25 62.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.364 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.563 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -110.12 -9.24 11.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.15 40.56 5.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -150.74 159.31 44.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.984 -1.304 . . . . 0.0 110.526 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.508 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.0 OUTLIER -67.0 156.32 88.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 108.858 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -72.01 -49.59 0.3 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 124.022 1.538 . . . . 0.0 110.496 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.533 ' C ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -35.98 -55.39 1.3 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.1 Cg_endo -75.83 -41.85 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.962 1.507 . . . . 0.0 110.007 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.516 ' CB ' HD12 ' A' ' 40' ' ' LEU . 35.9 t -39.9 -52.6 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.662 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -55.18 -49.03 72.92 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.51 -44.96 13.0 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.431 -0.793 . . . . 0.0 109.134 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' CG ' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.48 -51.89 31.7 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.594 0.711 . . . . 0.0 109.665 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 19' ' ' ILE . 2.9 t -64.44 -59.2 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.543 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -40.5 -45.71 2.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -51.75 -46.9 64.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.852 177.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' VAL . 12.9 mt -62.95 -27.66 69.55 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.414 -0.804 . . . . 0.0 109.665 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -66.69 -56.82 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 47.2 mtp180 -45.96 -24.43 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.355 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.648 ' CB ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mm-40 -95.7 3.95 53.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.307 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.91 44.35 19.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' ' 55' ' ' GLN . 19.0 m-30 -116.65 0.93 12.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -1.231 . . . . 0.0 110.177 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 5.9 mm . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 16' ' ' ASP . 4.6 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.8 tpt180 -48.42 -20.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.37 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.562 HG22 ' CB ' ' A' ' 48' ' ' ARG . 7.6 mm -73.92 -45.2 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD2' ' NE ' ' A' ' 51' ' ' ARG . 47.7 m-20 -70.62 -35.74 73.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -69.22 -65.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 1.6 t-20 -52.61 -26.52 13.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.549 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 3.2 mt -70.07 -47.26 69.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.419 ' CD1' HD13 ' A' ' 52' ' ' LEU . 40.7 mt -64.27 -33.15 75.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.117 -0.989 . . . . 0.0 109.19 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.43 -28.45 65.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.359 -0.838 . . . . 0.0 109.408 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' OE1' ' CB ' ' A' ' 37' ' ' ARG . 3.6 mm-40 -78.55 -35.46 46.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.469 -0.769 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' N ' ' A' ' 23' ' ' LEU . 2.9 mm? -68.67 -35.84 77.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -74.75 -36.82 62.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.778 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -76.82 -36.59 56.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.82 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -122.22 76.5 1.31 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.164 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' ' HD2' ' A' ' 28' ' ' ARG . . . -67.8 58.14 0.35 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HD3' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -173.77 36.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 0.0 110.007 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -123.51 153.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.466 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.404 ' O ' HD13 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -100.06 -94.03 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 3.3 p30 -138.76 -46.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.483 ' N ' ' CG ' ' A' ' 31' ' ' ASN . 31.0 t -44.99 -64.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.992 -1.067 . . . . 0.0 109.412 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.541 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 5.7 tp10 -62.01 -27.39 68.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 108.816 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.627 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.71 -16.04 61.21 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.524 -0.735 . . . . 0.0 109.401 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 9.7 p -88.98 -36.49 15.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.721 -0.612 . . . . 0.0 110.679 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.9 -50.25 8.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.246 -0.909 . . . . 0.0 111.188 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.539 ' CB ' ' OE1' ' A' ' 22' ' ' GLU . 7.3 mtp85 -54.84 -17.06 3.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.126 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 34' ' ' LEU . 15.7 m -100.42 -21.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.26 39.04 4.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.61 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.905 -1.35 . . . . 0.0 110.744 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -68.65 155.08 93.75 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.868 177.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.559 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 49.8 Cg_endo -74.06 -45.65 0.35 Allowed 'Trans proline' 0 C--N 1.286 -2.713 0 O-C-N 123.992 1.522 . . . . 0.0 110.737 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.538 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.96 -55.61 3.69 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.9 Cg_endo -75.64 -39.74 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.915 1.482 . . . . 0.0 110.026 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.549 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 51.6 t -39.43 -47.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 108.731 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.19 -49.97 72.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 14.5 mt-10 -46.97 -37.91 9.82 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.219 -0.925 . . . . 0.0 108.817 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.562 ' CB ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -70.77 -58.0 4.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.464 -0.772 . . . . 0.0 109.101 177.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -54.03 -50.45 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.23 -0.919 . . . . 0.0 109.17 177.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 18.1 mmt180 -41.76 -53.81 3.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.384 -0.822 . . . . 0.0 109.533 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NE ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -46.61 -44.15 17.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.735 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 49' ' ' VAL . 66.4 mt -69.95 -26.02 63.92 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -71.13 -66.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 110.134 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -56.34 -24.51 44.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.194 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.588 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.8 mm100 -79.45 5.13 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 68.4 48.69 49.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 55' ' ' GLN . 21.0 m-85 -134.06 8.54 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.525 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 17.0 mm . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.402 0.62 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 15.2 mmt180 -53.15 -39.3 63.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 110.496 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.544 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 4.4 mm -72.8 -21.17 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.735 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB3' ' CD2' ' A' ' 52' ' ' LEU . 96.2 m-20 -86.33 -56.62 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.639 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 8.3 ptt85 -57.18 -42.55 81.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 110.271 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.531 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -68.3 -41.87 80.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.409 -0.807 . . . . 0.0 109.384 178.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.544 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 6.1 mt -65.72 -30.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.23 -0.918 . . . . 0.0 109.357 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.546 ' CD1' HD12 ' A' ' 52' ' ' LEU . 14.3 mt -74.01 -44.62 53.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -64.78 -28.16 69.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.509 ' OE1' ' CG1' ' A' ' 38' ' ' VAL . 8.9 mt-10 -76.46 -38.94 54.61 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.368 -0.832 . . . . 0.0 109.943 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.471 HD11 HD13 ' A' ' 34' ' ' LEU . 14.7 mt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -43.93 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -25.61 56.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.517 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -137.69 87.94 2.29 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.911 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.55 7.69 46.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.602 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -114.67 28.21 8.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' ASP . 6.9 tt -108.9 137.33 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.4 p -94.72 157.68 15.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 110.222 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -42.26 -49.19 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.456 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.449 ' O ' ' OG ' ' A' ' 35' ' ' SER . 78.7 t -44.05 -65.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.958 -1.089 . . . . 0.0 109.402 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -61.89 -28.7 69.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.22 -0.925 . . . . 0.0 108.782 177.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.623 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -72.69 -14.63 61.62 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 178.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 25.1 p -86.74 -43.34 12.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.461 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -16.53 46.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.254 -0.904 . . . . 0.0 111.221 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.525 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -81.29 -15.54 55.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.977 -1.077 . . . . 0.0 110.773 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -108.35 -8.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.223 -0.923 . . . . 0.0 109.874 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 40.63 4.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.533 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -151.77 165.63 33.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -1.23 . . . . 0.0 110.549 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.25 157.07 85.33 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.786 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.582 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.5 Cg_endo -72.25 -44.8 0.74 Allowed 'Trans proline' 0 C--N 1.286 -2.729 0 O-C-N 124.005 1.529 . . . . 0.0 110.539 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.543 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.06 -55.87 4.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.363 178.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -75.35 -42.2 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.901 1.474 . . . . 0.0 110.202 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' C ' ' O ' ' A' ' 44' ' ' PRO . 42.5 t -40.14 -51.02 2.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 108.708 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -58.26 -46.4 86.07 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -48.47 -42.59 33.15 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.318 -0.864 . . . . 0.0 108.959 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.508 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.21 -55.32 10.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.695 0.76 . . . . 0.0 109.555 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.544 HG11 ' N ' ' A' ' 50' ' ' ARG . 1.6 t -59.06 -55.51 23.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.976 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.556 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -39.8 -50.02 2.37 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.405 -0.81 . . . . 0.0 109.645 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.03 -47.2 33.72 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.697 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.546 HD12 ' CD1' ' A' ' 20' ' ' LEU . 97.0 mt -59.61 -26.26 65.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -68.22 -57.58 5.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 110.248 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -46.58 -36.63 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 7.8 mm-40 -81.82 8.38 10.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 64.28 60.11 7.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.517 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 14.8 m-85 -135.38 12.54 3.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 110.312 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 5.2 mm . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 110.24 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 7.7 t70 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.333 0.587 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -45.5 -30.17 1.35 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' HB ' ' HG2' ' A' ' 48' ' ' ARG . 17.9 mm -73.54 -18.76 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 0.7 OUTLIER -84.27 -48.61 9.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.179 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -61.07 -47.82 84.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 33.9 p-10 -66.18 -37.64 86.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.016 -1.052 . . . . 0.0 109.283 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.545 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 5.8 mt -64.38 -29.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.234 -0.916 . . . . 0.0 109.23 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD22 ' CD2' ' A' ' 57' ' ' PHE . 40.7 mt -72.23 -46.77 54.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.662 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 7.3 t30 -61.41 -29.15 69.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.382 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 3.4 mm-40 -74.87 -36.93 62.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.433 -0.792 . . . . 0.0 109.705 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.9 mm? -66.17 -37.77 86.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.338 -0.851 . . . . 0.0 109.669 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -35.92 67.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.784 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -81.45 -24.49 36.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.882 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ARG . 1.4 m-20 -125.06 69.72 1.14 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.58 61.74 0.11 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.69 32.02 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.367 -1.078 . . . . 0.0 109.83 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.501 HG13 ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -124.71 151.6 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.456 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 35.7 m -102.9 -92.96 0.33 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.214 -0.929 . . . . 0.0 110.333 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.2 p-10 -139.37 -47.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -0.938 . . . . 0.0 110.26 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 35' ' ' SER . 78.8 t -45.91 -65.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.961 -1.087 . . . . 0.0 109.129 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' HB3' HG13 ' A' ' 29' ' ' ILE . 11.9 tp10 -61.27 -27.71 68.66 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.94 . . . . 0.0 108.756 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.518 -0.739 . . . . 0.0 109.543 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ASN . 24.6 p -88.25 -39.87 14.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -82.58 -27.28 31.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.923 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 8.1 mtt180 -69.17 -17.37 63.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.12 -0.988 . . . . 0.0 110.379 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -110.05 -6.02 11.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.49 -0.756 . . . . 0.0 109.913 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.65 44.96 5.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -156.19 167.77 29.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.002 -1.293 . . . . 0.0 110.84 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.519 ' C ' ' HB2' ' A' ' 35' ' ' SER . 4.6 m -72.89 154.41 90.99 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.528 -0.732 . . . . 0.0 109.149 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 50.1 Cg_endo -73.85 -49.2 0.21 Allowed 'Trans proline' 0 C--N 1.288 -2.621 0 O-C-N 124.06 1.558 . . . . 0.0 110.733 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.539 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -36.52 -53.46 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 48.8 Cg_endo -75.85 -45.28 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.915 1.482 . . . . 0.0 109.969 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.563 ' HB2' HD12 ' A' ' 40' ' ' LEU . 18.3 t -38.68 -52.01 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 108.898 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.71 -49.88 75.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.01 -43.87 4.43 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.55 ' HG2' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.06 -42.04 63.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.546 -0.721 . . . . 0.0 109.629 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -67.37 -46.97 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.756 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.561 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 1.3 mtm180 -47.84 -51.3 23.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.174 -0.954 . . . . 0.0 109.118 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' C ' ' CD ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -48.85 -45.95 41.58 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 108.853 177.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.519 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 86.5 mt -63.31 -17.69 62.81 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.785 . . . . 0.0 109.448 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -75.66 -53.2 8.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.471 -0.768 . . . . 0.0 110.215 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -55.3 -33.22 63.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -76.22 -0.96 24.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.36 40.64 23.12 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CD2' HD22 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -119.72 -0.08 10.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.161 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.505 HD11 HD23 ' A' ' 20' ' ' LEU . 5.2 mm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 38.0 m-20 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.404 0.621 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' ASN . 18.3 mmt-85 -62.04 -16.9 55.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 110.318 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.554 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 7.9 mm -84.87 -49.75 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 0.0 109.833 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.448 ' O ' HD13 ' A' ' 52' ' ' LEU . 2.6 m-20 -71.67 -40.02 69.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.92 . . . . 0.0 110.145 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.5 OUTLIER -71.68 -46.16 59.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 110.027 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 52.1 t30 -67.29 -34.31 77.14 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.22 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 8.0 mt -63.68 -39.64 86.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.458 -0.777 . . . . 0.0 109.186 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' CD1' HD21 ' A' ' 52' ' ' LEU . 80.3 mt -68.31 -45.93 71.64 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.151 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -60.15 -37.41 80.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.183 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.69 -40.96 76.03 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 23' ' ' LEU . 2.7 mm? -64.44 -37.84 88.94 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.288 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -69.32 -44.9 70.76 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 109.508 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -74.36 -19.85 60.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.959 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' OD1' ' NH2' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -148.98 61.68 1.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 110.112 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -52.84 -28.67 32.06 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -76.8 51.7 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -1.138 . . . . 0.0 110.345 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' A' ' 26' ' ' ASP . 18.9 tt -138.73 154.07 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.31 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.434 ' O ' HD12 ' A' ' 34' ' ' LEU . 42.1 t -99.93 -115.61 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.317 -0.864 . . . . 0.0 110.352 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 35' ' ' SER . 9.6 p30 -121.21 -46.4 2.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.3 t -44.58 -62.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.995 -1.066 . . . . 0.0 109.416 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.255 -0.903 . . . . 0.0 108.786 177.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -76.77 -15.65 59.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 31' ' ' ASN . 16.5 p -88.08 -38.81 15.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.538 -0.726 . . . . 0.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -31.38 23.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.295 -0.878 . . . . 0.0 110.916 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 6.2 mtp85 -65.12 -16.63 63.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.351 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 34' ' ' LEU . 1.2 m -109.65 -11.99 11.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 110.036 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.81 42.55 5.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.575 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.75 166.28 32.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.956 -1.32 . . . . 0.0 110.734 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.486 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -70.32 155.55 93.26 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 108.786 177.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 51.3 Cg_endo -74.29 -42.91 0.59 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 O-C-N 123.808 1.425 . . . . 0.0 110.556 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.557 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.97 -57.51 2.06 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.731 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 50.0 Cg_endo -76.47 -41.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.843 1.444 . . . . 0.0 110.205 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 53.8 t -39.21 -45.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 108.825 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.49 -47.99 74.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -48.06 -39.35 19.77 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.685 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HD2' ' CG2' ' A' ' 15' ' ' ILE . 5.4 mmt180 -70.64 -46.86 62.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.665 0.745 . . . . 0.0 109.16 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -64.33 -45.29 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.374 -0.829 . . . . 0.0 109.847 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.532 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 12.6 mmm-85 -47.59 -49.35 26.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.449 -0.782 . . . . 0.0 109.465 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -51.16 -43.43 61.25 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.882 178.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.55 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . 93.8 mt -66.61 -16.67 64.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.432 -0.793 . . . . 0.0 109.891 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -78.08 -61.19 2.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.523 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -49.87 -29.68 8.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.649 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.582 ' OE1' ' CG ' ' A' ' 57' ' ' PHE . 4.1 pt20 -82.51 12.23 4.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.39 52.78 44.0 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.582 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -131.42 8.41 4.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -1.151 . . . . 0.0 110.15 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 5.7 mm . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.323 0.582 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 17.1 mmt-85 -49.59 -20.58 0.8 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.318 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 48' ' ' ARG . 10.2 mm -74.66 -24.33 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.436 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 48' ' ' ARG . 50.2 m-20 -84.36 -56.52 3.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 110.372 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -56.75 -43.94 81.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.035 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.515 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 16.4 m120 -64.78 -41.2 96.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.011 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.527 HG21 ' CG2' ' A' ' 49' ' ' VAL . 3.5 mt -62.0 -39.59 84.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.444 -0.785 . . . . 0.0 109.264 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.444 HD13 ' CD2' ' A' ' 52' ' ' LEU . 16.0 mt -66.56 -40.91 89.25 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.66 -32.4 73.7 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.385 -0.822 . . . . 0.0 109.446 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.61 -31.22 46.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 109.62 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.585 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -73.33 -31.91 64.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.371 -0.83 . . . . 0.0 109.571 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -78.15 -36.63 47.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.395 -0.816 . . . . 0.0 109.769 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 30.0 pttt -74.67 -33.56 62.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.67 68.21 0.86 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.087 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.09 60.66 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -175.37 28.67 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.384 -1.068 . . . . 0.0 109.658 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.522 HG13 ' HB3' ' A' ' 33' ' ' GLU . 16.1 tt -116.6 146.56 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.408 -0.808 . . . . 0.0 110.218 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.464 ' OG ' ' OD1' ' A' ' 31' ' ' ASN . 42.5 t -91.66 -91.42 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 110.275 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 2.3 p-10 -143.74 -47.4 0.28 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.532 HG22 ' ND2' ' A' ' 31' ' ' ASN . 59.3 t -44.25 -61.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.013 -1.054 . . . . 0.0 109.177 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.522 ' HB3' HG13 ' A' ' 29' ' ' ILE . 4.2 tp10 -62.81 -31.95 73.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.278 -0.888 . . . . 0.0 108.805 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.59 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -70.28 -15.25 62.87 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.603 -0.686 . . . . 0.0 109.487 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.567 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 8.7 p -87.76 -37.6 16.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.723 . . . . 0.0 110.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -32.36 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.9 . . . . 0.0 111.273 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -66.27 -16.99 64.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.687 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -109.46 -8.06 11.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 44.59 5.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.581 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -152.54 165.82 33.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.0 -1.294 . . . . 0.0 110.71 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.474 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.61 156.83 90.98 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 108.807 177.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 51.6 Cg_endo -74.5 -48.69 0.19 Allowed 'Trans proline' 0 C--N 1.287 -2.681 0 O-C-N 123.83 1.437 . . . . 0.0 110.543 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -54.13 3.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.011 . . . . 0.0 109.434 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.7 Cg_endo -75.85 -40.66 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.001 1.527 . . . . 0.0 110.135 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 50.3 t -40.56 -44.74 2.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.085 . . . . 0.0 108.718 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.86 -45.16 87.26 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 1.6 mm-40 -50.12 -35.48 25.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HD2' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -74.49 -48.37 27.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.701 . . . . 0.0 109.288 177.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -65.74 -56.71 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 178.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.538 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -43.59 -42.95 5.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.54 -43.83 68.72 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 71.7 mt -69.29 -16.96 63.68 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.629 -0.669 . . . . 0.0 109.785 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 1.9 mt-10 -75.7 -56.29 4.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -53.82 -27.72 31.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.393 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.581 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 66.1 mm-40 -85.38 17.13 3.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.001 . . . . 0.0 110.251 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.44 56.94 21.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 55' ' ' GLN . 20.6 m-85 -137.2 6.74 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.13 -1.217 . . . . 0.0 110.239 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.416 ' HB ' ' CG ' ' A' ' 53' ' ' GLU . 13.5 mm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.022 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.383 0.611 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.6 -22.65 5.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.51 HG22 ' CG ' ' A' ' 48' ' ' ARG . 13.8 mm -71.74 -30.51 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.903 . . . . 0.0 110.5 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.535 ' HB3' ' CG ' ' A' ' 52' ' ' LEU . 50.5 m-20 -76.02 -61.3 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 110.539 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HD2' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -52.64 -39.99 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.493 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 6.7 t30 -67.74 -35.72 79.26 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 109.226 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.508 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 18.6 mt -63.14 -41.96 94.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.362 -0.836 . . . . 0.0 109.094 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 17' ' ' ARG . 25.8 mt -56.21 -42.15 76.74 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.129 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -59.36 -49.65 77.01 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.288 -0.882 . . . . 0.0 109.027 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -61.93 -37.68 85.58 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 178.201 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 19' ' ' ILE . 2.3 mm? -67.36 -35.67 79.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.385 -0.822 . . . . 0.0 109.434 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -39.82 39.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.408 -0.808 . . . . 0.0 109.656 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' HD3' ' OE1' ' A' ' 22' ' ' GLU . 2.4 pttt -77.55 -30.27 52.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 109.747 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.6 m-20 -140.33 61.07 1.53 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 110.317 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -56.22 -163.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.32 25.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -1.195 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 37' ' ' ARG . 10.3 tt -108.88 137.62 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 20.4 m -72.04 -137.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.852 . . . . 0.0 110.4 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 35' ' ' SER . 3.1 p30 -110.86 -43.12 3.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.319 -0.863 . . . . 0.0 109.907 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 32.8 t -44.8 -56.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.13 -0.981 . . . . 0.0 109.153 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -65.64 -34.41 78.17 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.34 -0.85 . . . . 0.0 108.887 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -70.3 -14.97 62.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.717 . . . . 0.0 109.777 178.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.3 p -85.64 -49.7 7.79 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 110.59 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.404 ' N ' ' OG ' ' A' ' 35' ' ' SER . 1.9 mtpp -78.68 -22.11 47.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 110.801 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.502 ' HD2' ' CD1' ' A' ' 29' ' ' ILE . 15.9 mtt-85 -70.02 -17.21 63.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.093 -1.004 . . . . 0.0 110.163 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -112.66 -9.56 12.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.672 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.99 42.0 4.81 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.544 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.41 161.21 42.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.961 -1.317 . . . . 0.0 110.72 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.515 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -66.28 157.07 83.21 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 108.8 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.579 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.8 Cg_endo -73.5 -44.61 0.5 Allowed 'Trans proline' 0 C--N 1.287 -2.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.456 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.526 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.24 -56.12 2.79 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.93 . . . . 0.0 109.551 179.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.7 Cg_endo -74.96 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.99 1.521 . . . . 0.0 109.907 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.524 ' C ' ' O ' ' A' ' 44' ' ' PRO . 45.0 t -37.32 -53.01 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.579 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -54.95 -54.29 44.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -43.87 -43.53 6.4 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.386 -0.821 . . . . 0.0 109.298 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.51 ' CG ' HG22 ' A' ' 15' ' ' ILE . 1.4 mmt180 -66.57 -48.67 68.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.791 . . . . 0.0 109.16 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 50' ' ' ARG . 1.1 t -61.61 -43.48 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.411 -0.806 . . . . 0.0 109.507 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 5.8 mmm180 -45.78 -52.19 11.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.389 -0.819 . . . . 0.0 109.396 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.489 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -53.24 -40.57 64.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.065 178.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 16' ' ' ASP . 16.2 mt -73.48 -31.3 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -0.764 . . . . 0.0 109.753 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -82.09 -30.15 31.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -74.0 -18.56 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 15.53 23.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.258 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.62 58.68 6.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.468 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -145.41 11.93 1.33 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -1.121 . . . . 0.0 110.296 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 53' ' ' GLU . 8.0 mm . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.276 0.56 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.493 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 12.0 mmt85 -56.02 -24.88 41.96 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.354 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.561 HG22 ' CB ' ' A' ' 48' ' ' ARG . 10.6 mm -74.93 -35.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.552 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 6.2 m-20 -74.84 -56.6 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.574 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.493 ' CD ' ' HA ' ' A' ' 14' ' ' ARG . 2.6 ptt85 -55.53 -45.1 77.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.306 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 11.1 m120 -64.8 -34.12 77.61 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.095 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 5.9 mt -64.79 -44.33 96.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD1' HD22 ' A' ' 52' ' ' LEU . 12.2 mt -63.29 -41.24 98.97 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 109.261 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.76 -31.2 72.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.266 -0.896 . . . . 0.0 109.258 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' OE1' HG11 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -77.49 -43.24 32.84 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.45 -0.781 . . . . 0.0 109.835 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.2 mm? -62.17 -36.31 81.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 109.38 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' C ' ' OE1' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -68.71 -44.88 72.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.742 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -71.77 -37.5 70.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.925 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -135.87 92.04 2.77 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.56 -10.06 86.47 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.577 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.8 mpt_? -85.89 26.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -1.164 . . . . 0.0 110.467 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.468 HD12 ' HG ' ' A' ' 34' ' ' LEU . 4.0 tt -111.45 155.04 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.944 . . . . 0.0 110.329 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.8 m -108.17 -94.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 110.414 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' SER . 18.7 p-10 -136.69 -50.96 0.67 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.481 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 77.7 t -43.29 -58.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.246 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -65.42 -27.48 68.56 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.864 . . . . 0.0 108.864 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -75.67 -15.38 60.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.551 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.8 p -88.09 -48.99 7.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 111.031 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.67 -22.37 34.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.067 -1.021 . . . . 0.0 111.184 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 7.8 mtp180 -72.59 -16.09 61.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.554 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -109.76 -9.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.311 -0.868 . . . . 0.0 110.062 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.65 41.51 4.42 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.565 ' CD1' ' HA ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -153.55 165.45 35.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.107 -1.231 . . . . 0.0 110.667 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.4 m -72.21 159.76 84.56 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 108.865 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.57 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 49.3 Cg_endo -73.39 -51.36 0.16 Allowed 'Trans proline' 0 C--N 1.285 -2.769 0 O-C-N 123.87 1.458 . . . . 0.0 110.609 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.548 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.31 -55.18 1.87 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 109.705 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 47.9 Cg_endo -75.83 -40.58 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.998 1.525 . . . . 0.0 110.064 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 42.2 t -39.45 -48.59 1.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.105 -0.997 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 50' ' ' ARG . 1.3 mp -58.49 -52.41 65.77 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.82 -38.38 2.12 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.356 -0.84 . . . . 0.0 108.997 177.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.561 ' CB ' HG22 ' A' ' 15' ' ' ILE . 4.6 mmp_? -71.54 -56.31 6.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.233 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -56.01 -40.05 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 178.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 7.5 mmt85 -52.78 -48.67 66.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 109.699 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.552 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -53.15 -37.21 61.64 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.971 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 94.4 mt -67.93 -23.12 65.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.444 -0.785 . . . . 0.0 109.887 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 40.8 mt-10 -77.65 -51.23 10.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.886 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -48.48 -39.71 24.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.026 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.46 ' NE2' ' HD2' ' A' ' 51' ' ' ARG . 3.3 pt20 -86.37 27.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.85 76.25 0.14 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 1.0 OUTLIER -151.29 13.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.505 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.483 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 15.1 mm . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.267 0.556 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 18' ' ' ASN . 9.2 mmt85 -60.97 -29.97 69.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.269 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.576 HG23 ' CB ' ' A' ' 48' ' ' ARG . 4.9 mm -81.38 -27.66 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.702 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.465 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 3.1 m-20 -84.54 -31.37 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.253 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -75.56 -46.59 31.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 110.157 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 39.4 p-10 -69.14 -32.48 71.87 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.189 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.547 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 6.3 mt -69.18 -38.31 77.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.468 HD11 HD21 ' A' ' 52' ' ' LEU . 22.9 mt -68.82 -40.49 79.45 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 29.9 t-20 -67.56 -26.42 66.28 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.205 -0.934 . . . . 0.0 109.267 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -87.04 -40.96 14.23 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 1.3 mt -69.18 -24.29 64.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -84.37 -37.84 21.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.451 -0.781 . . . . 0.0 109.969 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 4.0 pttt -83.09 -32.34 26.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.818 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 29' ' ' ILE . 19.4 t0 -129.56 55.49 1.76 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.34 -25.61 2.03 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -82.21 9.84 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -1.143 . . . . 0.0 110.185 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 26' ' ' ASP . 5.8 tt -74.15 154.96 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -104.4 147.06 27.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 110.15 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 35' ' ' SER . 1.0 OUTLIER -39.98 -52.51 2.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.262 -0.899 . . . . 0.0 109.809 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 31' ' ' ASN . 18.0 t -44.79 -57.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 108.939 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 tp10 -65.29 -29.5 70.26 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 108.727 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.581 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -72.81 -16.6 61.61 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 109.512 178.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 21.1 p -88.69 -44.99 10.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.594 -0.691 . . . . 0.0 110.604 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 6.1 mtpp -82.44 -43.97 16.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 3.7 mtt-85 -56.99 -16.65 7.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 0.0 110.23 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' HG ' ' A' ' 40' ' ' LEU . 18.7 m -101.3 -21.05 5.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.403 -0.811 . . . . 0.0 110.019 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.14 37.8 3.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -154.92 171.66 19.32 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.879 -1.365 . . . . 0.0 110.793 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.57 158.82 82.79 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 108.877 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 48.7 Cg_endo -73.54 -45.22 0.43 Allowed 'Trans proline' 0 C--N 1.287 -2.709 0 O-C-N 123.987 1.52 . . . . 0.0 110.646 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.54 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -42.03 -55.64 6.03 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 109.443 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 47' ' ' GLU . 50.2 Cg_endo -76.02 -36.9 1.76 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.88 1.463 . . . . 0.0 110.281 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 40.9 t -43.47 -47.71 7.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.064 . . . . 0.0 108.652 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.54 -39.51 88.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -55.97 -41.99 75.6 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.576 ' CB ' HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -70.58 -47.98 57.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.592 -0.692 . . . . 0.0 109.284 178.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 52' ' ' LEU . 1.2 t -58.89 -51.89 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.483 -0.761 . . . . 0.0 109.343 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -41.97 -53.7 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.455 -0.778 . . . . 0.0 109.325 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -48.05 -42.7 29.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.432 -0.792 . . . . 0.0 109.052 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 49' ' ' VAL . 12.7 mt -72.13 -23.38 61.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 0.0 109.775 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -63.04 -59.92 4.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.233 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.7 -28.64 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.329 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.584 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mm-40 -74.75 0.51 15.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 66.93 51.6 38.84 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 55' ' ' GLN . 22.0 m-85 -131.15 9.43 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -1.159 . . . . 0.0 110.28 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.523 HG23 HD13 ' A' ' 58' ' ' ILE . 1.2 mt . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.294 -0.879 . . . . 0.0 110.022 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.287 0.565 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.514 ' CD ' ' CZ ' ' A' ' 17' ' ' ARG . 25.0 mmt-85 -54.86 -19.18 5.97 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.556 HG22 ' CB ' ' A' ' 48' ' ' ARG . 3.0 mm -83.86 -49.82 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.484 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 7.0 m-20 -66.65 -33.41 75.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -74.42 -55.45 5.97 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 17.3 t-20 -58.53 -29.65 66.48 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 109.092 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 12.7 mt -67.52 -43.92 86.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.536 -0.728 . . . . 0.0 109.308 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD1' HD23 ' A' ' 52' ' ' LEU . 34.4 mt -66.14 -40.13 90.38 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.216 -0.927 . . . . 0.0 109.345 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.2 t-20 -67.77 -31.1 70.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.296 -0.877 . . . . 0.0 109.235 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -80.04 -36.01 36.36 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.493 -0.754 . . . . 0.0 109.614 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' O ' ' N ' ' A' ' 27' ' ' GLY . 0.3 OUTLIER -69.18 -35.13 75.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.539 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.43 -39.27 67.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 2.3 tttt -82.0 -20.26 38.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.403 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 13.0 m-20 -144.88 53.06 1.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.019 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -47.01 -37.44 9.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -70.49 57.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.487 HG13 ' HB3' ' A' ' 33' ' ' GLU . 2.3 tt -141.6 135.9 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.429 ' O ' HD11 ' A' ' 34' ' ' LEU . 33.2 t -82.35 -94.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.376 -0.828 . . . . 0.0 110.356 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 10.8 p-10 -140.1 -48.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.145 -0.972 . . . . 0.0 110.432 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' ASN . 77.9 t -42.0 -64.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.525 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB3' HG13 ' A' ' 29' ' ' ILE . 5.3 tp10 -63.24 -22.84 67.13 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.176 -0.953 . . . . 0.0 108.979 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -79.54 -15.12 58.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.637 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 13.8 p -87.89 -45.53 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 110.838 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 14.2 pttt -80.84 -38.16 28.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.096 -1.003 . . . . 0.0 110.952 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.487 ' HD2' ' HG3' ' A' ' 33' ' ' GLU . 39.2 mtt180 -57.38 -16.59 9.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 34' ' ' LEU . 2.1 m -108.98 -15.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.14 37.0 5.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' CD1' ' HA ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -149.19 160.97 42.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.954 -1.321 . . . . 0.0 110.559 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.471 ' C ' ' HB2' ' A' ' 35' ' ' SER . 20.5 m -66.69 159.41 74.69 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 108.766 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.585 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.46 -45.38 0.42 Allowed 'Trans proline' 0 C--N 1.286 -2.718 0 O-C-N 123.934 1.492 . . . . 0.0 110.551 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.563 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.98 -60.8 0.9 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.792 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 43' ' ' THR . 47.3 Cg_endo -73.9 -37.63 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.825 1.434 . . . . 0.0 110.175 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 42.4 t -38.63 -50.13 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.585 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -59.12 -52.8 64.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -43.65 -36.96 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.03 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.556 ' CB ' HG22 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -72.87 -60.1 2.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 2.2 t -54.29 -44.44 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 6.5 mmt85 -48.89 -50.04 36.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 109.636 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -50.57 -36.76 36.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.451 -0.78 . . . . 0.0 109.043 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 20' ' ' LEU . 70.4 mt -73.14 -19.37 61.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.482 -0.762 . . . . 0.0 110.028 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -74.97 -58.93 2.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 0.0 110.394 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.486 ' CD ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -51.78 -21.74 3.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.383 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 29.4 mm100 -91.27 17.25 8.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 110.268 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.21 49.77 54.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 7.3 m-85 -127.93 8.71 6.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.255 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.457 HD12 ' HB3' ' A' ' 52' ' ' LEU . 6.9 mm . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.41 0.624 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -43.21 -34.69 1.19 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.531 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 5.0 mm -74.4 -21.99 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 110.642 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.53 ' CA ' HD13 ' A' ' 52' ' ' LEU . 66.4 m-20 -87.19 -56.96 3.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.109 -0.994 . . . . 0.0 110.522 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.74 -37.4 73.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.08 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.522 ' N ' ' HD3' ' A' ' 17' ' ' ARG . 17.7 t-20 -72.27 -42.67 65.32 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.356 -0.84 . . . . 0.0 109.132 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 9.0 mt -68.26 -31.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.282 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.546 ' CG ' HD11 ' A' ' 52' ' ' LEU . 15.5 mt -73.38 -40.64 64.18 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.314 -0.866 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.36 -27.96 66.71 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.312 -0.867 . . . . 0.0 109.295 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.521 ' OE1' ' NE ' ' A' ' 37' ' ' ARG . 22.4 mm-40 -80.34 -27.57 38.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.47 -0.769 . . . . 0.0 109.685 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.539 HD22 ' CD1' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -72.0 -34.29 68.76 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.276 -0.89 . . . . 0.0 109.288 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -73.81 -40.85 63.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.756 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -74.26 -30.19 62.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.828 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.507 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -125.54 71.13 1.21 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.105 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -67.66 57.05 0.34 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -179.73 38.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 110.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.425 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 1.8 tt -119.42 135.4 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.428 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -81.81 158.74 23.98 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.3 m120 -50.09 -47.67 53.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 93.5 t -41.92 -63.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.079 -1.013 . . . . 0.0 109.495 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -62.55 -33.02 74.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.597 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -68.09 -14.59 63.09 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.416 0.627 . . . . 0.0 109.765 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.566 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 12.5 p -86.55 -51.16 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.456 -0.777 . . . . 0.0 110.785 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' OG ' ' A' ' 35' ' ' SER . 12.6 mttt -77.05 -16.38 59.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 0.0 111.227 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -79.75 -16.05 56.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.109 . . . . 0.0 110.513 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -110.21 -4.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.205 -0.934 . . . . 0.0 110.054 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.65 42.48 5.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.536 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -154.52 163.72 39.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.117 -1.225 . . . . 0.0 110.557 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.9 159.12 86.36 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 51.2 Cg_endo -74.46 -46.89 0.25 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 123.969 1.51 . . . . 0.0 110.467 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.534 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.04 -54.67 4.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.988 . . . . 0.0 109.458 178.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.7 Cg_endo -76.1 -42.27 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.027 1.541 . . . . 0.0 110.26 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.513 ' C ' ' O ' ' A' ' 44' ' ' PRO . 47.1 t -38.88 -48.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 108.7 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.58 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -61.22 -50.77 71.74 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 4.2 mt-10 -45.19 -34.26 2.67 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.876 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 0.8 OUTLIER -73.83 -52.16 13.96 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.679 0.752 . . . . 0.0 109.172 177.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.541 HG11 ' N ' ' A' ' 50' ' ' ARG . 1.2 t -63.42 -47.56 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.925 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -48.32 -45.64 35.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.27 -41.15 68.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 177.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.546 HD11 ' CG ' ' A' ' 20' ' ' LEU . 95.9 mt -67.01 -27.01 67.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.438 -0.789 . . . . 0.0 109.866 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -63.08 -59.89 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.274 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.9 -24.46 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.525 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 15.1 mm-40 -92.2 11.43 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 110.292 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 61.12 54.98 32.14 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 11.9 m-85 -130.7 2.84 4.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 110.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 5.8 mm . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 110.24 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' CB ' ' OD1' ' A' ' 16' ' ' ASP . 2.9 t0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.351 0.596 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -57.08 -24.2 52.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 110.314 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.528 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.6 mm -74.47 -33.98 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.943 . . . . 0.0 110.527 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.524 ' CA ' HD12 ' A' ' 52' ' ' LEU . 4.3 m-20 -71.66 -59.95 2.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.472 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' CD ' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -55.27 -43.74 75.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.023 . . . . 0.0 110.543 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 2.8 m120 -64.86 -37.61 88.22 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.17 -0.956 . . . . 0.0 109.276 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.483 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 9.5 mt -63.06 -38.91 83.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.39 -0.819 . . . . 0.0 109.356 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 90.4 mt -65.29 -41.2 94.37 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.11 -34.95 78.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.336 -0.852 . . . . 0.0 109.377 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 60.3 mm-40 -73.03 -41.83 63.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 109.601 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 HD11 ' A' ' 34' ' ' LEU . 37.2 mt -66.85 -30.86 71.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 109.334 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -66.18 -39.29 89.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 4.1 mtmp? -81.05 -18.61 46.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 25' ' ' LYS . 7.2 m-20 -140.85 94.5 2.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.81 . . . . 0.0 109.951 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.86 29.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -130.37 39.86 3.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 110.157 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' ASP . 5.4 tt -126.49 130.72 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 110.39 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 20.9 p -72.15 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' SER . 6.2 m-80 -112.61 -30.9 6.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.926 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 48.7 t -50.27 -63.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.173 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tp10 -62.21 -29.0 70.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.194 -0.941 . . . . 0.0 108.82 177.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.657 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -73.71 -14.78 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.459 0.647 . . . . 0.0 109.818 178.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.554 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 18.3 p -87.79 -45.81 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.497 -0.752 . . . . 0.0 111.004 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -82.55 -22.91 34.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 0.0 111.223 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -74.32 -15.68 60.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.014 -1.054 . . . . 0.0 110.552 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 ' O ' ' A' ' 34' ' ' LEU . 1.4 m -106.49 -13.12 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.424 -0.798 . . . . 0.0 109.969 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.93 40.09 3.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.559 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.52 168.83 24.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.037 -1.273 . . . . 0.0 110.654 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -76.05 158.88 81.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 108.876 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.572 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 48.3 Cg_endo -74.59 -43.8 0.44 Allowed 'Trans proline' 0 C--N 1.288 -2.616 0 O-C-N 123.964 1.507 . . . . 0.0 110.464 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.541 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.35 -55.51 4.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.973 . . . . 0.0 109.471 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.4 Cg_endo -76.29 -42.94 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.894 1.471 . . . . 0.0 110.126 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.1 t -39.8 -46.0 1.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.95 -1.094 . . . . 0.0 108.626 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -64.63 -49.54 70.63 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 17.3 mt-10 -46.22 -43.03 15.07 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.482 -0.887 . . . . 0.0 108.894 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.527 ' HD3' ' CG2' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -68.43 -45.76 71.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.367 -0.833 . . . . 0.0 109.153 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -63.87 -47.69 89.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.432 -0.793 . . . . 0.0 109.604 178.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 12.4 mmt85 -43.46 -55.69 4.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.838 . . . . 0.0 109.443 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.57 -43.48 25.41 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.869 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.524 HD12 ' CA ' ' A' ' 16' ' ' ASP . 30.2 mt -70.98 -41.97 70.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.758 . . . . 0.0 109.796 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.547 ' HA ' ' CG1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.47 -57.66 9.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 110.138 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -54.81 -17.87 4.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.051 179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.498 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -89.77 9.91 25.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.94 44.16 47.22 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.526 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 14.1 m-85 -135.28 12.03 3.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -1.165 . . . . 0.0 110.261 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.547 ' CG1' ' HA ' ' A' ' 53' ' ' GLU . 10.8 mm . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 110.316 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.257 0.551 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 3.5 mmt180 -52.62 -29.03 23.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.344 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' CB ' ' HD2' ' A' ' 48' ' ' ARG . 9.0 mm -80.37 -29.88 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.616 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.533 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 5.2 m-20 -82.19 -36.92 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 2.9 ptt180 -70.62 -44.21 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 22.6 m-20 -67.78 -36.22 80.08 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 24.7 mt -68.76 -37.79 77.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.475 HD11 HD23 ' A' ' 52' ' ' LEU . 11.9 mt -65.67 -36.87 84.89 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.349 -0.845 . . . . 0.0 109.249 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.56 -35.48 79.12 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.394 -0.816 . . . . 0.0 109.198 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.498 ' OE1' ' CG1' ' A' ' 38' ' ' VAL . 7.1 mt-10 -72.87 -40.15 65.88 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.452 -0.78 . . . . 0.0 109.764 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.7 mt -66.89 -37.05 83.66 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.22 -0.925 . . . . 0.0 109.306 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -63.44 -40.67 97.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.399 -0.813 . . . . 0.0 109.235 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 -25.3 44.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.32 96.36 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.63 39.48 3.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -153.74 21.35 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -1.114 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 34' ' ' LEU . 4.5 tt -101.84 140.22 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 31' ' ' ASN . 13.5 t -84.92 -120.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.567 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 7.6 p30 -120.8 -46.44 2.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.0 t -45.22 -60.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.283 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.3 tt0 -62.04 -30.34 70.91 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.216 -0.928 . . . . 0.0 108.989 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.608 ' O ' HG22 ' A' ' 38' ' ' VAL . 6.4 tp -74.67 -16.19 60.77 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.58 -0.7 . . . . 0.0 110.063 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 11.6 p -84.37 -37.97 20.89 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.412 -0.805 . . . . 0.0 110.279 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -87.13 -17.9 31.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.449 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -75.1 -18.02 60.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.503 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -111.46 -11.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 121.405 -0.81 . . . . 0.0 109.731 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.62 41.36 4.77 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -148.02 168.57 21.98 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.998 -1.295 . . . . 0.0 110.466 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 3.5 m -72.75 154.82 91.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 108.872 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 48.3 Cg_endo -72.53 -48.31 0.33 Allowed 'Trans proline' 0 C--N 1.288 -2.642 0 O-C-N 123.961 1.506 . . . . 0.0 110.733 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.27 -54.22 4.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.3 Cg_endo -76.02 -41.01 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.977 1.514 . . . . 0.0 110.134 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' A' ' 40' ' ' LEU . 50.6 t -39.89 -46.19 1.96 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.043 . . . . 0.0 108.731 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.04 -49.28 75.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -46.3 -41.84 13.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.898 177.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.55 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -67.57 -56.62 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.535 HG21 ' CD2' ' A' ' 34' ' ' LEU . 1.4 t -55.71 -51.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 3.0 mmt85 -40.94 -49.92 3.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.533 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -49.82 -44.25 49.18 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' VAL . 49.3 mt -67.22 -20.29 65.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.769 . . . . 0.0 109.881 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.72 -64.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -46.31 -23.92 0.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.299 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 20.7 mm-40 -85.97 11.06 12.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 59.5 54.38 38.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.434 ' CD2' ' HB3' ' A' ' 55' ' ' GLN . 12.4 m-85 -139.53 9.82 2.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -1.2 . . . . 0.0 110.339 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.471 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 10.3 mm . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.29 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.324 0.583 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -47.11 -46.01 22.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 110.351 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.566 ' HB ' ' CD ' ' A' ' 48' ' ' ARG . 20.5 mm -65.88 -17.1 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 110.66 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 51' ' ' ARG . 20.4 m-20 -84.04 -62.71 1.5 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.059 -1.026 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.84 -45.23 67.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.128 -0.982 . . . . 0.0 110.022 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.51 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -64.66 -42.36 95.46 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 109.285 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 1.3 mt -58.74 -35.0 53.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.36 -0.838 . . . . 0.0 109.347 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 67.2 mt -67.06 -45.24 77.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.45 -27.06 68.73 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.219 -0.926 . . . . 0.0 109.245 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 11.9 mm-40 -85.37 -43.67 13.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.516 -0.74 . . . . 0.0 110.147 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -65.77 -20.28 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 109.558 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -85.58 -41.32 15.36 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 1.3 ptmt -60.5 -30.78 69.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 27.0 p30 -150.87 71.23 1.02 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.09 -23.42 1.65 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' CD ' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.08 9.31 4.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.366 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 7.1 tt -76.53 153.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.878 . . . . 0.0 110.454 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.3 m -104.6 155.58 18.72 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' SER . 5.3 p-10 -46.25 -47.36 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.128 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.488 ' O ' ' OG ' ' A' ' 35' ' ' SER . 4.7 t -49.65 -55.45 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.935 -1.103 . . . . 0.0 108.881 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.4 tt0 -67.21 -32.38 73.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -68.53 -20.04 64.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.59 0.71 . . . . 0.0 109.486 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' ASN . 25.3 p -83.47 -46.2 12.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.557 -0.714 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -82.25 -27.1 32.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -58.37 -24.54 60.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.224 -0.923 . . . . 0.0 109.736 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.654 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.0 -3.87 10.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 178.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.29 46.76 5.73 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.654 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -150.24 156.65 41.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.273 . . . . 0.0 111.019 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.493 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -62.65 153.31 78.69 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 46.2 Cg_endo -72.86 -41.93 1.27 Allowed 'Trans proline' 0 C--N 1.283 -2.887 0 O-C-N 123.842 1.443 . . . . 0.0 110.682 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -56.03 2.75 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.606 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 47' ' ' GLU . 49.8 Cg_endo -74.74 -37.76 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.9 1.473 . . . . 0.0 110.121 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 48.5 t -41.85 -45.89 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.029 -1.044 . . . . 0.0 108.651 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.96 -43.27 93.23 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' PRO . 58.2 mt-10 -55.0 -43.69 73.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.566 ' CD ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.83 -44.65 76.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.636 0.731 . . . . 0.0 109.189 178.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -62.8 -50.41 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -0.833 . . . . 0.0 109.599 178.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -41.85 -51.37 4.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -51.35 -45.1 62.22 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.134 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.548 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 16.5 mt -72.19 -23.5 61.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.14 -48.94 78.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -0.791 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -65.18 -17.24 64.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.512 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 77.2 mm-40 -79.81 8.61 6.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.73 31.35 71.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.5 ' C ' ' CG1' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -112.86 4.05 16.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -1.142 . . . . 0.0 109.999 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.5 ' CG1' ' C ' ' A' ' 57' ' ' PHE . 1.1 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.36 -0.838 . . . . 0.0 110.167 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ASP . 10.4 t70 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.357 0.599 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -40.88 -45.59 2.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.36 -0.837 . . . . 0.0 110.565 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.518 HG13 HD22 ' A' ' 40' ' ' LEU . 6.4 mm -70.19 -26.34 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 28.1 m-20 -72.51 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 0.0 110.303 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -35.92 68.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 109.985 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 3.5 t-20 -71.32 -42.86 68.06 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.783 . . . . 0.0 109.095 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 15' ' ' ILE . 14.0 mt -66.31 -34.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.51 ' CD1' HD23 ' A' ' 52' ' ' LEU . 49.0 mt -72.18 -39.89 68.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.401 -0.812 . . . . 0.0 109.433 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.67 -37.07 84.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.88 -33.08 63.91 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.466 -0.771 . . . . 0.0 109.473 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.528 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 17.5 mt -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -73.66 -44.74 55.94 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.521 -0.737 . . . . 0.0 109.739 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -70.21 -32.33 70.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.603 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 29' ' ' ILE . 5.9 m-20 -130.05 86.17 2.37 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.84 0.71 50.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' C ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -111.03 31.9 5.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.165 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.488 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 14.9 tt -115.84 144.88 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.462 ' OG ' ' OD1' ' A' ' 31' ' ' ASN . 44.8 t -87.96 -110.92 0.06 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 110.408 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 35' ' ' SER . 4.5 p-10 -124.88 -50.33 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 31' ' ' ASN . 69.5 t -41.17 -64.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 37' ' ' ARG . 4.1 tp10 -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.224 -0.922 . . . . 0.0 108.851 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 38' ' ' VAL . 1.1 tt -67.8 -23.57 65.21 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.557 -0.714 . . . . 0.0 109.609 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -78.57 -41.88 30.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.437 -0.789 . . . . 0.0 110.286 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -67.09 -28.31 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 1.1 mmt180 -73.03 -17.81 61.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 34' ' ' LEU . 3.6 t -107.23 11.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.914 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.47 18.05 21.3 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 41' ' ' SER . 15.0 tp -123.4 134.95 53.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -1.003 . . . . 0.0 110.203 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.548 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.8 m -47.0 158.7 0.42 Allowed Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.735 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.6 -42.58 0.82 Allowed 'Trans proline' 0 C--N 1.285 -2.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.39 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.529 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.41 -55.54 3.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.32 178.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 44.4 Cg_endo -74.26 -50.37 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.91 1.479 . . . . 0.0 110.136 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.512 ' C ' ' O ' ' A' ' 44' ' ' PRO . 39.4 t -38.19 -46.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 108.873 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -63.42 -53.05 58.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 1.3 mt-10 -46.29 -46.01 17.73 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.955 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.495 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -68.22 -43.83 77.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.576 -0.702 . . . . 0.0 109.33 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -62.87 -43.81 99.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.531 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 18.7 mmm-85 -51.36 -46.48 62.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.576 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.59 -34.08 64.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.862 178.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.576 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 5.2 mt -76.68 -19.05 58.17 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.743 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.55 -59.92 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 110.197 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -54.19 -22.97 12.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.56 11.44 7.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 51.43 59.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 13.4 m-85 -134.29 6.58 3.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -1.129 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.485 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 6.3 mm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.327 0.584 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 8.4 mmt180 -47.3 -22.81 0.45 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.333 -0.855 . . . . 0.0 110.284 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.597 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -80.51 -44.35 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 110.129 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.45 ' OD2' ' O ' ' A' ' 48' ' ' ARG . 2.7 m-20 -58.55 -44.87 89.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.161 -0.962 . . . . 0.0 109.901 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -65.93 -47.82 73.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.915 . . . . 0.0 109.799 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.539 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 1.5 m-20 -61.87 -41.79 98.27 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.388 -0.82 . . . . 0.0 108.879 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.528 HG22 ' CG2' ' A' ' 49' ' ' VAL . 7.6 mt -62.09 -41.06 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.462 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.537 ' CD1' HD22 ' A' ' 52' ' ' LEU . 13.8 mt -70.34 -40.94 73.82 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.1 t-20 -66.41 -34.39 77.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 6.2 mm-40 -76.32 -29.49 57.34 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.424 -0.797 . . . . 0.0 109.696 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' CG ' HD12 ' A' ' 34' ' ' LEU . 21.5 mt -72.48 -32.7 66.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -79.24 -42.52 25.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.518 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -67.03 -33.69 76.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -141.34 63.37 1.44 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.911 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.01 -161.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.06 30.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -1.194 . . . . 0.0 109.946 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.515 HD12 ' NH2' ' A' ' 37' ' ' ARG . 4.9 tt -117.43 131.9 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.361 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 37.0 t -67.73 168.88 10.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.954 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.6 OUTLIER -65.37 -39.91 92.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.36 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 31' ' ' ASN . 46.6 t -44.54 -61.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 109.221 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.99 -33.66 74.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.307 -0.87 . . . . 0.0 108.751 177.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.556 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.95 -20.39 65.05 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.525 0.678 . . . . 0.0 109.674 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 8.4 p -87.77 -24.39 23.8 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.41 -0.806 . . . . 0.0 110.488 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -79.25 -33.14 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.71 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.554 ' CD ' ' HA ' ' A' ' 34' ' ' LEU . 4.4 ptm180 -81.67 -16.04 52.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.074 -1.016 . . . . 0.0 110.745 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.556 ' CG2' ' O ' ' A' ' 34' ' ' LEU . 4.5 t -97.66 12.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.207 -0.933 . . . . 0.0 110.144 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.98 21.76 8.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 41' ' ' SER . 15.2 tp -127.83 133.37 49.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.52 -0.988 . . . . 0.0 110.253 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.577 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -47.81 160.63 0.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 120.993 -1.067 . . . . 0.0 108.536 177.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.9 Cg_endo -73.92 -45.57 0.37 Allowed 'Trans proline' 0 C--N 1.282 -2.935 0 O-C-N 123.651 1.343 . . . . 0.0 110.654 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -38.73 -53.18 3.44 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 109.643 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 43' ' ' THR . 44.6 Cg_endo -75.45 -49.01 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.044 1.549 . . . . 0.0 109.77 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 12.8 t -43.62 -37.87 2.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.047 -1.033 . . . . 0.0 108.494 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.567 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 1.5 mt -70.77 -45.87 63.95 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 70.8 mt-10 -49.79 -46.3 50.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.088 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.567 ' HG2' ' HB ' ' A' ' 15' ' ' ILE . 3.6 mpt_? -69.69 -36.48 76.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -71.66 -47.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.272 -0.893 . . . . 0.0 110.017 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.567 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -48.25 -48.06 35.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 51' ' ' ARG . 2.4 tpp180 -53.38 -45.91 69.41 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.903 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD22 ' CD1' ' A' ' 20' ' ' LEU . 78.1 mt -67.59 -16.59 64.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -58.89 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 110.254 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.434 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 61.4 mtt85 -73.75 -21.81 60.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 110.372 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HG2' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -148.51 53.74 1.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -161.71 -123.58 0.67 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 63.4 m-85 -146.96 76.16 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 5.5 mm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 5.1 t70 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.342 0.591 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.52 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 9.4 mmt180 -48.18 -25.64 1.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.322 -0.861 . . . . 0.0 110.346 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.559 HG23 ' CG ' ' A' ' 48' ' ' ARG . 19.2 mm -69.93 -33.57 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.265 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.576 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 1.4 m-20 -73.81 -59.45 2.71 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -53.6 -33.4 54.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.812 179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 59.8 t-20 -70.27 -43.12 71.12 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.384 -0.822 . . . . 0.0 109.192 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.502 ' CG2' HG21 ' A' ' 49' ' ' VAL . 40.4 mt -61.75 -35.92 70.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.494 ' HG ' HD12 ' A' ' 52' ' ' LEU . 20.2 mt -67.33 -43.63 81.11 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.285 -0.885 . . . . 0.0 109.286 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.67 -32.83 69.48 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 34' ' ' LEU . 22.3 mm-40 -75.42 -45.09 41.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.853 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 23' ' ' LEU . 2.1 mm? -57.6 -44.14 85.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.659 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -68.04 -40.42 82.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.377 -0.827 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 27.6 mtpt -68.66 -20.16 64.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.909 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' ARG . 35.1 m-20 -147.4 79.23 1.49 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 110.188 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.88 58.36 0.21 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -178.26 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -1.181 . . . . 0.0 110.008 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.561 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.7 tt -122.35 147.04 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 9.1 p -87.83 -167.11 1.78 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.108 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 34' ' ' LEU . 12.9 m-80 -78.78 -49.97 12.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -0.919 . . . . 0.0 110.333 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.6 t -40.02 -57.78 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 109.706 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -61.66 -33.5 74.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.186 -0.946 . . . . 0.0 108.759 177.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -67.16 -57.86 5.95 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 178.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.555 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 3.1 p -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.608 -0.682 . . . . 0.0 110.29 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -80.11 -22.99 41.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 34' ' ' LEU . 12.5 mmt180 -78.33 -17.86 55.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 40' ' ' LEU . 3.2 m -105.88 -12.33 9.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 39.85 5.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.76 169.19 23.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.016 -1.284 . . . . 0.0 110.775 179.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.2 154.09 94.01 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.4 Cg_endo -73.58 -44.0 0.57 Allowed 'Trans proline' 0 C--N 1.287 -2.698 0 O-C-N 124.004 1.529 . . . . 0.0 110.802 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.94 -56.26 1.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 53.8 Cg_endo -77.52 -42.57 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.93 1.49 . . . . 0.0 110.174 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.518 ' C ' ' O ' ' A' ' 44' ' ' PRO . 36.9 t -37.4 -50.39 1.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 108.877 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.34 -51.77 68.11 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.7 mm-40 -44.89 -41.22 6.96 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.303 -0.873 . . . . 0.0 108.949 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.559 ' CG ' HG23 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.97 -45.33 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -62.54 -44.59 99.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 178.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.528 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 8.2 mmm180 -48.96 -47.39 44.02 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.339 -0.851 . . . . 0.0 109.019 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -50.5 -40.66 51.88 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.576 ' CD1' ' HB3' ' A' ' 16' ' ' ASP . 90.1 mt -75.44 -37.52 60.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.577 -0.702 . . . . 0.0 109.667 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 58' ' ' ILE . 7.1 tp10 -73.25 -26.6 61.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 110.337 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -68.66 -42.12 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.209 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' OE1' ' CG ' ' A' ' 57' ' ' PHE . 6.2 pt20 -76.99 2.09 15.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.64 8.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 1.3 m-85 -119.28 11.01 12.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -1.183 . . . . 0.0 110.152 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.531 HG13 ' N ' ' A' ' 53' ' ' GLU . 15.0 mm . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.097 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 15' ' ' ILE . 1.4 m-20 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.235 0.54 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 6.7 mmt-85 -46.03 -22.33 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 110.358 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.552 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 6.6 mm -73.48 -34.43 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.462 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -78.0 -45.02 24.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -51.87 63.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.954 . . . . 0.0 110.0 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.555 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 7.8 t-20 -60.85 -40.45 92.91 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.385 -0.822 . . . . 0.0 109.332 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 10.5 mt -64.77 -38.5 82.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.282 -0.887 . . . . 0.0 109.559 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.563 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 14.4 mt -73.38 -35.24 65.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.351 -0.843 . . . . 0.0 109.307 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.69 -31.15 64.82 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.43 -0.794 . . . . 0.0 109.453 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 5.6 mm-40 -72.13 -32.85 67.32 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.402 -0.811 . . . . 0.0 109.86 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 34' ' ' LEU . 4.3 mt -69.89 -36.41 75.41 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.203 -0.936 . . . . 0.0 109.488 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -64.07 -42.97 96.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -69.49 -28.9 66.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.435 178.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -133.41 76.12 1.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 110.055 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.76 58.82 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.57 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -1.114 . . . . 0.0 110.182 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 ' NH1' ' A' ' 37' ' ' ARG . 5.5 tt -112.17 141.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 17.6 m -77.9 -138.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.417 -0.802 . . . . 0.0 110.138 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -108.86 -41.1 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' ASN . 76.2 t -44.43 -62.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 109.355 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 1.1 tp10 -61.84 -26.44 68.13 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.613 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -78.54 -15.28 58.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.697 -0.627 . . . . 0.0 110.071 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.574 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 23.6 p -87.93 -44.67 10.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.819 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 7.8 pttt -79.84 -41.05 27.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 111.126 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 13.9 ptm180 -63.01 -16.2 58.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.065 -1.022 . . . . 0.0 110.628 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.613 HG21 ' O ' ' A' ' 34' ' ' LEU . 14.5 m -98.51 -22.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.358 -0.838 . . . . 0.0 110.005 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.97 35.38 3.46 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.585 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -153.36 169.02 24.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.019 -1.283 . . . . 0.0 110.624 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.0 m -74.17 158.75 85.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.747 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 49.9 Cg_endo -74.16 -49.75 0.18 Allowed 'Trans proline' 0 C--N 1.286 -2.72 0 O-C-N 123.9 1.473 . . . . 0.0 110.565 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.559 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.92 -53.67 3.43 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.428 179.142 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 50.3 Cg_endo -76.46 -41.69 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.898 1.473 . . . . 0.0 110.219 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.527 ' CB ' HD13 ' A' ' 40' ' ' LEU . 53.8 t -40.33 -51.19 2.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 108.718 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.58 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.25 -47.4 81.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -46.4 -38.83 9.52 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.864 177.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.527 ' HD2' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.36 -46.91 53.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.535 -0.728 . . . . 0.0 109.266 178.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.6 OUTLIER -65.77 -51.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.473 -0.767 . . . . 0.0 109.96 178.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.569 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 2.4 mmm180 -46.07 -44.11 15.18 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -54.44 -44.75 72.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.563 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 61.0 mt -65.08 -16.69 63.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.469 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.99 -58.56 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.243 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 2.6 ptp180 -49.19 -27.94 4.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.438 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 73.5 mm-40 -81.77 10.87 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.74 93.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -129.85 15.44 5.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.353 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HB ' ' HG2' ' A' ' 53' ' ' GLU . 6.0 mm . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -80.01 -22.3 42.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.264 -0.897 . . . . 0.0 110.362 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.551 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 13.4 mm -78.87 -29.68 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 48' ' ' ARG . 85.3 m-20 -81.56 -39.91 23.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.073 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -51.68 56.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.214 -0.929 . . . . 0.0 110.032 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.559 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -62.84 -39.43 94.34 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.404 -0.81 . . . . 0.0 109.363 178.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 8.0 mt -64.07 -38.25 81.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.453 -0.779 . . . . 0.0 109.56 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.539 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 12.9 mt -70.03 -37.42 75.59 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 26.2 m-20 -70.83 -29.32 65.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.845 . . . . 0.0 109.603 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.575 ' CB ' ' CZ ' ' A' ' 37' ' ' ARG . 6.2 mm-40 -82.23 -29.14 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.445 -0.785 . . . . 0.0 109.848 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.96 -37.36 84.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -42.48 33.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 1.5 pttt -75.17 -29.71 60.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.995 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -133.14 53.31 2.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.134 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -53.54 -169.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.32 16.84 1.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -1.143 . . . . 0.0 110.197 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.588 ' CD1' ' NH1' ' A' ' 37' ' ' ARG . 12.9 tt -102.64 134.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 110.124 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 36.5 m -75.02 -131.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.403 -0.81 . . . . 0.0 110.502 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 35' ' ' SER . 26.5 p-10 -111.78 -47.02 3.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.217 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t -43.1 -67.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.976 -1.078 . . . . 0.0 109.276 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' O ' ' HD3' ' A' ' 37' ' ' ARG . 3.4 tp10 -56.34 -25.95 50.84 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.203 -0.936 . . . . 0.0 108.665 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -77.64 -18.73 56.46 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.41 0.624 . . . . 0.0 109.906 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.58 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 6.4 p -90.33 -47.75 7.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.532 -0.73 . . . . 0.0 110.864 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 35' ' ' SER . 10.6 ttmt -79.21 -24.83 42.85 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 111.288 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.588 ' NH1' ' CD1' ' A' ' 29' ' ' ILE . 28.4 ptt180 -75.8 -14.91 60.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 110.62 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -107.64 -11.02 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 110.071 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 42.12 4.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -155.79 167.38 30.58 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.064 -1.256 . . . . 0.0 110.852 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.2 m -72.98 156.71 89.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.02 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.58 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 48.8 Cg_endo -74.18 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.635 0 O-C-N 123.972 1.512 . . . . 0.0 110.826 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.54 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -39.38 -53.86 3.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 109.421 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' GLU . 49.1 Cg_endo -77.24 -42.53 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.021 1.537 . . . . 0.0 110.335 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 44.6 t -38.47 -53.38 1.55 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 0.0 108.866 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.557 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -55.25 -49.63 71.54 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.25 -38.04 1.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.958 177.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.51 -49.29 27.34 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.627 0.727 . . . . 0.0 109.173 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -63.49 -40.49 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.577 ' N ' HG13 ' A' ' 49' ' ' VAL . 4.2 mmm180 -53.86 -46.17 71.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.081 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -52.04 -42.16 62.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.539 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 64.4 mt -70.77 -22.4 62.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.546 -0.721 . . . . 0.0 109.781 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 2.8 tm-20 -68.5 -69.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.6 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -52.95 -19.38 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 110.639 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 8.7 mm100 -86.54 13.41 8.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.01 . . . . 0.0 110.481 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 61.84 51.42 57.39 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CD2' ' HB3' ' A' ' 55' ' ' GLN . 21.3 m-85 -139.94 9.38 2.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -1.218 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 8.5 mm . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.203 0.525 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -40.54 -27.49 0.05 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.361 -0.837 . . . . 0.0 110.41 -179.133 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 8.5 mm -72.97 -46.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 110.421 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.523 ' O ' HD12 ' A' ' 52' ' ' LEU . 1.4 m-20 -68.93 -26.24 64.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -75.88 -66.43 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -53.45 -28.28 29.35 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 108.988 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.562 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 3.4 mt -64.79 -50.66 74.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.091 178.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' CD2' HD13 ' A' ' 52' ' ' LEU . 72.0 mt -55.55 -42.19 74.3 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -59.02 -38.77 80.05 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 25.5 mt-10 -63.61 -39.65 94.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.45 -0.782 . . . . 0.0 109.744 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.562 ' CD2' ' O ' ' A' ' 19' ' ' ILE . 2.1 mm? -66.58 -40.6 89.02 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -65.69 -36.45 83.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.317 -0.864 . . . . 0.0 109.303 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 1.6 pttp -79.1 -29.38 43.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -136.67 95.27 3.11 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 110.024 179.123 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.86 13.37 43.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.01 34.92 4.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -1.217 . . . . 0.0 110.381 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.457 HG23 ' HB3' ' A' ' 26' ' ' ASP . 11.3 tt -116.48 139.84 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.615 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' HD13 ' A' ' 34' ' ' LEU . 2.7 t -76.19 -129.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.364 -0.835 . . . . 0.0 110.027 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.9 OUTLIER -117.89 -38.25 3.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.019 -1.05 . . . . 0.0 110.29 179.347 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.464 ' O ' ' OG ' ' A' ' 35' ' ' SER . 98.0 t -45.39 -56.65 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.041 -1.037 . . . . 0.0 109.068 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 1.7 tp10 -66.99 -32.88 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.336 -0.853 . . . . 0.0 108.844 177.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.551 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -69.46 -15.8 63.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.558 -0.714 . . . . 0.0 109.492 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.557 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 16.2 p -86.27 -47.08 9.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.495 -0.753 . . . . 0.0 110.355 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.99 -16.8 52.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.181 -0.95 . . . . 0.0 110.724 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -74.64 -19.94 60.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -107.94 -5.97 10.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.396 -0.815 . . . . 0.0 109.756 179.102 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.92 40.65 5.51 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -152.18 160.38 43.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.294 . . . . 0.0 110.72 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.472 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -69.59 160.12 80.89 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.582 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -73.06 -45.21 0.47 Allowed 'Trans proline' 0 C--N 1.284 -2.859 0 O-C-N 123.926 1.487 . . . . 0.0 110.489 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.39 -57.79 1.36 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.177 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 52.1 Cg_endo -76.5 -41.49 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.898 1.473 . . . . 0.0 110.135 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 53.6 t -39.13 -53.05 1.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 108.661 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.591 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 1.1 mt -52.82 -51.98 58.76 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 176.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.0 -43.06 4.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.265 177.7 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD3' ' CG2' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -72.21 -56.25 5.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -0.815 . . . . 0.0 109.492 178.581 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 1.6 t -54.72 -48.93 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.331 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmt180 -43.33 -52.27 5.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.369 178.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.04 -41.41 16.68 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.922 178.064 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.542 HD13 ' CD2' ' A' ' 20' ' ' LEU . 92.8 mt -68.07 -28.33 67.27 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.452 -0.78 . . . . 0.0 109.715 178.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' ARG . 1.9 tm-20 -64.62 -63.63 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.825 . . . . 0.0 110.161 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -50.27 -27.04 5.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.147 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 28.6 mm-40 -83.42 5.59 23.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.57 59.97 7.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.53 10.81 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 10.7 mm . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.348 0.594 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -43.65 -33.9 1.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.406 -0.808 . . . . 0.0 110.264 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.575 HG22 ' CB ' ' A' ' 48' ' ' ARG . 7.1 mm -73.65 -33.74 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.53 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 93.4 m-20 -76.67 -45.82 28.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.599 ' CD ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -62.81 -44.2 96.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.072 -1.018 . . . . 0.0 110.217 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 9.1 m-20 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 178.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.53 HG12 ' CD2' ' A' ' 34' ' ' LEU . 7.2 mt -69.79 -33.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 178.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 65.9 mt -70.9 -38.25 72.99 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.247 -0.908 . . . . 0.0 109.388 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -31.9 70.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.567 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -78.5 -32.12 48.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.382 -0.824 . . . . 0.0 109.605 178.98 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 12.6 mt -71.13 -37.34 72.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.306 -0.871 . . . . 0.0 109.475 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.6 -38.63 84.27 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 178.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 24.5 pttt -79.73 -38.16 33.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.481 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -116.49 91.84 3.7 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 110.093 179.363 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.8 22.48 13.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.46 9.85 4.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -1.115 . . . . 0.0 110.073 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.515 ' CG2' ' OE2' ' A' ' 22' ' ' GLU . 13.6 tt -85.72 143.67 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 110.405 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 m -92.38 -73.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 110.537 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.566 ' ND2' ' HG ' ' A' ' 46' ' ' LEU . 10.7 t-20 -164.3 -54.6 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.478 ' C ' ' O ' ' A' ' 31' ' ' ASN . 3.2 t -42.64 -52.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.998 -1.064 . . . . 0.0 109.081 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -69.08 -29.23 67.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.147 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -73.66 -16.61 61.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.608 -0.683 . . . . 0.0 109.749 178.508 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.55 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 19.3 p -88.07 -47.76 8.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -81.96 -17.11 48.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -77.43 -16.03 59.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.013 -1.055 . . . . 0.0 110.611 -179.359 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.549 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.48 -6.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.985 179.489 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.27 42.75 5.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -153.31 164.06 38.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.987 -1.302 . . . . 0.0 110.643 178.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -71.51 160.93 81.14 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.576 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 49.3 Cg_endo -74.28 -54.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.285 -2.794 0 O-C-N 123.953 1.502 . . . . 0.0 110.649 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.547 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 m -35.14 -54.25 1.1 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.1 Cg_endo -74.83 -42.6 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.88 1.463 . . . . 0.0 109.867 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 40.8 t -39.15 -49.15 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.785 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.576 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 2.1 mp -56.93 -52.77 63.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -42.87 -41.03 3.14 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.73 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.575 ' CB ' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -73.14 -53.78 10.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.615 -0.678 . . . . 0.0 109.683 178.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -56.7 -43.83 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 1.5 mmm-85 -50.72 -48.4 58.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.203 -0.936 . . . . 0.0 109.131 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -50.6 -39.2 49.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.521 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 93.0 mt -70.63 -19.84 62.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.689 178.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.483 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 1.3 mt-10 -78.21 -55.07 5.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 110.062 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -44.64 -49.33 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.394 -0.816 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 52' ' ' LEU . 11.0 pt20 -70.61 -1.96 12.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.325 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 75.17 66.27 1.94 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -141.84 9.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 110.131 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.495 ' CD1' ' HB3' ' A' ' 52' ' ' LEU . 6.2 mm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.277 0.56 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 4.8 mmt85 -69.56 -35.49 75.44 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.297 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.616 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -70.96 -35.22 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 110.273 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HA ' HD11 ' A' ' 52' ' ' LEU . 63.8 m-20 -62.24 -67.17 0.44 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.545 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 3.1 ptm85 -50.76 -44.86 58.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.242 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 97.2 m-20 -66.21 -37.52 85.76 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.512 HD11 ' CG2' ' A' ' 15' ' ' ILE . 3.2 mt -66.91 -34.3 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 109.228 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD12 ' CE2' ' A' ' 57' ' ' PHE . 12.6 mt -68.74 -43.26 76.26 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.09 -30.88 71.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.292 -0.88 . . . . 0.0 109.511 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 24.6 mm-40 -76.84 -30.46 56.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.826 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' CD2' HD13 ' A' ' 34' ' ' LEU . 2.4 mm? -75.46 -30.98 60.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 178.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.704 178.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.51 -40.39 57.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.836 179.185 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.532 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -136.51 64.05 1.56 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.328 -0.857 . . . . 0.0 110.073 179.182 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.05 -164.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 48.8 23.81 0.73 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 110.274 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.557 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 2.6 tt -106.65 142.14 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.164 -0.96 . . . . 0.0 110.341 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 p -80.91 179.87 7.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.387 -0.821 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.3 p-10 -71.92 -50.02 32.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' ASN . 48.4 t -40.91 -48.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.453 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.557 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.0 -36.73 82.82 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.324 -0.86 . . . . 0.0 108.868 177.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.548 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -67.78 -54.56 18.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.441 178.162 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.602 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 4.5 p -44.84 -44.89 9.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 32' ' ' VAL . 4.1 mtpp -73.82 -36.11 64.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.697 -178.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.12 -42.96 99.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 34' ' ' LEU . 9.1 m -92.1 20.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.977 179.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 48.98 23.66 3.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.579 ' CD1' ' HG3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -110.51 133.91 52.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.009 . . . . 0.0 110.82 -179.094 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.574 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -50.38 152.07 3.41 Favored Pre-proline 0 C--N 1.3 -1.554 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.971 176.177 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.602 ' N ' ' HB2' ' A' ' 35' ' ' SER . 44.4 Cg_endo -70.51 -47.26 0.73 Allowed 'Trans proline' 0 C--N 1.283 -2.89 0 O-C-N 123.703 1.37 . . . . 0.0 110.573 -177.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.543 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.27 -54.66 5.82 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.048 -1.033 . . . . 0.0 109.125 178.336 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 47' ' ' GLU . 42.3 Cg_endo -74.37 -48.39 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.95 1.5 . . . . 0.0 110.592 177.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 41' ' ' SER . 37.0 t -40.34 -42.05 1.48 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 108.742 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.2 mt -67.87 -47.06 69.95 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.9 mm-40 -49.73 -46.14 49.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.139 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.579 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.26 -46.04 74.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.3 178.26 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.546 HG11 ' N ' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -59.48 -46.89 92.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.469 -0.769 . . . . 0.0 109.786 178.591 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.546 ' N ' HG11 ' A' ' 49' ' ' VAL . 9.5 mmm180 -48.02 -50.61 27.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.4 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -48.83 -40.36 29.01 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.606 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 70.9 mt -74.02 -30.46 62.45 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.446 -0.783 . . . . 0.0 109.623 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 58' ' ' ILE . 5.8 tp10 -74.49 -62.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.479 -0.763 . . . . 0.0 110.298 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -46.92 -26.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -82.77 7.55 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 73.68 40.03 47.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -128.83 10.3 5.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.184 -1.186 . . . . 0.0 110.277 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.573 HG13 ' N ' ' A' ' 53' ' ' GLU . 7.5 mm . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 110.212 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' HB2' ' CG ' ' A' ' 16' ' ' ASP . 6.4 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.339 0.59 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 22.2 mmt-85 -53.0 -34.92 58.49 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 110.357 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.54 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 13.6 mm -75.8 -24.39 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' CG ' ' HB2' ' A' ' 13' ' ' ASP . 18.0 m-20 -80.6 -55.64 4.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.129 -0.982 . . . . 0.0 110.292 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.08 -43.87 82.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 2.7 m120 -66.32 -41.52 89.53 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.376 -0.827 . . . . 0.0 109.206 178.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 6.8 mt -65.06 -34.76 72.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 178.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 25.8 mt -70.8 -39.2 73.26 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.378 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 17' ' ' ARG . 3.3 m120 -68.91 -30.86 69.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.488 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 66.2 mm-40 -78.34 -32.34 49.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.431 -0.793 . . . . 0.0 109.763 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 23' ' ' LEU . 2.5 mm? -73.37 -32.23 64.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 178.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.486 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 19.1 tp60 -74.13 -33.93 63.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.919 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HE2' ' OE1' ' A' ' 22' ' ' GLU . 12.9 pttt -77.58 -34.27 53.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -128.07 76.56 1.7 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.111 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.07 59.59 0.15 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.41 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.299 179.85 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.5 tt -105.74 141.81 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.62 154.97 19.89 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.363 -0.836 . . . . 0.0 110.435 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.532 ' ND2' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -44.55 -55.3 5.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 0.0 110.369 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' ASN . 86.6 t -38.61 -58.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.175 -0.953 . . . . 0.0 109.552 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -65.12 -39.03 92.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.212 -0.93 . . . . 0.0 108.576 177.088 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.643 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -62.67 -15.07 50.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 178.39 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.57 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 12.7 p -88.0 -50.44 6.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.403 -0.811 . . . . 0.0 111.412 -178.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 13.2 mttt -81.89 -24.1 35.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 111.614 -177.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.584 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -73.66 -15.41 61.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.906 -1.121 . . . . 0.0 110.351 -179.191 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.643 HG21 ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -104.61 -16.91 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.333 -0.854 . . . . 0.0 109.895 178.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.32 38.8 3.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.543 ' HG ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.67 170.3 20.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.276 . . . . 0.0 110.736 179.262 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.7 m -75.6 160.68 78.75 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.57 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 49.5 Cg_endo -73.8 -54.51 0.1 Allowed 'Trans proline' 0 C--N 1.287 -2.7 0 O-C-N 123.998 1.525 . . . . 0.0 110.845 -178.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -38.06 -51.64 3.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.752 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.8 Cg_endo -76.12 -43.22 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.756 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 41.8 t -41.6 -43.72 2.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.075 -1.016 . . . . 0.0 108.469 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.63 -51.3 60.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 2.5 mt-10 -43.24 -38.46 2.57 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.142 -0.973 . . . . 0.0 108.594 177.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.456 ' CG ' HG23 ' A' ' 15' ' ' ILE . 3.5 mmt85 -71.69 -54.52 10.04 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.569 HG11 ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -60.41 -49.7 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 109.758 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.569 ' N ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -41.73 -51.41 4.13 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -51.19 -44.11 61.5 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.679 -0.808 . . . . 0.0 108.836 177.928 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 86.8 mt -66.64 -17.5 64.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.44 -0.787 . . . . 0.0 109.868 178.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.36 -64.7 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.246 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -46.95 -26.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.9 . . . . 0.0 110.4 -179.869 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mm-40 -82.73 7.68 14.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.02 91.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 19.3 m-85 -128.43 10.57 6.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 6.7 mm . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.373 0.606 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -54.86 -29.77 56.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.556 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 22.2 mm -67.22 -24.09 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 69.3 m-20 -83.07 -53.63 5.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 110.259 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -53.15 -50.19 65.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.33 -40.06 96.25 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 109.269 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 7.3 mt -64.52 -34.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.402 -0.811 . . . . 0.0 109.323 178.4 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HG ' HD11 ' A' ' 52' ' ' LEU . 9.3 mt -68.91 -42.35 76.94 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 178.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 178.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' HG13 ' A' ' 38' ' ' VAL . 11.3 mt-10 -72.57 -31.8 65.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.401 -0.812 . . . . 0.0 109.599 178.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.494 HD21 ' O ' ' A' ' 19' ' ' ILE . 2.4 mm? -68.34 -31.68 71.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 178.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -43.5 24.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.525 -0.734 . . . . 0.0 109.888 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -72.22 -49.21 36.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.968 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 27' ' ' GLY . 6.1 m-20 -121.98 71.04 0.98 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.244 -0.91 . . . . 0.0 110.071 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 28' ' ' ARG . . . -58.77 -151.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.604 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER 27.93 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.64 -0.918 . . . . 0.0 110.953 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 27' ' ' GLY . 8.8 tt -114.59 128.15 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -75.9 155.75 34.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.867 . . . . 0.0 110.281 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' SER . 7.4 p30 -46.24 -44.45 16.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 31' ' ' ASN . 58.8 t -40.37 -72.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 109.825 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -57.67 -25.01 59.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.865 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.612 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.584 -0.697 . . . . 0.0 109.913 179.003 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.574 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 23.4 p -88.17 -44.14 11.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.541 -0.724 . . . . 0.0 110.967 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -42.1 22.33 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 111.425 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -61.26 -15.81 38.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.512 -178.713 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 34' ' ' LEU . 15.1 m -100.41 -23.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 121.266 -0.896 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.99 32.25 4.76 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -148.06 168.99 20.94 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.008 -1.289 . . . . 0.0 110.647 179.005 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -72.75 158.41 87.32 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 108.977 177.34 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 48.1 Cg_endo -73.93 -46.59 0.31 Allowed 'Trans proline' 0 C--N 1.287 -2.703 0 O-C-N 123.928 1.488 . . . . 0.0 110.744 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.542 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.3 -54.81 4.51 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 109.548 179.254 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.1 Cg_endo -77.25 -40.02 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.887 1.467 . . . . 0.0 110.267 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 42.0 t -38.71 -45.78 1.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.025 . . . . 0.0 108.809 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -65.3 -50.36 65.97 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 6.1 mm-40 -42.86 -39.29 2.47 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.592 177.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.539 ' CG ' HG21 ' A' ' 15' ' ' ILE . 1.4 mmt85 -69.47 -55.6 9.79 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.663 0.745 . . . . 0.0 109.071 177.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG13 ' N ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -55.57 -43.04 71.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.32 -0.862 . . . . 0.0 109.479 178.292 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 10.1 mmt85 -45.86 -56.22 5.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.331 -0.856 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -46.74 -40.36 13.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 177.952 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 ' CD1' ' HB3' ' A' ' 16' ' ' ASP . 21.4 mt -77.4 -19.14 56.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.404 -0.81 . . . . 0.0 109.889 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -72.31 -59.32 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 0.0 110.384 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -57.52 -21.13 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -79.3 7.63 7.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 64.43 49.74 63.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 21.7 m-85 -139.07 17.77 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.279 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 7.8 mm . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.338 0.59 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -51.74 -24.45 5.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.298 -0.876 . . . . 0.0 110.306 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.583 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 10.5 mm -75.37 -34.28 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 110.237 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.474 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 72.5 m-20 -74.99 -38.25 61.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 110.266 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -67.39 -59.73 3.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.3 -31.75 65.97 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.357 -0.839 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.583 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 8.3 mt -69.49 -39.87 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.429 HD22 HD13 ' A' ' 58' ' ' ILE . 26.1 mt -69.88 -37.37 76.02 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -67.69 -29.06 68.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 178.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 4.6 mm-40 -73.36 -38.02 65.85 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.433 -0.792 . . . . 0.0 109.678 178.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 27' ' ' GLY . 63.7 mt -68.48 -32.91 73.23 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.229 -0.92 . . . . 0.0 109.256 178.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.69 -39.34 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.113 177.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -82.02 -26.9 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 0.0 109.635 178.688 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.576 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -142.0 63.83 1.41 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.47 -0.768 . . . . 0.0 109.932 178.883 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -49.43 -26.5 7.17 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 7.7 mpt_? -92.71 81.1 4.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -1.173 . . . . 0.0 110.493 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 10.0 tt -159.09 138.86 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.341 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -86.8 162.0 18.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.973 179.768 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' SER . 2.3 m-80 -53.45 -30.75 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 110.449 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.73 -66.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 109.156 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.499 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.2 tp10 -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.27 -0.894 . . . . 0.0 108.671 177.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.612 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.6 -14.58 62.12 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 178.286 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 23.5 p -87.04 -43.44 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.499 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -84.78 -17.28 38.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.514 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 12.8 mtt-85 -77.75 -16.63 58.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.018 -1.051 . . . . 0.0 110.67 -179.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -109.5 -7.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.482 -0.761 . . . . 0.0 110.01 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.97 42.88 5.21 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.64 167.6 28.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.046 -1.267 . . . . 0.0 110.685 179.034 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.51 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -73.54 160.76 81.52 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.97 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.591 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 52.3 Cg_endo -75.56 -49.64 0.13 Allowed 'Trans proline' 0 C--N 1.286 -2.738 0 O-C-N 123.932 1.491 . . . . 0.0 110.725 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.552 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -39.47 -51.55 4.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.795 179.405 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.3 Cg_endo -76.53 -43.12 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.915 1.481 . . . . 0.0 109.727 178.223 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 51.9 t -41.67 -42.36 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.591 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -67.72 -48.66 65.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 44' ' ' PRO . 66.6 mm-40 -48.05 -39.4 19.91 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.837 177.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 1.3 mmt180 -70.02 -51.84 28.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.13 178.049 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -59.67 -50.62 79.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.42 -0.8 . . . . 0.0 109.63 178.587 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.572 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 3.9 mmm180 -45.89 -42.15 12.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -57.31 -38.11 73.5 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.408 -0.807 . . . . 0.0 108.977 178.277 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.617 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 79.8 mt -74.77 -17.89 60.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.912 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -69.2 -53.82 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.133 -0.979 . . . . 0.0 109.739 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -75.03 -29.1 60.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 110.031 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 4.8 pt20 -140.92 56.06 1.57 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.893 . . . . 0.0 110.421 179.783 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -166.57 -137.6 2.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 56' ' ' GLY . 56.2 m-85 -139.78 83.08 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -1.12 . . . . 0.0 110.284 -179.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 4.6 mm . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.193 -0.942 . . . . 0.0 110.531 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HE3' ' CA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.815 0.34 . . . . 10.09 110.45 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 4' ' ' SER . 1.2 p -172.61 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.815 -1.178 . . . . 8.06 111.274 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' SER . 54.1 m-20 60.46 -75.06 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.462 -0.774 . . . . 5.91 110.813 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 74.45 11.55 4.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.507 -0.746 . . . . 4.79 111.304 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 23.0 mtmt -87.82 35.02 0.72 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.815 -1.178 . . . . 3.23 109.577 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -52.77 -64.12 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 5.28 110.39 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.616 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 6.0 mmt-85 49.39 -154.86 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.501 -1.296 . . . . 6.55 107.501 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 41.8 Cg_endo -74.59 58.39 4.58 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.97 -0.819 . . . . 1.91 109.97 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 12' ' ' LEU . . . -60.06 -51.02 61.44 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.426 -1.47 . . . . 2.09 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -44.81 -25.83 0.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -1.114 . . . . 4.91 109.145 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' GLY . 1.8 m-20 -144.05 71.91 1.33 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.58 0.705 . . . . 3.02 109.213 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -130.85 133.07 45.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.602 -0.686 . . . . 2.13 110.48 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.85 140.42 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 1.83 110.096 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 9.6 mmt180 -46.52 -32.02 3.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.93 -0.708 . . . . 3.4 110.631 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.546 HG21 ' CG ' ' A' ' 48' ' ' ARG . 6.6 mm -70.12 -37.24 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 1.2 111.63 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.472 ' HB3' ' CG ' ' A' ' 52' ' ' LEU . 73.3 m-20 -74.67 -54.37 7.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.916 -1.115 . . . . 1.25 111.417 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 1.3 ptm180 -57.08 -46.68 82.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 2.79 111.204 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 2.5 m-20 -65.75 -32.79 74.53 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.124 -1.03 . . . . 2.1 108.689 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.538 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 9.1 mt -69.38 -38.04 76.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 1.16 108.548 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.546 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 41.4 mt -67.5 -39.02 85.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.332 -0.988 . . . . 1.47 108.332 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.524 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 36.8 t-20 -65.31 -30.97 71.88 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.983 -0.747 . . . . 2.17 108.983 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.524 ' OE1' ' CG1' ' A' ' 38' ' ' VAL . 7.3 mt-10 -79.45 -32.87 42.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.543 -0.723 . . . . 2.07 109.419 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CG ' ' HB3' ' A' ' 61' ' ' TYR . 2.5 mm? -69.21 -41.61 76.84 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.365 -0.934 . . . . 2.01 108.666 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.474 ' OE1' ' CA ' ' A' ' 24' ' ' GLN . 2.2 tp60 -64.67 -38.35 90.71 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 2.5 108.909 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -78.08 -20.73 51.71 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.319 -0.993 . . . . 2.59 108.319 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.69 91.02 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.478 -0.889 . . . . 1.52 109.506 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.54 14.11 37.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.351 -1.099 . . . . 1.56 110.351 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 28.19 5.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.293 . . . . 4.22 110.015 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 tt -105.64 137.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 1.17 110.294 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.543 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 7.8 t -77.91 -123.45 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.826 -0.749 . . . . 2.14 110.128 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' SER . 14.2 p30 -122.44 -44.48 2.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.056 -1.028 . . . . 3.04 110.086 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.495 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 74.1 t -45.51 -55.45 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.902 -1.124 . . . . 1.2 108.428 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -64.32 -47.11 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.073 -1.454 . . . . 1.77 107.073 177.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.508 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -53.3 -19.17 3.01 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.568 0.699 . . . . 1.52 109.839 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' ASN . 3.7 p -87.45 -31.13 20.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.94 110.586 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -87.19 -31.62 20.25 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.272 -0.893 . . . . 2.64 112.586 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 13.3 mtp180 -68.85 -17.81 64.05 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.507 -1.371 . . . . 2.78 110.759 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.527 ' CG2' ' CD2' ' A' ' 40' ' ' LEU . 1.8 m -104.94 -11.33 9.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 C-N-CA 119.626 -0.83 . . . . 1.5 110.047 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.2 40.11 6.65 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.351 -0.928 . . . . 0.48 111.362 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -146.09 171.79 14.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.779 -1.424 . . . . 1.95 110.654 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 38.4 m -76.39 158.94 80.85 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.392 -1.336 . . . . 1.3 107.392 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.554 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 55.9 Cg_endo -77.13 -44.61 0.19 Allowed 'Trans proline' 0 C--N 1.282 -2.96 0 O-C-N 124.189 1.626 . . . . 0.32 111.27 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.503 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.34 -52.56 5.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 1.27 109.099 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.0 Cg_endo -79.76 -38.03 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.36 110.107 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.524 ' CB ' HD13 ' A' ' 40' ' ' LEU . 42.1 t -42.93 -46.75 5.51 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.749 -1.204 . . . . 1.03 107.749 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.554 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -62.02 -51.7 66.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.328 -1.36 . . . . 1.1 107.328 177.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -44.75 -37.39 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.099 -1.04 . . . . 2.03 108.212 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.546 ' CG ' HG21 ' A' ' 15' ' ' ILE . 2.6 mmt180 -73.64 -46.17 48.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.951 0.881 . . . . 2.34 108.717 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' CG1' HD21 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -65.86 -38.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.411 -0.806 . . . . 1.18 109.94 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HD3' ' CD1' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.74 -45.48 81.96 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.389 -0.967 . . . . 2.58 108.389 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -39.45 64.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.138 -1.43 . . . . 2.98 107.138 177.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.546 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 59.3 mt -73.06 -19.97 61.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.584 0.707 . . . . 1.26 109.31 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.33 -51.44 13.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 1.85 109.869 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -52.96 -30.15 33.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.527 -0.733 . . . . 4.17 110.364 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 13.0 mm-40 -84.33 11.05 9.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 2.99 109.843 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.26 48.57 73.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.13 -1.188 . . . . 2.13 110.13 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 20.8 m-85 -129.15 7.8 5.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.059 -1.259 . . . . 3.22 110.214 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.541 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 6.5 mm -135.45 40.71 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 1.24 109.448 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -92.4 -5.9 51.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.793 0.806 . . . . 2.77 109.166 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -136.56 -40.17 0.13 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.425 -1.87 . . . . 2.37 108.425 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.569 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 9.5 m-30 -57.73 -111.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -1.038 . . . . 5.71 109.651 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.522 ' HB ' HD12 ' A' ' 23' ' ' LEU . 6.6 t -89.06 22.07 2.91 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.318 -1.353 . . . . 1.84 109.827 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -40.08 -30.74 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.058 0.933 . . . . 1.93 108.489 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.543 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -54.89 -32.41 60.92 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.049 0.928 . . . . 1.96 110.949 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -40.94 -24.94 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.436 0.636 . . . . 2.83 111.236 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.554 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 22.1 t-20 . . . . . 0 C--N 1.294 -1.809 0 CA-C-O 117.943 -1.027 . . . . 4.06 110.252 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.3 t -82.6 79.15 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.465 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 t0 44.44 86.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 66.8 m -152.16 -36.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 2.0 mttt 67.5 48.29 1.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.92 78.41 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HB3' ' CG ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -71.9 -57.63 3.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.552 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 41.6 Cg_endo -69.83 -48.95 0.6 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.973 1.512 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.24 170.82 15.69 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 11' ' ' ASP . 1.9 tttt 51.67 -141.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -1.157 . . . . 0.0 110.113 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 10' ' ' LYS . 5.0 m-20 -43.46 107.45 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.073 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.477 ' CD1' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -138.12 130.88 29.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.473 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' HB2' ' NH2' ' A' ' 51' ' ' ARG . 3.7 t70 -72.23 131.14 42.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 7.1 tpp85 -44.68 -33.89 2.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 9.3 mm -73.67 -20.91 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' OD2' ' CZ ' ' A' ' 51' ' ' ARG . 2.9 m-20 -85.17 -59.53 2.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 0.0 110.142 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -53.99 -40.21 66.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.472 ' OD1' ' HD2' ' A' ' 17' ' ' ARG . 10.1 m120 -69.56 -41.37 75.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.568 HG23 ' CG2' ' A' ' 49' ' ' VAL . 18.6 mt -67.87 -33.75 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.28 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 7' ' ' ARG . 14.3 mt -68.78 -36.47 78.34 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.51 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 5.4 t-20 -66.2 -37.62 86.01 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.47 ' OE2' ' O ' ' A' ' 37' ' ' ARG . 98.9 mt-10 -68.78 -39.24 80.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.707 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HB3' ' CG ' ' A' ' 61' ' ' TYR . 43.7 mt -64.38 -24.93 67.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.351 -0.843 . . . . 0.0 109.592 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -75.97 -39.13 56.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -84.01 -24.56 30.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 1.5 m-20 -133.85 90.57 2.72 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.04 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 9.8 51.88 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.485 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -123.07 39.36 3.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -1.131 . . . . 0.0 110.294 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.466 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 7.5 tt -117.86 139.8 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.379 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.54 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 9.1 t -86.96 -108.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.347 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' SER . 1.8 p-10 -128.58 -45.72 1.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.27 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 31' ' ' ASN . 93.8 t -46.03 -61.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.954 -1.091 . . . . 0.0 109.119 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.6 tp10 -64.05 -28.13 69.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.224 -0.923 . . . . 0.0 108.944 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.55 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -75.09 -15.3 60.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.713 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASN . 28.0 p -86.57 -44.18 12.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.567 -0.708 . . . . 0.0 110.597 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -82.0 -21.86 36.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 31.8 mtt-85 -70.74 -19.25 62.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.364 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.563 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -110.12 -9.24 11.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.15 40.56 5.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -150.74 159.31 44.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.984 -1.304 . . . . 0.0 110.526 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.508 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.0 OUTLIER -67.0 156.32 88.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 108.858 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.581 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -72.01 -49.59 0.3 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 124.022 1.538 . . . . 0.0 110.496 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.533 ' C ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -35.98 -55.39 1.3 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.1 Cg_endo -75.83 -41.85 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.962 1.507 . . . . 0.0 110.007 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.516 ' CB ' HD12 ' A' ' 40' ' ' LEU . 35.9 t -39.9 -52.6 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.662 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.581 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -55.18 -49.03 72.92 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.51 -44.96 13.0 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.431 -0.793 . . . . 0.0 109.134 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' CG ' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.48 -51.89 31.7 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.594 0.711 . . . . 0.0 109.665 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.568 ' CG2' HG23 ' A' ' 19' ' ' ILE . 2.9 t -64.44 -59.2 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.615 ' CD ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -40.5 -45.71 2.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -51.75 -46.9 64.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.852 177.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' VAL . 12.9 mt -62.95 -27.66 69.55 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.414 -0.804 . . . . 0.0 109.665 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' OE1' ' CB ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -66.69 -56.82 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 47.2 mtp180 -45.96 -24.43 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.355 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.648 ' CB ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mm-40 -95.7 3.95 53.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.307 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.91 44.35 19.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' ' 55' ' ' GLN . 19.0 m-30 -116.65 0.93 12.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -1.231 . . . . 0.0 110.177 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.544 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 5.9 mm -138.8 53.41 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -94.62 -17.6 22.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.474 -0.766 . . . . 0.0 109.6 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -122.07 -37.98 0.63 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.5 m-85 -57.9 -116.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 64' ' ' LEU . 9.4 t -89.79 26.75 1.7 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.95 -1.094 . . . . 0.0 109.781 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -38.19 -29.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.613 -0.679 . . . . 0.0 109.669 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.54 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 1.7 pp -56.27 -33.8 65.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.205 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -67.07 -5.29 12.6 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.613 -0.68 . . . . 0.0 110.53 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.59 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 43.2 p-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.315 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' O ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.201 0.524 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.84 9.41 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -146.63 44.92 1.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -46.46 174.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.255 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER 55.86 -140.12 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -35.69 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.583 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -69.26 -60.46 4.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.555 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 44.3 Cg_endo -72.95 -36.22 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' CA ' HD11 ' A' ' 12' ' ' LEU . . . 57.2 -136.86 50.11 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.7 tptp 41.37 -140.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -1.133 . . . . 0.0 110.238 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 10.6 p30 -58.92 100.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.116 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.529 HD11 ' CA ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -138.3 122.92 18.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.326 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 16' ' ' ASP . 4.6 p-10 -59.29 135.33 57.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.883 . . . . 0.0 110.033 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.8 tpt180 -48.42 -20.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.37 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.562 HG22 ' CB ' ' A' ' 48' ' ' ARG . 7.6 mm -73.92 -45.2 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD2' ' NE ' ' A' ' 51' ' ' ARG . 47.7 m-20 -70.62 -35.74 73.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -69.22 -65.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 1.6 t-20 -52.61 -26.52 13.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.549 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 3.2 mt -70.07 -47.26 69.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.419 ' CD1' HD13 ' A' ' 52' ' ' LEU . 40.7 mt -64.27 -33.15 75.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.117 -0.989 . . . . 0.0 109.19 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 47.0 t30 -70.43 -28.45 65.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.359 -0.838 . . . . 0.0 109.408 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' OE1' ' CB ' ' A' ' 37' ' ' ARG . 3.6 mm-40 -78.55 -35.46 46.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.469 -0.769 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CB ' ' HB3' ' A' ' 61' ' ' TYR . 2.9 mm? -68.67 -35.84 77.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -74.75 -36.82 62.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.778 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -76.82 -36.59 56.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.82 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -122.22 76.5 1.31 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.164 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' ' HD2' ' A' ' 28' ' ' ARG . . . -67.8 58.14 0.35 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HD3' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -173.77 36.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 0.0 110.007 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.541 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -123.51 153.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.466 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -100.06 -94.03 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 3.3 p30 -138.76 -46.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.483 ' N ' ' CG ' ' A' ' 31' ' ' ASN . 31.0 t -44.99 -64.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.992 -1.067 . . . . 0.0 109.412 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.541 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 5.7 tp10 -62.01 -27.39 68.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 108.816 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.627 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.71 -16.04 61.21 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.524 -0.735 . . . . 0.0 109.401 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 9.7 p -88.98 -36.49 15.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.721 -0.612 . . . . 0.0 110.679 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.9 -50.25 8.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.246 -0.909 . . . . 0.0 111.188 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.539 ' CB ' ' OE1' ' A' ' 22' ' ' GLU . 7.3 mtp85 -54.84 -17.06 3.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.126 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.627 HG21 ' O ' ' A' ' 34' ' ' LEU . 15.7 m -100.42 -21.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.26 39.04 4.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.61 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.905 -1.35 . . . . 0.0 110.744 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -68.65 155.08 93.75 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.868 177.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.559 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 49.8 Cg_endo -74.06 -45.65 0.35 Allowed 'Trans proline' 0 C--N 1.286 -2.713 0 O-C-N 123.992 1.522 . . . . 0.0 110.737 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.538 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.96 -55.61 3.69 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.9 Cg_endo -75.64 -39.74 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.915 1.482 . . . . 0.0 110.026 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.549 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 51.6 t -39.43 -47.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 108.731 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.19 -49.97 72.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 14.5 mt-10 -46.97 -37.91 9.82 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.219 -0.925 . . . . 0.0 108.817 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.562 ' CB ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -70.77 -58.0 4.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.464 -0.772 . . . . 0.0 109.101 177.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -54.03 -50.45 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.23 -0.919 . . . . 0.0 109.17 177.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 18.1 mmt180 -41.76 -53.81 3.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.384 -0.822 . . . . 0.0 109.533 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NE ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -46.61 -44.15 17.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.735 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 49' ' ' VAL . 66.4 mt -69.95 -26.02 63.92 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -71.13 -66.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 110.134 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -56.34 -24.51 44.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.194 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.588 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.8 mm100 -79.45 5.13 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 68.4 48.69 49.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 55' ' ' GLN . 21.0 m-85 -134.06 8.54 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 63' ' ' ALA . 17.0 mm -131.04 42.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -79.66 -3.26 46.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -144.42 -37.63 0.07 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.584 ' HB3' ' CB ' ' A' ' 23' ' ' LEU . 8.8 m-30 -56.21 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -1.08 . . . . 0.0 110.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' LEU . 15.1 t -88.5 26.09 1.54 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.921 -1.112 . . . . 0.0 109.892 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.568 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -34.72 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.523 0.678 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -58.79 -110.55 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.498 -0.751 . . . . 0.0 109.445 178.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER 37.04 29.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 110.419 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.25 0.548 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.43 167.28 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.393 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -132.38 95.6 3.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m -149.86 -179.23 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' CD ' ' HG3' ' A' ' 24' ' ' GLN . 1.3 mmpp? 50.71 88.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 110.186 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -95.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.268 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.612 ' NH2' ' CE2' ' A' ' 61' ' ' TYR . 2.5 mpp_? 53.34 -171.96 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.043 -1.036 . . . . 0.0 109.187 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.611 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 38.1 Cg_endo -67.86 56.85 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.42 1.221 . . . . 0.0 109.95 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 10' ' ' LYS . . . -45.61 -36.74 6.37 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 12' ' ' LEU . 7.3 pttt -60.09 -130.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -1.121 . . . . 0.0 110.013 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 5.0 m-20 -52.06 90.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.007 . . . . 0.0 110.182 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.5 OUTLIER -129.14 150.05 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.263 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.8 145.17 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.159 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 15.2 mmt180 -53.15 -39.3 63.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 110.496 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.544 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 4.4 mm -72.8 -21.17 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.735 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB3' ' CD2' ' A' ' 52' ' ' LEU . 96.2 m-20 -86.33 -56.62 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.639 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 8.3 ptt85 -57.18 -42.55 81.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 110.271 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.531 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -68.3 -41.87 80.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.409 -0.807 . . . . 0.0 109.384 178.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.544 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 6.1 mt -65.72 -30.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.23 -0.918 . . . . 0.0 109.357 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.546 ' CD1' HD12 ' A' ' 52' ' ' LEU . 14.3 mt -74.01 -44.62 53.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.401 ' HA ' ' HG3' ' A' ' 5' ' ' LYS . 18.3 t30 -64.78 -28.16 69.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.509 ' OE1' ' CG1' ' A' ' 38' ' ' VAL . 8.9 mt-10 -76.46 -38.94 54.61 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.368 -0.832 . . . . 0.0 109.943 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 61' ' ' TYR . 14.7 mt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.477 ' HG3' ' CD ' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -70.46 -43.93 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -25.61 56.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.517 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -137.69 87.94 2.29 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.911 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.55 7.69 46.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.602 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -114.67 28.21 8.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' ASP . 6.9 tt -108.9 137.33 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.4 p -94.72 157.68 15.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 110.222 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -42.26 -49.19 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.456 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.449 ' O ' ' OG ' ' A' ' 35' ' ' SER . 78.7 t -44.05 -65.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.958 -1.089 . . . . 0.0 109.402 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -61.89 -28.7 69.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.22 -0.925 . . . . 0.0 108.782 177.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.623 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -72.69 -14.63 61.62 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 178.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 25.1 p -86.74 -43.34 12.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.461 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -16.53 46.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.254 -0.904 . . . . 0.0 111.221 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.525 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -81.29 -15.54 55.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.977 -1.077 . . . . 0.0 110.773 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -108.35 -8.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.223 -0.923 . . . . 0.0 109.874 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 40.63 4.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.533 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -151.77 165.63 33.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -1.23 . . . . 0.0 110.549 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.25 157.07 85.33 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.786 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.582 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.5 Cg_endo -72.25 -44.8 0.74 Allowed 'Trans proline' 0 C--N 1.286 -2.729 0 O-C-N 124.005 1.529 . . . . 0.0 110.539 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.543 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.06 -55.87 4.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.363 178.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -75.35 -42.2 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.901 1.474 . . . . 0.0 110.202 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' C ' ' O ' ' A' ' 44' ' ' PRO . 42.5 t -40.14 -51.02 2.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 108.708 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.582 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -58.26 -46.4 86.07 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -48.47 -42.59 33.15 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.318 -0.864 . . . . 0.0 108.959 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.21 -55.32 10.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.695 0.76 . . . . 0.0 109.555 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 62' ' ' THR . 1.6 t -59.06 -55.51 23.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.976 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.556 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -39.8 -50.02 2.37 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.405 -0.81 . . . . 0.0 109.645 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.03 -47.2 33.72 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.697 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.546 HD12 ' CD1' ' A' ' 20' ' ' LEU . 97.0 mt -59.61 -26.26 65.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -68.22 -57.58 5.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 110.248 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -46.58 -36.63 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 7.8 mm-40 -81.82 8.38 10.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 64.28 60.11 7.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.526 ' CD2' ' HD3' ' A' ' 8' ' ' PRO . 14.8 m-85 -135.38 12.54 3.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 110.312 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 5.2 mm -137.23 52.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 110.24 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.08 -10.96 48.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.458 -0.776 . . . . 0.0 109.604 178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.51 -37.75 0.15 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.612 ' CE2' ' NH2' ' A' ' 7' ' ' ARG . 22.0 m-85 -64.44 -102.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -1.052 . . . . 0.0 110.11 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.578 ' CG2' HG12 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -80.42 6.96 10.79 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 109.97 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -40.58 -27.71 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.405 -0.809 . . . . 0.0 110.036 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 62' ' ' THR . 1.6 pp -57.7 -41.1 81.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.361 -0.837 . . . . 0.0 110.656 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.587 ' CG ' ' O ' ' A' ' 65' ' ' LEU . 1.8 pp -41.96 97.06 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.417 -0.802 . . . . 0.0 110.148 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.057 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.241 0.544 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -105.43 0.61 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.21 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.3 p30 -150.52 86.69 1.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.196 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 5' ' ' LYS . 2.1 m -168.24 137.19 2.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 15.7 mtmt 42.95 81.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 0.0 110.305 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 8.7 ttmt -174.18 82.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.377 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.552 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -75.95 -59.06 1.21 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.456 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 43.0 Cg_endo -71.7 -46.89 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.871 1.458 . . . . 0.0 110.453 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.04 -74.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.55 10.12 16.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.186 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.536 ' O ' ' HB3' ' A' ' 12' ' ' LEU . 31.0 m-20 -132.87 72.19 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 110.334 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.536 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 3.0 pp 179.82 140.24 0.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.371 -0.831 . . . . 0.0 110.483 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 7.7 t70 -79.81 156.12 27.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.446 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -45.5 -30.17 1.35 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' HB ' ' HG2' ' A' ' 48' ' ' ARG . 17.9 mm -73.54 -18.76 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 0.7 OUTLIER -84.27 -48.61 9.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.179 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' HB3' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -61.07 -47.82 84.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 33.9 p-10 -66.18 -37.64 86.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.016 -1.052 . . . . 0.0 109.283 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.545 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 5.8 mt -64.38 -29.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.234 -0.916 . . . . 0.0 109.23 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD22 ' CD2' ' A' ' 57' ' ' PHE . 40.7 mt -72.23 -46.77 54.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.662 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.475 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.3 t30 -61.41 -29.15 69.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.382 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 3.4 mm-40 -74.87 -36.93 62.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.433 -0.792 . . . . 0.0 109.705 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CG ' ' HB3' ' A' ' 61' ' ' TYR . 2.9 mm? -66.17 -37.77 86.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.338 -0.851 . . . . 0.0 109.669 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -72.83 -35.92 67.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.784 178.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -81.45 -24.49 36.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.882 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ARG . 1.4 m-20 -125.06 69.72 1.14 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.58 61.74 0.11 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.69 32.02 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.367 -1.078 . . . . 0.0 109.83 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.501 HG13 ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -124.71 151.6 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.456 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 35.7 m -102.9 -92.96 0.33 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.214 -0.929 . . . . 0.0 110.333 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.2 p-10 -139.37 -47.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -0.938 . . . . 0.0 110.26 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 35' ' ' SER . 78.8 t -45.91 -65.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.961 -1.087 . . . . 0.0 109.129 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' HB3' HG13 ' A' ' 29' ' ' ILE . 11.9 tp10 -61.27 -27.71 68.66 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.94 . . . . 0.0 108.756 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.518 -0.739 . . . . 0.0 109.543 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ASN . 24.6 p -88.25 -39.87 14.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -82.58 -27.28 31.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.923 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 8.1 mtt180 -69.17 -17.37 63.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.12 -0.988 . . . . 0.0 110.379 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -110.05 -6.02 11.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.49 -0.756 . . . . 0.0 109.913 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.65 44.96 5.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -156.19 167.77 29.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.002 -1.293 . . . . 0.0 110.84 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.519 ' C ' ' HB2' ' A' ' 35' ' ' SER . 4.6 m -72.89 154.41 90.99 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.528 -0.732 . . . . 0.0 109.149 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.555 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 50.1 Cg_endo -73.85 -49.2 0.21 Allowed 'Trans proline' 0 C--N 1.288 -2.621 0 O-C-N 124.06 1.558 . . . . 0.0 110.733 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.539 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -36.52 -53.46 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 48.8 Cg_endo -75.85 -45.28 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.915 1.482 . . . . 0.0 109.969 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.563 ' HB2' HD12 ' A' ' 40' ' ' LEU . 18.3 t -38.68 -52.01 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 108.898 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.555 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.71 -49.88 75.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.01 -43.87 4.43 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.55 ' HG2' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.06 -42.04 63.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.546 -0.721 . . . . 0.0 109.629 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -67.37 -46.97 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.756 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.561 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 1.3 mtm180 -47.84 -51.3 23.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.174 -0.954 . . . . 0.0 109.118 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' C ' ' CD ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -48.85 -45.95 41.58 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 108.853 177.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.519 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 86.5 mt -63.31 -17.69 62.81 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.785 . . . . 0.0 109.448 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -75.66 -53.2 8.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.471 -0.768 . . . . 0.0 110.215 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -55.3 -33.22 63.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -76.22 -0.96 24.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.36 40.64 23.12 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CD2' HD22 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -119.72 -0.08 10.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.161 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.547 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 5.2 mm -134.59 46.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.411 ' C ' ' HB1' ' A' ' 63' ' ' ALA . 6.8 pt20 -82.9 -6.61 59.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.622 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' N ' ' HB1' ' A' ' 63' ' ' ALA . . . -143.4 -44.48 0.05 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.584 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 25.1 m-85 -54.88 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -1.141 . . . . 0.0 110.008 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.557 ' CB ' HG21 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -82.27 8.47 11.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.944 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -39.36 -28.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.456 -0.778 . . . . 0.0 109.808 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 66' ' ' ASN . 1.0 OUTLIER -57.35 -34.87 69.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.392 -0.817 . . . . 0.0 110.526 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.575 ' CG ' ' O ' ' A' ' 65' ' ' LEU . 1.4 pp -41.26 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.5 t-20 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.283 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.253 0.549 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.69 104.66 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -100.69 72.64 1.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.462 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER -149.13 -78.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.347 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.485 ' HE3' ' HG3' ' A' ' 24' ' ' GLN . 5.6 mmpt? 54.77 33.32 19.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 110.017 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -177.75 63.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.992 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.564 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 4.2 mtt180 -86.55 -50.84 0.46 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.564 ' HD3' ' CB ' ' A' ' 7' ' ' ARG . 49.6 Cg_endo -84.48 24.02 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.953 1.502 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.506 ' HA3' ' HG ' ' A' ' 12' ' ' LEU . . . -165.72 81.08 0.11 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 2.6 tptt -43.71 125.08 3.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -1.197 . . . . 0.0 109.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 12' ' ' LEU . 61.1 m-20 55.61 37.75 29.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 11' ' ' ASP . 1.1 mt -32.36 149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.64 -0.663 . . . . 0.0 110.924 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 38.0 m-20 -45.51 153.01 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' ASN . 18.3 mmt-85 -62.04 -16.9 55.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 110.318 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.554 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 7.9 mm -84.87 -49.75 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 0.0 109.833 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' O ' HD13 ' A' ' 52' ' ' LEU . 2.6 m-20 -71.67 -40.02 69.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.92 . . . . 0.0 110.145 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.5 OUTLIER -71.68 -46.16 59.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 110.027 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 52.1 t30 -67.29 -34.31 77.14 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.22 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.554 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 8.0 mt -63.68 -39.64 86.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.458 -0.777 . . . . 0.0 109.186 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' CD1' HD21 ' A' ' 52' ' ' LEU . 80.3 mt -68.31 -45.93 71.64 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.151 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -60.15 -37.41 80.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.183 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.69 -40.96 76.03 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CG ' ' HB3' ' A' ' 61' ' ' TYR . 2.7 mm? -64.44 -37.84 88.94 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.288 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.485 ' HG3' ' HE3' ' A' ' 5' ' ' LYS . 8.5 tm0? -69.32 -44.9 70.76 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 109.508 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -74.36 -19.85 60.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.959 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' OD1' ' NH2' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -148.98 61.68 1.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 110.112 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -52.84 -28.67 32.06 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -76.8 51.7 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -1.138 . . . . 0.0 110.345 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' A' ' 26' ' ' ASP . 18.9 tt -138.73 154.07 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.31 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 42.1 t -99.93 -115.61 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.317 -0.864 . . . . 0.0 110.352 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 35' ' ' SER . 9.6 p30 -121.21 -46.4 2.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.3 t -44.58 -62.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.995 -1.066 . . . . 0.0 109.416 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.255 -0.903 . . . . 0.0 108.786 177.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -76.77 -15.65 59.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 31' ' ' ASN . 16.5 p -88.08 -38.81 15.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.538 -0.726 . . . . 0.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -31.38 23.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.295 -0.878 . . . . 0.0 110.916 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 6.2 mtp85 -65.12 -16.63 63.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.351 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 34' ' ' LEU . 1.2 m -109.65 -11.99 11.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 110.036 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.81 42.55 5.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.575 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.75 166.28 32.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.956 -1.32 . . . . 0.0 110.734 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.486 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -70.32 155.55 93.26 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 108.786 177.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 51.3 Cg_endo -74.29 -42.91 0.59 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 O-C-N 123.808 1.425 . . . . 0.0 110.556 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.557 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.97 -57.51 2.06 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.731 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.557 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 50.0 Cg_endo -76.47 -41.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.843 1.444 . . . . 0.0 110.205 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 53.8 t -39.21 -45.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 108.825 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.49 -47.99 74.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -48.06 -39.35 19.77 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.685 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.528 ' HD2' ' CG2' ' A' ' 15' ' ' ILE . 5.4 mmt180 -70.64 -46.86 62.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.665 0.745 . . . . 0.0 109.16 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.545 HG22 ' CB ' ' A' ' 62' ' ' THR . 0.5 OUTLIER -64.33 -45.29 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.374 -0.829 . . . . 0.0 109.847 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.589 ' CD ' ' CD1' ' A' ' 65' ' ' LEU . 12.6 mmm-85 -47.59 -49.35 26.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.449 -0.782 . . . . 0.0 109.465 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -51.16 -43.43 61.25 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.882 178.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.55 ' HA ' ' NE2' ' A' ' 55' ' ' GLN . 93.8 mt -66.61 -16.67 64.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.432 -0.793 . . . . 0.0 109.891 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -78.08 -61.19 2.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.523 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -49.87 -29.68 8.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.649 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.582 ' OE1' ' CG ' ' A' ' 57' ' ' PHE . 4.1 pt20 -82.51 12.23 4.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.39 52.78 44.0 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.582 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -131.42 8.41 4.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -1.151 . . . . 0.0 110.15 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 5.7 mm -140.8 51.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -11.71 57.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.01 -40.14 0.1 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.62 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 20.4 m-85 -58.75 -102.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -1.078 . . . . 0.0 110.111 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.545 ' CB ' HG22 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.15 11.58 7.87 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.08 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -38.28 -29.73 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.389 -0.819 . . . . 0.0 109.856 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -62.91 -115.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.589 ' CD1' ' CD ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER 37.89 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 64' ' ' LEU . 7.4 t30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.329 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.189 0.518 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 31.9 t -77.52 158.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.363 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 86.2 m-20 53.64 55.93 7.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -139.0 142.59 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HE3' ' NE2' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -107.43 74.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.166 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -103.7 -60.02 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.378 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.596 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 45.23 -168.64 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.064 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.7 Cg_endo -72.53 56.83 2.85 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.261 1.138 . . . . 0.0 109.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . -60.41 -134.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 9.8 ttmt 42.12 -105.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -1.157 . . . . 0.0 109.944 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' N ' ' HG2' ' A' ' 10' ' ' LYS . 33.7 p-10 -73.3 79.61 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.965 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 13.5 tp -151.83 140.36 20.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 110.32 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 135.21 56.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 17.1 mmt-85 -49.59 -20.58 0.8 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.318 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 48' ' ' ARG . 10.2 mm -74.66 -24.33 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.436 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.477 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 50.2 m-20 -84.36 -56.52 3.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 110.372 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -56.75 -43.94 81.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.035 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.515 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 16.4 m120 -64.78 -41.2 96.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.011 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.527 HG21 ' CG2' ' A' ' 49' ' ' VAL . 3.5 mt -62.0 -39.59 84.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.444 -0.785 . . . . 0.0 109.264 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.476 HD22 ' HD3' ' A' ' 7' ' ' ARG . 16.0 mt -66.56 -40.91 89.25 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.66 -32.4 73.7 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.385 -0.822 . . . . 0.0 109.446 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.61 -31.22 46.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 109.62 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.585 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -73.33 -31.91 64.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.371 -0.83 . . . . 0.0 109.571 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.507 ' NE2' ' HE3' ' A' ' 5' ' ' LYS . 3.5 tp-100 -78.15 -36.63 47.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.395 -0.816 . . . . 0.0 109.769 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 30.0 pttt -74.67 -33.56 62.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.67 68.21 0.86 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.087 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.09 60.66 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -175.37 28.67 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.384 -1.068 . . . . 0.0 109.658 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.522 HG13 ' HB3' ' A' ' 33' ' ' GLU . 16.1 tt -116.6 146.56 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.408 -0.808 . . . . 0.0 110.218 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.464 ' OG ' ' OD1' ' A' ' 31' ' ' ASN . 42.5 t -91.66 -91.42 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 110.275 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 2.3 p-10 -143.74 -47.4 0.28 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.532 HG22 ' ND2' ' A' ' 31' ' ' ASN . 59.3 t -44.25 -61.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.013 -1.054 . . . . 0.0 109.177 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.522 ' HB3' HG13 ' A' ' 29' ' ' ILE . 4.2 tp10 -62.81 -31.95 73.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.278 -0.888 . . . . 0.0 108.805 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.59 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -70.28 -15.25 62.87 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.603 -0.686 . . . . 0.0 109.487 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.567 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 8.7 p -87.76 -37.6 16.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.723 . . . . 0.0 110.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -32.36 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.9 . . . . 0.0 111.273 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -66.27 -16.99 64.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.687 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -109.46 -8.06 11.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 44.59 5.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.581 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -152.54 165.82 33.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.0 -1.294 . . . . 0.0 110.71 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.474 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.61 156.83 90.98 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 108.807 177.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 51.6 Cg_endo -74.5 -48.69 0.19 Allowed 'Trans proline' 0 C--N 1.287 -2.681 0 O-C-N 123.83 1.437 . . . . 0.0 110.543 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.533 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -54.13 3.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.011 . . . . 0.0 109.434 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.7 Cg_endo -75.85 -40.66 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.001 1.527 . . . . 0.0 110.135 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 50.3 t -40.56 -44.74 2.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.085 . . . . 0.0 108.718 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.568 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.86 -45.16 87.26 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 1.6 mm-40 -50.12 -35.48 25.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HD2' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -74.49 -48.37 27.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.701 . . . . 0.0 109.288 177.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.559 ' CG1' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -65.74 -56.71 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 178.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.538 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -43.59 -42.95 5.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.54 -43.83 68.72 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 71.7 mt -69.29 -16.96 63.68 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.629 -0.669 . . . . 0.0 109.785 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 1.9 mt-10 -75.7 -56.29 4.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -53.82 -27.72 31.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.393 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.581 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 66.1 mm-40 -85.38 17.13 3.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.001 . . . . 0.0 110.251 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.44 56.94 21.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 55' ' ' GLN . 20.6 m-85 -137.2 6.74 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.13 -1.217 . . . . 0.0 110.239 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 13.5 mm -132.41 33.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -82.25 3.95 25.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.773 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -143.23 -44.1 0.05 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 60.6 m-85 -56.9 -112.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 110.184 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 64' ' ' LEU . 15.4 t -89.63 24.51 2.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.935 -1.103 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -32.38 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.588 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -55.9 -110.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 177.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.559 HD22 ' CG1' ' A' ' 49' ' ' VAL . 0.2 OUTLIER 36.42 29.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.379 -0.825 . . . . 0.0 110.612 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.257 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.549 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 1.9 ttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 1' ' ' MET . 8.7 p 37.3 35.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.499 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -74.81 -165.16 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 p -141.35 154.33 45.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.55 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -109.34 94.31 4.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.309 -0.869 . . . . 0.0 110.173 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -166.53 88.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.5 -55.91 38.32 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.227 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 42.2 Cg_endo -71.25 -46.76 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.949 1.5 . . . . 0.0 110.397 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.549 ' O ' ' CD2' ' A' ' 12' ' ' LEU . . . 68.18 -57.01 0.42 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 8' ' ' PRO . 1.4 tpmt? -90.34 2.1 55.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -1.183 . . . . 0.0 110.038 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.467 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -127.03 53.6 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 110.078 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 9' ' ' GLY . 1.8 pt? -176.2 130.42 0.22 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 0.0 110.097 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 162.11 29.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.295 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.6 -22.65 5.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.51 HG22 ' CG ' ' A' ' 48' ' ' ARG . 13.8 mm -71.74 -30.51 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.903 . . . . 0.0 110.5 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.535 ' HB3' ' CG ' ' A' ' 52' ' ' LEU . 50.5 m-20 -76.02 -61.3 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 110.539 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HD2' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -52.64 -39.99 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.493 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 6.7 t30 -67.74 -35.72 79.26 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 109.226 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.508 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 18.6 mt -63.14 -41.96 94.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.362 -0.836 . . . . 0.0 109.094 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.485 ' HB3' ' HB3' ' A' ' 5' ' ' LYS . 25.8 mt -56.21 -42.15 76.74 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.129 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.55 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 61.7 t-20 -59.36 -49.65 77.01 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.288 -0.882 . . . . 0.0 109.027 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -61.93 -37.68 85.58 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 178.201 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.565 ' CG ' ' HB3' ' A' ' 61' ' ' TYR . 2.3 mm? -67.36 -35.67 79.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.385 -0.822 . . . . 0.0 109.434 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -39.82 39.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.408 -0.808 . . . . 0.0 109.656 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' HD3' ' OE1' ' A' ' 22' ' ' GLU . 2.4 pttt -77.55 -30.27 52.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 109.747 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.6 m-20 -140.33 61.07 1.53 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 110.317 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -56.22 -163.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.32 25.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -1.195 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 37' ' ' ARG . 10.3 tt -108.88 137.62 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.572 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 20.4 m -72.04 -137.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.852 . . . . 0.0 110.4 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 35' ' ' SER . 3.1 p30 -110.86 -43.12 3.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.319 -0.863 . . . . 0.0 109.907 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 32.8 t -44.8 -56.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.13 -0.981 . . . . 0.0 109.153 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -65.64 -34.41 78.17 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.34 -0.85 . . . . 0.0 108.887 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -70.3 -14.97 62.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.717 . . . . 0.0 109.777 178.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.3 p -85.64 -49.7 7.79 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 110.59 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.404 ' N ' ' OG ' ' A' ' 35' ' ' SER . 1.9 mtpp -78.68 -22.11 47.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 110.801 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.502 ' HD2' ' CD1' ' A' ' 29' ' ' ILE . 15.9 mtt-85 -70.02 -17.21 63.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.093 -1.004 . . . . 0.0 110.163 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -112.66 -9.56 12.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.672 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.99 42.0 4.81 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.41 161.21 42.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.961 -1.317 . . . . 0.0 110.72 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.515 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -66.28 157.07 83.21 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 108.8 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.579 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.8 Cg_endo -73.5 -44.61 0.5 Allowed 'Trans proline' 0 C--N 1.287 -2.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.456 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.526 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.24 -56.12 2.79 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.93 . . . . 0.0 109.551 179.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.7 Cg_endo -74.96 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.99 1.521 . . . . 0.0 109.907 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.524 ' C ' ' O ' ' A' ' 44' ' ' PRO . 45.0 t -37.32 -53.01 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.579 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -54.95 -54.29 44.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -43.87 -43.53 6.4 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.386 -0.821 . . . . 0.0 109.298 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.51 ' CG ' HG22 ' A' ' 15' ' ' ILE . 1.4 mmt180 -66.57 -48.67 68.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.791 . . . . 0.0 109.16 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 50' ' ' ARG . 1.1 t -61.61 -43.48 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.411 -0.806 . . . . 0.0 109.507 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 5.8 mmm180 -45.78 -52.19 11.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.389 -0.819 . . . . 0.0 109.396 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.489 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -53.24 -40.57 64.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.065 178.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 16' ' ' ASP . 16.2 mt -73.48 -31.3 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -0.764 . . . . 0.0 109.753 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -82.09 -30.15 31.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -74.0 -18.56 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 15.53 23.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.258 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.62 58.68 6.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -145.41 11.93 1.33 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -1.121 . . . . 0.0 110.296 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 53' ' ' GLU . 8.0 mm -140.62 37.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -14.58 58.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -125.0 -40.84 0.4 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.565 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 18.5 m-30 -56.64 -115.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -1.065 . . . . 0.0 110.062 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.558 ' O ' ' C ' ' A' ' 63' ' ' ALA . 9.4 t -87.1 24.77 1.47 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.956 -1.09 . . . . 0.0 110.08 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -34.16 -34.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.709 . . . . 0.0 109.328 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -56.29 -108.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 109.421 177.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.526 ' CD1' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER 36.85 28.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.306 -0.871 . . . . 0.0 110.49 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.554 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.269 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.296 0.57 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.23 48.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.09 -34.7 22.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -165.61 -177.92 4.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 21' ' ' ASN . 35.5 mtmm -106.77 80.43 1.45 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.481 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 11.6 tttm -87.55 -117.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.372 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.645 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 59.97 -159.06 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.973 -1.08 . . . . 0.0 109.053 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.645 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 42.5 Cg_endo -75.33 57.73 4.86 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.064 1.034 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.18 -25.6 51.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -75.76 1.93 13.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -1.177 . . . . 0.0 110.098 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.85 74.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.399 -0.813 . . . . 0.0 109.694 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.4 147.76 36.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.397 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -50.22 142.57 9.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 110.047 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.493 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 12.0 mmt85 -56.02 -24.88 41.96 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.354 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.561 HG22 ' CB ' ' A' ' 48' ' ' ARG . 10.6 mm -74.93 -35.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.552 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 6.2 m-20 -74.84 -56.6 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.574 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.493 ' CD ' ' HA ' ' A' ' 14' ' ' ARG . 2.6 ptt85 -55.53 -45.1 77.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.306 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 11.1 m120 -64.8 -34.12 77.61 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.095 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 5.9 mt -64.79 -44.33 96.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD1' HD22 ' A' ' 52' ' ' LEU . 12.2 mt -63.29 -41.24 98.97 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 109.261 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.463 ' HA ' ' HE3' ' A' ' 5' ' ' LYS . 2.7 t-20 -62.76 -31.2 72.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.266 -0.896 . . . . 0.0 109.258 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' OE1' HG11 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -77.49 -43.24 32.84 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.45 -0.781 . . . . 0.0 109.835 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.558 ' CB ' ' HB3' ' A' ' 61' ' ' TYR . 2.2 mm? -62.17 -36.31 81.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 109.38 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' C ' ' OE1' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -68.71 -44.88 72.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.742 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -71.77 -37.5 70.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.925 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -135.87 92.04 2.77 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.56 -10.06 86.47 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.577 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.8 mpt_? -85.89 26.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -1.164 . . . . 0.0 110.467 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.468 HD12 ' HG ' ' A' ' 34' ' ' LEU . 4.0 tt -111.45 155.04 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.944 . . . . 0.0 110.329 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 73.8 m -108.17 -94.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 110.414 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' SER . 18.7 p-10 -136.69 -50.96 0.67 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.481 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 77.7 t -43.29 -58.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.246 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' O ' ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -65.42 -27.48 68.56 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.864 . . . . 0.0 108.864 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -75.67 -15.38 60.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.551 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.8 p -88.09 -48.99 7.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 111.031 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.67 -22.37 34.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.067 -1.021 . . . . 0.0 111.184 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 7.8 mtp180 -72.59 -16.09 61.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.554 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -109.76 -9.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.311 -0.868 . . . . 0.0 110.062 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.65 41.51 4.42 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.565 ' CD1' ' HA ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -153.55 165.45 35.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.107 -1.231 . . . . 0.0 110.667 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.4 m -72.21 159.76 84.56 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 108.865 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.57 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 49.3 Cg_endo -73.39 -51.36 0.16 Allowed 'Trans proline' 0 C--N 1.285 -2.769 0 O-C-N 123.87 1.458 . . . . 0.0 110.609 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.548 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.31 -55.18 1.87 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 109.705 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 47.9 Cg_endo -75.83 -40.58 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.998 1.525 . . . . 0.0 110.064 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.565 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 42.2 t -39.45 -48.59 1.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.105 -0.997 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.582 ' O ' ' HG2' ' A' ' 50' ' ' ARG . 1.3 mp -58.49 -52.41 65.77 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.82 -38.38 2.12 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.356 -0.84 . . . . 0.0 108.997 177.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.561 ' CB ' HG22 ' A' ' 15' ' ' ILE . 4.6 mmp_? -71.54 -56.31 6.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.233 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -56.01 -40.05 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 178.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 7.5 mmt85 -52.78 -48.67 66.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 109.699 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.552 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -53.15 -37.21 61.64 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.971 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 94.4 mt -67.93 -23.12 65.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.444 -0.785 . . . . 0.0 109.887 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 40.8 mt-10 -77.65 -51.23 10.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.886 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -48.48 -39.71 24.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.026 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.46 ' NE2' ' HD2' ' A' ' 51' ' ' ARG . 3.3 pt20 -86.37 27.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.85 76.25 0.14 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.584 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -151.29 13.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.505 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 63' ' ' ALA . 15.1 mm -137.95 24.51 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.53 -8.13 53.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -135.55 -38.09 0.18 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.558 ' HB3' ' CB ' ' A' ' 23' ' ' LEU . 91.8 m-85 -57.71 -113.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -1.113 . . . . 0.0 109.829 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.573 ' O ' ' N ' ' A' ' 64' ' ' LEU . 6.9 t -90.43 32.0 0.98 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.855 -1.153 . . . . 0.0 109.912 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.528 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -34.96 -32.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.708 0.766 . . . . 0.0 109.072 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.6 OUTLIER -75.81 -139.48 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.674 -0.641 . . . . 0.0 109.418 177.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.603 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 58.93 9.0 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.053 -1.03 . . . . 0.0 110.277 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 179.634 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.291 0.567 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t 48.93 86.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.3 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.82 80.22 3.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 p -104.75 87.54 2.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.486 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -78.54 72.81 5.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 17.6 mmtt -63.55 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.731 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 54.59 -163.13 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 108.974 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 42.3 Cg_endo -74.39 57.73 4.25 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.125 1.066 . . . . 0.0 110.069 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . -39.08 -37.32 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' LEU . 1.1 tptp -60.74 -135.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -1.196 . . . . 0.0 110.159 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.53 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.226 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -113.38 111.58 22.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.69 151.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 110.01 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 18' ' ' ASN . 9.2 mmt85 -60.97 -29.97 69.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.269 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.576 HG23 ' CB ' ' A' ' 48' ' ' ARG . 4.9 mm -81.38 -27.66 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.702 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.465 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 3.1 m-20 -84.54 -31.37 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.253 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -75.56 -46.59 31.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 110.157 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 39.4 p-10 -69.14 -32.48 71.87 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.189 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.547 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 6.3 mt -69.18 -38.31 77.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.468 HD11 HD21 ' A' ' 52' ' ' LEU . 22.9 mt -68.82 -40.49 79.45 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 29.9 t-20 -67.56 -26.42 66.28 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.205 -0.934 . . . . 0.0 109.267 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -87.04 -40.96 14.23 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 62' ' ' THR . 1.3 mt -69.18 -24.29 64.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.486 ' CG ' ' HG3' ' A' ' 5' ' ' LYS . 5.6 tp60 -84.37 -37.84 21.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.451 -0.781 . . . . 0.0 109.969 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 4.0 pttt -83.09 -32.34 26.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.818 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 29' ' ' ILE . 19.4 t0 -129.56 55.49 1.76 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.34 -25.61 2.03 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -82.21 9.84 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -1.143 . . . . 0.0 110.185 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 5.8 tt -74.15 154.96 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -104.4 147.06 27.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 110.15 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 35' ' ' SER . 1.0 OUTLIER -39.98 -52.51 2.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.262 -0.899 . . . . 0.0 109.809 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 31' ' ' ASN . 18.0 t -44.79 -57.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 108.939 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 tp10 -65.29 -29.5 70.26 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 108.727 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.581 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -72.81 -16.6 61.61 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 109.512 178.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.537 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 21.1 p -88.69 -44.99 10.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.594 -0.691 . . . . 0.0 110.604 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 6.1 mtpp -82.44 -43.97 16.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 3.7 mtt-85 -56.99 -16.65 7.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 0.0 110.23 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.602 HG23 ' HG ' ' A' ' 40' ' ' LEU . 18.7 m -101.3 -21.05 5.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.403 -0.811 . . . . 0.0 110.019 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.14 37.8 3.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -154.92 171.66 19.32 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.879 -1.365 . . . . 0.0 110.793 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.57 158.82 82.79 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 108.877 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 48.7 Cg_endo -73.54 -45.22 0.43 Allowed 'Trans proline' 0 C--N 1.287 -2.709 0 O-C-N 123.987 1.52 . . . . 0.0 110.646 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.54 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -42.03 -55.64 6.03 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 109.443 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 47' ' ' GLU . 50.2 Cg_endo -76.02 -36.9 1.76 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.88 1.463 . . . . 0.0 110.281 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 40.9 t -43.47 -47.71 7.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.064 . . . . 0.0 108.652 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.53 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.54 -39.51 88.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -55.97 -41.99 75.6 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.576 ' CB ' HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -70.58 -47.98 57.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.592 -0.692 . . . . 0.0 109.284 178.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' A' ' 52' ' ' LEU . 1.2 t -58.89 -51.89 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.483 -0.761 . . . . 0.0 109.343 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -41.97 -53.7 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.455 -0.778 . . . . 0.0 109.325 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -48.05 -42.7 29.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.432 -0.792 . . . . 0.0 109.052 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 49' ' ' VAL . 12.7 mt -72.13 -23.38 61.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 0.0 109.775 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.62 ' CG ' ' HA ' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -63.04 -59.92 4.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.233 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.7 -28.64 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.329 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.584 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mm-40 -74.75 0.51 15.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 66.93 51.6 38.84 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 55' ' ' GLN . 22.0 m-85 -131.15 9.43 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -1.159 . . . . 0.0 110.28 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 63' ' ' ALA . 1.2 mt -149.56 118.36 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.294 -0.879 . . . . 0.0 110.022 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.413 ' HG2' ' HA ' ' A' ' 63' ' ' ALA . 2.1 pt20 -73.26 78.82 1.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 62' ' ' THR . . . 111.87 50.89 0.58 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.62 ' HA ' ' CG ' ' A' ' 53' ' ' GLU . 64.5 m-85 60.22 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 110.511 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.629 ' OG1' ' HB3' ' A' ' 65' ' ' LEU . 2.5 p -90.12 -8.69 50.73 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 109.942 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.588 ' N ' HG22 ' A' ' 58' ' ' ILE . . . 55.72 32.14 18.82 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.507 -0.746 . . . . 0.0 109.617 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' A' ' 65' ' ' LEU . 4.1 pp -175.13 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 110.269 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.652 HD11 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.57 -7.14 6.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.461 -0.775 . . . . 0.0 110.632 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.576 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 14.9 p-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.191 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.65 114.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -101.8 75.67 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -150.45 83.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' N ' ' CE ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER 55.75 176.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -102.59 -105.15 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.911 . . . . 0.0 110.345 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.603 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 58.94 -173.67 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.029 -1.044 . . . . 0.0 109.216 -179.124 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.4 Cg_endo -67.41 58.31 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.437 1.23 . . . . 0.0 109.845 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -54.98 -24.84 36.09 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 13.6 pttp -64.39 -9.62 19.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -175.58 89.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.972 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' HG ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -134.4 121.89 21.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.359 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.68 145.94 6.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 110.029 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.514 ' CD ' ' CZ ' ' A' ' 17' ' ' ARG . 25.0 mmt-85 -54.86 -19.18 5.97 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.556 HG22 ' CB ' ' A' ' 48' ' ' ARG . 3.0 mm -83.86 -49.82 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.484 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 7.0 m-20 -66.65 -33.41 75.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -74.42 -55.45 5.97 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 17.3 t-20 -58.53 -29.65 66.48 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 109.092 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 12.7 mt -67.52 -43.92 86.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.536 -0.728 . . . . 0.0 109.308 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD1' HD23 ' A' ' 52' ' ' LEU . 34.4 mt -66.14 -40.13 90.38 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.216 -0.927 . . . . 0.0 109.345 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.467 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 6.2 t-20 -67.77 -31.1 70.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.296 -0.877 . . . . 0.0 109.235 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -80.04 -36.01 36.36 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.493 -0.754 . . . . 0.0 109.614 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -69.18 -35.13 75.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.539 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.43 -39.27 67.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 2.3 tttt -82.0 -20.26 38.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.403 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 13.0 m-20 -144.88 53.06 1.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.019 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -47.01 -37.44 9.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -70.49 57.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.487 HG13 ' HB3' ' A' ' 33' ' ' GLU . 2.3 tt -141.6 135.9 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.522 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 33.2 t -82.35 -94.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.376 -0.828 . . . . 0.0 110.356 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 10.8 p-10 -140.1 -48.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.145 -0.972 . . . . 0.0 110.432 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' ASN . 77.9 t -42.0 -64.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.525 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB3' HG13 ' A' ' 29' ' ' ILE . 5.3 tp10 -63.24 -22.84 67.13 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.176 -0.953 . . . . 0.0 108.979 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -79.54 -15.12 58.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.637 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 13.8 p -87.89 -45.53 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 110.838 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 14.2 pttt -80.84 -38.16 28.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.096 -1.003 . . . . 0.0 110.952 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.487 ' HD2' ' HG3' ' A' ' 33' ' ' GLU . 39.2 mtt180 -57.38 -16.59 9.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 34' ' ' LEU . 2.1 m -108.98 -15.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.14 37.0 5.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' CD1' ' HA ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -149.19 160.97 42.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.954 -1.321 . . . . 0.0 110.559 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.471 ' C ' ' HB2' ' A' ' 35' ' ' SER . 20.5 m -66.69 159.41 74.69 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 108.766 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.585 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.46 -45.38 0.42 Allowed 'Trans proline' 0 C--N 1.286 -2.718 0 O-C-N 123.934 1.492 . . . . 0.0 110.551 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.563 ' CB ' ' CD ' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.98 -60.8 0.9 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.792 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 43' ' ' THR . 47.3 Cg_endo -73.9 -37.63 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.825 1.434 . . . . 0.0 110.175 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 42.4 t -38.63 -50.13 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.585 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -59.12 -52.8 64.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -43.65 -36.96 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.03 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.556 ' CB ' HG22 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -72.87 -60.1 2.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.547 ' CG1' HD22 ' A' ' 65' ' ' LEU . 2.2 t -54.29 -44.44 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 6.5 mmt85 -48.89 -50.04 36.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 109.636 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -50.57 -36.76 36.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.451 -0.78 . . . . 0.0 109.043 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 20' ' ' LEU . 70.4 mt -73.14 -19.37 61.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.482 -0.762 . . . . 0.0 110.028 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -74.97 -58.93 2.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 0.0 110.394 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.486 ' CD ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -51.78 -21.74 3.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.383 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 29.4 mm100 -91.27 17.25 8.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 110.268 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.21 49.77 54.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.565 ' CE2' ' HD3' ' A' ' 8' ' ' PRO . 7.3 m-85 -127.93 8.71 6.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.255 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.556 HG23 ' N ' ' A' ' 63' ' ' ALA . 6.9 mm -136.85 32.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.12 -8.73 57.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -132.93 -39.99 0.2 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.54 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 15.9 m-30 -58.36 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -1.137 . . . . 0.0 110.022 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.571 ' N ' HD11 ' A' ' 23' ' ' LEU . 8.0 t -89.31 35.1 0.8 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.02 -1.05 . . . . 0.0 110.031 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.556 ' N ' HG23 ' A' ' 58' ' ' ILE . . . -35.32 -32.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.5 OUTLIER -71.74 -140.92 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.669 -0.645 . . . . 0.0 109.428 177.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.698 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 54.59 12.02 0.5 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.073 -1.017 . . . . 0.0 110.23 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.883 -1.135 . . . . 0.0 110.304 179.298 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.0 m -60.21 118.44 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.285 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -79.41 125.08 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 1.1 t -143.36 162.65 35.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.404 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER 69.22 -58.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 17.2 mtpt 64.07 -66.05 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.967 . . . . 0.0 110.548 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.636 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER 45.62 -167.09 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.636 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 40.7 Cg_endo -72.74 58.7 3.3 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.358 1.189 . . . . 0.0 109.754 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . -40.51 -48.52 3.86 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -70.35 124.74 24.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 110.182 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 52.04 94.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 0.0 110.204 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' CG ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -133.79 145.97 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.461 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER -91.95 133.81 35.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -43.21 -34.69 1.19 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.531 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 5.0 mm -74.4 -21.99 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 110.642 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.53 ' CA ' HD13 ' A' ' 52' ' ' LEU . 66.4 m-20 -87.19 -56.96 3.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.109 -0.994 . . . . 0.0 110.522 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.74 -37.4 73.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.08 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.522 ' N ' ' HD3' ' A' ' 17' ' ' ARG . 17.7 t-20 -72.27 -42.67 65.32 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.356 -0.84 . . . . 0.0 109.132 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.531 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 9.0 mt -68.26 -31.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.282 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.561 ' HB3' ' CD ' ' A' ' 7' ' ' ARG . 15.5 mt -73.38 -40.64 64.18 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.314 -0.866 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.36 -27.96 66.71 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.312 -0.867 . . . . 0.0 109.295 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' OE1' ' NE ' ' A' ' 37' ' ' ARG . 22.4 mm-40 -80.34 -27.57 38.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.47 -0.769 . . . . 0.0 109.685 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 HD22 ' CD1' ' A' ' 34' ' ' LEU . 0.7 OUTLIER -72.0 -34.29 68.76 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.276 -0.89 . . . . 0.0 109.288 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -73.81 -40.85 63.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.756 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -74.26 -30.19 62.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.828 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.507 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -125.54 71.13 1.21 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.105 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -67.66 57.05 0.34 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -179.73 38.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 110.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.425 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 1.8 tt -119.42 135.4 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.428 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -81.81 158.74 23.98 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' SER . 16.3 m120 -50.09 -47.67 53.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 93.5 t -41.92 -63.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.079 -1.013 . . . . 0.0 109.495 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -62.55 -33.02 74.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.597 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -68.09 -14.59 63.09 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.416 0.627 . . . . 0.0 109.765 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.566 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 12.5 p -86.55 -51.16 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.456 -0.777 . . . . 0.0 110.785 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' OG ' ' A' ' 35' ' ' SER . 12.6 mttt -77.05 -16.38 59.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 0.0 111.227 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -79.75 -16.05 56.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.109 . . . . 0.0 110.513 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -110.21 -4.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.205 -0.934 . . . . 0.0 110.054 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.65 42.48 5.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.536 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -154.52 163.72 39.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.117 -1.225 . . . . 0.0 110.557 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.9 159.12 86.36 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 51.2 Cg_endo -74.46 -46.89 0.25 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 123.969 1.51 . . . . 0.0 110.467 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.534 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.04 -54.67 4.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.988 . . . . 0.0 109.458 178.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.7 Cg_endo -76.1 -42.27 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.027 1.541 . . . . 0.0 110.26 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.513 ' C ' ' O ' ' A' ' 44' ' ' PRO . 47.1 t -38.88 -48.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 108.7 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.58 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -61.22 -50.77 71.74 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 4.2 mt-10 -45.19 -34.26 2.67 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.876 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 0.8 OUTLIER -73.83 -52.16 13.96 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.679 0.752 . . . . 0.0 109.172 177.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.548 ' CG1' HD22 ' A' ' 65' ' ' LEU . 1.2 t -63.42 -47.56 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.925 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.543 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -48.32 -45.64 35.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.27 -41.15 68.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 177.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.546 HD11 ' CG ' ' A' ' 20' ' ' LEU . 95.9 mt -67.01 -27.01 67.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.438 -0.789 . . . . 0.0 109.866 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.426 ' HG3' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -63.08 -59.89 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.274 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.9 -24.46 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.525 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 15.1 mm-40 -92.2 11.43 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 110.292 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 61.12 54.98 32.14 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 11.9 m-85 -130.7 2.84 4.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 110.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.54 HG21 ' CD2' ' A' ' 65' ' ' LEU . 5.8 mm -132.04 34.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 110.24 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -80.6 -7.78 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.754 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -140.04 -37.21 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.536 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 15.3 m-30 -55.83 -111.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.028 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.525 HG23 ' CG2' ' A' ' 58' ' ' ILE . 4.8 t -87.59 27.79 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.037 -1.039 . . . . 0.0 109.928 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -38.85 -31.3 0.06 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.235 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -53.64 -28.41 32.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.687 0.756 . . . . 0.0 109.954 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HG ' ' N ' ' A' ' 66' ' ' ASN . 0.7 OUTLIER -41.42 -24.14 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.739 -0.601 . . . . 0.0 110.781 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.595 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 33.7 t-20 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.983 . . . . 0.0 110.283 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.266 0.555 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.05 -11.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.162 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 4' ' ' SER . 28.8 t0 -46.62 140.65 4.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.3 OUTLIER 66.1 111.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.36 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' CD ' ' HG2' ' A' ' 24' ' ' GLN . 1.8 mtpp -77.58 -63.63 1.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.291 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 2.3 ttmt -176.92 -129.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 110.244 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.616 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 63.29 -170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 120.991 -1.068 . . . . 0.0 108.991 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.9 Cg_endo -68.42 55.99 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.295 1.155 . . . . 0.0 109.941 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -48.66 -42.84 28.46 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 33.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.1 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 12' ' ' LEU . 0.7 OUTLIER -159.3 62.59 0.39 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 3.7 pp 175.46 -177.91 0.12 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.488 -0.757 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' CB ' ' OD1' ' A' ' 16' ' ' ASP . 2.9 t0 -96.06 161.22 14.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.323 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -57.08 -24.2 52.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 110.314 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.528 ' CG2' HD11 ' A' ' 40' ' ' LEU . 4.6 mm -74.47 -33.98 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.943 . . . . 0.0 110.527 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.524 ' CA ' HD12 ' A' ' 52' ' ' LEU . 4.3 m-20 -71.66 -59.95 2.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.472 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.519 ' HB3' HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -55.27 -43.74 75.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.023 . . . . 0.0 110.543 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 2.8 m120 -64.86 -37.61 88.22 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.17 -0.956 . . . . 0.0 109.276 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.483 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 9.5 mt -63.06 -38.91 83.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.39 -0.819 . . . . 0.0 109.356 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 90.4 mt -65.29 -41.2 94.37 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.11 -34.95 78.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.336 -0.852 . . . . 0.0 109.377 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 60.3 mm-40 -73.03 -41.83 63.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 109.601 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 61' ' ' TYR . 37.2 mt -66.85 -30.86 71.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 109.334 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.509 ' HG2' ' CD ' ' A' ' 5' ' ' LYS . 4.0 tp60 -66.18 -39.29 89.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 4.1 mtmp? -81.05 -18.61 46.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 25' ' ' LYS . 7.2 m-20 -140.85 94.5 2.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.81 . . . . 0.0 109.951 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.86 29.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -130.37 39.86 3.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 110.157 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 26' ' ' ASP . 5.4 tt -126.49 130.72 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 110.39 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 20.9 p -72.15 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' SER . 6.2 m-80 -112.61 -30.9 6.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.926 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 48.7 t -50.27 -63.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.173 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tp10 -62.21 -29.0 70.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.194 -0.941 . . . . 0.0 108.82 177.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.657 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -73.71 -14.78 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.459 0.647 . . . . 0.0 109.818 178.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.554 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 18.3 p -87.79 -45.81 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.497 -0.752 . . . . 0.0 111.004 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -82.55 -22.91 34.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 0.0 111.223 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -74.32 -15.68 60.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.014 -1.054 . . . . 0.0 110.552 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 ' O ' ' A' ' 34' ' ' LEU . 1.4 m -106.49 -13.12 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.424 -0.798 . . . . 0.0 109.969 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.93 40.09 3.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.559 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.52 168.83 24.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.037 -1.273 . . . . 0.0 110.654 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -76.05 158.88 81.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 108.876 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.572 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 48.3 Cg_endo -74.59 -43.8 0.44 Allowed 'Trans proline' 0 C--N 1.288 -2.616 0 O-C-N 123.964 1.507 . . . . 0.0 110.464 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.541 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.35 -55.51 4.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.973 . . . . 0.0 109.471 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.4 Cg_endo -76.29 -42.94 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.894 1.471 . . . . 0.0 110.126 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.1 t -39.8 -46.0 1.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.95 -1.094 . . . . 0.0 108.626 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -64.63 -49.54 70.63 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 17.3 mt-10 -46.22 -43.03 15.07 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.482 -0.887 . . . . 0.0 108.894 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.527 ' HD3' ' CG2' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -68.43 -45.76 71.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.367 -0.833 . . . . 0.0 109.153 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -63.87 -47.69 89.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.432 -0.793 . . . . 0.0 109.604 178.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.537 ' HD3' ' CD1' ' A' ' 65' ' ' LEU . 12.4 mmt85 -43.46 -55.69 4.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.838 . . . . 0.0 109.443 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -47.57 -43.48 25.41 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.869 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.524 HD12 ' CA ' ' A' ' 16' ' ' ASP . 30.2 mt -70.98 -41.97 70.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.758 . . . . 0.0 109.796 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.547 ' HA ' ' CG1' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.47 -57.66 9.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 110.138 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -54.81 -17.87 4.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.051 179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.498 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -89.77 9.91 25.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.94 44.16 47.22 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CD1' ' HD2' ' A' ' 7' ' ' ARG . 14.1 m-85 -135.28 12.03 3.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -1.165 . . . . 0.0 110.261 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.547 ' CG1' ' HA ' ' A' ' 53' ' ' GLU . 10.8 mm -141.99 48.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 110.316 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -92.26 -6.03 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.921 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -134.5 -41.25 0.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.536 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 19.9 m-85 -57.05 -111.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 109.914 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 64' ' ' LEU . 11.0 t -86.59 18.95 3.06 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.0 -1.062 . . . . 0.0 109.703 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -38.54 -30.04 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 62' ' ' THR . 1.7 pp -55.12 -33.76 63.14 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.537 ' CD1' ' HD3' ' A' ' 50' ' ' ARG . 1.9 pp -39.82 -26.39 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.709 -0.619 . . . . 0.0 110.596 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.8 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.277 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.06 169.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -154.25 19.75 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.359 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.33 -63.4 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.499 ' CE ' ' HA ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -60.49 145.4 48.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 2.7 mmtp -135.82 -89.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.453 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.625 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 50.77 -165.37 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.625 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.3 Cg_endo -74.21 58.43 4.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.303 1.159 . . . . 0.0 109.978 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.83 63.98 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -65.44 -8.3 18.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -1.19 . . . . 0.0 109.98 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.6 OUTLIER -164.12 77.47 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.536 ' HG ' ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -129.22 144.94 51.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.657 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.475 ' N ' HD21 ' A' ' 12' ' ' LEU . 24.4 t0 -66.04 137.44 57.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.92 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 3.5 mmt180 -52.62 -29.03 23.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.344 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' CB ' ' HD2' ' A' ' 48' ' ' ARG . 9.0 mm -80.37 -29.88 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.616 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 5.2 m-20 -82.19 -36.92 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 2.9 ptt180 -70.62 -44.21 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 22.6 m-20 -67.78 -36.22 80.08 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.536 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 24.7 mt -68.76 -37.79 77.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.475 HD11 HD23 ' A' ' 52' ' ' LEU . 11.9 mt -65.67 -36.87 84.89 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.349 -0.845 . . . . 0.0 109.249 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.499 ' HA ' ' CE ' ' A' ' 5' ' ' LYS . 8.0 t30 -67.56 -35.48 79.12 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.394 -0.816 . . . . 0.0 109.198 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.498 ' OE1' ' CG1' ' A' ' 38' ' ' VAL . 7.1 mt-10 -72.87 -40.15 65.88 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.452 -0.78 . . . . 0.0 109.764 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.567 HD22 ' N ' ' A' ' 62' ' ' THR . 34.7 mt -66.89 -37.05 83.66 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.22 -0.925 . . . . 0.0 109.306 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' OE1' ' OH ' ' A' ' 61' ' ' TYR . 64.7 tp60 -63.44 -40.67 97.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.399 -0.813 . . . . 0.0 109.235 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 -25.3 44.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.32 96.36 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.63 39.48 3.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -153.74 21.35 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -1.114 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 34' ' ' LEU . 4.5 tt -101.84 140.22 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 31' ' ' ASN . 13.5 t -84.92 -120.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.567 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 7.6 p30 -120.8 -46.44 2.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.0 t -45.22 -60.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.283 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.3 tt0 -62.04 -30.34 70.91 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.216 -0.928 . . . . 0.0 108.989 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.608 ' O ' HG22 ' A' ' 38' ' ' VAL . 6.4 tp -74.67 -16.19 60.77 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.58 -0.7 . . . . 0.0 110.063 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 11.6 p -84.37 -37.97 20.89 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.412 -0.805 . . . . 0.0 110.279 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -87.13 -17.9 31.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.449 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -75.1 -18.02 60.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.503 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 34' ' ' LEU . 0.2 OUTLIER -111.46 -11.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 121.405 -0.81 . . . . 0.0 109.731 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.62 41.36 4.77 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -148.02 168.57 21.98 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.998 -1.295 . . . . 0.0 110.466 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 3.5 m -72.75 154.82 91.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 108.872 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 48.3 Cg_endo -72.53 -48.31 0.33 Allowed 'Trans proline' 0 C--N 1.288 -2.642 0 O-C-N 123.961 1.506 . . . . 0.0 110.733 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.27 -54.22 4.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.179 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.3 Cg_endo -76.02 -41.01 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.977 1.514 . . . . 0.0 110.134 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' A' ' 40' ' ' LEU . 50.6 t -39.89 -46.19 1.96 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.043 . . . . 0.0 108.731 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.04 -49.28 75.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -46.3 -41.84 13.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.898 177.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.55 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 0.3 OUTLIER -67.57 -56.62 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.565 HG13 ' CG2' ' A' ' 62' ' ' THR . 1.4 t -55.71 -51.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 3.0 mmt85 -40.94 -49.92 3.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.533 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -49.82 -44.25 49.18 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 49' ' ' VAL . 49.3 mt -67.22 -20.29 65.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.769 . . . . 0.0 109.881 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.471 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.72 -64.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -46.31 -23.92 0.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.299 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 20.7 mm-40 -85.97 11.06 12.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 59.5 54.38 38.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.434 ' CD2' ' HB3' ' A' ' 55' ' ' GLN . 12.4 m-85 -139.53 9.82 2.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -1.2 . . . . 0.0 110.339 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.575 ' CG2' HG23 ' A' ' 62' ' ' THR . 10.3 mm -136.72 29.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.29 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -83.1 -9.4 59.23 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.402 -0.811 . . . . 0.0 109.666 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -125.4 -41.74 0.35 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.517 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 8.7 m-30 -57.32 -113.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.575 HG23 ' CG2' ' A' ' 58' ' ' ILE . 2.6 t -89.9 27.28 1.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -38.46 -29.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.407 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 62' ' ' THR . 3.6 pp -53.47 -34.28 57.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 110.043 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.658 HD11 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.75 -6.46 15.94 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.604 -0.685 . . . . 0.0 110.497 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.547 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 8.0 t30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.191 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.192 0.52 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 3' ' ' ASP . 98.0 t -58.4 144.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' HG11 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -147.28 107.06 3.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.2 102.58 6.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -171.6 58.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.263 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HG2' ' CD1' ' A' ' 12' ' ' LEU . 7.1 ttmt -177.06 58.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -54.03 -60.95 6.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.127 -0.983 . . . . 0.0 109.944 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 47.1 Cg_endo -74.16 53.6 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.935 1.492 . . . . 0.0 110.022 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . -52.85 -168.65 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 9' ' ' GLY . 2.1 tttm 66.24 -129.51 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 109.974 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.85 89.48 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 110.264 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -117.05 133.11 56.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -59.53 128.33 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -47.11 -46.01 22.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 110.351 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.566 ' HB ' ' CD ' ' A' ' 48' ' ' ARG . 20.5 mm -65.88 -17.1 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 110.66 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.472 ' OD2' ' HG2' ' A' ' 51' ' ' ARG . 20.4 m-20 -84.04 -62.71 1.5 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.059 -1.026 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.84 -45.23 67.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.128 -0.982 . . . . 0.0 110.022 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.51 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -64.66 -42.36 95.46 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 109.285 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 1.3 mt -58.74 -35.0 53.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.36 -0.838 . . . . 0.0 109.347 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 67.2 mt -67.06 -45.24 77.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.45 -27.06 68.73 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.219 -0.926 . . . . 0.0 109.245 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 11.9 mm-40 -85.37 -43.67 13.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.516 -0.74 . . . . 0.0 110.147 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -65.77 -20.28 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 109.558 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' HB2' ' HE3' ' A' ' 5' ' ' LYS . 3.6 tp60 -85.58 -41.32 15.36 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 1.3 ptmt -60.5 -30.78 69.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 27.0 p30 -150.87 71.23 1.02 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.09 -23.42 1.65 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' CD ' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.08 9.31 4.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.366 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.53 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 7.1 tt -76.53 153.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.878 . . . . 0.0 110.454 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.537 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 2.3 m -104.6 155.58 18.72 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' SER . 5.3 p-10 -46.25 -47.36 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.128 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.488 ' O ' ' OG ' ' A' ' 35' ' ' SER . 4.7 t -49.65 -55.45 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.935 -1.103 . . . . 0.0 108.881 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.4 tt0 -67.21 -32.38 73.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -68.53 -20.04 64.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.59 0.71 . . . . 0.0 109.486 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' ASN . 25.3 p -83.47 -46.2 12.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.557 -0.714 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -82.25 -27.1 32.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -58.37 -24.54 60.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.224 -0.923 . . . . 0.0 109.736 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.654 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.0 -3.87 10.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 178.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.29 46.76 5.73 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.654 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -150.24 156.65 41.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.273 . . . . 0.0 111.019 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.493 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -62.65 153.31 78.69 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 46.2 Cg_endo -72.86 -41.93 1.27 Allowed 'Trans proline' 0 C--N 1.283 -2.887 0 O-C-N 123.842 1.443 . . . . 0.0 110.682 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -56.03 2.75 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.606 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' A' ' 47' ' ' GLU . 49.8 Cg_endo -74.74 -37.76 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.9 1.473 . . . . 0.0 110.121 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.57 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 48.5 t -41.85 -45.89 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.029 -1.044 . . . . 0.0 108.651 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.96 -43.27 93.23 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' PRO . 58.2 mt-10 -55.0 -43.69 73.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.566 ' CD ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.83 -44.65 76.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.636 0.731 . . . . 0.0 109.189 178.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' ' C ' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -62.8 -50.41 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -0.833 . . . . 0.0 109.599 178.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.601 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -41.85 -51.37 4.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -51.35 -45.1 62.22 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.134 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.548 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 16.5 mt -72.19 -23.5 61.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.472 ' CG ' ' HA ' ' A' ' 61' ' ' TYR . 13.0 tm-20 -58.14 -48.94 78.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -0.791 . . . . 0.0 110.098 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -65.18 -17.24 64.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.512 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 77.2 mm-40 -79.81 8.61 6.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.73 31.35 71.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.548 ' CE1' ' HG2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -112.86 4.05 16.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -1.142 . . . . 0.0 109.999 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.583 ' CG2' ' O ' ' A' ' 61' ' ' TYR . 1.1 mt -150.24 124.18 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.36 -0.838 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -86.94 84.74 7.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.113 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 62' ' ' THR . . . 111.32 52.91 0.54 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.601 ' CD1' ' HD2' ' A' ' 50' ' ' ARG . 96.1 m-85 57.58 -82.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.324 -1.104 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 65' ' ' LEU . 1.4 p -91.12 1.11 57.33 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.107 -0.996 . . . . 0.0 109.274 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.582 ' HB1' ' CG2' ' A' ' 58' ' ' ILE . . . 71.11 29.17 2.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.456 0.646 . . . . 0.0 109.949 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 0.8 OUTLIER 176.12 -30.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.905 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.592 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 0.0 OUTLIER -50.44 -19.16 0.78 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.668 -0.645 . . . . 0.0 110.254 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.514 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.3 t-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.338 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' VAL . 6.1 ttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.271 0.558 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' MET . 47.3 t -42.47 -43.67 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER 62.36 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.9 m -88.36 30.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 5.3 ttpt -62.46 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -119.32 -40.03 2.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.64 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 41.64 -162.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.403 -0.811 . . . . 0.0 109.142 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.7 Cg_endo -75.14 58.08 4.86 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.235 1.124 . . . . 0.0 109.788 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 10' ' ' LYS . . . -38.52 -29.81 0.08 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -60.16 -131.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.948 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.73 87.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.042 -1.036 . . . . 0.0 110.014 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -110.59 149.58 30.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ASP . 10.4 t70 -85.85 131.64 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -40.88 -45.59 2.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.36 -0.837 . . . . 0.0 110.565 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.518 HG13 HD22 ' A' ' 40' ' ' LEU . 6.4 mm -70.19 -26.34 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 28.1 m-20 -72.51 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 0.0 110.303 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -35.92 68.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 109.985 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 3.5 t-20 -71.32 -42.86 68.06 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.783 . . . . 0.0 109.095 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 15' ' ' ILE . 14.0 mt -66.31 -34.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.51 ' CD1' HD23 ' A' ' 52' ' ' LEU . 49.0 mt -72.18 -39.89 68.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.401 -0.812 . . . . 0.0 109.433 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.67 -37.07 84.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.528 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -73.88 -33.08 63.91 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.466 -0.771 . . . . 0.0 109.473 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 61' ' ' TYR . 17.5 mt -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 3.5 tm0? -73.66 -44.74 55.94 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.521 -0.737 . . . . 0.0 109.739 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -70.21 -32.33 70.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.603 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 29' ' ' ILE . 5.9 m-20 -130.05 86.17 2.37 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.84 0.71 50.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' C ' ' HD3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -111.03 31.9 5.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.165 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.488 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 14.9 tt -115.84 144.88 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.575 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 44.8 t -87.96 -110.92 0.06 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 110.408 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.572 ' O ' ' N ' ' A' ' 35' ' ' SER . 4.5 p-10 -124.88 -50.33 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 31' ' ' ASN . 69.5 t -41.17 -64.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 37' ' ' ARG . 4.1 tp10 -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.224 -0.922 . . . . 0.0 108.851 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 38' ' ' VAL . 1.1 tt -67.8 -23.57 65.21 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.557 -0.714 . . . . 0.0 109.609 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -78.57 -41.88 30.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.437 -0.789 . . . . 0.0 110.286 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -67.09 -28.31 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 1.1 mmt180 -73.03 -17.81 61.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 34' ' ' LEU . 3.6 t -107.23 11.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.914 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.47 18.05 21.3 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 41' ' ' SER . 15.0 tp -123.4 134.95 53.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -1.003 . . . . 0.0 110.203 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.548 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.8 m -47.0 158.7 0.42 Allowed Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.735 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.6 -42.58 0.82 Allowed 'Trans proline' 0 C--N 1.285 -2.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.39 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.529 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.41 -55.54 3.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.32 178.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 44.4 Cg_endo -74.26 -50.37 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.91 1.479 . . . . 0.0 110.136 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.512 ' C ' ' O ' ' A' ' 44' ' ' PRO . 39.4 t -38.19 -46.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 108.873 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.559 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -63.42 -53.05 58.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 1.3 mt-10 -46.29 -46.01 17.73 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.955 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.495 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -68.22 -43.83 77.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.576 -0.702 . . . . 0.0 109.33 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -62.87 -43.81 99.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.531 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 18.7 mmm-85 -51.36 -46.48 62.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.576 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.59 -34.08 64.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.862 178.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.576 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 5.2 mt -76.68 -19.05 58.17 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.743 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.485 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.55 -59.92 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 110.197 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -54.19 -22.97 12.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.56 11.44 7.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 51.43 59.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CE2' ' HD3' ' A' ' 8' ' ' PRO . 13.4 m-85 -134.29 6.58 3.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -1.129 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.555 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 6.3 mm -137.17 38.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.266 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -1.27 57.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 109.611 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -138.32 -39.89 0.11 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.529 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 14.0 m-30 -58.59 -114.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -1.12 . . . . 0.0 109.898 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 64' ' ' LEU . 14.2 t -87.1 23.03 1.89 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -34.53 -32.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.548 0.689 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -58.67 -110.92 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.574 -0.704 . . . . 0.0 109.434 177.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER 34.95 30.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 110.46 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.556 ' N ' ' O ' ' A' ' 64' ' ' LEU . 7.2 t30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.287 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.292 0.568 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 2' ' ' VAL . 7.8 p -65.8 139.9 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 4' ' ' SER . 2.7 p30 -69.52 -33.33 72.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.262 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.522 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER 55.51 77.51 0.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.325 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -135.04 32.42 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 110.193 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.09 63.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.506 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.549 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 2.1 ttt180 -64.46 -56.95 19.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 109.796 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 48.4 Cg_endo -74.95 44.64 1.19 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.427 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 12' ' ' LEU . . . -50.27 -37.46 31.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 17.6 ttpt -66.54 -8.3 25.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.179 . . . . 0.0 110.145 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.92 84.91 1.02 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -0.788 . . . . 0.0 110.012 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.45 HD11 ' HA2' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -140.61 86.05 2.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 110.363 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -42.63 145.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.109 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 8.4 mmt180 -47.3 -22.81 0.45 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.333 -0.855 . . . . 0.0 110.284 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.597 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -80.51 -44.35 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 110.129 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' OD2' ' O ' ' A' ' 48' ' ' ARG . 2.7 m-20 -58.55 -44.87 89.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.161 -0.962 . . . . 0.0 109.901 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -65.93 -47.82 73.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.915 . . . . 0.0 109.799 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.539 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 1.5 m-20 -61.87 -41.79 98.27 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.388 -0.82 . . . . 0.0 108.879 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.528 HG22 ' CG2' ' A' ' 49' ' ' VAL . 7.6 mt -62.09 -41.06 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.462 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.537 ' CD1' HD22 ' A' ' 52' ' ' LEU . 13.8 mt -70.34 -40.94 73.82 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.1 t-20 -66.41 -34.39 77.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 6.2 mm-40 -76.32 -29.49 57.34 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.424 -0.797 . . . . 0.0 109.696 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 21.5 mt -72.48 -32.7 66.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.538 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 1.4 tp60 -79.24 -42.52 25.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -67.03 -33.69 76.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -141.34 63.37 1.44 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.911 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.01 -161.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.06 30.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -1.194 . . . . 0.0 109.946 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.515 HD12 ' NH2' ' A' ' 37' ' ' ARG . 4.9 tt -117.43 131.9 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.361 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 37.0 t -67.73 168.88 10.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.954 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.6 OUTLIER -65.37 -39.91 92.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.36 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 31' ' ' ASN . 46.6 t -44.54 -61.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 109.221 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.99 -33.66 74.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.307 -0.87 . . . . 0.0 108.751 177.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.556 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -67.95 -20.39 65.05 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.525 0.678 . . . . 0.0 109.674 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 8.4 p -87.77 -24.39 23.8 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.41 -0.806 . . . . 0.0 110.488 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -79.25 -33.14 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.71 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.554 ' CD ' ' HA ' ' A' ' 34' ' ' LEU . 4.4 ptm180 -81.67 -16.04 52.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.074 -1.016 . . . . 0.0 110.745 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.556 ' CG2' ' O ' ' A' ' 34' ' ' LEU . 4.5 t -97.66 12.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.207 -0.933 . . . . 0.0 110.144 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.98 21.76 8.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 41' ' ' SER . 15.2 tp -127.83 133.37 49.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.52 -0.988 . . . . 0.0 110.253 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.577 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -47.81 160.63 0.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 120.993 -1.067 . . . . 0.0 108.536 177.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.9 Cg_endo -73.92 -45.57 0.37 Allowed 'Trans proline' 0 C--N 1.282 -2.935 0 O-C-N 123.651 1.343 . . . . 0.0 110.654 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.538 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -38.73 -53.18 3.44 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 109.643 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 43' ' ' THR . 44.6 Cg_endo -75.45 -49.01 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.044 1.549 . . . . 0.0 109.77 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 12.8 t -43.62 -37.87 2.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.047 -1.033 . . . . 0.0 108.494 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.567 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 1.5 mt -70.77 -45.87 63.95 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 70.8 mt-10 -49.79 -46.3 50.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.088 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.567 ' HG2' ' HB ' ' A' ' 15' ' ' ILE . 3.6 mpt_? -69.69 -36.48 76.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -71.66 -47.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.272 -0.893 . . . . 0.0 110.017 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -48.25 -48.06 35.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 51' ' ' ARG . 2.4 tpp180 -53.38 -45.91 69.41 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.903 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD22 ' CD1' ' A' ' 20' ' ' LEU . 78.1 mt -67.59 -16.59 64.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -58.89 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 110.254 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.434 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 61.4 mtt85 -73.75 -21.81 60.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 110.372 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HG2' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -148.51 53.74 1.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -161.71 -123.58 0.67 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 63.4 m-85 -146.96 76.16 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 5.5 mm -137.0 24.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.63 1.47 38.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.506 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -145.5 -39.91 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 93.0 m-85 -56.18 -110.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -1.081 . . . . 0.0 109.904 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.543 HG21 ' CG2' ' A' ' 58' ' ' ILE . 2.7 t -85.28 21.06 1.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.893 -1.129 . . . . 0.0 109.695 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.503 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -39.32 -28.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.484 -0.76 . . . . 0.0 109.224 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 62' ' ' THR . 2.0 pp -54.28 -34.21 60.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.615 0.721 . . . . 0.0 110.035 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.693 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -65.35 -5.81 8.37 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.632 -0.668 . . . . 0.0 110.656 -179.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.557 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 3.7 p30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.218 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.212 0.53 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -108.28 146.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.376 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.35 107.6 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.4 p -121.87 40.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.307 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -106.62 22.96 15.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 110.329 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' ARG . 38.9 mtpt -89.91 -11.54 41.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.684 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 15.9 mmm180 43.83 -156.03 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.122 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.684 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 43.0 Cg_endo -77.83 20.41 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.129 1.068 . . . . 0.0 110.305 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . 41.51 -98.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.46 79.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 110.402 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 12' ' ' LEU . 0.6 OUTLIER 175.0 32.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.51 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 2.4 pp 179.99 156.88 0.66 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.423 -0.798 . . . . 0.0 110.312 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 5.1 t70 -89.92 156.0 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.52 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 9.4 mmt180 -48.18 -25.64 1.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.322 -0.861 . . . . 0.0 110.346 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.559 HG23 ' CG ' ' A' ' 48' ' ' ARG . 19.2 mm -69.93 -33.57 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.265 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.576 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 1.4 m-20 -73.81 -59.45 2.71 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -53.6 -33.4 54.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.812 179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 59.8 t-20 -70.27 -43.12 71.12 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.384 -0.822 . . . . 0.0 109.192 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.502 ' CG2' HG21 ' A' ' 49' ' ' VAL . 40.4 mt -61.75 -35.92 70.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.494 ' HG ' HD12 ' A' ' 52' ' ' LEU . 20.2 mt -67.33 -43.63 81.11 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.285 -0.885 . . . . 0.0 109.286 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.527 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 11.1 t30 -58.67 -32.83 69.48 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.478 ' HB3' HD21 ' A' ' 34' ' ' LEU . 22.3 mm-40 -75.42 -45.09 41.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.853 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 23' ' ' LEU . 2.1 mm? -57.6 -44.14 85.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.659 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -68.04 -40.42 82.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.377 -0.827 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 27.6 mtpt -68.66 -20.16 64.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.909 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' ARG . 35.1 m-20 -147.4 79.23 1.49 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 110.188 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.88 58.36 0.21 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -178.26 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -1.181 . . . . 0.0 110.008 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.561 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.7 tt -122.35 147.04 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 9.1 p -87.83 -167.11 1.78 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.108 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 34' ' ' LEU . 12.9 m-80 -78.78 -49.97 12.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -0.919 . . . . 0.0 110.333 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.6 t -40.02 -57.78 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 109.706 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -61.66 -33.5 74.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.186 -0.946 . . . . 0.0 108.759 177.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -67.16 -57.86 5.95 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 178.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.555 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 3.1 p -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.608 -0.682 . . . . 0.0 110.29 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -80.11 -22.99 41.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' A' ' 34' ' ' LEU . 12.5 mmt180 -78.33 -17.86 55.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 40' ' ' LEU . 3.2 m -105.88 -12.33 9.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 39.85 5.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.76 169.19 23.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.016 -1.284 . . . . 0.0 110.775 179.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.2 154.09 94.01 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.4 Cg_endo -73.58 -44.0 0.57 Allowed 'Trans proline' 0 C--N 1.287 -2.698 0 O-C-N 124.004 1.529 . . . . 0.0 110.802 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.94 -56.26 1.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 53.8 Cg_endo -77.52 -42.57 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.93 1.49 . . . . 0.0 110.174 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.518 ' C ' ' O ' ' A' ' 44' ' ' PRO . 36.9 t -37.4 -50.39 1.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 108.877 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.34 -51.77 68.11 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.7 mm-40 -44.89 -41.22 6.96 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.303 -0.873 . . . . 0.0 108.949 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' CG ' HG23 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.97 -45.33 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.528 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -62.54 -44.59 99.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 178.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.528 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 8.2 mmm180 -48.96 -47.39 44.02 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.339 -0.851 . . . . 0.0 109.019 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.533 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -50.5 -40.66 51.88 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.576 ' CD1' ' HB3' ' A' ' 16' ' ' ASP . 90.1 mt -75.44 -37.52 60.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.577 -0.702 . . . . 0.0 109.667 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 58' ' ' ILE . 7.1 tp10 -73.25 -26.6 61.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 110.337 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -68.66 -42.12 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.209 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' OE1' ' CG ' ' A' ' 57' ' ' PHE . 6.2 pt20 -76.99 2.09 15.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.64 8.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.6 ' CD2' ' CZ ' ' A' ' 7' ' ' ARG . 1.3 m-85 -119.28 11.01 12.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -1.183 . . . . 0.0 110.152 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.536 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 15.0 mm -136.04 26.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.097 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.4 0.21 20.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.365 -0.834 . . . . 0.0 109.917 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -140.97 -42.86 0.07 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.5 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 94.2 m-85 -57.41 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -1.109 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.515 ' CG2' HG22 ' A' ' 49' ' ' VAL . 5.1 t -87.33 26.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.903 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -37.97 -32.1 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.521 -0.737 . . . . 0.0 109.444 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -53.83 -27.49 29.93 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.741 0.781 . . . . 0.0 109.872 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.571 ' HG ' ' N ' ' A' ' 66' ' ' ASN . 1.1 pp -40.03 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.741 -0.599 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.571 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 2.0 t-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tmm? . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.186 0.517 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t 61.27 -139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.364 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.59 -157.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 10.3 m -112.05 175.54 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.568 ' HD3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER 57.78 101.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 7' ' ' ARG . 1.8 ptpt -133.37 4.7 3.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.243 -0.911 . . . . 0.0 110.419 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.691 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 41.85 -159.33 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 108.932 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.691 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 41.2 Cg_endo -73.75 4.46 4.08 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.065 1.034 . . . . 0.0 109.658 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.574 ' N ' HD12 ' A' ' 12' ' ' LEU . . . 54.01 167.12 0.02 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 9' ' ' GLY . 1.7 tttt 58.86 127.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -1.097 . . . . 0.0 110.495 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' LYS . 1.5 t70 40.5 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.482 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 9' ' ' GLY . 0.2 OUTLIER -136.77 113.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.273 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 15' ' ' ILE . 1.4 m-20 -64.05 130.18 42.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.943 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 6.7 mmt-85 -46.03 -22.33 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 110.358 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.552 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 6.6 mm -73.48 -34.43 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.462 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.525 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -78.0 -45.02 24.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.522 ' CG ' ' HG3' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -63.52 -51.87 63.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.954 . . . . 0.0 110.0 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.555 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 7.8 t-20 -60.85 -40.45 92.91 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.385 -0.822 . . . . 0.0 109.332 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.552 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 10.5 mt -64.77 -38.5 82.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.282 -0.887 . . . . 0.0 109.559 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.563 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 14.4 mt -73.38 -35.24 65.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.351 -0.843 . . . . 0.0 109.307 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.568 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 49.5 t30 -72.69 -31.15 64.82 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.43 -0.794 . . . . 0.0 109.453 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 5.6 mm-40 -72.13 -32.85 67.32 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.402 -0.811 . . . . 0.0 109.86 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' CD1' ' OG1' ' A' ' 62' ' ' THR . 4.3 mt -69.89 -36.41 75.41 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.203 -0.936 . . . . 0.0 109.488 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.501 ' HB2' ' HE3' ' A' ' 5' ' ' LYS . 2.8 tp-100 -64.07 -42.97 96.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -69.49 -28.9 66.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.435 178.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -133.41 76.12 1.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 110.055 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.76 58.82 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.57 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -1.114 . . . . 0.0 110.182 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.478 HD13 ' NH1' ' A' ' 37' ' ' ARG . 5.5 tt -112.17 141.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.537 ' HA ' HD12 ' A' ' 64' ' ' LEU . 17.6 m -77.9 -138.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.417 -0.802 . . . . 0.0 110.138 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -108.86 -41.1 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' ASN . 76.2 t -44.43 -62.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 109.355 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 1.1 tp10 -61.84 -26.44 68.13 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.613 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -78.54 -15.28 58.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.697 -0.627 . . . . 0.0 110.071 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.574 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 23.6 p -87.93 -44.67 10.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.819 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 7.8 pttt -79.84 -41.05 27.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 111.126 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 13.9 ptm180 -63.01 -16.2 58.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.065 -1.022 . . . . 0.0 110.628 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.613 HG21 ' O ' ' A' ' 34' ' ' LEU . 14.5 m -98.51 -22.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.358 -0.838 . . . . 0.0 110.005 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.97 35.38 3.46 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.585 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -153.36 169.02 24.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.019 -1.283 . . . . 0.0 110.624 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.0 m -74.17 158.75 85.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.747 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 49.9 Cg_endo -74.16 -49.75 0.18 Allowed 'Trans proline' 0 C--N 1.286 -2.72 0 O-C-N 123.9 1.473 . . . . 0.0 110.565 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.559 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.92 -53.67 3.43 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.428 179.142 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 50.3 Cg_endo -76.46 -41.69 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.898 1.473 . . . . 0.0 110.219 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' CB ' HD13 ' A' ' 40' ' ' LEU . 53.8 t -40.33 -51.19 2.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 108.718 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.58 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.25 -47.4 81.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -46.4 -38.83 9.52 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.864 177.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.527 ' HD2' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.36 -46.91 53.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.535 -0.728 . . . . 0.0 109.266 178.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 50' ' ' ARG . 0.6 OUTLIER -65.77 -51.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.473 -0.767 . . . . 0.0 109.96 178.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.569 ' N ' ' CG1' ' A' ' 49' ' ' VAL . 2.4 mmm180 -46.07 -44.11 15.18 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -54.44 -44.75 72.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.563 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 61.0 mt -65.08 -16.69 63.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.469 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.99 -58.56 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.243 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 2.6 ptp180 -49.19 -27.94 4.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.438 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 73.5 mm-40 -81.77 10.87 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.74 93.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 7' ' ' ARG . 0.3 OUTLIER -129.85 15.44 5.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.353 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 6.0 mm -138.41 47.48 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -13.41 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.12 -43.75 0.1 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' A' ' 23' ' ' LEU . 62.9 m-85 -55.97 -100.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -1.061 . . . . 0.0 109.959 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.556 ' OG1' ' CD1' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.33 13.02 7.06 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.947 -1.096 . . . . 0.0 110.199 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 58' ' ' ILE . . . -39.71 -29.95 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.779 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -63.77 -120.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.812 . . . . 0.0 109.98 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.547 ' HB2' HD23 ' A' ' 46' ' ' LEU . 0.2 OUTLIER 40.06 28.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 110.319 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.1 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.288 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.159 0.504 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.23 -26.88 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 110.257 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 4' ' ' SER . 0.2 OUTLIER -165.79 -77.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 3.0 p 175.1 128.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.417 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -84.77 50.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.477 ' C ' ' HD3' ' A' ' 7' ' ' ARG . 12.0 mtpp -98.32 -58.48 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.552 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.619 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 43.22 -161.98 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.389 -0.819 . . . . 0.0 108.887 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 43.7 Cg_endo -77.33 52.06 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.183 1.096 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.28 -36.39 10.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -58.3 -15.26 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 0.0 110.041 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.39 79.17 1.39 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.993 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 140.42 24.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.316 -0.865 . . . . 0.0 110.401 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.72 173.29 6.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -80.01 -22.3 42.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.264 -0.897 . . . . 0.0 110.362 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.551 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 13.4 mm -78.87 -29.68 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 48' ' ' ARG . 85.3 m-20 -81.56 -39.91 23.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.073 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -51.68 56.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.214 -0.929 . . . . 0.0 110.032 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.559 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -62.84 -39.43 94.34 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.404 -0.81 . . . . 0.0 109.363 178.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.551 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 8.0 mt -64.07 -38.25 81.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.453 -0.779 . . . . 0.0 109.56 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.539 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 12.9 mt -70.03 -37.42 75.59 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 26.2 m-20 -70.83 -29.32 65.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.845 . . . . 0.0 109.603 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.575 ' CB ' ' CZ ' ' A' ' 37' ' ' ARG . 6.2 mm-40 -82.23 -29.14 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.445 -0.785 . . . . 0.0 109.848 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.576 HD11 ' N ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -66.96 -37.36 84.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -42.48 33.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 1.5 pttt -75.17 -29.71 60.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.995 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -133.14 53.31 2.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.134 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -53.54 -169.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.32 16.84 1.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -1.143 . . . . 0.0 110.197 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.588 ' CD1' ' NH1' ' A' ' 37' ' ' ARG . 12.9 tt -102.64 134.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 110.124 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 36.5 m -75.02 -131.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.403 -0.81 . . . . 0.0 110.502 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 35' ' ' SER . 26.5 p-10 -111.78 -47.02 3.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.217 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t -43.1 -67.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.976 -1.078 . . . . 0.0 109.276 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' O ' ' HD3' ' A' ' 37' ' ' ARG . 3.4 tp10 -56.34 -25.95 50.84 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.203 -0.936 . . . . 0.0 108.665 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -77.64 -18.73 56.46 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.41 0.624 . . . . 0.0 109.906 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.58 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 6.4 p -90.33 -47.75 7.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.532 -0.73 . . . . 0.0 110.864 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 35' ' ' SER . 10.6 ttmt -79.21 -24.83 42.85 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 111.288 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.588 ' NH1' ' CD1' ' A' ' 29' ' ' ILE . 28.4 ptt180 -75.8 -14.91 60.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 110.62 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -107.64 -11.02 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 110.071 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 42.12 4.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.523 ' CD1' ' HA ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -155.79 167.38 30.58 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.064 -1.256 . . . . 0.0 110.852 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.2 m -72.98 156.71 89.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.02 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.58 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 48.8 Cg_endo -74.18 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.635 0 O-C-N 123.972 1.512 . . . . 0.0 110.826 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.54 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -39.38 -53.86 3.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 109.421 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' GLU . 49.1 Cg_endo -77.24 -42.53 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.021 1.537 . . . . 0.0 110.335 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 44.6 t -38.47 -53.38 1.55 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 0.0 108.866 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.557 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -55.25 -49.63 71.54 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.25 -38.04 1.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.958 177.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.51 -49.29 27.34 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.627 0.727 . . . . 0.0 109.173 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -63.49 -40.49 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.577 ' N ' HG13 ' A' ' 49' ' ' VAL . 4.2 mmm180 -53.86 -46.17 71.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.081 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -52.04 -42.16 62.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.539 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 64.4 mt -70.77 -22.4 62.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.546 -0.721 . . . . 0.0 109.781 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.488 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 2.8 tm-20 -68.5 -69.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.6 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -52.95 -19.38 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 110.639 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 8.7 mm100 -86.54 13.41 8.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.01 . . . . 0.0 110.481 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 61.84 51.42 57.39 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CE2' ' HD3' ' A' ' 8' ' ' PRO . 21.3 m-85 -139.94 9.38 2.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -1.218 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 8.5 mm -140.79 31.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.267 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -84.44 -3.8 58.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -138.27 -42.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.514 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 14.5 m-30 -55.86 -108.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -1.088 . . . . 0.0 109.885 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.576 ' N ' HD11 ' A' ' 23' ' ' LEU . 4.7 t -88.15 22.46 2.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.931 -1.106 . . . . 0.0 109.807 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -37.87 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -54.41 -30.91 53.9 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.596 0.713 . . . . 0.0 110.008 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.703 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.02 -3.19 4.92 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.561 -0.712 . . . . 0.0 110.545 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.533 ' N ' HD13 ' A' ' 65' ' ' LEU . 5.2 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.256 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 tpt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.243 0.544 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.456 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 21.7 t -76.25 -27.34 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 10.4 t0 66.65 117.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.388 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.41 -163.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.539 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -88.46 41.86 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.221 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 3.3 mtpm? 58.03 -113.87 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.88 . . . . 0.0 110.572 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.598 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 64.47 -171.5 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.988 -1.07 . . . . 0.0 109.112 -178.847 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.1 Cg_endo -70.28 55.24 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.398 1.209 . . . . 0.0 109.774 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.84 -33.66 6.7 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -59.14 -17.04 23.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -1.166 . . . . 0.0 110.01 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -149.68 81.01 1.39 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 109.957 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.538 ' HB3' ' CG ' ' A' ' 17' ' ' ARG . 0.4 OUTLIER -146.98 144.36 29.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 -179.319 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -80.59 127.76 32.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.208 -0.933 . . . . 0.0 109.661 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -40.54 -27.49 0.05 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.361 -0.837 . . . . 0.0 110.41 -179.133 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 8.5 mm -72.97 -46.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 110.421 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.523 ' O ' HD12 ' A' ' 52' ' ' LEU . 1.4 m-20 -68.93 -26.24 64.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' CG ' ' HB3' ' A' ' 12' ' ' LEU . 9.3 mtp180 -75.88 -66.43 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -53.45 -28.28 29.35 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 108.988 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.562 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 3.4 mt -64.79 -50.66 74.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.091 178.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' CD2' HD13 ' A' ' 52' ' ' LEU . 72.0 mt -55.55 -42.19 74.3 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.509 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 10.8 t30 -59.02 -38.77 80.05 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 25.5 mt-10 -63.61 -39.65 94.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.45 -0.782 . . . . 0.0 109.744 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.646 ' CG ' ' HB3' ' A' ' 61' ' ' TYR . 2.1 mm? -66.58 -40.6 89.02 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 7.0 tp-100 -65.69 -36.45 83.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.317 -0.864 . . . . 0.0 109.303 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 1.6 pttp -79.1 -29.38 43.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' HB3' HG23 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -136.67 95.27 3.11 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 110.024 179.123 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.86 13.37 43.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.527 ' NE ' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.01 34.92 4.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -1.217 . . . . 0.0 110.381 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.457 HG23 ' HB3' ' A' ' 26' ' ' ASP . 11.3 tt -116.48 139.84 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.615 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.459 ' HA ' ' CD2' ' A' ' 64' ' ' LEU . 2.7 t -76.19 -129.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.364 -0.835 . . . . 0.0 110.027 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.9 OUTLIER -117.89 -38.25 3.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.019 -1.05 . . . . 0.0 110.29 179.347 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.464 ' O ' ' OG ' ' A' ' 35' ' ' SER . 98.0 t -45.39 -56.65 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.041 -1.037 . . . . 0.0 109.068 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 1.7 tp10 -66.99 -32.88 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.336 -0.853 . . . . 0.0 108.844 177.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.551 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -69.46 -15.8 63.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.558 -0.714 . . . . 0.0 109.492 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.557 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 16.2 p -86.27 -47.08 9.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.495 -0.753 . . . . 0.0 110.355 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.99 -16.8 52.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.181 -0.95 . . . . 0.0 110.724 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -74.64 -19.94 60.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -107.94 -5.97 10.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.396 -0.815 . . . . 0.0 109.756 179.102 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.92 40.65 5.51 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -152.18 160.38 43.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.294 . . . . 0.0 110.72 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.472 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -69.59 160.12 80.89 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.582 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 47.6 Cg_endo -73.06 -45.21 0.47 Allowed 'Trans proline' 0 C--N 1.284 -2.859 0 O-C-N 123.926 1.487 . . . . 0.0 110.489 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.39 -57.79 1.36 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.177 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 52.1 Cg_endo -76.5 -41.49 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.898 1.473 . . . . 0.0 110.135 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 53.6 t -39.13 -53.05 1.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 108.661 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.591 ' O ' ' CG ' ' A' ' 50' ' ' ARG . 1.1 mt -52.82 -51.98 58.76 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 176.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.0 -43.06 4.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.265 177.7 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HD3' ' CG2' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -72.21 -56.25 5.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -0.815 . . . . 0.0 109.492 178.581 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 1.6 t -54.72 -48.93 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.331 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmt180 -43.33 -52.27 5.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.369 178.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.04 -41.41 16.68 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.922 178.064 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.542 HD13 ' CD2' ' A' ' 20' ' ' LEU . 92.8 mt -68.07 -28.33 67.27 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.452 -0.78 . . . . 0.0 109.715 178.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' ARG . 1.9 tm-20 -64.62 -63.63 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.825 . . . . 0.0 110.161 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -50.27 -27.04 5.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.147 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 7' ' ' ARG . 28.6 mm-40 -83.42 5.59 23.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.57 59.97 7.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.596 ' CE2' ' HG3' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -146.53 10.81 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.573 ' CG2' HG23 ' A' ' 62' ' ' THR . 10.7 mm -140.41 32.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -87.16 -4.1 59.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.69 178.891 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.54 -41.35 0.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.646 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 11.4 m-85 -61.31 -115.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.054 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.573 HG23 ' CG2' ' A' ' 58' ' ' ILE . 1.8 t -82.41 23.96 0.72 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.999 -1.063 . . . . 0.0 109.911 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.516 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -38.57 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 62' ' ' THR . 4.2 pp -51.61 -34.5 37.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.649 0.737 . . . . 0.0 109.819 178.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.668 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.91 -5.87 14.29 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.646 -0.659 . . . . 0.0 110.274 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 65' ' ' LEU . 21.5 t30 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.193 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.215 0.531 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m -71.48 69.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.291 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 4' ' ' SER . 2.7 m-20 -62.93 -64.15 1.0 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 79.7 p -179.31 166.85 1.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -88.87 155.15 19.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.917 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -94.54 -128.71 0.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.641 -179.354 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.641 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 64.28 -168.69 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.066 -1.021 . . . . 0.0 109.131 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.641 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.6 Cg_endo -68.07 58.37 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.244 1.128 . . . . 0.0 110.012 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.474 ' HA2' HD11 ' A' ' 12' ' ' LEU . . . -49.2 -25.14 5.43 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' LEU . 4.3 pttm -62.36 -134.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.513 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 5.4 m-20 -45.18 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -128.44 139.07 52.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.672 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.6 127.2 30.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -43.65 -33.9 1.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.406 -0.808 . . . . 0.0 110.264 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.575 HG22 ' CB ' ' A' ' 48' ' ' ARG . 7.1 mm -73.65 -33.74 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.53 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 93.4 m-20 -76.67 -45.82 28.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.599 ' CD ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -62.81 -44.2 96.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.072 -1.018 . . . . 0.0 110.217 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' N ' ' CD ' ' A' ' 17' ' ' ARG . 9.1 m-20 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 178.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.53 HG12 ' CD2' ' A' ' 34' ' ' LEU . 7.2 mt -69.79 -33.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 178.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 65.9 mt -70.9 -38.25 72.99 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.247 -0.908 . . . . 0.0 109.388 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -31.9 70.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.567 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -78.5 -32.12 48.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.382 -0.824 . . . . 0.0 109.605 178.98 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' HB3' ' CG ' ' A' ' 61' ' ' TYR . 12.6 mt -71.13 -37.34 72.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.306 -0.871 . . . . 0.0 109.475 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.536 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 2.9 tp-100 -67.6 -38.63 84.27 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 178.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 24.5 pttt -79.73 -38.16 33.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.481 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -116.49 91.84 3.7 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 110.093 179.363 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.8 22.48 13.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.492 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.46 9.85 4.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -1.115 . . . . 0.0 110.073 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.515 ' CG2' ' OE2' ' A' ' 22' ' ' GLU . 13.6 tt -85.72 143.67 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 110.405 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.539 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 21.0 m -92.38 -73.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 110.537 -179.309 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.566 ' ND2' ' HG ' ' A' ' 46' ' ' LEU . 10.7 t-20 -164.3 -54.6 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.478 ' C ' ' O ' ' A' ' 31' ' ' ASN . 3.2 t -42.64 -52.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.998 -1.064 . . . . 0.0 109.081 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -69.08 -29.23 67.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.147 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -73.66 -16.61 61.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.608 -0.683 . . . . 0.0 109.749 178.508 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.55 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 19.3 p -88.07 -47.76 8.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -81.96 -17.11 48.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.532 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -77.43 -16.03 59.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.013 -1.055 . . . . 0.0 110.611 -179.359 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.549 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.48 -6.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.985 179.489 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.27 42.75 5.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 35' ' ' SER . 0.3 OUTLIER -153.31 164.06 38.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.987 -1.302 . . . . 0.0 110.643 178.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -71.51 160.93 81.14 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 49.3 Cg_endo -74.28 -54.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.285 -2.794 0 O-C-N 123.953 1.502 . . . . 0.0 110.649 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.547 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 m -35.14 -54.25 1.1 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.547 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.1 Cg_endo -74.83 -42.6 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.88 1.463 . . . . 0.0 109.867 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 40.8 t -39.15 -49.15 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.785 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.576 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 2.1 mp -56.93 -52.77 63.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -42.87 -41.03 3.14 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.73 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.575 ' CB ' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -73.14 -53.78 10.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.615 -0.678 . . . . 0.0 109.683 178.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.7 -43.83 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 1.5 mmm-85 -50.72 -48.4 58.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.203 -0.936 . . . . 0.0 109.131 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -50.6 -39.2 49.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.521 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 93.0 mt -70.63 -19.84 62.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.689 178.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.483 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 1.3 mt-10 -78.21 -55.07 5.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 110.062 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -44.64 -49.33 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.394 -0.816 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 52' ' ' LEU . 11.0 pt20 -70.61 -1.96 12.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.325 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 75.17 66.27 1.94 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.618 ' CG ' ' CD ' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -141.84 9.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 110.131 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' A' ' 62' ' ' THR . 6.2 mm -135.26 11.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -64.52 -12.47 44.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 109.691 179.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.77 -37.39 0.62 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.572 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 14.2 m-30 -63.46 -116.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -1.052 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 64' ' ' LEU . 6.4 t -89.16 31.3 0.89 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.007 -1.058 . . . . 0.0 109.927 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.558 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -33.91 -33.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.645 0.736 . . . . 0.0 109.041 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.6 OUTLIER -62.36 -128.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.593 -0.692 . . . . 0.0 109.532 177.64 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.774 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 41.39 21.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.896 . . . . 0.0 110.464 178.856 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.3 t-20 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.138 . . . . 0.0 110.199 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' O ' ' HB ' ' A' ' 2' ' ' VAL . 1.5 ptt? . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.323 0.583 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 1' ' ' MET . 3.7 p 178.76 143.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.93 . . . . 0.0 110.198 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -133.88 -0.22 3.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.379 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.34 -62.26 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HD2' ' HB2' ' A' ' 24' ' ' GLN . 7.0 mtpp -114.76 105.57 13.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -117.45 -116.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.616 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 61.37 -169.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.933 -1.104 . . . . 0.0 109.117 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 38.4 Cg_endo -70.02 57.07 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.286 1.15 . . . . 0.0 109.943 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.6 -42.21 57.85 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.91 142.26 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.155 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 12' ' ' LEU . 68.9 m-20 53.82 -117.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 0.0 110.017 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 0.5 OUTLIER 67.81 141.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.335 179.72 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.07 160.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 4.8 mmt85 -69.56 -35.49 75.44 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.297 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.616 ' N ' ' CD1' ' A' ' 15' ' ' ILE . 1.2 mp -70.96 -35.22 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 110.273 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HA ' HD11 ' A' ' 52' ' ' LEU . 63.8 m-20 -62.24 -67.17 0.44 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.545 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.455 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 3.1 ptm85 -50.76 -44.86 58.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.242 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 97.2 m-20 -66.21 -37.52 85.76 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.512 HD11 ' CG2' ' A' ' 15' ' ' ILE . 3.2 mt -66.91 -34.3 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 109.228 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD12 ' CE2' ' A' ' 57' ' ' PHE . 12.6 mt -68.74 -43.26 76.26 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.09 -30.88 71.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.292 -0.88 . . . . 0.0 109.511 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 24.6 mm-40 -76.84 -30.46 56.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.826 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.626 ' CG ' ' HB3' ' A' ' 61' ' ' TYR . 2.4 mm? -75.46 -30.98 60.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 178.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 1.1 mm100 -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.704 178.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.51 -40.39 57.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.836 179.185 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.532 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -136.51 64.05 1.56 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.328 -0.857 . . . . 0.0 110.073 179.182 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.05 -164.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 48.8 23.81 0.73 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 110.274 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.557 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 2.6 tt -106.65 142.14 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.164 -0.96 . . . . 0.0 110.341 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.54 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 4.4 p -80.91 179.87 7.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.387 -0.821 . . . . 0.0 110.197 -179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 34' ' ' LEU . 9.3 p-10 -71.92 -50.02 32.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' ASN . 48.4 t -40.91 -48.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.453 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.557 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.0 -36.73 82.82 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.324 -0.86 . . . . 0.0 108.868 177.51 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.548 HD13 ' CD2' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -67.78 -54.56 18.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.441 178.162 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.602 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 4.5 p -44.84 -44.89 9.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 32' ' ' VAL . 4.1 mtpp -73.82 -36.11 64.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.697 -178.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.12 -42.96 99.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 34' ' ' LEU . 9.1 m -92.1 20.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.977 179.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 48.98 23.66 3.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.579 ' CD1' ' HG3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -110.51 133.91 52.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.009 . . . . 0.0 110.82 -179.094 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.574 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.5 OUTLIER -50.38 152.07 3.41 Favored Pre-proline 0 C--N 1.3 -1.554 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.971 176.177 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.602 ' N ' ' HB2' ' A' ' 35' ' ' SER . 44.4 Cg_endo -70.51 -47.26 0.73 Allowed 'Trans proline' 0 C--N 1.283 -2.89 0 O-C-N 123.703 1.37 . . . . 0.0 110.573 -177.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.543 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.27 -54.66 5.82 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.048 -1.033 . . . . 0.0 109.125 178.336 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 47' ' ' GLU . 42.3 Cg_endo -74.37 -48.39 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.95 1.5 . . . . 0.0 110.592 177.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 41' ' ' SER . 37.0 t -40.34 -42.05 1.48 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 108.742 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.2 mt -67.87 -47.06 69.95 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.9 mm-40 -49.73 -46.14 49.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.139 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.579 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.26 -46.04 74.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.3 178.26 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.546 HG11 ' N ' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -59.48 -46.89 92.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.469 -0.769 . . . . 0.0 109.786 178.591 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.546 ' N ' HG11 ' A' ' 49' ' ' VAL . 9.5 mmm180 -48.02 -50.61 27.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.4 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -48.83 -40.36 29.01 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.606 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 49' ' ' VAL . 70.9 mt -74.02 -30.46 62.45 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.446 -0.783 . . . . 0.0 109.623 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 58' ' ' ILE . 5.8 tp10 -74.49 -62.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.479 -0.763 . . . . 0.0 110.298 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -46.92 -26.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.45 ' NE2' ' HG3' ' A' ' 8' ' ' PRO . 11.9 mm100 -82.77 7.55 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 7' ' ' ARG . . . 73.68 40.03 47.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -128.83 10.3 5.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.184 -1.186 . . . . 0.0 110.277 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.573 HG13 ' N ' ' A' ' 53' ' ' GLU . 7.5 mm -140.93 35.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.02 -5.33 59.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.418 -0.801 . . . . 0.0 109.843 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -133.94 -41.23 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.626 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 16.8 m-30 -57.48 -114.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 0.0 109.933 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.568 HG23 ' CG2' ' A' ' 58' ' ' ILE . 3.7 t -85.76 24.44 1.25 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.896 -1.128 . . . . 0.0 109.975 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -37.4 -33.62 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.54 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -51.87 -27.1 11.63 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.73 0.776 . . . . 0.0 109.856 178.593 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 66' ' ' ASN . 1.2 pp -41.94 -24.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.66 -0.65 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.575 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 43.6 p30 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.296 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 3' ' ' ASP . 5.7 t -112.52 49.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER 41.87 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.308 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 5' ' ' LYS . 33.5 p -70.73 -126.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 110.125 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' N ' ' OG ' ' A' ' 4' ' ' SER . 12.2 mtmt 52.94 60.4 3.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 110.272 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 5.3 mmtt -68.58 -96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.391 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.598 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 61.36 -173.22 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 109.231 -179.358 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.3 Cg_endo -67.06 60.45 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.417 1.22 . . . . 0.0 109.797 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -50.95 -174.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 12' ' ' LEU . 41.7 tttt 53.28 -130.62 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -1.194 . . . . 0.0 109.856 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' LYS . 3.4 p-10 -43.57 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.138 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -151.07 129.17 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 -179.637 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.497 ' N ' HD23 ' A' ' 12' ' ' LEU . 6.4 m-20 -43.13 132.08 4.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.101 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.494 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 22.2 mmt-85 -53.0 -34.92 58.49 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 110.357 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.54 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 13.6 mm -75.8 -24.39 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' CG ' ' HB2' ' A' ' 13' ' ' ASP . 18.0 m-20 -80.6 -55.64 4.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.129 -0.982 . . . . 0.0 110.292 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.08 -43.87 82.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 2.7 m120 -66.32 -41.52 89.53 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.376 -0.827 . . . . 0.0 109.206 178.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.54 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 6.8 mt -65.06 -34.76 72.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 178.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.525 ' HG ' ' CD1' ' A' ' 52' ' ' LEU . 25.8 mt -70.8 -39.2 73.26 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.378 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 17' ' ' ARG . 3.3 m120 -68.91 -30.86 69.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.488 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 66.2 mm-40 -78.34 -32.34 49.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.431 -0.793 . . . . 0.0 109.763 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.614 ' CG ' ' HB3' ' A' ' 61' ' ' TYR . 2.5 mm? -73.37 -32.23 64.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 178.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.594 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 19.1 tp60 -74.13 -33.93 63.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.919 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HE2' ' OE1' ' A' ' 22' ' ' GLU . 12.9 pttt -77.58 -34.27 53.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -128.07 76.56 1.7 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.111 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.07 59.59 0.15 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.41 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.299 179.85 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.5 tt -105.74 141.81 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.62 154.97 19.89 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.363 -0.836 . . . . 0.0 110.435 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.532 ' ND2' ' HG ' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -44.55 -55.3 5.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 0.0 110.369 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' ASN . 86.6 t -38.61 -58.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.175 -0.953 . . . . 0.0 109.552 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -65.12 -39.03 92.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.212 -0.93 . . . . 0.0 108.576 177.088 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.643 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -62.67 -15.07 50.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 178.39 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.57 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 12.7 p -88.0 -50.44 6.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.403 -0.811 . . . . 0.0 111.412 -178.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 13.2 mttt -81.89 -24.1 35.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 111.614 -177.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.584 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -73.66 -15.41 61.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.906 -1.121 . . . . 0.0 110.351 -179.191 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.643 HG21 ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -104.61 -16.91 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.333 -0.854 . . . . 0.0 109.895 178.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.32 38.8 3.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.543 ' HG ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.67 170.3 20.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.276 . . . . 0.0 110.736 179.262 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.7 m -75.6 160.68 78.75 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.57 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 49.5 Cg_endo -73.8 -54.51 0.1 Allowed 'Trans proline' 0 C--N 1.287 -2.7 0 O-C-N 123.998 1.525 . . . . 0.0 110.845 -178.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -38.06 -51.64 3.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.752 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.8 Cg_endo -76.12 -43.22 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.756 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 41.8 t -41.6 -43.72 2.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.075 -1.016 . . . . 0.0 108.469 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.63 -51.3 60.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 2.5 mt-10 -43.24 -38.46 2.57 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.142 -0.973 . . . . 0.0 108.594 177.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.456 ' CG ' HG23 ' A' ' 15' ' ' ILE . 3.5 mmt85 -71.69 -54.52 10.04 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.574 HG23 ' CB ' ' A' ' 62' ' ' THR . 0.9 OUTLIER -60.41 -49.7 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 109.758 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.569 ' N ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -41.73 -51.41 4.13 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -51.19 -44.11 61.5 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.679 -0.808 . . . . 0.0 108.836 177.928 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 20' ' ' LEU . 86.8 mt -66.64 -17.5 64.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.44 -0.787 . . . . 0.0 109.868 178.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.36 -64.7 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.246 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -46.95 -26.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.9 . . . . 0.0 110.4 -179.869 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mm-40 -82.73 7.68 14.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.02 91.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.582 ' CD1' ' HD2' ' A' ' 7' ' ' ARG . 19.3 m-85 -128.43 10.57 6.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 62' ' ' THR . 6.7 mm -140.88 48.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.331 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -79.58 -15.92 56.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.024 179.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -134.46 -45.67 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.614 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 25.7 m-85 -51.16 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -1.005 . . . . 0.0 110.112 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.574 ' CB ' HG23 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -85.3 13.73 6.16 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 109.889 179.773 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 58' ' ' ILE . . . -42.07 -27.26 0.12 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -54.84 -32.73 60.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.465 -0.772 . . . . 0.0 110.25 179.642 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.71 HD11 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -59.73 -8.16 1.94 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.536 -0.728 . . . . 0.0 110.587 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.59 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 44.3 t-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.254 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' C ' HG13 ' A' ' 2' ' ' VAL . 56.5 mtp . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.236 0.541 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG13 ' C ' ' A' ' 1' ' ' MET . 6.3 m -129.07 -163.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.32 -11.25 7.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.84 134.83 57.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.278 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HD2' ' HA ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -95.48 6.61 48.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.258 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 6.3 mtpt 60.72 -121.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.147 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.616 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tpp180 59.14 -171.27 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.886 -1.134 . . . . 0.0 109.02 -179.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.6 Cg_endo -67.66 57.77 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.338 1.178 . . . . 0.0 109.885 179.206 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -47.48 -64.2 2.99 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -42.2 146.78 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -1.164 . . . . 0.0 110.188 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 12' ' ' LEU . 64.8 m-20 45.11 -127.49 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.92 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 HD22 ' CG ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 67.08 134.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 0.0 110.393 179.617 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.82 136.79 57.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.166 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -54.86 -29.77 56.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.556 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 22.2 mm -67.22 -24.09 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 69.3 m-20 -83.07 -53.63 5.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 110.259 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -53.15 -50.19 65.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.33 -40.06 96.25 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 109.269 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 7.3 mt -64.52 -34.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.402 -0.811 . . . . 0.0 109.323 178.4 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HG ' HD11 ' A' ' 52' ' ' LEU . 9.3 mt -68.91 -42.35 76.94 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 178.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.468 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 m-80 -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' HG13 ' A' ' 38' ' ' VAL . 11.3 mt-10 -72.57 -31.8 65.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.401 -0.812 . . . . 0.0 109.599 178.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.623 ' CG ' ' HB3' ' A' ' 61' ' ' TYR . 2.4 mm? -68.34 -31.68 71.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 178.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.459 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.92 -43.5 24.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.525 -0.734 . . . . 0.0 109.888 179.076 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -72.22 -49.21 36.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.968 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 27' ' ' GLY . 6.1 m-20 -121.98 71.04 0.98 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.244 -0.91 . . . . 0.0 110.071 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 28' ' ' ARG . . . -58.77 -151.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER 27.93 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.64 -0.918 . . . . 0.0 110.953 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 27' ' ' GLY . 8.8 tt -114.59 128.15 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -75.9 155.75 34.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.867 . . . . 0.0 110.281 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' SER . 7.4 p30 -46.24 -44.45 16.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 31' ' ' ASN . 58.8 t -40.37 -72.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 109.825 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -57.67 -25.01 59.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.865 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.612 ' O ' HG21 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.584 -0.697 . . . . 0.0 109.913 179.003 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.574 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 23.4 p -88.17 -44.14 11.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.541 -0.724 . . . . 0.0 110.967 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -42.1 22.33 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 111.425 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -61.26 -15.81 38.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.512 -178.713 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 34' ' ' LEU . 15.1 m -100.41 -23.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 121.266 -0.896 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.99 32.25 4.76 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -148.06 168.99 20.94 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.008 -1.289 . . . . 0.0 110.647 179.005 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -72.75 158.41 87.32 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 108.977 177.34 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 48.1 Cg_endo -73.93 -46.59 0.31 Allowed 'Trans proline' 0 C--N 1.287 -2.703 0 O-C-N 123.928 1.488 . . . . 0.0 110.744 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.542 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.3 -54.81 4.51 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 109.548 179.254 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.1 Cg_endo -77.25 -40.02 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.887 1.467 . . . . 0.0 110.267 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.543 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 42.0 t -38.71 -45.78 1.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.025 . . . . 0.0 108.809 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -65.3 -50.36 65.97 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 6.1 mm-40 -42.86 -39.29 2.47 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.592 177.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.539 ' CG ' HG21 ' A' ' 15' ' ' ILE . 1.4 mmt85 -69.47 -55.6 9.79 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.663 0.745 . . . . 0.0 109.071 177.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.578 ' CG1' ' HG ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -55.57 -43.04 71.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.32 -0.862 . . . . 0.0 109.479 178.292 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 10.1 mmt85 -45.86 -56.22 5.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.331 -0.856 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -46.74 -40.36 13.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 177.952 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 ' CD1' ' HB3' ' A' ' 16' ' ' ASP . 21.4 mt -77.4 -19.14 56.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.404 -0.81 . . . . 0.0 109.889 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -72.31 -59.32 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 0.0 110.384 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -57.52 -21.13 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -79.3 7.63 7.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 64.43 49.74 63.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.543 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 21.7 m-85 -139.07 17.77 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.279 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.593 ' CG2' ' CG2' ' A' ' 62' ' ' THR . 7.8 mm -142.75 23.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -3.22 30.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.892 179.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -137.44 -43.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.623 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 64.3 m-85 -55.61 -108.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 0.0 109.893 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.593 ' CG2' ' CG2' ' A' ' 58' ' ' ILE . 3.0 t -85.98 23.26 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.913 -1.117 . . . . 0.0 109.662 178.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.518 ' CA ' ' O ' ' A' ' 58' ' ' ILE . . . -37.94 -30.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.518 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 62' ' ' THR . 1.0 OUTLIER -51.51 -32.98 29.68 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.605 178.515 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.737 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -59.09 151.07 23.3 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.67 -0.644 . . . . 0.0 110.341 179.549 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.55 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . 21.0 t-20 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.214 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.236 0.541 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.97 133.81 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.249 -0.907 . . . . 0.0 110.269 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 38.7 p-10 -84.75 47.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.333 -0.855 . . . . 0.0 110.265 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -70.62 177.77 3.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.528 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 4.3 mtpm? -58.3 144.75 40.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.94 . . . . 0.0 110.321 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' ARG . 3.9 mtmt -113.02 -17.12 12.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.317 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.685 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 39.59 -156.43 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.879 . . . . 0.0 109.113 179.577 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.685 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 43.2 Cg_endo -76.15 5.87 4.26 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.063 1.033 . . . . 0.0 109.914 179.188 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.503 ' N ' HD13 ' A' ' 12' ' ' LEU . . . 41.7 -146.07 0.61 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 43.09 -133.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 0.0 110.231 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.511 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 1.2 m-20 -64.76 103.64 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.972 . . . . 0.0 110.407 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.503 HD13 ' N ' ' A' ' 9' ' ' GLY . 1.4 mt -143.95 96.22 2.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -47.41 141.89 4.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -51.74 -24.45 5.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.298 -0.876 . . . . 0.0 110.306 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.583 ' O ' ' CG1' ' A' ' 19' ' ' ILE . 10.5 mm -75.37 -34.28 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 110.237 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.474 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 72.5 m-20 -74.99 -38.25 61.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 110.266 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 12' ' ' LEU . 15.5 mtt180 -67.39 -59.73 3.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.294 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.3 -31.75 65.97 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.357 -0.839 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.583 ' CG1' ' O ' ' A' ' 15' ' ' ILE . 8.3 mt -69.49 -39.87 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.486 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 26.1 mt -69.88 -37.37 76.02 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.505 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 35.8 t-20 -67.69 -29.06 68.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 178.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 4.6 mm-40 -73.36 -38.02 65.85 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.433 -0.792 . . . . 0.0 109.678 178.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 61' ' ' TYR . 63.7 mt -68.48 -32.91 73.23 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.229 -0.92 . . . . 0.0 109.256 178.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.528 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 3.7 tt0 -70.69 -39.34 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.113 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -82.02 -26.9 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 0.0 109.635 178.688 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.576 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -142.0 63.83 1.41 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.47 -0.768 . . . . 0.0 109.932 178.883 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -49.43 -26.5 7.17 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 7.7 mpt_? -92.71 81.1 4.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -1.173 . . . . 0.0 110.493 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 10.0 tt -159.09 138.86 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.341 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.525 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -86.8 162.0 18.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.973 179.768 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' SER . 2.3 m-80 -53.45 -30.75 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 110.449 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.73 -66.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 109.156 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.499 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.2 tp10 -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.27 -0.894 . . . . 0.0 108.671 177.36 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.612 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.6 -14.58 62.12 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 178.286 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 42' ' ' PRO . 23.5 p -87.04 -43.44 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.499 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -84.78 -17.28 38.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.514 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 12.8 mtt-85 -77.75 -16.63 58.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.018 -1.051 . . . . 0.0 110.67 -179.411 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -109.5 -7.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.482 -0.761 . . . . 0.0 110.01 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.97 42.88 5.21 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.64 167.6 28.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.046 -1.267 . . . . 0.0 110.685 179.034 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.51 ' HB2' ' CD ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -73.54 160.76 81.52 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.97 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.591 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 52.3 Cg_endo -75.56 -49.64 0.13 Allowed 'Trans proline' 0 C--N 1.286 -2.738 0 O-C-N 123.932 1.491 . . . . 0.0 110.725 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.552 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -39.47 -51.55 4.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.795 179.405 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.3 Cg_endo -76.53 -43.12 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.915 1.481 . . . . 0.0 109.727 178.223 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.531 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 51.9 t -41.67 -42.36 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.591 ' CD1' ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -67.72 -48.66 65.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 44' ' ' PRO . 66.6 mm-40 -48.05 -39.4 19.91 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.837 177.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.537 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 1.3 mmt180 -70.02 -51.84 28.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.13 178.049 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -59.67 -50.62 79.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.42 -0.8 . . . . 0.0 109.63 178.587 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.572 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 3.9 mmm180 -45.89 -42.15 12.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -57.31 -38.11 73.5 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.408 -0.807 . . . . 0.0 108.977 178.277 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.617 ' N ' ' HG3' ' A' ' 51' ' ' ARG . 79.8 mt -74.77 -17.89 60.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.912 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' HD23 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -69.2 -53.82 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.133 -0.979 . . . . 0.0 109.739 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -75.03 -29.1 60.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 110.031 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 4.8 pt20 -140.92 56.06 1.57 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.893 . . . . 0.0 110.421 179.783 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -166.57 -137.6 2.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 56' ' ' GLY . 56.2 m-85 -139.78 83.08 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -1.12 . . . . 0.0 110.284 -179.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 57' ' ' PHE . 4.6 mm -134.97 17.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.193 -0.942 . . . . 0.0 110.531 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -3.12 30.11 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 178.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -144.23 -41.79 0.05 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.559 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 15.8 m-30 -52.84 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -1.11 . . . . 0.0 110.047 179.337 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.535 ' N ' HD22 ' A' ' 23' ' ' LEU . 3.9 t -89.56 26.93 1.59 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.049 -1.032 . . . . 0.0 109.826 179.169 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -39.01 -29.96 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.485 -0.76 . . . . 0.0 109.269 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.525 ' CD1' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -55.29 -25.15 32.39 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.678 0.751 . . . . 0.0 109.838 178.616 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.585 ' HG ' ' N ' ' A' ' 66' ' ' ASN . 0.7 OUTLIER -43.43 -22.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.718 -0.614 . . . . 0.0 110.569 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.585 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.255 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.618 0.723 . . . . 1.8300000000000001 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 9.6 mmt180 -46.52 -32.02 3.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.93 -0.708 . . . . 2.8300000000000001 110.631 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.743 HG23 HD22 ' A' ' 40' ' ' LEU . 6.6 mm -70.12 -37.24 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.46999999999999997 111.63 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.707 ' CA ' HD11 ' A' ' 52' ' ' LEU . 73.3 m-20 -74.67 -54.37 7.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.916 -1.115 . . . . 1.25 111.417 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 1.3 ptm180 -57.08 -46.68 82.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 2.3999999999999999 111.204 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.574 ' HB3' HG12 ' A' ' 38' ' ' VAL . 2.5 m-20 -65.75 -32.79 74.53 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.124 -1.03 . . . . 1.99 108.689 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.908 HG21 HG23 ' A' ' 49' ' ' VAL . 9.1 mt -69.38 -38.04 76.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.41999999999999998 108.548 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.06 HD11 HD22 ' A' ' 52' ' ' LEU . 41.4 mt -67.5 -39.02 85.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.332 -0.988 . . . . 0.90000000000000002 108.332 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -65.31 -30.97 71.88 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.983 -0.747 . . . . 1.8400000000000001 108.983 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.775 ' OE1' HG13 ' A' ' 38' ' ' VAL . 7.3 mt-10 -79.45 -32.87 42.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.543 -0.723 . . . . 2.0699999999999998 109.419 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.053 HD21 HD11 ' A' ' 34' ' ' LEU . 2.5 mm? -69.21 -41.61 76.84 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.365 -0.934 . . . . 1.3700000000000001 108.666 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.488 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 2.2 tp60 -64.67 -38.35 90.71 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 2.0699999999999998 108.909 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -78.08 -20.73 51.71 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.319 -0.993 . . . . 2.1400000000000001 108.319 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.2 m-20 -141.69 91.02 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.478 -0.889 . . . . 1.52 109.506 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.54 14.11 37.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.351 -1.099 . . . . 1.5600000000000001 110.351 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 28.19 5.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.293 . . . . 3.6400000000000001 110.015 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 26' ' ' ASP . 12.2 tt -105.64 137.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.64000000000000001 110.294 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' HD12 ' A' ' 34' ' ' LEU . 7.8 t -77.91 -123.45 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.826 -0.749 . . . . 1.76 110.128 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.684 HD22 HD21 ' A' ' 46' ' ' LEU . 14.2 p30 -122.44 -44.48 2.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.056 -1.028 . . . . 2.2799999999999998 110.086 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 74.1 t -45.51 -55.45 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.902 -1.124 . . . . 0.51000000000000001 108.428 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -64.32 -47.11 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.073 -1.454 . . . . 1.77 107.073 177.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.053 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.3 -19.17 3.01 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.568 0.699 . . . . 0.90000000000000002 109.839 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.55 ' HA ' ' HG ' ' A' ' 45' ' ' CYS . 3.7 p -87.45 -31.13 20.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.47999999999999998 110.586 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -87.19 -31.62 20.25 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.272 -0.893 . . . . 2.1899999999999999 112.586 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 13.3 mtp180 -68.85 -17.81 64.05 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.507 -1.371 . . . . 2.3799999999999999 110.759 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.848 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.8 m -104.94 -11.33 9.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 C-N-CA 119.626 -0.83 . . . . 0.91000000000000003 110.047 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.2 40.11 6.65 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.351 -0.928 . . . . 0.46999999999999997 111.362 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.848 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -146.09 171.79 14.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.779 -1.424 . . . . 1.4299999999999999 110.654 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 38.4 m -76.39 158.94 80.85 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.392 -1.336 . . . . 0.94999999999999996 107.392 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.103 ' O ' HD12 ' A' ' 46' ' ' LEU . 55.9 Cg_endo -77.13 -44.61 0.19 Allowed 'Trans proline' 0 C--N 1.282 -2.96 0 O-C-N 124.189 1.626 . . . . 0.28000000000000003 111.27 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.34 -52.56 5.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.67000000000000004 109.099 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.0 Cg_endo -79.76 -38.03 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.32000000000000001 110.107 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' HD12 ' A' ' 40' ' ' LEU . 42.1 t -42.93 -46.75 5.51 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.749 -1.204 . . . . 0.47999999999999998 107.749 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.103 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -62.02 -51.7 66.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.328 -1.36 . . . . 0.38 107.328 177.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -44.75 -37.39 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.099 -1.04 . . . . 2.0299999999999998 108.212 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.581 ' HG3' HG21 ' A' ' 15' ' ' ILE . 2.6 mmt180 -73.64 -46.17 48.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.951 0.881 . . . . 1.8300000000000001 108.717 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.908 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -65.86 -38.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.411 -0.806 . . . . 0.46999999999999997 109.94 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -56.74 -45.48 81.96 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.389 -0.967 . . . . 2.0800000000000001 108.389 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -39.45 64.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.138 -1.43 . . . . 2.4100000000000001 107.138 177.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 20' ' ' LEU . 59.3 mt -73.06 -19.97 61.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.584 0.707 . . . . 0.57999999999999996 109.31 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.33 -51.44 13.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 1.8500000000000001 109.869 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -52.96 -30.15 33.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.527 -0.733 . . . . 3.6200000000000001 110.364 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 13.0 mm-40 -84.33 11.05 9.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 2.5800000000000001 109.843 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.26 48.57 73.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.13 -1.188 . . . . 1.6499999999999999 110.13 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 1.041 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.8 m-85 -129.15 7.8 5.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.059 -1.259 . . . . 2.6400000000000001 110.214 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.041 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.5 mm . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.64000000000000001 109.448 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' HB2' ' NH2' ' A' ' 51' ' ' ARG . 3.7 t70 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.353 0.597 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 7.1 tpp85 -44.68 -33.89 2.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.854 HG23 HD22 ' A' ' 40' ' ' LEU . 9.3 mm -73.67 -20.91 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.697 ' CB ' HD11 ' A' ' 52' ' ' LEU . 2.9 m-20 -85.17 -59.53 2.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 0.0 110.142 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.501 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -53.99 -40.21 66.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.536 ' HB3' HG12 ' A' ' 38' ' ' VAL . 10.1 m120 -69.56 -41.37 75.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.945 HG21 ' CG2' ' A' ' 49' ' ' VAL . 18.6 mt -67.87 -33.75 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.28 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.764 HD11 HD22 ' A' ' 52' ' ' LEU . 14.3 mt -68.78 -36.47 78.34 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -66.2 -37.62 86.01 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.685 ' CD ' HG13 ' A' ' 38' ' ' VAL . 98.9 mt-10 -68.78 -39.24 80.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.707 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 23' ' ' LEU . 43.7 mt -64.38 -24.93 67.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.351 -0.843 . . . . 0.0 109.592 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -75.97 -39.13 56.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -84.01 -24.56 30.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 1.5 m-20 -133.85 90.57 2.72 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.04 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 9.8 51.88 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -123.07 39.36 3.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -1.131 . . . . 0.0 110.294 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.491 HG13 ' HB3' ' A' ' 33' ' ' GLU . 7.5 tt -117.86 139.8 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.379 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 31' ' ' ASN . 9.1 t -86.96 -108.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.347 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' SER . 1.8 p-10 -128.58 -45.72 1.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.27 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.434 HG23 ' ND2' ' A' ' 31' ' ' ASN . 93.8 t -46.03 -61.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.954 -1.091 . . . . 0.0 109.119 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HB3' HG13 ' A' ' 29' ' ' ILE . 1.6 tp10 -64.05 -28.13 69.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.224 -0.923 . . . . 0.0 108.944 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.808 HD21 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -75.09 -15.3 60.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.713 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASN . 28.0 p -86.57 -44.18 12.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.567 -0.708 . . . . 0.0 110.597 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -82.0 -21.86 36.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 31.8 mtt-85 -70.74 -19.25 62.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.364 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.873 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -110.12 -9.24 11.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.15 40.56 5.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.873 HD21 ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -150.74 159.31 44.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.984 -1.304 . . . . 0.0 110.526 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.528 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.0 OUTLIER -67.0 156.32 88.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 108.858 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.119 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.6 Cg_endo -72.01 -49.59 0.3 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 124.022 1.538 . . . . 0.0 110.496 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -35.98 -55.39 1.3 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.1 Cg_endo -75.83 -41.85 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.962 1.507 . . . . 0.0 110.007 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 35.9 t -39.9 -52.6 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.662 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.119 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -55.18 -49.03 72.92 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.51 -44.96 13.0 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.431 -0.793 . . . . 0.0 109.134 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HD3' ' HB ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.48 -51.89 31.7 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.594 0.711 . . . . 0.0 109.665 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.945 ' CG2' HG21 ' A' ' 19' ' ' ILE . 2.9 t -64.44 -59.2 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.552 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -40.5 -45.71 2.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -51.75 -46.9 64.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.852 177.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 20' ' ' LEU . 12.9 mt -62.95 -27.66 69.55 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.414 -0.804 . . . . 0.0 109.665 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.466 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -66.69 -56.82 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 47.2 mtp180 -45.96 -24.43 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.355 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.648 ' CB ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mm-40 -95.7 3.95 53.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.307 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.91 44.35 19.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.999 ' O ' HD13 ' A' ' 58' ' ' ILE . 19.0 m-30 -116.65 0.93 12.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -1.231 . . . . 0.0 110.177 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.999 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.9 mm . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 16' ' ' ASP . 4.6 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.8 tpt180 -48.42 -20.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.37 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.885 HD12 HD22 ' A' ' 40' ' ' LEU . 7.6 mm -73.92 -45.2 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD2' ' NE ' ' A' ' 51' ' ' ARG . 47.7 m-20 -70.62 -35.74 73.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -69.22 -65.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 1.6 t-20 -52.61 -26.52 13.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 15' ' ' ILE . 3.2 mt -70.07 -47.26 69.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.604 ' CG ' HD13 ' A' ' 52' ' ' LEU . 40.7 mt -64.27 -33.15 75.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.117 -0.989 . . . . 0.0 109.19 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.43 -28.45 65.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.359 -0.838 . . . . 0.0 109.408 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' OE1' ' CB ' ' A' ' 37' ' ' ARG . 3.6 mm-40 -78.55 -35.46 46.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.469 -0.769 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.093 HD21 HD11 ' A' ' 34' ' ' LEU . 2.9 mm? -68.67 -35.84 77.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -74.75 -36.82 62.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.778 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -76.82 -36.59 56.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.82 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -122.22 76.5 1.31 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.164 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' A' ' 28' ' ' ARG . . . -67.8 58.14 0.35 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -173.77 36.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 0.0 110.007 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -123.51 153.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.466 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.805 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -100.06 -94.03 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 3.3 p30 -138.76 -46.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.483 ' N ' ' CG ' ' A' ' 31' ' ' ASN . 31.0 t -44.99 -64.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.992 -1.067 . . . . 0.0 109.412 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 5.7 tp10 -62.01 -27.39 68.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 108.816 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.093 HD11 HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -73.71 -16.04 61.21 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.524 -0.735 . . . . 0.0 109.401 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -88.98 -36.49 15.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.721 -0.612 . . . . 0.0 110.679 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.9 -50.25 8.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.246 -0.909 . . . . 0.0 111.188 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.539 ' CB ' ' OE1' ' A' ' 22' ' ' GLU . 7.3 mtp85 -54.84 -17.06 3.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.126 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.812 ' HB ' HD21 ' A' ' 40' ' ' LEU . 15.7 m -100.42 -21.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.26 39.04 4.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.885 HD22 HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.905 -1.35 . . . . 0.0 110.744 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -68.65 155.08 93.75 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.868 177.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.083 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.8 Cg_endo -74.06 -45.65 0.35 Allowed 'Trans proline' 0 C--N 1.286 -2.713 0 O-C-N 123.992 1.522 . . . . 0.0 110.737 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.96 -55.61 3.69 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.9 Cg_endo -75.64 -39.74 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.915 1.482 . . . . 0.0 110.026 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 51.6 t -39.43 -47.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 108.731 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.083 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.19 -49.97 72.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 14.5 mt-10 -46.97 -37.91 9.82 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.219 -0.925 . . . . 0.0 108.817 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -70.77 -58.0 4.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.464 -0.772 . . . . 0.0 109.101 177.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.657 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -54.03 -50.45 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.23 -0.919 . . . . 0.0 109.17 177.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 18.1 mmt180 -41.76 -53.81 3.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.384 -0.822 . . . . 0.0 109.533 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NE ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -46.61 -44.15 17.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.735 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' ' 58' ' ' ILE . 66.4 mt -69.95 -26.02 63.92 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -71.13 -66.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 110.134 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -56.34 -24.51 44.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.194 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.604 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.8 mm100 -79.45 5.13 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 68.4 48.69 49.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.0 m-85 -134.06 8.54 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 52' ' ' LEU . 17.0 mm . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.402 0.62 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 15.2 mmt180 -53.15 -39.3 63.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 110.496 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.768 HG23 HD22 ' A' ' 40' ' ' LEU . 4.4 mm -72.8 -21.17 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.735 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.782 ' HB3' HD21 ' A' ' 52' ' ' LEU . 96.2 m-20 -86.33 -56.62 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.639 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 8.3 ptt85 -57.18 -42.55 81.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 110.271 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -68.3 -41.87 80.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.409 -0.807 . . . . 0.0 109.384 178.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.924 HG21 ' CG2' ' A' ' 49' ' ' VAL . 6.1 mt -65.72 -30.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.23 -0.918 . . . . 0.0 109.357 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.532 HD11 HD22 ' A' ' 52' ' ' LEU . 14.3 mt -74.01 -44.62 53.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -64.78 -28.16 69.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.588 ' OE1' HG13 ' A' ' 38' ' ' VAL . 8.9 mt-10 -76.46 -38.94 54.61 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.368 -0.832 . . . . 0.0 109.943 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 34' ' ' LEU . 14.7 mt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -43.93 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -25.61 56.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.517 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -137.69 87.94 2.29 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.911 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.55 7.69 46.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.602 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -114.67 28.21 8.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 26' ' ' ASP . 6.9 tt -108.9 137.33 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.4 p -94.72 157.68 15.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 110.222 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -42.26 -49.19 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.456 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 31' ' ' ASN . 78.7 t -44.05 -65.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.958 -1.089 . . . . 0.0 109.402 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -61.89 -28.7 69.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.22 -0.925 . . . . 0.0 108.782 177.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -72.69 -14.63 61.62 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 178.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 25.1 p -86.74 -43.34 12.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.461 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -16.53 46.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.254 -0.904 . . . . 0.0 111.221 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -81.29 -15.54 55.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.977 -1.077 . . . . 0.0 110.773 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.882 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -108.35 -8.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.223 -0.923 . . . . 0.0 109.874 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 40.63 4.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.882 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -151.77 165.63 33.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -1.23 . . . . 0.0 110.549 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.25 157.07 85.33 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.786 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.111 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.5 Cg_endo -72.25 -44.8 0.74 Allowed 'Trans proline' 0 C--N 1.286 -2.729 0 O-C-N 124.005 1.529 . . . . 0.0 110.539 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.06 -55.87 4.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.363 178.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -75.35 -42.2 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.901 1.474 . . . . 0.0 110.202 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.701 ' HB2' HD12 ' A' ' 40' ' ' LEU . 42.5 t -40.14 -51.02 2.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 108.708 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.111 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -58.26 -46.4 86.07 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -48.47 -42.59 33.15 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.318 -0.864 . . . . 0.0 108.959 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.21 -55.32 10.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.695 0.76 . . . . 0.0 109.555 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.924 ' CG2' HG21 ' A' ' 19' ' ' ILE . 1.6 t -59.06 -55.51 23.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.976 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.563 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -39.8 -50.02 2.37 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.405 -0.81 . . . . 0.0 109.645 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.03 -47.2 33.72 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.697 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.795 ' HB3' HD11 ' A' ' 58' ' ' ILE . 97.0 mt -59.61 -26.26 65.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -68.22 -57.58 5.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 110.248 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -46.58 -36.63 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 7.8 mm-40 -81.82 8.38 10.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.28 60.11 7.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 1.013 ' O ' HD13 ' A' ' 58' ' ' ILE . 14.8 m-85 -135.38 12.54 3.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 110.312 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.013 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.2 mm . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 110.24 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 7.7 t70 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.333 0.587 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -45.5 -30.17 1.35 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.913 HG21 ' HD3' ' A' ' 48' ' ' ARG . 17.9 mm -73.54 -18.76 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.685 ' CA ' HD11 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -84.27 -48.61 9.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.179 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -61.07 -47.82 84.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 33.9 p-10 -66.18 -37.64 86.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.016 -1.052 . . . . 0.0 109.283 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.973 HG21 HG23 ' A' ' 49' ' ' VAL . 5.8 mt -64.38 -29.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.234 -0.916 . . . . 0.0 109.23 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.081 HD11 HD22 ' A' ' 52' ' ' LEU . 40.7 mt -72.23 -46.77 54.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.662 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 7.3 t30 -61.41 -29.15 69.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.382 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 3.4 mm-40 -74.87 -36.93 62.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.433 -0.792 . . . . 0.0 109.705 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 34' ' ' LEU . 2.9 mm? -66.17 -37.77 86.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.338 -0.851 . . . . 0.0 109.669 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -35.92 67.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.784 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -81.45 -24.49 36.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.882 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ARG . 1.4 m-20 -125.06 69.72 1.14 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.58 61.74 0.11 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.69 32.02 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.367 -1.078 . . . . 0.0 109.83 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.528 HG13 ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -124.71 151.6 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.812 ' O ' HD12 ' A' ' 34' ' ' LEU . 35.7 m -102.9 -92.96 0.33 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.214 -0.929 . . . . 0.0 110.333 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.861 HD22 HD11 ' A' ' 46' ' ' LEU . 16.2 p-10 -139.37 -47.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -0.938 . . . . 0.0 110.26 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' ASN . 78.8 t -45.91 -65.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.961 -1.087 . . . . 0.0 109.129 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 29' ' ' ILE . 11.9 tp10 -61.27 -27.71 68.66 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.94 . . . . 0.0 108.756 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.929 HD11 HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.518 -0.739 . . . . 0.0 109.543 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.567 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 24.6 p -88.25 -39.87 14.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -82.58 -27.28 31.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.923 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 8.1 mtt180 -69.17 -17.37 63.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.12 -0.988 . . . . 0.0 110.379 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.846 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -110.05 -6.02 11.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.49 -0.756 . . . . 0.0 109.913 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.65 44.96 5.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.846 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -156.19 167.77 29.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.002 -1.293 . . . . 0.0 110.84 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.54 ' C ' ' HB2' ' A' ' 35' ' ' SER . 4.6 m -72.89 154.41 90.99 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.528 -0.732 . . . . 0.0 109.149 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.067 ' O ' HD12 ' A' ' 46' ' ' LEU . 50.1 Cg_endo -73.85 -49.2 0.21 Allowed 'Trans proline' 0 C--N 1.288 -2.621 0 O-C-N 124.06 1.558 . . . . 0.0 110.733 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.575 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -36.52 -53.46 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 48.8 Cg_endo -75.85 -45.28 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.915 1.482 . . . . 0.0 109.969 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' HB2' HD12 ' A' ' 40' ' ' LEU . 18.3 t -38.68 -52.01 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 108.898 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.067 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.71 -49.88 75.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.01 -43.87 4.43 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.913 ' HD3' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.06 -42.04 63.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.546 -0.721 . . . . 0.0 109.629 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.973 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -67.37 -46.97 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.756 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.596 ' N ' HG12 ' A' ' 49' ' ' VAL . 1.3 mtm180 -47.84 -51.3 23.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.174 -0.954 . . . . 0.0 109.118 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -48.85 -45.95 41.58 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 108.853 177.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.081 HD22 HD11 ' A' ' 20' ' ' LEU . 86.5 mt -63.31 -17.69 62.81 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.785 . . . . 0.0 109.448 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -75.66 -53.2 8.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.471 -0.768 . . . . 0.0 110.215 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -55.3 -33.22 63.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -76.22 -0.96 24.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.36 40.64 23.12 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.941 ' CE2' HD13 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -119.72 -0.08 10.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.161 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.892 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.2 mm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 38.0 m-20 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.404 0.621 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' ASN . 18.3 mmt-85 -62.04 -16.9 55.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 110.318 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 40' ' ' LEU . 7.9 mm -84.87 -49.75 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 0.0 109.833 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' HA ' HD11 ' A' ' 52' ' ' LEU . 2.6 m-20 -71.67 -40.02 69.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.92 . . . . 0.0 110.145 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.5 OUTLIER -71.68 -46.16 59.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 110.027 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 52.1 t30 -67.29 -34.31 77.14 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.22 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.881 HG21 HG23 ' A' ' 49' ' ' VAL . 8.0 mt -63.68 -39.64 86.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.458 -0.777 . . . . 0.0 109.186 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.053 HD11 HD22 ' A' ' 52' ' ' LEU . 80.3 mt -68.31 -45.93 71.64 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.151 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -60.15 -37.41 80.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.183 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.69 -40.96 76.03 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 34' ' ' LEU . 2.7 mm? -64.44 -37.84 88.94 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.288 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -69.32 -44.9 70.76 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 109.508 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -74.36 -19.85 60.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.959 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -148.98 61.68 1.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 110.112 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -52.84 -28.67 32.06 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -76.8 51.7 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -1.138 . . . . 0.0 110.345 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 26' ' ' ASP . 18.9 tt -138.73 154.07 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.31 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.77 ' O ' HD12 ' A' ' 34' ' ' LEU . 42.1 t -99.93 -115.61 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.317 -0.864 . . . . 0.0 110.352 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.666 ' CB ' HD21 ' A' ' 46' ' ' LEU . 9.6 p30 -121.21 -46.4 2.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.3 t -44.58 -62.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.995 -1.066 . . . . 0.0 109.416 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.255 -0.903 . . . . 0.0 108.786 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -76.77 -15.65 59.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.55 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 16.5 p -88.08 -38.81 15.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.538 -0.726 . . . . 0.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -31.38 23.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.295 -0.878 . . . . 0.0 110.916 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -65.12 -16.63 63.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.351 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.884 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.2 m -109.65 -11.99 11.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 110.036 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.81 42.55 5.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.884 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.75 166.28 32.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.956 -1.32 . . . . 0.0 110.734 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.502 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -70.32 155.55 93.26 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 108.786 177.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.069 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.3 Cg_endo -74.29 -42.91 0.59 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 O-C-N 123.808 1.425 . . . . 0.0 110.556 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.97 -57.51 2.06 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.731 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 50.0 Cg_endo -76.47 -41.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.843 1.444 . . . . 0.0 110.205 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.721 ' HB2' HD12 ' A' ' 40' ' ' LEU . 53.8 t -39.21 -45.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 108.825 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.069 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.49 -47.99 74.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -48.06 -39.35 19.77 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.685 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' CD ' HG21 ' A' ' 15' ' ' ILE . 5.4 mmt180 -70.64 -46.86 62.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.665 0.745 . . . . 0.0 109.16 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -64.33 -45.29 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.374 -0.829 . . . . 0.0 109.847 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.577 ' N ' HG12 ' A' ' 49' ' ' VAL . 12.6 mmm-85 -47.59 -49.35 26.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.449 -0.782 . . . . 0.0 109.465 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -51.16 -43.43 61.25 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.882 178.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 20' ' ' LEU . 93.8 mt -66.61 -16.67 64.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.432 -0.793 . . . . 0.0 109.891 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -78.08 -61.19 2.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.523 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -49.87 -29.68 8.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.649 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.732 ' NE2' ' CG ' ' A' ' 57' ' ' PHE . 3.8 pt20 -82.51 12.23 4.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.39 52.78 44.0 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.949 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -131.42 8.41 4.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -1.151 . . . . 0.0 110.15 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.949 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.7 mm . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.323 0.582 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.531 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 17.1 mmt-85 -49.59 -20.58 0.8 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.318 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.918 HG23 HD22 ' A' ' 40' ' ' LEU . 10.2 mm -74.66 -24.33 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.436 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' CA ' HD11 ' A' ' 52' ' ' LEU . 50.2 m-20 -84.36 -56.52 3.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 110.372 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -56.75 -43.94 81.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.035 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.532 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 53.3 m-80 -64.78 -41.2 96.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.011 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.871 HG21 HG23 ' A' ' 49' ' ' VAL . 3.5 mt -62.0 -39.59 84.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.444 -0.785 . . . . 0.0 109.264 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.827 HD11 HD22 ' A' ' 52' ' ' LEU . 16.0 mt -66.56 -40.91 89.25 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.66 -32.4 73.7 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.385 -0.822 . . . . 0.0 109.446 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.739 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -78.61 -31.22 46.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 109.62 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.802 ' CD2' HD11 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -73.33 -31.91 64.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.371 -0.83 . . . . 0.0 109.571 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -78.15 -36.63 47.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.395 -0.816 . . . . 0.0 109.769 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 30.0 pttt -74.67 -33.56 62.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.67 68.21 0.86 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.087 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.09 60.66 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -175.37 28.67 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.384 -1.068 . . . . 0.0 109.658 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.739 HG21 ' OE2' ' A' ' 22' ' ' GLU . 16.1 tt -116.6 146.56 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.408 -0.808 . . . . 0.0 110.218 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 t -91.66 -91.42 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 110.275 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 2.3 p-10 -143.74 -47.4 0.28 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 59.3 t -44.25 -61.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.013 -1.054 . . . . 0.0 109.177 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HB3' HG13 ' A' ' 29' ' ' ILE . 4.2 tp10 -62.81 -31.95 73.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.278 -0.888 . . . . 0.0 108.805 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.802 HD11 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -70.28 -15.25 62.87 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.603 -0.686 . . . . 0.0 109.487 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.7 p -87.76 -37.6 16.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.723 . . . . 0.0 110.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -32.36 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.9 . . . . 0.0 111.273 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -66.27 -16.99 64.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.687 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.925 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -109.46 -8.06 11.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 44.59 5.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.925 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -152.54 165.82 33.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.0 -1.294 . . . . 0.0 110.71 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.488 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.61 156.83 90.98 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 108.807 177.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.098 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.6 Cg_endo -74.5 -48.69 0.19 Allowed 'Trans proline' 0 C--N 1.287 -2.681 0 O-C-N 123.83 1.437 . . . . 0.0 110.543 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -54.13 3.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.011 . . . . 0.0 109.434 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.7 Cg_endo -75.85 -40.66 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.001 1.527 . . . . 0.0 110.135 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.692 ' HB2' HD12 ' A' ' 40' ' ' LEU . 50.3 t -40.56 -44.74 2.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.085 . . . . 0.0 108.718 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.098 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.86 -45.16 87.26 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 1.6 mm-40 -50.12 -35.48 25.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.81 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -74.49 -48.37 27.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.701 . . . . 0.0 109.288 177.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.871 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -65.74 -56.71 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 178.609 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.689 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -43.59 -42.95 5.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.54 -43.83 68.72 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.827 HD22 HD11 ' A' ' 20' ' ' LEU . 71.7 mt -69.29 -16.96 63.68 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.629 -0.669 . . . . 0.0 109.785 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 1.9 mt-10 -75.7 -56.29 4.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -53.82 -27.72 31.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.393 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.607 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 66.1 mm-40 -85.38 17.13 3.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.001 . . . . 0.0 110.251 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.44 56.94 21.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.614 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.6 m-85 -137.2 6.74 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.13 -1.217 . . . . 0.0 110.239 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 52' ' ' LEU . 13.5 mm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.022 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.383 0.611 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.6 -22.65 5.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.869 HG23 HD22 ' A' ' 40' ' ' LEU . 13.8 mm -71.74 -30.51 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.903 . . . . 0.0 110.5 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.817 ' C ' HD11 ' A' ' 52' ' ' LEU . 50.5 m-20 -76.02 -61.3 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 110.539 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.81 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.64 -39.99 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.493 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 1.4 t-20 -67.74 -35.72 79.26 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 109.226 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.909 HG21 HG23 ' A' ' 49' ' ' VAL . 18.6 mt -63.14 -41.96 94.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.362 -0.836 . . . . 0.0 109.094 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 17' ' ' ARG . 25.8 mt -56.21 -42.15 76.74 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.129 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -59.36 -49.65 77.01 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.288 -0.882 . . . . 0.0 109.027 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -61.93 -37.68 85.58 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 178.201 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.941 HD21 ' CD1' ' A' ' 34' ' ' LEU . 2.3 mm? -67.36 -35.67 79.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.385 -0.822 . . . . 0.0 109.434 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -39.82 39.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.408 -0.808 . . . . 0.0 109.656 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HD3' ' OE1' ' A' ' 22' ' ' GLU . 2.4 pttt -77.55 -30.27 52.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 109.747 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.6 m-20 -140.33 61.07 1.53 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 110.317 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -56.22 -163.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.32 25.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -1.195 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 37' ' ' ARG . 10.3 tt -108.88 137.62 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' HD12 ' A' ' 34' ' ' LEU . 20.4 m -72.04 -137.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.852 . . . . 0.0 110.4 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.1 p30 -110.86 -43.12 3.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.319 -0.863 . . . . 0.0 109.907 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 32.8 t -44.8 -56.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.13 -0.981 . . . . 0.0 109.153 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.64 -34.41 78.17 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.34 -0.85 . . . . 0.0 108.887 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.941 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -70.3 -14.97 62.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.717 . . . . 0.0 109.777 178.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.548 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 8.3 p -85.64 -49.7 7.79 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 110.59 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.404 ' N ' ' OG ' ' A' ' 35' ' ' SER . 1.9 mtpp -78.68 -22.11 47.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 110.801 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 29' ' ' ILE . 15.9 mtt-85 -70.02 -17.21 63.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.093 -1.004 . . . . 0.0 110.163 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.86 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.66 -9.56 12.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.672 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.99 42.0 4.81 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.869 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -152.41 161.21 42.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.961 -1.317 . . . . 0.0 110.72 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -66.28 157.07 83.21 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 108.8 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.091 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.8 Cg_endo -73.5 -44.61 0.5 Allowed 'Trans proline' 0 C--N 1.287 -2.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.456 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.567 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.24 -56.12 2.79 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.93 . . . . 0.0 109.551 179.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.7 Cg_endo -74.96 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.99 1.521 . . . . 0.0 109.907 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' HD12 ' A' ' 40' ' ' LEU . 45.0 t -37.32 -53.01 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.091 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -54.95 -54.29 44.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -43.87 -43.53 6.4 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.386 -0.821 . . . . 0.0 109.298 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HD2' HG21 ' A' ' 15' ' ' ILE . 1.4 mmt180 -66.57 -48.67 68.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.791 . . . . 0.0 109.16 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.909 HG23 HG21 ' A' ' 19' ' ' ILE . 1.1 t -61.61 -43.48 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.411 -0.806 . . . . 0.0 109.507 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 5.8 mmm180 -45.78 -52.19 11.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.389 -0.819 . . . . 0.0 109.396 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.489 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -53.24 -40.57 64.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.065 178.065 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.893 ' HB3' HD11 ' A' ' 58' ' ' ILE . 16.2 mt -73.48 -31.3 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -0.764 . . . . 0.0 109.753 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -82.09 -30.15 31.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -74.0 -18.56 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.71 15.53 23.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.258 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.62 58.68 6.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.867 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -145.41 11.93 1.33 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -1.121 . . . . 0.0 110.296 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.893 HD11 ' HB3' ' A' ' 52' ' ' LEU . 8.0 mm . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.276 0.56 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.525 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 12.0 mmt85 -56.02 -24.88 41.96 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.354 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.862 HG23 HD22 ' A' ' 40' ' ' LEU . 10.6 mm -74.93 -35.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.751 ' HB3' HD21 ' A' ' 52' ' ' LEU . 6.2 m-20 -74.84 -56.6 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.574 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.718 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.6 ptt85 -55.53 -45.1 77.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.306 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 14' ' ' ARG . 49.4 m-20 -64.8 -34.12 77.61 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.095 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.648 HD12 ' O ' ' A' ' 15' ' ' ILE . 5.9 mt -64.79 -44.33 96.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.946 HD11 HD22 ' A' ' 52' ' ' LEU . 12.2 mt -63.29 -41.24 98.97 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 109.261 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.76 -31.2 72.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.266 -0.896 . . . . 0.0 109.258 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.697 ' OE2' HG13 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -77.49 -43.24 32.84 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.45 -0.781 . . . . 0.0 109.835 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 HD11 ' A' ' 34' ' ' LEU . 2.2 mm? -62.17 -36.31 81.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 109.38 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' OE1' ' C ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -68.71 -44.88 72.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.742 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -71.77 -37.5 70.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.925 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -135.87 92.04 2.77 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.56 -10.06 86.47 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.577 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.8 mpt_? -85.89 26.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -1.164 . . . . 0.0 110.467 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.487 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 4.0 tt -111.45 155.04 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.944 . . . . 0.0 110.329 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.652 ' O ' HD12 ' A' ' 34' ' ' LEU . 73.8 m -108.17 -94.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 110.414 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' SER . 18.7 p-10 -136.69 -50.96 0.67 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.481 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 77.7 t -43.29 -58.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.246 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.42 -27.48 68.56 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.864 . . . . 0.0 108.864 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.066 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -75.67 -15.38 60.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.565 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.8 p -88.09 -48.99 7.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 111.031 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.67 -22.37 34.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.067 -1.021 . . . . 0.0 111.184 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 7.8 mtp180 -72.59 -16.09 61.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.554 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.811 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -109.76 -9.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.311 -0.868 . . . . 0.0 110.062 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.65 41.51 4.42 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.862 HD22 HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -153.55 165.45 35.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.107 -1.231 . . . . 0.0 110.667 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.4 m -72.21 159.76 84.56 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 108.865 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.074 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.3 Cg_endo -73.39 -51.36 0.16 Allowed 'Trans proline' 0 C--N 1.285 -2.769 0 O-C-N 123.87 1.458 . . . . 0.0 110.609 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.31 -55.18 1.87 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 109.705 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.9 Cg_endo -75.83 -40.58 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.998 1.525 . . . . 0.0 110.064 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.2 t -39.45 -48.59 1.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.105 -0.997 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.074 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.3 mp -58.49 -52.41 65.77 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.82 -38.38 2.12 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.356 -0.84 . . . . 0.0 108.997 177.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' HG21 ' A' ' 15' ' ' ILE . 4.6 mmp_? -71.54 -56.31 6.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.233 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.606 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -56.01 -40.05 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 178.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 7.5 mmt85 -52.78 -48.67 66.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 109.699 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.552 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -53.15 -37.21 61.64 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.971 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.946 HD22 HD11 ' A' ' 20' ' ' LEU . 94.4 mt -67.93 -23.12 65.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.444 -0.785 . . . . 0.0 109.887 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 40.8 mt-10 -77.65 -51.23 10.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.886 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -48.48 -39.71 24.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.026 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.462 ' NE2' ' HD2' ' A' ' 51' ' ' ARG . 3.3 pt20 -86.37 27.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.85 76.25 0.14 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.898 ' CE2' HD13 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -151.29 13.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.505 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.849 HD11 ' HB3' ' A' ' 52' ' ' LEU . 15.1 mm . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.267 0.556 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 18' ' ' ASN . 9.2 mmt85 -60.97 -29.97 69.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.269 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.743 HD12 HD22 ' A' ' 40' ' ' LEU . 4.9 mm -81.38 -27.66 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.702 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.543 ' CA ' HD11 ' A' ' 52' ' ' LEU . 3.1 m-20 -84.54 -31.37 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.253 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -75.56 -46.59 31.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 110.157 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 39.4 p-10 -69.14 -32.48 71.87 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.189 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG12 HG11 ' A' ' 38' ' ' VAL . 6.3 mt -69.18 -38.31 77.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.879 HD11 ' CD2' ' A' ' 52' ' ' LEU . 22.9 mt -68.82 -40.49 79.45 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 29.9 t-20 -67.56 -26.42 66.28 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.205 -0.934 . . . . 0.0 109.267 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -87.04 -40.96 14.23 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.749 HD13 HG23 ' A' ' 58' ' ' ILE . 1.3 mt -69.18 -24.29 64.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -84.37 -37.84 21.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.451 -0.781 . . . . 0.0 109.969 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 4.0 pttt -83.09 -32.34 26.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.818 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 29' ' ' ILE . 19.4 t0 -129.56 55.49 1.76 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.34 -25.61 2.03 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -82.21 9.84 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -1.143 . . . . 0.0 110.185 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 26' ' ' ASP . 5.8 tt -74.15 154.96 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -104.4 147.06 27.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 110.15 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.829 ' OD1' HD11 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -39.98 -52.51 2.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.262 -0.899 . . . . 0.0 109.809 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 31' ' ' ASN . 18.0 t -44.79 -57.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 108.939 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 tp10 -65.29 -29.5 70.26 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 108.727 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -72.81 -16.6 61.61 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 109.512 178.293 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 21.1 p -88.69 -44.99 10.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.594 -0.691 . . . . 0.0 110.604 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 6.1 mtpp -82.44 -43.97 16.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 3.7 mtt-85 -56.99 -16.65 7.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 0.0 110.23 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.784 HG23 ' CD2' ' A' ' 40' ' ' LEU . 18.7 m -101.3 -21.05 5.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.403 -0.811 . . . . 0.0 110.019 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 101.14 37.8 3.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.784 ' CD2' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -154.92 171.66 19.32 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.879 -1.365 . . . . 0.0 110.793 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.57 158.82 82.79 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 108.877 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.043 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.7 Cg_endo -73.54 -45.22 0.43 Allowed 'Trans proline' 0 C--N 1.287 -2.709 0 O-C-N 123.987 1.52 . . . . 0.0 110.646 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -42.03 -55.64 6.03 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 109.443 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.2 Cg_endo -76.02 -36.9 1.76 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.88 1.463 . . . . 0.0 110.281 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 40.9 t -43.47 -47.71 7.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.064 . . . . 0.0 108.652 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.043 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.54 -39.51 88.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -55.97 -41.99 75.6 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.709 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -70.58 -47.98 57.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.592 -0.692 . . . . 0.0 109.284 178.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.627 HG12 ' N ' ' A' ' 50' ' ' ARG . 1.2 t -58.89 -51.89 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.483 -0.761 . . . . 0.0 109.343 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -41.97 -53.7 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.455 -0.778 . . . . 0.0 109.325 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -48.05 -42.7 29.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.432 -0.792 . . . . 0.0 109.052 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.879 ' CD2' HD11 ' A' ' 20' ' ' LEU . 12.7 mt -72.13 -23.38 61.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 0.0 109.775 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -63.04 -59.92 4.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.233 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.7 -28.64 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.329 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.608 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mm-40 -74.75 0.51 15.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 66.93 51.6 38.84 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.608 ' CE2' ' HB3' ' A' ' 55' ' ' GLN . 22.0 m-85 -131.15 9.43 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -1.159 . . . . 0.0 110.28 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 52' ' ' LEU . 1.2 mt . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.294 -0.879 . . . . 0.0 110.022 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.287 0.565 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.532 ' HD3' ' NH1' ' A' ' 17' ' ' ARG . 25.0 mmt-85 -54.86 -19.18 5.97 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.828 HG23 HD22 ' A' ' 40' ' ' LEU . 3.0 mm -83.86 -49.82 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.78 ' HB3' HD21 ' A' ' 52' ' ' LEU . 7.0 m-20 -66.65 -33.41 75.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' NH1' ' HD3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -74.42 -55.45 5.97 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 17.3 t-20 -58.53 -29.65 66.48 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 109.092 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.622 HG21 HG22 ' A' ' 49' ' ' VAL . 12.7 mt -67.52 -43.92 86.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.536 -0.728 . . . . 0.0 109.308 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.753 HD11 HD22 ' A' ' 52' ' ' LEU . 34.4 mt -66.14 -40.13 90.38 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.216 -0.927 . . . . 0.0 109.345 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.2 t-20 -67.77 -31.1 70.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.296 -0.877 . . . . 0.0 109.235 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -80.04 -36.01 36.36 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.493 -0.754 . . . . 0.0 109.614 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 HD11 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.18 -35.13 75.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.539 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.43 -39.27 67.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 2.3 tttt -82.0 -20.26 38.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 29' ' ' ILE . 13.0 m-20 -144.88 53.06 1.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.019 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -47.01 -37.44 9.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -70.49 57.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 26' ' ' ASP . 2.3 tt -141.6 135.9 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.413 ' O ' HD12 ' A' ' 34' ' ' LEU . 33.2 t -82.35 -94.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.376 -0.828 . . . . 0.0 110.356 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 10.8 p-10 -140.1 -48.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.145 -0.972 . . . . 0.0 110.432 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' ASN . 77.9 t -42.0 -64.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.525 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.506 ' HB3' HG13 ' A' ' 29' ' ' ILE . 5.3 tp10 -63.24 -22.84 67.13 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.176 -0.953 . . . . 0.0 108.979 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -79.54 -15.12 58.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.637 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 13.8 p -87.89 -45.53 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 110.838 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 14.2 pttt -80.84 -38.16 28.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.096 -1.003 . . . . 0.0 110.952 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HD2' ' HG3' ' A' ' 33' ' ' GLU . 39.2 mtt180 -57.38 -16.59 9.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.824 ' HB ' HD21 ' A' ' 40' ' ' LEU . 2.1 m -108.98 -15.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.14 37.0 5.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.828 HD22 HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -149.19 160.97 42.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.954 -1.321 . . . . 0.0 110.559 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.486 ' C ' ' HB2' ' A' ' 35' ' ' SER . 20.5 m -66.69 159.41 74.69 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 108.766 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.056 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.46 -45.38 0.42 Allowed 'Trans proline' 0 C--N 1.286 -2.718 0 O-C-N 123.934 1.492 . . . . 0.0 110.551 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.98 -60.8 0.9 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.792 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.3 Cg_endo -73.9 -37.63 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.825 1.434 . . . . 0.0 110.175 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.4 t -38.63 -50.13 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.056 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -59.12 -52.8 64.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -43.65 -36.96 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.03 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.705 ' CD ' HG21 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -72.87 -60.1 2.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 52' ' ' LEU . 2.2 t -54.29 -44.44 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 6.5 mmt85 -48.89 -50.04 36.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 109.636 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -50.57 -36.76 36.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.451 -0.78 . . . . 0.0 109.043 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.78 HD21 ' HB3' ' A' ' 16' ' ' ASP . 70.4 mt -73.14 -19.37 61.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.482 -0.762 . . . . 0.0 110.028 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -74.97 -58.93 2.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 0.0 110.394 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.491 ' CD ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -51.78 -21.74 3.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.383 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 29.4 mm100 -91.27 17.25 8.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 110.268 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.21 49.77 54.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' O ' HD13 ' A' ' 58' ' ' ILE . 7.3 m-85 -127.93 8.71 6.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.255 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.728 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.9 mm . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.41 0.624 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -43.21 -34.69 1.19 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.897 HG23 HD22 ' A' ' 40' ' ' LEU . 5.0 mm -74.4 -21.99 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 110.642 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.675 ' HB3' HD21 ' A' ' 52' ' ' LEU . 66.4 m-20 -87.19 -56.96 3.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.109 -0.994 . . . . 0.0 110.522 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.74 -37.4 73.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.08 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 17' ' ' ARG . 17.7 t-20 -72.27 -42.67 65.32 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.356 -0.84 . . . . 0.0 109.132 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.051 HG21 HG23 ' A' ' 49' ' ' VAL . 9.0 mt -68.26 -31.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.282 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.795 HD11 HD22 ' A' ' 52' ' ' LEU . 15.5 mt -73.38 -40.64 64.18 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.314 -0.866 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.36 -27.96 66.71 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.312 -0.867 . . . . 0.0 109.295 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.521 ' OE1' ' NE ' ' A' ' 37' ' ' ARG . 22.4 mm-40 -80.34 -27.57 38.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.47 -0.769 . . . . 0.0 109.685 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.043 HD21 HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -72.0 -34.29 68.76 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.276 -0.89 . . . . 0.0 109.288 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -73.81 -40.85 63.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.756 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -74.26 -30.19 62.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.828 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -125.54 71.13 1.21 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.105 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -67.66 57.05 0.34 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -179.73 38.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 110.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 1.8 tt -119.42 135.4 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.428 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -81.81 158.74 23.98 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 16.3 m120 -50.09 -47.67 53.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 93.5 t -41.92 -63.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.079 -1.013 . . . . 0.0 109.495 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -62.55 -33.02 74.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.043 HD11 HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -68.09 -14.59 63.09 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.416 0.627 . . . . 0.0 109.765 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 12.5 p -86.55 -51.16 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.456 -0.777 . . . . 0.0 110.785 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' OG ' ' A' ' 35' ' ' SER . 12.6 mttt -77.05 -16.38 59.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 0.0 111.227 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -79.75 -16.05 56.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.109 . . . . 0.0 110.513 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.904 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -110.21 -4.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.205 -0.934 . . . . 0.0 110.054 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.65 42.48 5.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.904 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -154.52 163.72 39.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.117 -1.225 . . . . 0.0 110.557 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.9 159.12 86.36 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.247 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.08 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.2 Cg_endo -74.46 -46.89 0.25 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 123.969 1.51 . . . . 0.0 110.467 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.04 -54.67 4.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.988 . . . . 0.0 109.458 178.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.7 Cg_endo -76.1 -42.27 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.027 1.541 . . . . 0.0 110.26 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.765 ' HB2' HD12 ' A' ' 40' ' ' LEU . 47.1 t -38.88 -48.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 108.7 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.08 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -61.22 -50.77 71.74 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.2 mt-10 -45.19 -34.26 2.67 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.876 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -73.83 -52.16 13.96 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.679 0.752 . . . . 0.0 109.172 177.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.051 HG23 HG21 ' A' ' 19' ' ' ILE . 1.2 t -63.42 -47.56 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.925 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -48.32 -45.64 35.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.27 -41.15 68.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 177.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.795 HD22 HD11 ' A' ' 20' ' ' LEU . 95.9 mt -67.01 -27.01 67.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.438 -0.789 . . . . 0.0 109.866 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -63.08 -59.89 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.274 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.9 -24.46 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 15.1 mm-40 -92.2 11.43 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 110.292 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 61.12 54.98 32.14 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 1.069 ' O ' HD13 ' A' ' 58' ' ' ILE . 11.9 m-85 -130.7 2.84 4.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 110.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.069 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.8 mm . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 110.24 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' CB ' ' OD1' ' A' ' 16' ' ' ASP . 2.9 t0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.351 0.596 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -57.08 -24.2 52.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 110.314 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 ' HD3' ' A' ' 48' ' ' ARG . 4.6 mm -74.47 -33.98 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.943 . . . . 0.0 110.527 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.566 ' C ' HD11 ' A' ' 52' ' ' LEU . 4.3 m-20 -71.66 -59.95 2.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.472 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.449 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -55.27 -43.74 75.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.023 . . . . 0.0 110.543 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 2.8 m120 -64.86 -37.61 88.22 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.17 -0.956 . . . . 0.0 109.276 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.059 HG21 HG23 ' A' ' 49' ' ' VAL . 9.5 mt -63.06 -38.91 83.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.39 -0.819 . . . . 0.0 109.356 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.746 ' CG ' HD13 ' A' ' 52' ' ' LEU . 90.4 mt -65.29 -41.2 94.37 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.11 -34.95 78.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.336 -0.852 . . . . 0.0 109.377 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 60.3 mm-40 -73.03 -41.83 63.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 109.601 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.2 mt -66.85 -30.86 71.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 109.334 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -66.18 -39.29 89.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 4.1 mtmp? -81.05 -18.61 46.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.54 ' O ' HG22 ' A' ' 29' ' ' ILE . 7.2 m-20 -140.85 94.5 2.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.81 . . . . 0.0 109.951 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.86 29.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -130.37 39.86 3.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 110.157 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 26' ' ' ASP . 5.4 tt -126.49 130.72 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 110.39 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 20.9 p -72.15 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' SER . 6.2 m-80 -112.61 -30.9 6.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.926 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 48.7 t -50.27 -63.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.173 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tp10 -62.21 -29.0 70.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.194 -0.941 . . . . 0.0 108.82 177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.617 HD22 HG12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -73.71 -14.78 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.459 0.647 . . . . 0.0 109.818 178.716 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.544 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 18.3 p -87.79 -45.81 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.497 -0.752 . . . . 0.0 111.004 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -82.55 -22.91 34.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 0.0 111.223 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.56 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -74.32 -15.68 60.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.014 -1.054 . . . . 0.0 110.552 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.854 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.4 m -106.49 -13.12 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.424 -0.798 . . . . 0.0 109.969 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.93 40.09 3.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.854 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.52 168.83 24.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.037 -1.273 . . . . 0.0 110.654 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -76.05 158.88 81.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 108.876 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.075 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.3 Cg_endo -74.59 -43.8 0.44 Allowed 'Trans proline' 0 C--N 1.288 -2.616 0 O-C-N 123.964 1.507 . . . . 0.0 110.464 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.35 -55.51 4.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.973 . . . . 0.0 109.471 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.4 Cg_endo -76.29 -42.94 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.894 1.471 . . . . 0.0 110.126 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.1 t -39.8 -46.0 1.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.95 -1.094 . . . . 0.0 108.626 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -64.63 -49.54 70.63 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 17.3 mt-10 -46.22 -43.03 15.07 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.482 -0.887 . . . . 0.0 108.894 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.775 ' HD3' HG21 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -68.43 -45.76 71.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.367 -0.833 . . . . 0.0 109.153 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.059 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -63.87 -47.69 89.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.432 -0.793 . . . . 0.0 109.604 178.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.619 ' N ' HG12 ' A' ' 49' ' ' VAL . 12.4 mmt85 -43.46 -55.69 4.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.838 . . . . 0.0 109.443 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.57 -43.48 25.41 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.869 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.746 HD13 ' CG ' ' A' ' 20' ' ' LEU . 30.2 mt -70.98 -41.97 70.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.758 . . . . 0.0 109.796 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.47 -57.66 9.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 110.138 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -54.81 -17.87 4.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.051 179.716 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.501 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -89.77 9.91 25.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.94 44.16 47.22 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.891 ' O ' HD13 ' A' ' 58' ' ' ILE . 14.1 m-85 -135.28 12.03 3.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -1.165 . . . . 0.0 110.261 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.891 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.8 mm . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 110.316 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.257 0.551 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 3.5 mmt180 -52.62 -29.03 23.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.344 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 HD22 ' A' ' 40' ' ' LEU . 9.0 mm -80.37 -29.88 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.616 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.706 ' HB3' HD11 ' A' ' 52' ' ' LEU . 5.2 m-20 -82.19 -36.92 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 2.9 ptt180 -70.62 -44.21 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 22.6 m-20 -67.78 -36.22 80.08 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.921 HG21 ' CG2' ' A' ' 49' ' ' VAL . 24.7 mt -68.76 -37.79 77.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.825 ' HG ' HD13 ' A' ' 52' ' ' LEU . 11.9 mt -65.67 -36.87 84.89 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.349 -0.845 . . . . 0.0 109.249 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.56 -35.48 79.12 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.394 -0.816 . . . . 0.0 109.198 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.806 ' OE1' HG13 ' A' ' 38' ' ' VAL . 7.1 mt-10 -72.87 -40.15 65.88 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.452 -0.78 . . . . 0.0 109.764 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.458 HD23 ' CG2' ' A' ' 29' ' ' ILE . 34.7 mt -66.89 -37.05 83.66 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.22 -0.925 . . . . 0.0 109.306 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -63.44 -40.67 97.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.399 -0.813 . . . . 0.0 109.235 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 -25.3 44.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.32 96.36 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.63 39.48 3.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -153.74 21.35 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -1.114 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.668 HD13 HD12 ' A' ' 34' ' ' LEU . 4.5 tt -101.84 140.22 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 31' ' ' ASN . 13.5 t -84.92 -120.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.653 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 7.6 p30 -120.8 -46.44 2.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.0 t -45.22 -60.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.283 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.3 tt0 -62.04 -30.34 70.91 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.216 -0.928 . . . . 0.0 108.989 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.668 HD12 HD13 ' A' ' 29' ' ' ILE . 6.4 tp -74.67 -16.19 60.77 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.58 -0.7 . . . . 0.0 110.063 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' ASN . 11.6 p -84.37 -37.97 20.89 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.412 -0.805 . . . . 0.0 110.279 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -87.13 -17.9 31.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.449 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -75.1 -18.02 60.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.503 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -111.46 -11.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 121.405 -0.81 . . . . 0.0 109.731 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.62 41.36 4.77 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.878 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -148.02 168.57 21.98 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.998 -1.295 . . . . 0.0 110.466 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 3.5 m -72.75 154.82 91.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 108.872 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.073 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.3 Cg_endo -72.53 -48.31 0.33 Allowed 'Trans proline' 0 C--N 1.288 -2.642 0 O-C-N 123.961 1.506 . . . . 0.0 110.733 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.27 -54.22 4.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.179 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.3 Cg_endo -76.02 -41.01 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.977 1.514 . . . . 0.0 110.134 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 50.6 t -39.89 -46.19 1.96 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.043 . . . . 0.0 108.731 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.073 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.04 -49.28 75.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -46.3 -41.84 13.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.898 177.655 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.576 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -67.57 -56.62 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.921 ' CG2' HG21 ' A' ' 19' ' ' ILE . 1.4 t -55.71 -51.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 3.0 mmt85 -40.94 -49.92 3.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.533 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -49.82 -44.25 49.18 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.825 HD13 ' HG ' ' A' ' 20' ' ' LEU . 49.3 mt -67.22 -20.29 65.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.769 . . . . 0.0 109.881 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.72 -64.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -46.31 -23.92 0.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.299 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 20.7 mm-40 -85.97 11.06 12.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 59.5 54.38 38.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.82 ' O ' HD13 ' A' ' 58' ' ' ILE . 12.4 m-85 -139.53 9.82 2.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -1.2 . . . . 0.0 110.339 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.3 mm . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.29 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.324 0.583 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -47.11 -46.01 22.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 110.351 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.673 HG23 HD22 ' A' ' 40' ' ' LEU . 20.5 mm -65.88 -17.1 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 110.66 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.55 ' C ' HD11 ' A' ' 52' ' ' LEU . 20.4 m-20 -84.04 -62.71 1.5 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.059 -1.026 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.84 -45.23 67.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.128 -0.982 . . . . 0.0 110.022 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.505 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 9.9 t-20 -64.66 -42.36 95.46 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 109.285 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.825 HD13 HG23 ' A' ' 49' ' ' VAL . 1.3 mt -58.74 -35.0 53.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.36 -0.838 . . . . 0.0 109.347 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 52' ' ' LEU . 67.2 mt -67.06 -45.24 77.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.45 -27.06 68.73 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.219 -0.926 . . . . 0.0 109.245 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 11.9 mm-40 -85.37 -43.67 13.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.516 -0.74 . . . . 0.0 110.147 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -65.77 -20.28 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 109.558 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -85.58 -41.32 15.36 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 1.3 ptmt -60.5 -30.78 69.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.522 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 27.0 p30 -150.87 71.23 1.02 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.09 -23.42 1.65 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.08 9.31 4.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.366 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 37' ' ' ARG . 7.1 tt -76.53 153.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.878 . . . . 0.0 110.454 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.3 m -104.6 155.58 18.72 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' SER . 6.2 p30 -46.25 -47.36 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.128 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' A' ' 35' ' ' SER . 4.7 t -49.65 -55.45 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.935 -1.103 . . . . 0.0 108.881 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.4 tt0 -67.21 -32.38 73.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -68.53 -20.04 64.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.59 0.71 . . . . 0.0 109.486 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.537 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 25.3 p -83.47 -46.2 12.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.557 -0.714 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -82.25 -27.1 32.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.68 ' HG3' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -58.37 -24.54 60.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.224 -0.923 . . . . 0.0 109.736 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.767 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.0 -3.87 10.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 178.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.29 46.76 5.73 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.767 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -150.24 156.65 41.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.273 . . . . 0.0 111.019 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.51 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -62.65 153.31 78.69 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.07 ' O ' HD12 ' A' ' 46' ' ' LEU . 46.2 Cg_endo -72.86 -41.93 1.27 Allowed 'Trans proline' 0 C--N 1.283 -2.887 0 O-C-N 123.842 1.443 . . . . 0.0 110.682 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -56.03 2.75 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.606 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.8 Cg_endo -74.74 -37.76 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.9 1.473 . . . . 0.0 110.121 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.675 ' HA ' HD11 ' A' ' 40' ' ' LEU . 48.5 t -41.85 -45.89 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.029 -1.044 . . . . 0.0 108.651 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.07 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.96 -43.27 93.23 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' PRO . 58.2 mt-10 -55.0 -43.69 73.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.572 ' CD ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.83 -44.65 76.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.636 0.731 . . . . 0.0 109.189 178.166 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.825 HG23 HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -62.8 -50.41 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -0.833 . . . . 0.0 109.599 178.539 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -41.85 -51.37 4.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.495 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -51.35 -45.1 62.22 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.134 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.828 ' HB3' HD11 ' A' ' 58' ' ' ILE . 16.5 mt -72.19 -23.5 61.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.14 -48.94 78.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -0.791 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.514 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -65.18 -17.24 64.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 13.1 mm100 -79.81 8.61 6.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.73 31.35 71.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -112.86 4.05 16.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -1.142 . . . . 0.0 109.999 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 52' ' ' LEU . 1.1 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.36 -0.838 . . . . 0.0 110.167 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ASP . 10.4 t70 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.357 0.599 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -40.88 -45.59 2.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.36 -0.837 . . . . 0.0 110.565 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.78 HG21 ' CD2' ' A' ' 40' ' ' LEU . 6.4 mm -70.19 -26.34 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 28.1 m-20 -72.51 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 0.0 110.303 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -35.92 68.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 109.985 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.74 ' HB3' HG13 ' A' ' 38' ' ' VAL . 3.5 t-20 -71.32 -42.86 68.06 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.783 . . . . 0.0 109.095 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.115 HG21 HG23 ' A' ' 49' ' ' VAL . 14.0 mt -66.31 -34.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.913 HD11 ' CD2' ' A' ' 52' ' ' LEU . 49.0 mt -72.18 -39.89 68.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.401 -0.812 . . . . 0.0 109.433 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.67 -37.07 84.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.989 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.88 -33.08 63.91 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.466 -0.771 . . . . 0.0 109.473 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.52 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 17.5 mt -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -73.66 -44.74 55.94 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.521 -0.737 . . . . 0.0 109.739 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -70.21 -32.33 70.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.603 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.541 ' O ' HG22 ' A' ' 29' ' ' ILE . 5.9 m-20 -130.05 86.17 2.37 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.84 0.71 50.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -111.03 31.9 5.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.165 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.989 HG21 ' OE2' ' A' ' 22' ' ' GLU . 14.9 tt -115.84 144.88 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.739 ' O ' HD12 ' A' ' 34' ' ' LEU . 44.8 t -87.96 -110.92 0.06 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 110.408 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.689 ' CB ' HD21 ' A' ' 46' ' ' LEU . 4.5 p-10 -124.88 -50.33 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 31' ' ' ASN . 69.5 t -41.17 -64.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 37' ' ' ARG . 4.1 tp10 -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.224 -0.922 . . . . 0.0 108.851 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 30' ' ' SER . 1.1 tt -67.8 -23.57 65.21 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.557 -0.714 . . . . 0.0 109.609 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -78.57 -41.88 30.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.437 -0.789 . . . . 0.0 110.286 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -67.09 -28.31 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 1.1 mmt180 -73.03 -17.81 61.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 18' ' ' ASN . 3.6 t -107.23 11.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.914 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.47 18.05 21.3 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.78 ' CD2' HG21 ' A' ' 15' ' ' ILE . 15.0 tp -123.4 134.95 53.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -1.003 . . . . 0.0 110.203 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.563 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.8 m -47.0 158.7 0.42 Allowed Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.735 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.061 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.6 -42.58 0.82 Allowed 'Trans proline' 0 C--N 1.285 -2.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.39 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.41 -55.54 3.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.32 178.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.711 ' CG ' HD11 ' A' ' 40' ' ' LEU . 44.4 Cg_endo -74.26 -50.37 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.91 1.479 . . . . 0.0 110.136 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 39.4 t -38.19 -46.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 108.873 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.061 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -63.42 -53.05 58.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 1.3 mt-10 -46.29 -46.01 17.73 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.955 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -68.22 -43.83 77.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.576 -0.702 . . . . 0.0 109.33 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.115 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -62.87 -43.81 99.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.55 ' N ' HG12 ' A' ' 49' ' ' VAL . 18.7 mmm-85 -51.36 -46.48 62.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.566 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.59 -34.08 64.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.862 178.015 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.913 ' CD2' HD11 ' A' ' 20' ' ' LEU . 5.2 mt -76.68 -19.05 58.17 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.743 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.55 -59.92 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 110.197 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -54.19 -22.97 12.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.56 11.44 7.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 51.43 59.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.917 ' O ' HD13 ' A' ' 58' ' ' ILE . 13.4 m-85 -134.29 6.58 3.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -1.129 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.917 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.3 mm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.327 0.584 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 8.4 mmt180 -47.3 -22.81 0.45 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.333 -0.855 . . . . 0.0 110.284 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.754 HG21 ' CD2' ' A' ' 40' ' ' LEU . 1.2 mp -80.51 -44.35 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 110.129 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.541 ' HB3' HD11 ' A' ' 52' ' ' LEU . 2.7 m-20 -58.55 -44.87 89.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.161 -0.962 . . . . 0.0 109.901 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -65.93 -47.82 73.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.915 . . . . 0.0 109.799 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.584 ' HB3' HG13 ' A' ' 38' ' ' VAL . 1.5 m-20 -61.87 -41.79 98.27 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.388 -0.82 . . . . 0.0 108.879 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.997 HG21 HG23 ' A' ' 49' ' ' VAL . 7.6 mt -62.09 -41.06 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.462 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.095 HD11 HD22 ' A' ' 52' ' ' LEU . 13.8 mt -70.34 -40.94 73.82 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.1 t-20 -66.41 -34.39 77.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 6.2 mm-40 -76.32 -29.49 57.34 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.424 -0.797 . . . . 0.0 109.696 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.767 HD21 ' CD1' ' A' ' 34' ' ' LEU . 21.5 mt -72.48 -32.7 66.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -79.24 -42.52 25.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.518 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -67.03 -33.69 76.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.552 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -141.34 63.37 1.44 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.911 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.01 -161.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.06 30.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -1.194 . . . . 0.0 109.946 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 26' ' ' ASP . 4.9 tt -117.43 131.9 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.361 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 37.0 t -67.73 168.88 10.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.954 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.6 OUTLIER -65.37 -39.91 92.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.36 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 31' ' ' ASN . 46.6 t -44.54 -61.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 109.221 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.99 -33.66 74.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.307 -0.87 . . . . 0.0 108.751 177.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.767 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -67.95 -20.39 65.05 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.525 0.678 . . . . 0.0 109.674 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.4 p -87.77 -24.39 23.8 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.41 -0.806 . . . . 0.0 110.488 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 4.7 mtmt -79.25 -33.14 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.71 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.591 ' CD ' ' HA ' ' A' ' 34' ' ' LEU . 4.4 ptm180 -81.67 -16.04 52.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.074 -1.016 . . . . 0.0 110.745 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 34' ' ' LEU . 4.5 t -97.66 12.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.207 -0.933 . . . . 0.0 110.144 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.98 21.76 8.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.754 ' CD2' HG21 ' A' ' 15' ' ' ILE . 15.2 tp -127.83 133.37 49.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.52 -0.988 . . . . 0.0 110.253 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.593 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -47.81 160.63 0.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 120.993 -1.067 . . . . 0.0 108.536 177.359 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.042 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.9 Cg_endo -73.92 -45.57 0.37 Allowed 'Trans proline' 0 C--N 1.282 -2.935 0 O-C-N 123.651 1.343 . . . . 0.0 110.654 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.554 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -38.73 -53.18 3.44 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 109.643 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.587 ' HB2' HD11 ' A' ' 40' ' ' LEU . 44.6 Cg_endo -75.45 -49.01 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.044 1.549 . . . . 0.0 109.77 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HA ' HD11 ' A' ' 19' ' ' ILE . 12.8 t -43.62 -37.87 2.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.047 -1.033 . . . . 0.0 108.494 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.042 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -70.77 -45.87 63.95 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 70.8 mt-10 -49.79 -46.3 50.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.088 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.598 ' CB ' HG22 ' A' ' 15' ' ' ILE . 3.6 mpt_? -69.69 -36.48 76.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.997 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -71.66 -47.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.272 -0.893 . . . . 0.0 110.017 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.608 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -48.25 -48.06 35.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 2.4 tpp180 -53.38 -45.91 69.41 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.903 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.095 HD22 HD11 ' A' ' 20' ' ' LEU . 78.1 mt -67.59 -16.59 64.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -58.89 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 110.254 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.445 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 61.4 mtt85 -73.75 -21.81 60.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 110.372 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' HG2' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -148.51 53.74 1.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -161.71 -123.58 0.67 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 1.061 ' O ' HD13 ' A' ' 58' ' ' ILE . 63.4 m-85 -146.96 76.16 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.061 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.5 mm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 5.1 t70 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.342 0.591 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.547 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 9.4 mmt180 -48.18 -25.64 1.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.322 -0.861 . . . . 0.0 110.346 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.875 HD12 HD22 ' A' ' 40' ' ' LEU . 19.2 mm -69.93 -33.57 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.265 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 52' ' ' LEU . 1.4 m-20 -73.81 -59.45 2.71 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.547 ' CD ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -53.6 -33.4 54.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.812 179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.579 ' CG ' HG12 ' A' ' 38' ' ' VAL . 59.8 t-20 -70.27 -43.12 71.12 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.384 -0.822 . . . . 0.0 109.192 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.043 HG21 HG23 ' A' ' 49' ' ' VAL . 40.4 mt -61.75 -35.92 70.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.937 HD11 HD22 ' A' ' 52' ' ' LEU . 20.2 mt -67.33 -43.63 81.11 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.285 -0.885 . . . . 0.0 109.286 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.67 -32.83 69.48 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 22.3 mm-40 -75.42 -45.09 41.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.853 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 19' ' ' ILE . 2.1 mm? -57.6 -44.14 85.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.659 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -68.04 -40.42 82.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.377 -0.827 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 27.6 mtpt -68.66 -20.16 64.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.909 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' ARG . 35.1 m-20 -147.4 79.23 1.49 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 110.188 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.88 58.36 0.21 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.26 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -1.181 . . . . 0.0 110.008 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.7 tt -122.35 147.04 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 9.1 p -87.83 -167.11 1.78 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.108 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 12.9 m-80 -78.78 -49.97 12.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -0.919 . . . . 0.0 110.333 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.6 t -40.02 -57.78 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 109.706 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -61.66 -33.5 74.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.186 -0.946 . . . . 0.0 108.759 177.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.749 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -67.16 -57.86 5.95 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 178.082 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.577 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 3.1 p -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.608 -0.682 . . . . 0.0 110.29 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -80.11 -22.99 41.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 34' ' ' LEU . 12.5 mmt180 -78.33 -17.86 55.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.855 HG23 ' HG ' ' A' ' 40' ' ' LEU . 3.2 m -105.88 -12.33 9.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 39.85 5.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.875 HD22 HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -153.76 169.19 23.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.016 -1.284 . . . . 0.0 110.775 179.025 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.2 154.09 94.01 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.058 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.4 Cg_endo -73.58 -44.0 0.57 Allowed 'Trans proline' 0 C--N 1.287 -2.698 0 O-C-N 124.004 1.529 . . . . 0.0 110.802 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.602 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.94 -56.26 1.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.8 Cg_endo -77.52 -42.57 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.93 1.49 . . . . 0.0 110.174 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 36.9 t -37.4 -50.39 1.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 108.877 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.058 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.34 -51.77 68.11 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.7 mm-40 -44.89 -41.22 6.96 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.303 -0.873 . . . . 0.0 108.949 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.69 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.97 -45.33 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.043 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -62.54 -44.59 99.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 178.207 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.552 ' N ' HG12 ' A' ' 49' ' ' VAL . 8.2 mmm180 -48.96 -47.39 44.02 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.339 -0.851 . . . . 0.0 109.019 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -50.5 -40.66 51.88 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.937 HD22 HD11 ' A' ' 20' ' ' LEU . 90.1 mt -75.44 -37.52 60.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.577 -0.702 . . . . 0.0 109.667 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 58' ' ' ILE . 7.1 tp10 -73.25 -26.6 61.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 110.337 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -68.66 -42.12 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.209 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' OE1' ' CG ' ' A' ' 57' ' ' PHE . 6.2 pt20 -76.99 2.09 15.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.64 8.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.721 ' O ' HD13 ' A' ' 58' ' ' ILE . 1.3 m-85 -119.28 11.01 12.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -1.183 . . . . 0.0 110.152 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 52' ' ' LEU . 15.0 mm . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.097 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 15' ' ' ILE . 1.4 m-20 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.235 0.54 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 6.7 mmt-85 -46.03 -22.33 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 110.358 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' HD2' ' A' ' 48' ' ' ARG . 6.6 mm -73.48 -34.43 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.462 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.812 ' HB3' HD11 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -78.0 -45.02 24.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -51.87 63.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.954 . . . . 0.0 110.0 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.555 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 7.8 t-20 -60.85 -40.45 92.91 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.385 -0.822 . . . . 0.0 109.332 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.072 HG21 HG23 ' A' ' 49' ' ' VAL . 10.5 mt -64.77 -38.5 82.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.282 -0.887 . . . . 0.0 109.559 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.883 ' HG ' HD13 ' A' ' 52' ' ' LEU . 14.4 mt -73.38 -35.24 65.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.351 -0.843 . . . . 0.0 109.307 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.69 -31.15 64.82 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.43 -0.794 . . . . 0.0 109.453 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 5.6 mm-40 -72.13 -32.85 67.32 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.402 -0.811 . . . . 0.0 109.86 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.89 -36.41 75.41 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.203 -0.936 . . . . 0.0 109.488 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -64.07 -42.97 96.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.49 -28.9 66.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.435 178.575 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.517 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -133.41 76.12 1.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 110.055 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.76 58.82 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.57 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -1.114 . . . . 0.0 110.182 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 tt -112.17 141.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.621 ' O ' HD12 ' A' ' 34' ' ' LEU . 17.6 m -77.9 -138.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.417 -0.802 . . . . 0.0 110.138 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.606 ' OD1' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -108.86 -41.1 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' ASN . 76.2 t -44.43 -62.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 109.355 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.481 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 1.1 tp10 -61.84 -26.44 68.13 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -78.54 -15.28 58.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.697 -0.627 . . . . 0.0 110.071 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ASN . 23.6 p -87.93 -44.67 10.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.819 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 7.8 pttt -79.84 -41.05 27.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 111.126 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 13.9 ptm180 -63.01 -16.2 58.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.065 -1.022 . . . . 0.0 110.628 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.782 HG23 ' HG ' ' A' ' 40' ' ' LEU . 14.5 m -98.51 -22.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.358 -0.838 . . . . 0.0 110.005 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 103.97 35.38 3.46 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.782 ' HG ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -153.36 169.02 24.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.019 -1.283 . . . . 0.0 110.624 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.0 m -74.17 158.75 85.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.747 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.085 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.9 Cg_endo -74.16 -49.75 0.18 Allowed 'Trans proline' 0 C--N 1.286 -2.72 0 O-C-N 123.9 1.473 . . . . 0.0 110.565 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.92 -53.67 3.43 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.428 179.142 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.634 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.3 Cg_endo -76.46 -41.69 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.898 1.473 . . . . 0.0 110.219 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 53.8 t -40.33 -51.19 2.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 108.718 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.085 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.25 -47.4 81.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -46.4 -38.83 9.52 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.864 177.551 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.815 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.36 -46.91 53.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.535 -0.728 . . . . 0.0 109.266 178.291 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.072 HG23 HG21 ' A' ' 19' ' ' ILE . 0.6 OUTLIER -65.77 -51.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.473 -0.767 . . . . 0.0 109.96 178.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.703 ' N ' HG12 ' A' ' 49' ' ' VAL . 2.4 mmm180 -46.07 -44.11 15.18 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -54.44 -44.75 72.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' A' ' 58' ' ' ILE . 61.0 mt -65.08 -16.69 63.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.99 -58.56 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.243 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 2.6 ptp180 -49.19 -27.94 4.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.438 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.472 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 73.5 mm-40 -81.77 10.87 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.74 93.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.818 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -129.85 15.44 5.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.353 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.922 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.0 mm . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -80.01 -22.3 42.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.264 -0.897 . . . . 0.0 110.362 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.788 HG23 HD22 ' A' ' 40' ' ' LEU . 13.4 mm -78.87 -29.68 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.798 ' HB3' HD21 ' A' ' 52' ' ' LEU . 85.3 m-20 -81.56 -39.91 23.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.073 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -51.68 56.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.214 -0.929 . . . . 0.0 110.032 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.559 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.5 m-20 -62.84 -39.43 94.34 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.404 -0.81 . . . . 0.0 109.363 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 34' ' ' LEU . 8.0 mt -64.07 -38.25 81.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.453 -0.779 . . . . 0.0 109.56 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.021 HD11 HD22 ' A' ' 52' ' ' LEU . 12.9 mt -70.03 -37.42 75.59 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 26.2 m-20 -70.83 -29.32 65.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.845 . . . . 0.0 109.603 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 37' ' ' ARG . 6.2 mm-40 -82.23 -29.14 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.445 -0.785 . . . . 0.0 109.848 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.96 -37.36 84.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -42.48 33.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 1.5 pttt -75.17 -29.71 60.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.995 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -133.14 53.31 2.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.134 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -53.54 -169.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.32 16.84 1.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -1.143 . . . . 0.0 110.197 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.982 HD13 ' NH1' ' A' ' 37' ' ' ARG . 12.9 tt -102.64 134.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 110.124 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 34' ' ' LEU . 36.5 m -75.02 -131.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.403 -0.81 . . . . 0.0 110.502 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 35' ' ' SER . 26.5 p-10 -111.78 -47.02 3.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.217 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t -43.1 -67.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.976 -1.078 . . . . 0.0 109.276 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 3.4 tp10 -56.34 -25.95 50.84 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.203 -0.936 . . . . 0.0 108.665 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.849 HD11 HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -77.64 -18.73 56.46 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.41 0.624 . . . . 0.0 109.906 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' ASN . 6.4 p -90.33 -47.75 7.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.532 -0.73 . . . . 0.0 110.864 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 35' ' ' SER . 10.6 ttmt -79.21 -24.83 42.85 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 111.288 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.982 ' NH1' HD13 ' A' ' 29' ' ' ILE . 28.4 ptt180 -75.8 -14.91 60.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 110.62 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.8 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -107.64 -11.02 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 110.071 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 42.12 4.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.8 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.79 167.38 30.58 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.064 -1.256 . . . . 0.0 110.852 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.2 m -72.98 156.71 89.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.02 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.059 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -74.18 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.635 0 O-C-N 123.972 1.512 . . . . 0.0 110.826 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -39.38 -53.86 3.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 109.421 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.641 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.1 Cg_endo -77.24 -42.53 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.021 1.537 . . . . 0.0 110.335 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.767 ' HB2' HD12 ' A' ' 40' ' ' LEU . 44.6 t -38.47 -53.38 1.55 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 0.0 108.866 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.059 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -55.25 -49.63 71.54 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.25 -38.04 1.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.958 177.42 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.584 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.51 -49.29 27.34 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.627 0.727 . . . . 0.0 109.173 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -63.49 -40.49 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 4.2 mmm180 -53.86 -46.17 71.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.081 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -52.04 -42.16 62.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.021 HD22 HD11 ' A' ' 20' ' ' LEU . 64.4 mt -70.77 -22.4 62.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.546 -0.721 . . . . 0.0 109.781 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 2.8 tm-20 -68.5 -69.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.6 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -52.95 -19.38 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 110.639 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.574 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 8.7 mm100 -86.54 13.41 8.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.01 . . . . 0.0 110.481 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 61.84 51.42 57.39 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.922 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.3 m-85 -139.94 9.38 2.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -1.218 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 57' ' ' PHE . 8.5 mm . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.203 0.525 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -40.54 -27.49 0.05 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.361 -0.837 . . . . 0.0 110.41 -179.133 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.906 HG23 HD22 ' A' ' 40' ' ' LEU . 8.5 mm -72.97 -46.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 110.421 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 13' ' ' ASP . 1.4 m-20 -68.93 -26.24 64.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -75.88 -66.43 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.443 ' HB3' HG12 ' A' ' 38' ' ' VAL . 9.2 t-20 -53.45 -28.28 29.35 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 108.988 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.791 HG13 HG11 ' A' ' 38' ' ' VAL . 3.4 mt -64.79 -50.66 74.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.091 178.046 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.914 HD11 HD22 ' A' ' 52' ' ' LEU . 72.0 mt -55.55 -42.19 74.3 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -59.02 -38.77 80.05 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.746 ' OE2' HG13 ' A' ' 38' ' ' VAL . 25.5 mt-10 -63.61 -39.65 94.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.45 -0.782 . . . . 0.0 109.744 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 34' ' ' LEU . 2.1 mm? -66.58 -40.6 89.02 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -65.69 -36.45 83.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.317 -0.864 . . . . 0.0 109.303 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 1.6 pttp -79.1 -29.38 43.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -136.67 95.27 3.11 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 110.024 179.123 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.86 13.37 43.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.527 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.01 34.92 4.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -1.217 . . . . 0.0 110.381 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 26' ' ' ASP . 11.3 tt -116.48 139.84 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.615 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.546 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.7 t -76.19 -129.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.364 -0.835 . . . . 0.0 110.027 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -117.89 -38.25 3.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.019 -1.05 . . . . 0.0 110.29 179.347 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' ASN . 98.0 t -45.39 -56.65 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.041 -1.037 . . . . 0.0 109.068 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 1.7 tp10 -66.99 -32.88 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.336 -0.853 . . . . 0.0 108.844 177.387 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -69.46 -15.8 63.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.558 -0.714 . . . . 0.0 109.492 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 16.2 p -86.27 -47.08 9.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.495 -0.753 . . . . 0.0 110.355 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.99 -16.8 52.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.181 -0.95 . . . . 0.0 110.724 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -74.64 -19.94 60.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.859 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.94 -5.97 10.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.396 -0.815 . . . . 0.0 109.756 179.102 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.92 40.65 5.51 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -152.18 160.38 43.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.294 . . . . 0.0 110.72 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.485 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -69.59 160.12 80.89 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.069 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.6 Cg_endo -73.06 -45.21 0.47 Allowed 'Trans proline' 0 C--N 1.284 -2.859 0 O-C-N 123.926 1.487 . . . . 0.0 110.489 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.39 -57.79 1.36 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.177 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 52.1 Cg_endo -76.5 -41.49 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.898 1.473 . . . . 0.0 110.135 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.714 ' HB2' HD12 ' A' ' 40' ' ' LEU . 53.6 t -39.13 -53.05 1.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 108.661 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.069 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -52.82 -51.98 58.76 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 176.42 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.0 -43.06 4.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.265 177.7 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.863 ' CD ' HG21 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -72.21 -56.25 5.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -0.815 . . . . 0.0 109.492 178.581 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG23 HD13 ' A' ' 19' ' ' ILE . 1.6 t -54.72 -48.93 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.331 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmt180 -43.33 -52.27 5.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.369 178.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.04 -41.41 16.68 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.922 178.064 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.914 HD22 HD11 ' A' ' 20' ' ' LEU . 92.8 mt -68.07 -28.33 67.27 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.452 -0.78 . . . . 0.0 109.715 178.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' ARG . 1.9 tm-20 -64.62 -63.63 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.825 . . . . 0.0 110.161 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -50.27 -27.04 5.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.147 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 28.6 mm-40 -83.42 5.59 23.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.57 59.97 7.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.953 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.53 10.81 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.953 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.7 mm . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.348 0.594 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -43.65 -33.9 1.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.406 -0.808 . . . . 0.0 110.264 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 1.028 HG23 HD22 ' A' ' 40' ' ' LEU . 7.1 mm -73.65 -33.74 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.53 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.663 ' HB3' HD21 ' A' ' 52' ' ' LEU . 93.4 m-20 -76.67 -45.82 28.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.599 ' CD ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -62.81 -44.2 96.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.072 -1.018 . . . . 0.0 110.217 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.788 ' HB3' HG12 ' A' ' 38' ' ' VAL . 9.1 m-20 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 178.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.685 HD13 HG23 ' A' ' 49' ' ' VAL . 7.2 mt -69.79 -33.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 178.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.964 HD11 HD22 ' A' ' 52' ' ' LEU . 65.9 mt -70.9 -38.25 72.99 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.247 -0.908 . . . . 0.0 109.388 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -31.9 70.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.024 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -78.5 -32.12 48.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.382 -0.824 . . . . 0.0 109.605 178.98 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 12.6 mt -71.13 -37.34 72.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.306 -0.871 . . . . 0.0 109.475 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.6 -38.63 84.27 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 178.451 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 24.5 pttt -79.73 -38.16 33.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.481 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -116.49 91.84 3.7 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 110.093 179.363 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.8 22.48 13.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.46 9.85 4.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -1.115 . . . . 0.0 110.073 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.024 HG21 ' OE2' ' A' ' 22' ' ' GLU . 13.6 tt -85.72 143.67 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 110.405 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 m -92.38 -73.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 110.537 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.702 ' OD1' HD11 ' A' ' 46' ' ' LEU . 10.7 t-20 -164.3 -54.6 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.478 ' C ' ' O ' ' A' ' 31' ' ' ASN . 3.2 t -42.64 -52.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.998 -1.064 . . . . 0.0 109.081 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -69.08 -29.23 67.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.147 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.652 HD21 HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -73.66 -16.61 61.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.608 -0.683 . . . . 0.0 109.749 178.508 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.564 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 19.3 p -88.07 -47.76 8.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -81.96 -17.11 48.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -77.43 -16.03 59.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.013 -1.055 . . . . 0.0 110.611 -179.359 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.898 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.48 -6.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.985 179.489 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.27 42.75 5.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.028 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -153.31 164.06 38.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.987 -1.302 . . . . 0.0 110.643 178.852 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -71.51 160.93 81.14 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.97 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.078 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.3 Cg_endo -74.28 -54.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.285 -2.794 0 O-C-N 123.953 1.502 . . . . 0.0 110.649 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 m -35.14 -54.25 1.1 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.1 Cg_endo -74.83 -42.6 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.88 1.463 . . . . 0.0 109.867 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.692 ' HB2' HD12 ' A' ' 40' ' ' LEU . 40.8 t -39.15 -49.15 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.785 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.078 HD12 ' O ' ' A' ' 42' ' ' PRO . 2.1 mp -56.93 -52.77 63.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -42.87 -41.03 3.14 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.73 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.612 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -73.14 -53.78 10.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.615 -0.678 . . . . 0.0 109.683 178.614 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.685 HG23 HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -56.7 -43.83 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 1.5 mmm-85 -50.72 -48.4 58.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.203 -0.936 . . . . 0.0 109.131 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -50.6 -39.2 49.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.964 HD22 HD11 ' A' ' 20' ' ' LEU . 93.0 mt -70.63 -19.84 62.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.689 178.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.493 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 1.3 mt-10 -78.21 -55.07 5.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 110.062 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -44.64 -49.33 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.394 -0.816 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -70.61 -1.96 12.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.325 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 75.17 66.27 1.94 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.823 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -141.84 9.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 110.131 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.962 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.2 mm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.277 0.56 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.473 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 4.8 mmt85 -69.56 -35.49 75.44 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.297 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.898 HG21 HD12 ' A' ' 40' ' ' LEU . 1.2 mp -70.96 -35.22 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 110.273 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.758 ' CA ' HD11 ' A' ' 52' ' ' LEU . 63.8 m-20 -62.24 -67.17 0.44 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.545 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 3.1 ptm85 -50.76 -44.86 58.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.242 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.434 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 97.2 m-20 -66.21 -37.52 85.76 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.947 HG21 HG23 ' A' ' 49' ' ' VAL . 3.2 mt -66.91 -34.3 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 109.228 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.011 HD11 HD22 ' A' ' 52' ' ' LEU . 12.6 mt -68.74 -43.26 76.26 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.09 -30.88 71.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.292 -0.88 . . . . 0.0 109.511 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 24.6 mm-40 -76.84 -30.46 56.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.826 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 34' ' ' LEU . 2.4 mm? -75.46 -30.98 60.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 178.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.704 178.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.51 -40.39 57.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.836 179.185 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.532 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -136.51 64.05 1.56 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.328 -0.857 . . . . 0.0 110.073 179.182 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.05 -164.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 48.8 23.81 0.73 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 110.274 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 2.6 tt -106.65 142.14 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.164 -0.96 . . . . 0.0 110.341 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 p -80.91 179.87 7.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.387 -0.821 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.604 HD22 HD11 ' A' ' 46' ' ' LEU . 9.3 p-10 -71.92 -50.02 32.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' ASN . 48.4 t -40.91 -48.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.453 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.0 -36.73 82.82 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.324 -0.86 . . . . 0.0 108.868 177.51 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.042 HD11 HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -67.78 -54.56 18.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.441 178.162 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.629 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 4.5 p -44.84 -44.89 9.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 32' ' ' VAL . 4.1 mtpp -73.82 -36.11 64.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.697 -178.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.12 -42.96 99.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 34' ' ' LEU . 9.1 m -92.1 20.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.977 179.295 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 48.98 23.66 3.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.898 HD12 HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -110.51 133.91 52.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.009 . . . . 0.0 110.82 -179.094 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -50.38 152.07 3.41 Favored Pre-proline 0 C--N 1.3 -1.554 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.971 176.177 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.087 ' O ' HD12 ' A' ' 46' ' ' LEU . 44.4 Cg_endo -70.51 -47.26 0.73 Allowed 'Trans proline' 0 C--N 1.283 -2.89 0 O-C-N 123.703 1.37 . . . . 0.0 110.573 -177.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.27 -54.66 5.82 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.048 -1.033 . . . . 0.0 109.125 178.336 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.649 ' HG2' HD22 ' A' ' 40' ' ' LEU . 42.3 Cg_endo -74.37 -48.39 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.95 1.5 . . . . 0.0 110.592 177.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' HA ' HD13 ' A' ' 40' ' ' LEU . 37.0 t -40.34 -42.05 1.48 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 108.742 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.087 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mt -67.87 -47.06 69.95 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.9 mm-40 -49.73 -46.14 49.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.139 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.26 -46.04 74.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.3 178.26 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.947 HG23 HG21 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -59.48 -46.89 92.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.469 -0.769 . . . . 0.0 109.786 178.591 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.605 ' N ' HG12 ' A' ' 49' ' ' VAL . 9.5 mmm180 -48.02 -50.61 27.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.4 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -48.83 -40.36 29.01 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.606 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 20' ' ' LEU . 70.9 mt -74.02 -30.46 62.45 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.446 -0.783 . . . . 0.0 109.623 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.603 ' N ' HG13 ' A' ' 58' ' ' ILE . 5.8 tp10 -74.49 -62.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.479 -0.763 . . . . 0.0 110.298 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -46.92 -26.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -82.77 7.55 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 73.68 40.03 47.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.869 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -128.83 10.3 5.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.184 -1.186 . . . . 0.0 110.277 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 57' ' ' PHE . 7.5 mm . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 110.212 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' CG ' ' A' ' 16' ' ' ASP . 6.4 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.339 0.59 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 22.2 mmt-85 -53.0 -34.92 58.49 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 110.357 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.878 HD12 HD22 ' A' ' 40' ' ' LEU . 13.6 mm -75.8 -24.39 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 13' ' ' ASP . 18.0 m-20 -80.6 -55.64 4.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.129 -0.982 . . . . 0.0 110.292 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.08 -43.87 82.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 2.7 m120 -66.32 -41.52 89.53 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.376 -0.827 . . . . 0.0 109.206 178.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 49' ' ' VAL . 6.8 mt -65.06 -34.76 72.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 178.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.872 HD11 HD22 ' A' ' 52' ' ' LEU . 25.8 mt -70.8 -39.2 73.26 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.378 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 17' ' ' ARG . 3.3 m120 -68.91 -30.86 69.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.488 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 66.2 mm-40 -78.34 -32.34 49.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.431 -0.793 . . . . 0.0 109.763 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 HD11 ' A' ' 34' ' ' LEU . 2.5 mm? -73.37 -32.23 64.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 178.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.486 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 19.1 tp60 -74.13 -33.93 63.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.919 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 12.9 pttt -77.58 -34.27 53.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -128.07 76.56 1.7 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.111 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.07 59.59 0.15 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.41 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.299 179.85 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.5 tt -105.74 141.81 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.62 154.97 19.89 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.363 -0.836 . . . . 0.0 110.435 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.98 ' ND2' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -44.55 -55.3 5.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 0.0 110.369 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' ASN . 86.6 t -38.61 -58.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.175 -0.953 . . . . 0.0 109.552 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -65.12 -39.03 92.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.212 -0.93 . . . . 0.0 108.576 177.088 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.67 -15.07 50.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 178.39 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.562 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 12.7 p -88.0 -50.44 6.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.403 -0.811 . . . . 0.0 111.412 -178.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 13.2 mttt -81.89 -24.1 35.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 111.614 -177.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.596 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -73.66 -15.41 61.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.906 -1.121 . . . . 0.0 110.351 -179.191 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.879 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -104.61 -16.91 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.333 -0.854 . . . . 0.0 109.895 178.97 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.32 38.8 3.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.879 HD21 ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.67 170.3 20.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.276 . . . . 0.0 110.736 179.262 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.7 m -75.6 160.68 78.75 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.01 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.5 Cg_endo -73.8 -54.51 0.1 Allowed 'Trans proline' 0 C--N 1.287 -2.7 0 O-C-N 123.998 1.525 . . . . 0.0 110.845 -178.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -38.06 -51.64 3.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.752 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 43' ' ' THR . 48.8 Cg_endo -76.12 -43.22 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.756 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 41.8 t -41.6 -43.72 2.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.075 -1.016 . . . . 0.0 108.469 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.01 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.63 -51.3 60.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 2.5 mt-10 -43.24 -38.46 2.57 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.142 -0.973 . . . . 0.0 108.594 177.411 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.631 ' HG3' HG21 ' A' ' 15' ' ' ILE . 3.5 mmt85 -71.69 -54.52 10.04 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.031 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -60.41 -49.7 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 109.758 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.651 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -41.73 -51.41 4.13 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -51.19 -44.11 61.5 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.679 -0.808 . . . . 0.0 108.836 177.928 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 20' ' ' LEU . 86.8 mt -66.64 -17.5 64.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.44 -0.787 . . . . 0.0 109.868 178.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.36 -64.7 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.246 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -46.95 -26.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.9 . . . . 0.0 110.4 -179.869 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.551 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mm-40 -82.73 7.68 14.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.02 91.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.987 ' O ' HD13 ' A' ' 58' ' ' ILE . 19.3 m-85 -128.43 10.57 6.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.987 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.7 mm . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.373 0.606 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -54.86 -29.77 56.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.926 HD12 HD22 ' A' ' 40' ' ' LEU . 22.2 mm -67.22 -24.09 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.785 ' HB3' HD11 ' A' ' 52' ' ' LEU . 69.3 m-20 -83.07 -53.63 5.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 110.259 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -53.15 -50.19 65.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.33 -40.06 96.25 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 109.269 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.881 HG21 HG23 ' A' ' 49' ' ' VAL . 7.3 mt -64.52 -34.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.402 -0.811 . . . . 0.0 109.323 178.4 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.862 ' HG ' HD13 ' A' ' 52' ' ' LEU . 9.3 mt -68.91 -42.35 76.94 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 178.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 178.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.471 ' OE1' HG12 ' A' ' 38' ' ' VAL . 11.3 mt-10 -72.57 -31.8 65.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.401 -0.812 . . . . 0.0 109.599 178.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.031 HD21 HD11 ' A' ' 34' ' ' LEU . 2.4 mm? -68.34 -31.68 71.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 178.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -43.5 24.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.525 -0.734 . . . . 0.0 109.888 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -72.22 -49.21 36.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.968 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 27' ' ' GLY . 6.1 m-20 -121.98 71.04 0.98 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.244 -0.91 . . . . 0.0 110.071 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 28' ' ' ARG . . . -58.77 -151.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.604 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER 27.93 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.64 -0.918 . . . . 0.0 110.953 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 27' ' ' GLY . 8.8 tt -114.59 128.15 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -75.9 155.75 34.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.867 . . . . 0.0 110.281 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' SER . 7.4 p30 -46.24 -44.45 16.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 31' ' ' ASN . 58.8 t -40.37 -72.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 109.825 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -57.67 -25.01 59.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.865 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.031 HD11 HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.584 -0.697 . . . . 0.0 109.913 179.003 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 31' ' ' ASN . 23.4 p -88.17 -44.14 11.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.541 -0.724 . . . . 0.0 110.967 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -42.1 22.33 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 111.425 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -61.26 -15.81 38.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.512 -178.713 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.79 HG23 ' HG ' ' A' ' 40' ' ' LEU . 15.1 m -100.41 -23.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 121.266 -0.896 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.99 32.25 4.76 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.926 HD22 HD12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -148.06 168.99 20.94 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.008 -1.289 . . . . 0.0 110.647 179.005 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -72.75 158.41 87.32 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 108.977 177.34 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.055 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.1 Cg_endo -73.93 -46.59 0.31 Allowed 'Trans proline' 0 C--N 1.287 -2.703 0 O-C-N 123.928 1.488 . . . . 0.0 110.744 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.3 -54.81 4.51 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 109.548 179.254 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.1 Cg_endo -77.25 -40.02 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.887 1.467 . . . . 0.0 110.267 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.0 t -38.71 -45.78 1.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.025 . . . . 0.0 108.809 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.055 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -65.3 -50.36 65.97 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 6.1 mm-40 -42.86 -39.29 2.47 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.592 177.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' HG13 ' A' ' 15' ' ' ILE . 1.4 mmt85 -69.47 -55.6 9.79 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.663 0.745 . . . . 0.0 109.071 177.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -55.57 -43.04 71.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.32 -0.862 . . . . 0.0 109.479 178.292 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 10.1 mmt85 -45.86 -56.22 5.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.331 -0.856 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -46.74 -40.36 13.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 177.952 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.862 HD13 ' HG ' ' A' ' 20' ' ' LEU . 21.4 mt -77.4 -19.14 56.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.404 -0.81 . . . . 0.0 109.889 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -72.31 -59.32 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 0.0 110.384 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -57.52 -21.13 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 68.8 mm-40 -79.3 7.63 7.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 64.43 49.74 63.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.924 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.7 m-85 -139.07 17.77 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.279 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 57' ' ' PHE . 7.8 mm . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.338 0.59 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -51.74 -24.45 5.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.298 -0.876 . . . . 0.0 110.306 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.866 HG23 HD22 ' A' ' 40' ' ' LEU . 10.5 mm -75.37 -34.28 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 110.237 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.727 ' HB3' HD11 ' A' ' 52' ' ' LEU . 72.5 m-20 -74.99 -38.25 61.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 110.266 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -67.39 -59.73 3.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.3 -31.75 65.97 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.357 -0.839 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.935 HG21 HG23 ' A' ' 49' ' ' VAL . 8.3 mt -69.49 -39.87 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 58' ' ' ILE . 26.1 mt -69.88 -37.37 76.02 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -67.69 -29.06 68.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 178.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 4.6 mm-40 -73.36 -38.02 65.85 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.433 -0.792 . . . . 0.0 109.678 178.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 27' ' ' GLY . 63.7 mt -68.48 -32.91 73.23 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.229 -0.92 . . . . 0.0 109.256 178.639 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.69 -39.34 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.113 177.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -82.02 -26.9 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 0.0 109.635 178.688 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.571 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -142.0 63.83 1.41 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.47 -0.768 . . . . 0.0 109.932 178.883 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -49.43 -26.5 7.17 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 7.7 mpt_? -92.71 81.1 4.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -1.173 . . . . 0.0 110.493 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 10.0 tt -159.09 138.86 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.341 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -86.8 162.0 18.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.973 179.768 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -53.45 -30.75 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 110.449 -179.582 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.73 -66.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 109.156 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.2 tp10 -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.27 -0.894 . . . . 0.0 108.671 177.36 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.6 -14.58 62.12 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 178.286 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 23.5 p -87.04 -43.44 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.499 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -84.78 -17.28 38.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 12.8 mtt-85 -77.75 -16.63 58.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.018 -1.051 . . . . 0.0 110.67 -179.411 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.906 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -109.5 -7.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.482 -0.761 . . . . 0.0 110.01 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.97 42.88 5.21 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.906 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.64 167.6 28.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.046 -1.267 . . . . 0.0 110.685 179.034 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -73.54 160.76 81.52 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.97 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 1.037 ' O ' HD12 ' A' ' 46' ' ' LEU . 52.3 Cg_endo -75.56 -49.64 0.13 Allowed 'Trans proline' 0 C--N 1.286 -2.738 0 O-C-N 123.932 1.491 . . . . 0.0 110.725 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -39.47 -51.55 4.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.795 179.405 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.3 Cg_endo -76.53 -43.12 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.915 1.481 . . . . 0.0 109.727 178.223 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.738 ' HB2' HD12 ' A' ' 40' ' ' LEU . 51.9 t -41.67 -42.36 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.037 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -67.72 -48.66 65.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.588 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 44' ' ' PRO . 66.6 mm-40 -48.05 -39.4 19.91 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.837 177.236 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 1.3 mmt180 -70.02 -51.84 28.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.13 178.049 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.935 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -59.67 -50.62 79.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.42 -0.8 . . . . 0.0 109.63 178.587 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.675 ' N ' HG12 ' A' ' 49' ' ' VAL . 3.9 mmm180 -45.89 -42.15 12.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -57.31 -38.11 73.5 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.408 -0.807 . . . . 0.0 108.977 178.277 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 16' ' ' ASP . 79.8 mt -74.77 -17.89 60.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.912 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -69.2 -53.82 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.133 -0.979 . . . . 0.0 109.739 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -75.03 -29.1 60.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 110.031 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 4.8 pt20 -140.92 56.06 1.57 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.893 . . . . 0.0 110.421 179.783 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -166.57 -137.6 2.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 1.074 ' O ' HD13 ' A' ' 58' ' ' ILE . 56.2 m-85 -139.78 83.08 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -1.12 . . . . 0.0 110.284 -179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.074 HD13 ' O ' ' A' ' 57' ' ' PHE . 4.6 mm . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.193 -0.942 . . . . 0.0 110.531 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HE2' ' CA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.815 0.34 . . . . 9.8100000000000005 110.45 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 3' ' ' ASP . 1.2 p -172.61 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.815 -1.178 . . . . 7.7400000000000002 111.274 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 2' ' ' VAL . 54.1 m-20 60.46 -75.06 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.462 -0.774 . . . . 5.7800000000000002 110.813 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 74.45 11.55 4.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.507 -0.746 . . . . 4.5300000000000002 111.304 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 23.0 mtmt -87.82 35.02 0.72 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.815 -1.178 . . . . 2.79 109.577 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -52.77 -64.12 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 4.96 110.39 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.616 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 6.0 mmt-85 49.39 -154.86 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.501 -1.296 . . . . 5.8300000000000001 107.501 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 41.8 Cg_endo -74.59 58.39 4.58 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.97 -0.819 . . . . 1.9099999999999999 109.97 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 12' ' ' LEU . . . -60.06 -51.02 61.44 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.426 -1.47 . . . . 1.95 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -44.81 -25.83 0.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -1.114 . . . . 4.5099999999999998 109.145 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' GLY . 1.8 m-20 -144.05 71.91 1.33 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.58 0.705 . . . . 3.02 109.213 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' A' ' 16' ' ' ASP . 0.7 OUTLIER -130.85 133.07 45.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.602 -0.686 . . . . 1.5900000000000001 110.48 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.85 140.42 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 1.8300000000000001 110.096 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 9.6 mmt180 -46.52 -32.02 3.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.93 -0.708 . . . . 2.8300000000000001 110.631 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.743 HG23 HD22 ' A' ' 40' ' ' LEU . 6.6 mm -70.12 -37.24 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.46999999999999997 111.63 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.719 ' HB2' HD22 ' A' ' 12' ' ' LEU . 73.3 m-20 -74.67 -54.37 7.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.916 -1.115 . . . . 1.25 111.417 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 1.3 ptm180 -57.08 -46.68 82.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 2.3999999999999999 111.204 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.574 ' HB3' HG12 ' A' ' 38' ' ' VAL . 2.5 m-20 -65.75 -32.79 74.53 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.124 -1.03 . . . . 1.99 108.689 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.908 HG21 HG23 ' A' ' 49' ' ' VAL . 9.1 mt -69.38 -38.04 76.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.41999999999999998 108.548 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.06 HD11 HD22 ' A' ' 52' ' ' LEU . 41.4 mt -67.5 -39.02 85.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.332 -0.988 . . . . 0.90000000000000002 108.332 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.505 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 36.8 t-20 -65.31 -30.97 71.88 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.983 -0.747 . . . . 1.8400000000000001 108.983 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.775 ' OE1' HG13 ' A' ' 38' ' ' VAL . 7.3 mt-10 -79.45 -32.87 42.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.543 -0.723 . . . . 2.0699999999999998 109.419 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.053 HD21 HD11 ' A' ' 34' ' ' LEU . 2.5 mm? -69.21 -41.61 76.84 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.365 -0.934 . . . . 1.3700000000000001 108.666 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.488 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 2.2 tp60 -64.67 -38.35 90.71 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 2.0699999999999998 108.909 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -78.08 -20.73 51.71 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.319 -0.993 . . . . 2.1400000000000001 108.319 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.2 m-20 -141.69 91.02 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.478 -0.889 . . . . 1.52 109.506 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.54 14.11 37.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.351 -1.099 . . . . 1.5600000000000001 110.351 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 28.19 5.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.293 . . . . 3.6400000000000001 110.015 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 26' ' ' ASP . 12.2 tt -105.64 137.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.64000000000000001 110.294 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.828 ' HA ' HD11 ' A' ' 64' ' ' LEU . 7.8 t -77.91 -123.45 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.826 -0.749 . . . . 1.76 110.128 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.684 HD22 HD21 ' A' ' 46' ' ' LEU . 14.2 p30 -122.44 -44.48 2.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.056 -1.028 . . . . 2.2799999999999998 110.086 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 74.1 t -45.51 -55.45 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.902 -1.124 . . . . 0.51000000000000001 108.428 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -64.32 -47.11 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.073 -1.454 . . . . 1.77 107.073 177.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.053 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.3 -19.17 3.01 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.568 0.699 . . . . 0.90000000000000002 109.839 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.55 ' HA ' ' HG ' ' A' ' 45' ' ' CYS . 3.7 p -87.45 -31.13 20.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.47999999999999998 110.586 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -87.19 -31.62 20.25 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.272 -0.893 . . . . 2.1899999999999999 112.586 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 13.3 mtp180 -68.85 -17.81 64.05 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.507 -1.371 . . . . 2.3799999999999999 110.759 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.848 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.8 m -104.94 -11.33 9.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 C-N-CA 119.626 -0.83 . . . . 0.91000000000000003 110.047 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.2 40.11 6.65 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.351 -0.928 . . . . 0.46999999999999997 111.362 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.848 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -146.09 171.79 14.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.779 -1.424 . . . . 1.4299999999999999 110.654 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 38.4 m -76.39 158.94 80.85 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.392 -1.336 . . . . 0.94999999999999996 107.392 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.103 ' O ' HD12 ' A' ' 46' ' ' LEU . 55.9 Cg_endo -77.13 -44.61 0.19 Allowed 'Trans proline' 0 C--N 1.282 -2.96 0 O-C-N 124.189 1.626 . . . . 0.28000000000000003 111.27 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.34 -52.56 5.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.67000000000000004 109.099 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.0 Cg_endo -79.76 -38.03 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.32000000000000001 110.107 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' HD12 ' A' ' 40' ' ' LEU . 42.1 t -42.93 -46.75 5.51 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.749 -1.204 . . . . 0.47999999999999998 107.749 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.103 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -62.02 -51.7 66.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.328 -1.36 . . . . 0.38 107.328 177.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -44.75 -37.39 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.099 -1.04 . . . . 2.0299999999999998 108.212 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.581 ' HG3' HG21 ' A' ' 15' ' ' ILE . 2.6 mmt180 -73.64 -46.17 48.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.951 0.881 . . . . 1.8300000000000001 108.717 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.908 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -65.86 -38.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.411 -0.806 . . . . 0.46999999999999997 109.94 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' HD3' ' CD1' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.74 -45.48 81.96 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.389 -0.967 . . . . 2.0800000000000001 108.389 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -39.45 64.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.138 -1.43 . . . . 2.4100000000000001 107.138 177.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 20' ' ' LEU . 59.3 mt -73.06 -19.97 61.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.584 0.707 . . . . 0.57999999999999996 109.31 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.33 -51.44 13.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 1.8500000000000001 109.869 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -52.96 -30.15 33.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.527 -0.733 . . . . 3.6200000000000001 110.364 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 13.0 mm-40 -84.33 11.05 9.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 2.5800000000000001 109.843 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.26 48.57 73.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.13 -1.188 . . . . 1.6499999999999999 110.13 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 1.041 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.8 m-85 -129.15 7.8 5.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.059 -1.259 . . . . 2.6400000000000001 110.214 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.041 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.5 mm -135.45 40.71 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.64000000000000001 109.448 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -92.4 -5.9 51.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.793 0.806 . . . . 2.3799999999999999 109.166 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -136.56 -40.17 0.13 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.425 -1.87 . . . . 2.25 108.425 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 9.5 m-30 -57.73 -111.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -1.038 . . . . 5.5099999999999998 109.651 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.799 HG21 HG21 ' A' ' 49' ' ' VAL . 6.6 t -89.06 22.07 2.91 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.318 -1.353 . . . . 1.49 109.827 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -40.08 -30.74 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.058 0.933 . . . . 1.9299999999999999 108.489 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.828 HD11 ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -54.89 -32.41 60.92 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.049 0.928 . . . . 1.96 110.949 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.834 HD22 ' CG1' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -40.94 -24.94 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.436 0.636 . . . . 2.29 111.236 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.562 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 22.1 t-20 . . . . . 0 C--N 1.294 -1.809 0 CA-C-O 117.943 -1.027 . . . . 3.54 110.252 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.3 t -82.6 79.15 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.465 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 t0 44.44 86.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 66.8 m -152.16 -36.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.532 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 2.0 mttt 67.5 48.29 1.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.92 78.41 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.589 ' HB3' ' CG ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -71.9 -57.63 3.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.552 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HG2' HD11 ' A' ' 12' ' ' LEU . 41.6 Cg_endo -69.83 -48.95 0.6 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.973 1.512 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.24 170.82 15.69 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 11' ' ' ASP . 1.9 tttt 51.67 -141.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -1.157 . . . . 0.0 110.113 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 10' ' ' LYS . 5.0 m-20 -43.46 107.45 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.073 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.59 HD11 ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -138.12 130.88 29.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.473 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' HB2' ' NH2' ' A' ' 51' ' ' ARG . 3.7 t70 -72.23 131.14 42.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 7.1 tpp85 -44.68 -33.89 2.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.854 HG23 HD22 ' A' ' 40' ' ' LEU . 9.3 mm -73.67 -20.91 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.697 ' CB ' HD11 ' A' ' 52' ' ' LEU . 2.9 m-20 -85.17 -59.53 2.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 0.0 110.142 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.501 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -53.99 -40.21 66.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.536 ' HB3' HG12 ' A' ' 38' ' ' VAL . 10.1 m120 -69.56 -41.37 75.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.945 HG21 ' CG2' ' A' ' 49' ' ' VAL . 18.6 mt -67.87 -33.75 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.28 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.764 HD11 HD22 ' A' ' 52' ' ' LEU . 14.3 mt -68.78 -36.47 78.34 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.532 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 5.4 t-20 -66.2 -37.62 86.01 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.685 ' CD ' HG13 ' A' ' 38' ' ' VAL . 98.9 mt-10 -68.78 -39.24 80.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.707 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.747 HD22 ' HB3' ' A' ' 61' ' ' TYR . 43.7 mt -64.38 -24.93 67.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.351 -0.843 . . . . 0.0 109.592 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -75.97 -39.13 56.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -84.01 -24.56 30.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 1.5 m-20 -133.85 90.57 2.72 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.04 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 9.8 51.88 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.485 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -123.07 39.36 3.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -1.131 . . . . 0.0 110.294 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.491 HG13 ' HB3' ' A' ' 33' ' ' GLU . 7.5 tt -117.86 139.8 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.379 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.036 ' HA ' HD11 ' A' ' 64' ' ' LEU . 9.1 t -86.96 -108.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.347 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' SER . 1.8 p-10 -128.58 -45.72 1.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.27 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.434 HG23 ' ND2' ' A' ' 31' ' ' ASN . 93.8 t -46.03 -61.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.954 -1.091 . . . . 0.0 109.119 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HB3' HG13 ' A' ' 29' ' ' ILE . 1.6 tp10 -64.05 -28.13 69.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.224 -0.923 . . . . 0.0 108.944 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.808 HD21 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -75.09 -15.3 60.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.713 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASN . 28.0 p -86.57 -44.18 12.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.567 -0.708 . . . . 0.0 110.597 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -82.0 -21.86 36.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 31.8 mtt-85 -70.74 -19.25 62.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.364 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.873 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -110.12 -9.24 11.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.15 40.56 5.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.873 HD21 ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -150.74 159.31 44.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.984 -1.304 . . . . 0.0 110.526 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.528 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.0 OUTLIER -67.0 156.32 88.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 108.858 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.119 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.6 Cg_endo -72.01 -49.59 0.3 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 124.022 1.538 . . . . 0.0 110.496 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -35.98 -55.39 1.3 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.1 Cg_endo -75.83 -41.85 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.962 1.507 . . . . 0.0 110.007 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 35.9 t -39.9 -52.6 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.662 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.119 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -55.18 -49.03 72.92 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.51 -44.96 13.0 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.431 -0.793 . . . . 0.0 109.134 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HD3' ' HB ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.48 -51.89 31.7 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.594 0.711 . . . . 0.0 109.665 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.945 ' CG2' HG21 ' A' ' 19' ' ' ILE . 2.9 t -64.44 -59.2 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.615 ' CD ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -40.5 -45.71 2.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -51.75 -46.9 64.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.852 177.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 20' ' ' LEU . 12.9 mt -62.95 -27.66 69.55 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.414 -0.804 . . . . 0.0 109.665 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' OE1' ' CB ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -66.69 -56.82 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 47.2 mtp180 -45.96 -24.43 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.355 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.648 ' CB ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mm-40 -95.7 3.95 53.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.307 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.91 44.35 19.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.999 ' O ' HD13 ' A' ' 58' ' ' ILE . 19.0 m-30 -116.65 0.93 12.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -1.231 . . . . 0.0 110.177 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.999 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.9 mm -138.8 53.41 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -94.62 -17.6 22.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.474 -0.766 . . . . 0.0 109.6 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -122.07 -37.98 0.63 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.747 ' HB3' HD22 ' A' ' 23' ' ' LEU . 21.5 m-85 -57.9 -116.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.937 ' O ' HD12 ' A' ' 65' ' ' LEU . 9.4 t -89.79 26.75 1.7 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.95 -1.094 . . . . 0.0 109.781 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -38.19 -29.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.613 -0.679 . . . . 0.0 109.669 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.036 HD11 ' HA ' ' A' ' 30' ' ' SER . 1.7 pp -56.27 -33.8 65.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.205 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.11 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -67.07 -5.29 12.6 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.613 -0.68 . . . . 0.0 110.53 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 1.11 ' N ' HD13 ' A' ' 65' ' ' LEU . 43.2 p-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.315 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.201 0.524 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.84 9.41 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -146.63 44.92 1.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -46.46 174.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.255 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER 55.86 -140.12 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -35.69 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.593 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -69.26 -60.46 4.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.555 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 44.3 Cg_endo -72.95 -36.22 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.558 ' CA ' HD12 ' A' ' 12' ' ' LEU . . . 57.2 -136.86 50.11 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.7 tptp 41.37 -140.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -1.133 . . . . 0.0 110.238 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 10.6 p30 -58.92 100.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.116 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.558 HD12 ' CA ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -138.3 122.92 18.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.326 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 16' ' ' ASP . 4.6 p-10 -59.29 135.33 57.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.883 . . . . 0.0 110.033 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.8 tpt180 -48.42 -20.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.37 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.885 HD12 HD22 ' A' ' 40' ' ' LEU . 7.6 mm -73.92 -45.2 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD2' ' NE ' ' A' ' 51' ' ' ARG . 47.7 m-20 -70.62 -35.74 73.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -69.22 -65.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 1.6 t-20 -52.61 -26.52 13.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 15' ' ' ILE . 3.2 mt -70.07 -47.26 69.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.604 ' CG ' HD13 ' A' ' 52' ' ' LEU . 40.7 mt -64.27 -33.15 75.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.117 -0.989 . . . . 0.0 109.19 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 47.0 t30 -70.43 -28.45 65.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.359 -0.838 . . . . 0.0 109.408 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' OE1' ' CB ' ' A' ' 37' ' ' ARG . 3.6 mm-40 -78.55 -35.46 46.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.469 -0.769 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.093 HD21 HD11 ' A' ' 34' ' ' LEU . 2.9 mm? -68.67 -35.84 77.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -74.75 -36.82 62.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.778 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -76.82 -36.59 56.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.82 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -122.22 76.5 1.31 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.164 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' A' ' 28' ' ' ARG . . . -67.8 58.14 0.35 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -173.77 36.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 0.0 110.007 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -123.51 153.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.466 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.805 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -100.06 -94.03 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 3.3 p30 -138.76 -46.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.483 ' N ' ' CG ' ' A' ' 31' ' ' ASN . 31.0 t -44.99 -64.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.992 -1.067 . . . . 0.0 109.412 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 5.7 tp10 -62.01 -27.39 68.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 108.816 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.093 HD11 HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -73.71 -16.04 61.21 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.524 -0.735 . . . . 0.0 109.401 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -88.98 -36.49 15.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.721 -0.612 . . . . 0.0 110.679 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.9 -50.25 8.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.246 -0.909 . . . . 0.0 111.188 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.539 ' CB ' ' OE1' ' A' ' 22' ' ' GLU . 7.3 mtp85 -54.84 -17.06 3.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.126 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.812 ' HB ' HD21 ' A' ' 40' ' ' LEU . 15.7 m -100.42 -21.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.26 39.04 4.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.885 HD22 HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.905 -1.35 . . . . 0.0 110.744 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -68.65 155.08 93.75 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.868 177.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.083 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.8 Cg_endo -74.06 -45.65 0.35 Allowed 'Trans proline' 0 C--N 1.286 -2.713 0 O-C-N 123.992 1.522 . . . . 0.0 110.737 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.96 -55.61 3.69 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.9 Cg_endo -75.64 -39.74 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.915 1.482 . . . . 0.0 110.026 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 51.6 t -39.43 -47.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 108.731 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.083 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.19 -49.97 72.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 14.5 mt-10 -46.97 -37.91 9.82 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.219 -0.925 . . . . 0.0 108.817 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -70.77 -58.0 4.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.464 -0.772 . . . . 0.0 109.101 177.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.896 HG11 HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -54.03 -50.45 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.23 -0.919 . . . . 0.0 109.17 177.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 18.1 mmt180 -41.76 -53.81 3.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.384 -0.822 . . . . 0.0 109.533 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NE ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -46.61 -44.15 17.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.735 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' ' 58' ' ' ILE . 66.4 mt -69.95 -26.02 63.92 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -71.13 -66.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 110.134 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -56.34 -24.51 44.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.194 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.604 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.8 mm100 -79.45 5.13 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 68.4 48.69 49.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.0 m-85 -134.06 8.54 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.756 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 17.0 mm -131.04 42.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -79.66 -3.26 46.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -144.42 -37.63 0.07 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.587 ' HB3' ' CB ' ' A' ' 23' ' ' LEU . 8.8 m-30 -56.21 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -1.08 . . . . 0.0 110.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.969 ' O ' HD23 ' A' ' 65' ' ' LEU . 15.1 t -88.5 26.09 1.54 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.921 -1.112 . . . . 0.0 109.892 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -34.72 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.523 0.678 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -58.79 -110.55 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.498 -0.751 . . . . 0.0 109.445 178.129 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.969 HD23 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER 37.04 29.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 110.419 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.25 0.548 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.43 167.28 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.393 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -132.38 95.6 3.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m -149.86 -179.23 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HD3' ' HG3' ' A' ' 24' ' ' GLN . 1.3 mmpp? 50.71 88.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 110.186 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -95.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.268 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.751 ' HG2' HD13 ' A' ' 20' ' ' LEU . 2.5 mpp_? 53.34 -171.96 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.043 -1.036 . . . . 0.0 109.187 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 38.1 Cg_endo -67.86 56.85 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.42 1.221 . . . . 0.0 109.95 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -45.61 -36.74 6.37 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 12' ' ' LEU . 7.3 pttt -60.09 -130.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -1.121 . . . . 0.0 110.013 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 5.0 m-20 -52.06 90.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.007 . . . . 0.0 110.182 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.5 OUTLIER -129.14 150.05 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.263 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.8 145.17 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.159 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 15.2 mmt180 -53.15 -39.3 63.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 110.496 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.768 HG23 HD22 ' A' ' 40' ' ' LEU . 4.4 mm -72.8 -21.17 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.735 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.782 ' HB3' HD21 ' A' ' 52' ' ' LEU . 96.2 m-20 -86.33 -56.62 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.639 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 8.3 ptt85 -57.18 -42.55 81.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 110.271 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -68.3 -41.87 80.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.409 -0.807 . . . . 0.0 109.384 178.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.924 HG21 ' CG2' ' A' ' 49' ' ' VAL . 6.1 mt -65.72 -30.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.23 -0.918 . . . . 0.0 109.357 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.751 HD13 ' HG2' ' A' ' 7' ' ' ARG . 14.3 mt -74.01 -44.62 53.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 18.3 t30 -64.78 -28.16 69.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.588 ' OE1' HG13 ' A' ' 38' ' ' VAL . 8.9 mt-10 -76.46 -38.94 54.61 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.368 -0.832 . . . . 0.0 109.943 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.929 HD13 ' HB3' ' A' ' 61' ' ' TYR . 14.7 mt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.487 ' HG3' ' HD3' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -70.46 -43.93 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -25.61 56.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.517 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -137.69 87.94 2.29 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.911 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.55 7.69 46.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.602 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -114.67 28.21 8.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 26' ' ' ASP . 6.9 tt -108.9 137.33 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.4 p -94.72 157.68 15.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 110.222 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -42.26 -49.19 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.456 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 31' ' ' ASN . 78.7 t -44.05 -65.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.958 -1.089 . . . . 0.0 109.402 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -61.89 -28.7 69.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.22 -0.925 . . . . 0.0 108.782 177.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -72.69 -14.63 61.62 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 178.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 25.1 p -86.74 -43.34 12.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.461 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -16.53 46.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.254 -0.904 . . . . 0.0 111.221 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -81.29 -15.54 55.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.977 -1.077 . . . . 0.0 110.773 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.882 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -108.35 -8.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.223 -0.923 . . . . 0.0 109.874 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 40.63 4.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.882 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -151.77 165.63 33.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -1.23 . . . . 0.0 110.549 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.25 157.07 85.33 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.786 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.111 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.5 Cg_endo -72.25 -44.8 0.74 Allowed 'Trans proline' 0 C--N 1.286 -2.729 0 O-C-N 124.005 1.529 . . . . 0.0 110.539 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.06 -55.87 4.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.363 178.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -75.35 -42.2 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.901 1.474 . . . . 0.0 110.202 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.701 ' HB2' HD12 ' A' ' 40' ' ' LEU . 42.5 t -40.14 -51.02 2.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 108.708 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.111 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -58.26 -46.4 86.07 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -48.47 -42.59 33.15 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.318 -0.864 . . . . 0.0 108.959 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.21 -55.32 10.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.695 0.76 . . . . 0.0 109.555 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.924 ' CG2' HG21 ' A' ' 19' ' ' ILE . 1.6 t -59.06 -55.51 23.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.976 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.563 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -39.8 -50.02 2.37 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.405 -0.81 . . . . 0.0 109.645 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.03 -47.2 33.72 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.697 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.795 ' HB3' HD11 ' A' ' 58' ' ' ILE . 97.0 mt -59.61 -26.26 65.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -68.22 -57.58 5.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 110.248 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -46.58 -36.63 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 7.8 mm-40 -81.82 8.38 10.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.28 60.11 7.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 1.013 ' O ' HD13 ' A' ' 58' ' ' ILE . 14.8 m-85 -135.38 12.54 3.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 110.312 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.013 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.2 mm -137.23 52.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 110.24 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -88.08 -10.96 48.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.458 -0.776 . . . . 0.0 109.604 178.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.51 -37.75 0.15 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.929 ' HB3' HD13 ' A' ' 23' ' ' LEU . 22.0 m-85 -64.44 -102.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -1.052 . . . . 0.0 110.11 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.908 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -80.42 6.96 10.79 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 109.97 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.928 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -40.58 -27.71 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.405 -0.809 . . . . 0.0 110.036 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 65' ' ' LEU . 1.6 pp -57.7 -41.1 81.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.361 -0.837 . . . . 0.0 110.656 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.908 HD23 ' O ' ' A' ' 62' ' ' THR . 1.8 pp -41.96 97.06 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.417 -0.802 . . . . 0.0 110.148 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.057 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.241 0.544 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 2' ' ' VAL . 16.0 m -105.43 0.61 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.21 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.3 p30 -150.52 86.69 1.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.196 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 5' ' ' LYS . 2.1 m -168.24 137.19 2.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 15.7 mtmt 42.95 81.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 0.0 110.305 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -174.18 82.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.377 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.552 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -75.95 -59.06 1.21 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.456 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 43.0 Cg_endo -71.7 -46.89 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.871 1.458 . . . . 0.0 110.453 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.04 -74.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.55 10.12 16.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.186 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 12' ' ' LEU . 31.0 m-20 -132.87 72.19 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 110.334 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 3.0 pp 179.82 140.24 0.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.371 -0.831 . . . . 0.0 110.483 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 7.7 t70 -79.81 156.12 27.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -45.5 -30.17 1.35 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.913 HG21 ' HD3' ' A' ' 48' ' ' ARG . 17.9 mm -73.54 -18.76 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.685 ' CA ' HD11 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -84.27 -48.61 9.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.179 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -61.07 -47.82 84.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 33.9 p-10 -66.18 -37.64 86.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.016 -1.052 . . . . 0.0 109.283 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.973 HG21 HG23 ' A' ' 49' ' ' VAL . 5.8 mt -64.38 -29.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.234 -0.916 . . . . 0.0 109.23 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.081 HD11 HD22 ' A' ' 52' ' ' LEU . 40.7 mt -72.23 -46.77 54.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.662 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.49 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.3 t30 -61.41 -29.15 69.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.382 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 3.4 mm-40 -74.87 -36.93 62.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.433 -0.792 . . . . 0.0 109.705 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 34' ' ' LEU . 2.9 mm? -66.17 -37.77 86.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.338 -0.851 . . . . 0.0 109.669 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.546 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -72.83 -35.92 67.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.784 178.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -81.45 -24.49 36.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.882 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ARG . 1.4 m-20 -125.06 69.72 1.14 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.58 61.74 0.11 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.69 32.02 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.367 -1.078 . . . . 0.0 109.83 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.528 HG13 ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -124.71 151.6 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.812 ' O ' HD12 ' A' ' 34' ' ' LEU . 35.7 m -102.9 -92.96 0.33 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.214 -0.929 . . . . 0.0 110.333 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.861 HD22 HD11 ' A' ' 46' ' ' LEU . 16.2 p-10 -139.37 -47.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -0.938 . . . . 0.0 110.26 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' ASN . 78.8 t -45.91 -65.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.961 -1.087 . . . . 0.0 109.129 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 29' ' ' ILE . 11.9 tp10 -61.27 -27.71 68.66 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.94 . . . . 0.0 108.756 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.929 HD11 HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.518 -0.739 . . . . 0.0 109.543 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.567 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 24.6 p -88.25 -39.87 14.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -82.58 -27.28 31.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.923 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 8.1 mtt180 -69.17 -17.37 63.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.12 -0.988 . . . . 0.0 110.379 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.846 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -110.05 -6.02 11.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.49 -0.756 . . . . 0.0 109.913 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.65 44.96 5.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.846 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -156.19 167.77 29.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.002 -1.293 . . . . 0.0 110.84 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.54 ' C ' ' HB2' ' A' ' 35' ' ' SER . 4.6 m -72.89 154.41 90.99 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.528 -0.732 . . . . 0.0 109.149 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.067 ' O ' HD12 ' A' ' 46' ' ' LEU . 50.1 Cg_endo -73.85 -49.2 0.21 Allowed 'Trans proline' 0 C--N 1.288 -2.621 0 O-C-N 124.06 1.558 . . . . 0.0 110.733 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.575 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -36.52 -53.46 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 48.8 Cg_endo -75.85 -45.28 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.915 1.482 . . . . 0.0 109.969 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' HB2' HD12 ' A' ' 40' ' ' LEU . 18.3 t -38.68 -52.01 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 108.898 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.067 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.71 -49.88 75.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.01 -43.87 4.43 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.913 ' HD3' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.06 -42.04 63.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.546 -0.721 . . . . 0.0 109.629 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.98 HG13 HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -67.37 -46.97 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.756 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.596 ' N ' HG12 ' A' ' 49' ' ' VAL . 1.3 mtm180 -47.84 -51.3 23.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.174 -0.954 . . . . 0.0 109.118 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -48.85 -45.95 41.58 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 108.853 177.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.081 HD22 HD11 ' A' ' 20' ' ' LEU . 86.5 mt -63.31 -17.69 62.81 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.785 . . . . 0.0 109.448 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.825 ' HG3' HD21 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -75.66 -53.2 8.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.471 -0.768 . . . . 0.0 110.215 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -55.3 -33.22 63.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -76.22 -0.96 24.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.36 40.64 23.12 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.941 ' CE2' HD13 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -119.72 -0.08 10.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.161 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.892 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.2 mm -134.59 46.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 6.8 pt20 -82.9 -6.61 59.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.622 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.431 ' N ' ' HB2' ' A' ' 63' ' ' ALA . . . -143.4 -44.48 0.05 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.595 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 25.1 m-85 -54.88 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -1.141 . . . . 0.0 110.008 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.006 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -82.27 8.47 11.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.944 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.877 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -39.36 -28.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.456 -0.778 . . . . 0.0 109.808 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 66' ' ' ASN . 1.0 OUTLIER -57.35 -34.87 69.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.392 -0.817 . . . . 0.0 110.526 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.006 HD23 ' O ' ' A' ' 62' ' ' THR . 1.4 pp -41.26 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.5 t-20 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.283 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.253 0.549 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.69 104.66 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -100.69 72.64 1.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER -149.13 -78.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.347 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HE3' ' HG3' ' A' ' 24' ' ' GLN . 5.6 mmpt? 54.77 33.32 19.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 110.017 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -177.75 63.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.992 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.573 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 4.2 mtt180 -86.55 -50.84 0.46 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 7' ' ' ARG . 49.6 Cg_endo -84.48 24.02 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.953 1.502 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.502 ' HA3' ' HG ' ' A' ' 12' ' ' LEU . . . -165.72 81.08 0.11 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 2.6 tptt -43.71 125.08 3.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -1.197 . . . . 0.0 109.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 12' ' ' LEU . 61.1 m-20 55.61 37.75 29.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.717 HD21 ' NH1' ' A' ' 51' ' ' ARG . 1.1 mt -32.36 149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.64 -0.663 . . . . 0.0 110.924 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 38.0 m-20 -45.51 153.01 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' ASN . 18.3 mmt-85 -62.04 -16.9 55.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 110.318 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 40' ' ' LEU . 7.9 mm -84.87 -49.75 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 0.0 109.833 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.542 ' HB2' HD22 ' A' ' 12' ' ' LEU . 2.6 m-20 -71.67 -40.02 69.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.92 . . . . 0.0 110.145 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.5 OUTLIER -71.68 -46.16 59.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 110.027 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 52.1 t30 -67.29 -34.31 77.14 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.22 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.881 HG21 HG23 ' A' ' 49' ' ' VAL . 8.0 mt -63.68 -39.64 86.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.458 -0.777 . . . . 0.0 109.186 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.053 HD11 HD22 ' A' ' 52' ' ' LEU . 80.3 mt -68.31 -45.93 71.64 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.151 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -60.15 -37.41 80.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.183 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.69 -40.96 76.03 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 34' ' ' LEU . 2.7 mm? -64.44 -37.84 88.94 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.288 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.487 ' HG3' ' HE3' ' A' ' 5' ' ' LYS . 8.5 tm0? -69.32 -44.9 70.76 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 109.508 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -74.36 -19.85 60.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.959 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -148.98 61.68 1.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 110.112 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -52.84 -28.67 32.06 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -76.8 51.7 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -1.138 . . . . 0.0 110.345 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 26' ' ' ASP . 18.9 tt -138.73 154.07 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.31 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.931 ' HA ' HD11 ' A' ' 64' ' ' LEU . 42.1 t -99.93 -115.61 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.317 -0.864 . . . . 0.0 110.352 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.666 ' CB ' HD21 ' A' ' 46' ' ' LEU . 9.6 p30 -121.21 -46.4 2.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.3 t -44.58 -62.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.995 -1.066 . . . . 0.0 109.416 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.255 -0.903 . . . . 0.0 108.786 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -76.77 -15.65 59.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.55 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 16.5 p -88.08 -38.81 15.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.538 -0.726 . . . . 0.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -31.38 23.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.295 -0.878 . . . . 0.0 110.916 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -65.12 -16.63 63.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.351 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.884 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.2 m -109.65 -11.99 11.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 110.036 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.81 42.55 5.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.884 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.75 166.28 32.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.956 -1.32 . . . . 0.0 110.734 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.502 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -70.32 155.55 93.26 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 108.786 177.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.069 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.3 Cg_endo -74.29 -42.91 0.59 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 O-C-N 123.808 1.425 . . . . 0.0 110.556 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.97 -57.51 2.06 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.731 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 50.0 Cg_endo -76.47 -41.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.843 1.444 . . . . 0.0 110.205 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.721 ' HB2' HD12 ' A' ' 40' ' ' LEU . 53.8 t -39.21 -45.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 108.825 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.069 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.49 -47.99 74.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -48.06 -39.35 19.77 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.685 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' CD ' HG21 ' A' ' 15' ' ' ILE . 5.4 mmt180 -70.64 -46.86 62.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.665 0.745 . . . . 0.0 109.16 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.931 HG21 HG21 ' A' ' 62' ' ' THR . 0.5 OUTLIER -64.33 -45.29 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.374 -0.829 . . . . 0.0 109.847 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.874 ' HD2' HD11 ' A' ' 65' ' ' LEU . 12.6 mmm-85 -47.59 -49.35 26.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.449 -0.782 . . . . 0.0 109.465 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.717 ' NH1' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.16 -43.43 61.25 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.882 178.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 20' ' ' LEU . 93.8 mt -66.61 -16.67 64.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.432 -0.793 . . . . 0.0 109.891 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -78.08 -61.19 2.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.523 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -49.87 -29.68 8.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.649 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.765 ' NE2' HD23 ' A' ' 52' ' ' LEU . 4.1 pt20 -82.51 12.23 4.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.39 52.78 44.0 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.949 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -131.42 8.41 4.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -1.151 . . . . 0.0 110.15 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.949 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.7 mm -140.8 51.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.46 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -83.03 -11.71 57.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.01 -40.14 0.1 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.658 ' CA ' HD12 ' A' ' 23' ' ' LEU . 20.4 m-85 -58.75 -102.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -1.078 . . . . 0.0 110.111 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.931 HG21 HG21 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.15 11.58 7.87 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.08 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.938 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -38.28 -29.73 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.389 -0.819 . . . . 0.0 109.856 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.931 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -62.91 -115.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.185 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.874 HD11 ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER 37.89 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 64' ' ' LEU . 7.4 t30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.329 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.189 0.518 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 31.9 t -77.52 158.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.363 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 86.2 m-20 53.64 55.93 7.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -139.0 142.59 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.539 ' HE3' ' NE2' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -107.43 74.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.166 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -103.7 -60.02 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.378 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.626 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 45.23 -168.64 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.064 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 7' ' ' ARG . 39.7 Cg_endo -72.53 56.83 2.85 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.261 1.138 . . . . 0.0 109.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . -60.41 -134.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 9.8 ttmt 42.12 -105.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -1.157 . . . . 0.0 109.944 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' N ' ' HG2' ' A' ' 10' ' ' LYS . 33.7 p-10 -73.3 79.61 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.965 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 16' ' ' ASP . 13.5 tp -151.83 140.36 20.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 110.32 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 135.21 56.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.531 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 17.1 mmt-85 -49.59 -20.58 0.8 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.318 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.918 HG23 HD22 ' A' ' 40' ' ' LEU . 10.2 mm -74.66 -24.33 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.436 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' CA ' HD11 ' A' ' 52' ' ' LEU . 50.2 m-20 -84.36 -56.52 3.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 110.372 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -56.75 -43.94 81.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.035 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.532 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 53.3 m-80 -64.78 -41.2 96.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.011 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.871 HG21 HG23 ' A' ' 49' ' ' VAL . 3.5 mt -62.0 -39.59 84.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.444 -0.785 . . . . 0.0 109.264 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.827 HD11 HD22 ' A' ' 52' ' ' LEU . 16.0 mt -66.56 -40.91 89.25 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.66 -32.4 73.7 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.385 -0.822 . . . . 0.0 109.446 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.739 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -78.61 -31.22 46.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 109.62 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.802 ' CD2' HD11 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -73.33 -31.91 64.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.371 -0.83 . . . . 0.0 109.571 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' NE2' ' HE3' ' A' ' 5' ' ' LYS . 3.5 tp-100 -78.15 -36.63 47.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.395 -0.816 . . . . 0.0 109.769 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 30.0 pttt -74.67 -33.56 62.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.67 68.21 0.86 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.087 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.09 60.66 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -175.37 28.67 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.384 -1.068 . . . . 0.0 109.658 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.739 HG21 ' OE2' ' A' ' 22' ' ' GLU . 16.1 tt -116.6 146.56 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.408 -0.808 . . . . 0.0 110.218 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 t -91.66 -91.42 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 110.275 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 2.3 p-10 -143.74 -47.4 0.28 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 59.3 t -44.25 -61.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.013 -1.054 . . . . 0.0 109.177 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HB3' HG13 ' A' ' 29' ' ' ILE . 4.2 tp10 -62.81 -31.95 73.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.278 -0.888 . . . . 0.0 108.805 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.802 HD11 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -70.28 -15.25 62.87 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.603 -0.686 . . . . 0.0 109.487 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.7 p -87.76 -37.6 16.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.723 . . . . 0.0 110.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -32.36 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.9 . . . . 0.0 111.273 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -66.27 -16.99 64.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.687 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.925 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -109.46 -8.06 11.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 44.59 5.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.925 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -152.54 165.82 33.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.0 -1.294 . . . . 0.0 110.71 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.488 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.61 156.83 90.98 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 108.807 177.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.098 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.6 Cg_endo -74.5 -48.69 0.19 Allowed 'Trans proline' 0 C--N 1.287 -2.681 0 O-C-N 123.83 1.437 . . . . 0.0 110.543 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -54.13 3.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.011 . . . . 0.0 109.434 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.7 Cg_endo -75.85 -40.66 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.001 1.527 . . . . 0.0 110.135 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.692 ' HB2' HD12 ' A' ' 40' ' ' LEU . 50.3 t -40.56 -44.74 2.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.085 . . . . 0.0 108.718 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.098 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.86 -45.16 87.26 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 1.6 mm-40 -50.12 -35.48 25.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.81 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -74.49 -48.37 27.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.701 . . . . 0.0 109.288 177.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.871 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -65.74 -56.71 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 178.609 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.689 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -43.59 -42.95 5.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.54 -43.83 68.72 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.827 HD22 HD11 ' A' ' 20' ' ' LEU . 71.7 mt -69.29 -16.96 63.68 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.629 -0.669 . . . . 0.0 109.785 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 1.9 mt-10 -75.7 -56.29 4.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -53.82 -27.72 31.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.393 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.607 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 66.1 mm-40 -85.38 17.13 3.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.001 . . . . 0.0 110.251 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.44 56.94 21.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.614 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.6 m-85 -137.2 6.74 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.13 -1.217 . . . . 0.0 110.239 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.674 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 13.5 mm -132.41 33.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -82.25 3.95 25.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.773 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -143.23 -44.1 0.05 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.487 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 60.6 m-85 -56.9 -112.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 110.184 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.954 ' O ' HD23 ' A' ' 65' ' ' LEU . 15.4 t -89.63 24.51 2.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.935 -1.103 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -32.38 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.588 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -55.9 -110.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 177.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.954 HD23 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER 36.42 29.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.379 -0.825 . . . . 0.0 110.612 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.257 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.64 ' O ' HG12 ' A' ' 2' ' ' VAL . 1.9 ttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 1' ' ' MET . 8.7 p 37.3 35.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.499 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -74.81 -165.16 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 p -141.35 154.33 45.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -109.34 94.31 4.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.309 -0.869 . . . . 0.0 110.173 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -166.53 88.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.566 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.5 -55.91 38.32 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.227 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 42.2 Cg_endo -71.25 -46.76 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.949 1.5 . . . . 0.0 110.397 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.549 ' O ' ' CD2' ' A' ' 12' ' ' LEU . . . 68.18 -57.01 0.42 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 1.4 tpmt? -90.34 2.1 55.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -1.183 . . . . 0.0 110.038 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -127.03 53.6 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 110.078 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' A' ' 17' ' ' ARG . 1.8 pt? -176.2 130.42 0.22 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 0.0 110.097 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 162.11 29.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.295 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.6 -22.65 5.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.869 HG23 HD22 ' A' ' 40' ' ' LEU . 13.8 mm -71.74 -30.51 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.903 . . . . 0.0 110.5 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.817 ' C ' HD11 ' A' ' 52' ' ' LEU . 50.5 m-20 -76.02 -61.3 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 110.539 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.81 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.64 -39.99 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.493 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 1.4 t-20 -67.74 -35.72 79.26 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 109.226 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.909 HG21 HG23 ' A' ' 49' ' ' VAL . 18.6 mt -63.14 -41.96 94.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.362 -0.836 . . . . 0.0 109.094 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 17' ' ' ARG . 25.8 mt -56.21 -42.15 76.74 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.129 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.52 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 61.7 t-20 -59.36 -49.65 77.01 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.288 -0.882 . . . . 0.0 109.027 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -61.93 -37.68 85.58 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 178.201 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.941 HD21 ' CD1' ' A' ' 34' ' ' LEU . 2.3 mm? -67.36 -35.67 79.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.385 -0.822 . . . . 0.0 109.434 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -39.82 39.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.408 -0.808 . . . . 0.0 109.656 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HD3' ' OE1' ' A' ' 22' ' ' GLU . 2.4 pttt -77.55 -30.27 52.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 109.747 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.6 m-20 -140.33 61.07 1.53 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 110.317 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -56.22 -163.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.32 25.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -1.195 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 37' ' ' ARG . 10.3 tt -108.88 137.62 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.675 ' HA ' HD11 ' A' ' 64' ' ' LEU . 20.4 m -72.04 -137.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.852 . . . . 0.0 110.4 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.1 p30 -110.86 -43.12 3.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.319 -0.863 . . . . 0.0 109.907 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 32.8 t -44.8 -56.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.13 -0.981 . . . . 0.0 109.153 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.64 -34.41 78.17 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.34 -0.85 . . . . 0.0 108.887 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.941 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -70.3 -14.97 62.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.717 . . . . 0.0 109.777 178.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.548 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 8.3 p -85.64 -49.7 7.79 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 110.59 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.404 ' N ' ' OG ' ' A' ' 35' ' ' SER . 1.9 mtpp -78.68 -22.11 47.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 110.801 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 29' ' ' ILE . 15.9 mtt-85 -70.02 -17.21 63.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.093 -1.004 . . . . 0.0 110.163 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.86 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.66 -9.56 12.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.672 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.99 42.0 4.81 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.869 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -152.41 161.21 42.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.961 -1.317 . . . . 0.0 110.72 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -66.28 157.07 83.21 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 108.8 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.091 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.8 Cg_endo -73.5 -44.61 0.5 Allowed 'Trans proline' 0 C--N 1.287 -2.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.456 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.567 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.24 -56.12 2.79 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.93 . . . . 0.0 109.551 179.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.7 Cg_endo -74.96 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.99 1.521 . . . . 0.0 109.907 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' HD12 ' A' ' 40' ' ' LEU . 45.0 t -37.32 -53.01 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.091 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -54.95 -54.29 44.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -43.87 -43.53 6.4 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.386 -0.821 . . . . 0.0 109.298 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HD2' HG21 ' A' ' 15' ' ' ILE . 1.4 mmt180 -66.57 -48.67 68.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.791 . . . . 0.0 109.16 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.909 HG23 HG21 ' A' ' 19' ' ' ILE . 1.1 t -61.61 -43.48 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.411 -0.806 . . . . 0.0 109.507 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 5.8 mmm180 -45.78 -52.19 11.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.389 -0.819 . . . . 0.0 109.396 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.489 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -53.24 -40.57 64.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.065 178.065 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.893 ' HB3' HD11 ' A' ' 58' ' ' ILE . 16.2 mt -73.48 -31.3 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -0.764 . . . . 0.0 109.753 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -82.09 -30.15 31.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -74.0 -18.56 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.71 15.53 23.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.258 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.62 58.68 6.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.867 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -145.41 11.93 1.33 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -1.121 . . . . 0.0 110.296 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.893 HD11 ' HB3' ' A' ' 52' ' ' LEU . 8.0 mm -140.62 37.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -14.58 58.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -125.0 -40.84 0.4 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.574 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 18.5 m-30 -56.64 -115.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -1.065 . . . . 0.0 110.062 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.002 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.4 t -87.1 24.77 1.47 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.956 -1.09 . . . . 0.0 110.08 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -34.16 -34.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.709 . . . . 0.0 109.328 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.675 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -56.29 -108.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 109.421 177.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.002 HD23 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER 36.85 28.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.306 -0.871 . . . . 0.0 110.49 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.554 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.269 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.296 0.57 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.23 48.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.09 -34.7 22.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -165.61 -177.92 4.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 35.5 mtmm -106.77 80.43 1.45 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 11.6 tttm -87.55 -117.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.372 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.674 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 59.97 -159.06 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.973 -1.08 . . . . 0.0 109.053 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.674 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 42.5 Cg_endo -75.33 57.73 4.86 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.064 1.034 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.18 -25.6 51.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -75.76 1.93 13.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -1.177 . . . . 0.0 110.098 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.85 74.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.399 -0.813 . . . . 0.0 109.694 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.693 HD22 ' CB ' ' A' ' 16' ' ' ASP . 0.6 OUTLIER -142.4 147.76 36.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.397 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -50.22 142.57 9.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 110.047 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.525 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 12.0 mmt85 -56.02 -24.88 41.96 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.354 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.862 HG23 HD22 ' A' ' 40' ' ' LEU . 10.6 mm -74.93 -35.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.751 ' HB3' HD21 ' A' ' 52' ' ' LEU . 6.2 m-20 -74.84 -56.6 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.574 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.718 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.6 ptt85 -55.53 -45.1 77.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.306 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 14' ' ' ARG . 49.4 m-20 -64.8 -34.12 77.61 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.095 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.648 HD12 ' O ' ' A' ' 15' ' ' ILE . 5.9 mt -64.79 -44.33 96.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.946 HD11 HD22 ' A' ' 52' ' ' LEU . 12.2 mt -63.29 -41.24 98.97 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 109.261 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.403 ' HA ' ' HE3' ' A' ' 5' ' ' LYS . 2.7 t-20 -62.76 -31.2 72.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.266 -0.896 . . . . 0.0 109.258 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.697 ' OE2' HG13 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -77.49 -43.24 32.84 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.45 -0.781 . . . . 0.0 109.835 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 HD11 ' A' ' 34' ' ' LEU . 2.2 mm? -62.17 -36.31 81.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 109.38 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' OE1' ' C ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -68.71 -44.88 72.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.742 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -71.77 -37.5 70.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.925 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -135.87 92.04 2.77 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.56 -10.06 86.47 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.577 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.8 mpt_? -85.89 26.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -1.164 . . . . 0.0 110.467 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.487 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 4.0 tt -111.45 155.04 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.944 . . . . 0.0 110.329 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.757 ' HA ' HD11 ' A' ' 64' ' ' LEU . 73.8 m -108.17 -94.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 110.414 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' SER . 18.7 p-10 -136.69 -50.96 0.67 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.481 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 77.7 t -43.29 -58.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.246 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.42 -27.48 68.56 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.864 . . . . 0.0 108.864 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.066 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -75.67 -15.38 60.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.565 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.8 p -88.09 -48.99 7.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 111.031 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.67 -22.37 34.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.067 -1.021 . . . . 0.0 111.184 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 7.8 mtp180 -72.59 -16.09 61.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.554 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.811 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -109.76 -9.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.311 -0.868 . . . . 0.0 110.062 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.65 41.51 4.42 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.862 HD22 HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -153.55 165.45 35.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.107 -1.231 . . . . 0.0 110.667 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.4 m -72.21 159.76 84.56 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 108.865 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.074 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.3 Cg_endo -73.39 -51.36 0.16 Allowed 'Trans proline' 0 C--N 1.285 -2.769 0 O-C-N 123.87 1.458 . . . . 0.0 110.609 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.31 -55.18 1.87 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 109.705 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.9 Cg_endo -75.83 -40.58 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.998 1.525 . . . . 0.0 110.064 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.2 t -39.45 -48.59 1.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.105 -0.997 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.074 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.3 mp -58.49 -52.41 65.77 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.82 -38.38 2.12 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.356 -0.84 . . . . 0.0 108.997 177.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' HG21 ' A' ' 15' ' ' ILE . 4.6 mmp_? -71.54 -56.31 6.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.233 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.606 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -56.01 -40.05 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 178.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 7.5 mmt85 -52.78 -48.67 66.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 109.699 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.552 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -53.15 -37.21 61.64 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.971 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.946 HD22 HD11 ' A' ' 20' ' ' LEU . 94.4 mt -67.93 -23.12 65.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.444 -0.785 . . . . 0.0 109.887 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 40.8 mt-10 -77.65 -51.23 10.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.886 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -48.48 -39.71 24.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.026 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.462 ' NE2' ' HD2' ' A' ' 51' ' ' ARG . 3.3 pt20 -86.37 27.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.85 76.25 0.14 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.898 ' CE2' HD13 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -151.29 13.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.505 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.849 HD11 ' HB3' ' A' ' 52' ' ' LEU . 15.1 mm -137.95 24.51 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.53 -8.13 53.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -135.55 -38.09 0.18 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.559 ' HB3' ' CB ' ' A' ' 23' ' ' LEU . 91.8 m-85 -57.71 -113.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -1.113 . . . . 0.0 109.829 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.573 ' O ' ' N ' ' A' ' 64' ' ' LEU . 6.9 t -90.43 32.0 0.98 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.855 -1.153 . . . . 0.0 109.912 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -34.96 -32.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.708 0.766 . . . . 0.0 109.072 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.757 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -75.81 -139.48 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.674 -0.641 . . . . 0.0 109.418 177.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.673 ' HG ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER 58.93 9.0 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.053 -1.03 . . . . 0.0 110.277 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 179.634 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.291 0.567 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t 48.93 86.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.3 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.82 80.22 3.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 p -104.75 87.54 2.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -78.54 72.81 5.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 17.6 mmtt -63.55 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.731 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.906 ' HG3' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 54.59 -163.13 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 108.974 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.668 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 42.3 Cg_endo -74.39 57.73 4.25 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.125 1.066 . . . . 0.0 110.069 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . -39.08 -37.32 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' LEU . 1.1 tptp -60.74 -135.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -1.196 . . . . 0.0 110.159 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.53 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.226 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -113.38 111.58 22.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.69 151.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 110.01 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 18' ' ' ASN . 9.2 mmt85 -60.97 -29.97 69.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.269 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.743 HD12 HD22 ' A' ' 40' ' ' LEU . 4.9 mm -81.38 -27.66 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.702 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.543 ' CA ' HD11 ' A' ' 52' ' ' LEU . 3.1 m-20 -84.54 -31.37 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.253 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -75.56 -46.59 31.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 110.157 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 39.4 p-10 -69.14 -32.48 71.87 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.189 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG12 HG11 ' A' ' 38' ' ' VAL . 6.3 mt -69.18 -38.31 77.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.906 HD22 ' HG3' ' A' ' 7' ' ' ARG . 22.9 mt -68.82 -40.49 79.45 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 29.9 t-20 -67.56 -26.42 66.28 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.205 -0.934 . . . . 0.0 109.267 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -87.04 -40.96 14.23 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.002 HD21 HD23 ' A' ' 64' ' ' LEU . 1.3 mt -69.18 -24.29 64.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.501 ' CG ' ' HG3' ' A' ' 5' ' ' LYS . 5.6 tp60 -84.37 -37.84 21.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.451 -0.781 . . . . 0.0 109.969 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 4.0 pttt -83.09 -32.34 26.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.818 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 29' ' ' ILE . 19.4 t0 -129.56 55.49 1.76 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.34 -25.61 2.03 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -82.21 9.84 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -1.143 . . . . 0.0 110.185 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.891 ' O ' HD13 ' A' ' 64' ' ' LEU . 5.8 tt -74.15 154.96 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.866 ' HA ' HD13 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -104.4 147.06 27.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 110.15 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.829 ' OD1' HD11 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -39.98 -52.51 2.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.262 -0.899 . . . . 0.0 109.809 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 31' ' ' ASN . 18.0 t -44.79 -57.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 108.939 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 tp10 -65.29 -29.5 70.26 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 108.727 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.776 HD12 HD21 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -72.81 -16.6 61.61 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 109.512 178.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 21.1 p -88.69 -44.99 10.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.594 -0.691 . . . . 0.0 110.604 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 6.1 mtpp -82.44 -43.97 16.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 3.7 mtt-85 -56.99 -16.65 7.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 0.0 110.23 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.784 HG23 ' CD2' ' A' ' 40' ' ' LEU . 18.7 m -101.3 -21.05 5.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.403 -0.811 . . . . 0.0 110.019 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 101.14 37.8 3.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.784 ' CD2' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -154.92 171.66 19.32 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.879 -1.365 . . . . 0.0 110.793 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.57 158.82 82.79 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 108.877 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.043 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.7 Cg_endo -73.54 -45.22 0.43 Allowed 'Trans proline' 0 C--N 1.287 -2.709 0 O-C-N 123.987 1.52 . . . . 0.0 110.646 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -42.03 -55.64 6.03 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 109.443 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.2 Cg_endo -76.02 -36.9 1.76 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.88 1.463 . . . . 0.0 110.281 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 40.9 t -43.47 -47.71 7.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.064 . . . . 0.0 108.652 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.043 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.54 -39.51 88.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -55.97 -41.99 75.6 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.709 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -70.58 -47.98 57.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.592 -0.692 . . . . 0.0 109.284 178.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.627 HG12 ' N ' ' A' ' 50' ' ' ARG . 1.2 t -58.89 -51.89 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.483 -0.761 . . . . 0.0 109.343 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -41.97 -53.7 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.455 -0.778 . . . . 0.0 109.325 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -48.05 -42.7 29.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.432 -0.792 . . . . 0.0 109.052 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.879 ' CD2' HD11 ' A' ' 20' ' ' LEU . 12.7 mt -72.13 -23.38 61.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 0.0 109.775 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' CG ' ' HA ' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -63.04 -59.92 4.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.233 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.7 -28.64 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.329 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.608 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mm-40 -74.75 0.51 15.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 66.93 51.6 38.84 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.621 ' CE2' ' HA ' ' A' ' 7' ' ' ARG . 22.0 m-85 -131.15 9.43 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -1.159 . . . . 0.0 110.28 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.95 HG22 ' HB2' ' A' ' 63' ' ' ALA . 1.2 mt -149.56 118.36 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.294 -0.879 . . . . 0.0 110.022 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 63' ' ' ALA . 2.1 pt20 -73.26 78.82 1.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 62' ' ' THR . . . 111.87 50.89 0.58 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.784 ' O ' HG21 ' A' ' 58' ' ' ILE . 64.5 m-85 60.22 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 110.511 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.911 ' HG1' HD12 ' A' ' 65' ' ' LEU . 2.5 p -90.12 -8.69 50.73 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 109.942 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.95 ' HB2' HG22 ' A' ' 58' ' ' ILE . . . 55.72 32.14 18.82 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.507 -0.746 . . . . 0.0 109.617 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.002 HD23 HD21 ' A' ' 23' ' ' LEU . 4.1 pp -175.13 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 110.269 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.114 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -63.57 -7.14 6.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.461 -0.775 . . . . 0.0 110.632 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 1.114 ' N ' HD13 ' A' ' 65' ' ' LEU . 14.9 p-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.191 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.65 114.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -101.8 75.67 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -150.45 83.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' CE ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER 55.75 176.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -102.59 -105.15 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.911 . . . . 0.0 110.345 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.613 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 58.94 -173.67 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.029 -1.044 . . . . 0.0 109.216 -179.124 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.4 Cg_endo -67.41 58.31 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.437 1.23 . . . . 0.0 109.845 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -54.98 -24.84 36.09 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 13.6 pttp -64.39 -9.62 19.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -175.58 89.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.972 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -134.4 121.89 21.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.359 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.68 145.94 6.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 110.029 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.532 ' HD3' ' NH1' ' A' ' 17' ' ' ARG . 25.0 mmt-85 -54.86 -19.18 5.97 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.828 HG23 HD22 ' A' ' 40' ' ' LEU . 3.0 mm -83.86 -49.82 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.78 ' HB3' HD21 ' A' ' 52' ' ' LEU . 7.0 m-20 -66.65 -33.41 75.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' NH1' ' HD3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -74.42 -55.45 5.97 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 17.3 t-20 -58.53 -29.65 66.48 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 109.092 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.622 HG21 HG22 ' A' ' 49' ' ' VAL . 12.7 mt -67.52 -43.92 86.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.536 -0.728 . . . . 0.0 109.308 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.753 HD11 HD22 ' A' ' 52' ' ' LEU . 34.4 mt -66.14 -40.13 90.38 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.216 -0.927 . . . . 0.0 109.345 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 6.2 t-20 -67.77 -31.1 70.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.296 -0.877 . . . . 0.0 109.235 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -80.04 -36.01 36.36 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.493 -0.754 . . . . 0.0 109.614 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 HD11 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.18 -35.13 75.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.539 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.43 -39.27 67.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 2.3 tttt -82.0 -20.26 38.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 29' ' ' ILE . 13.0 m-20 -144.88 53.06 1.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.019 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -47.01 -37.44 9.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -70.49 57.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 26' ' ' ASP . 2.3 tt -141.6 135.9 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.701 ' HA ' HD11 ' A' ' 64' ' ' LEU . 33.2 t -82.35 -94.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.376 -0.828 . . . . 0.0 110.356 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 10.8 p-10 -140.1 -48.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.145 -0.972 . . . . 0.0 110.432 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' ASN . 77.9 t -42.0 -64.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.525 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.506 ' HB3' HG13 ' A' ' 29' ' ' ILE . 5.3 tp10 -63.24 -22.84 67.13 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.176 -0.953 . . . . 0.0 108.979 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -79.54 -15.12 58.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.637 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 13.8 p -87.89 -45.53 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 110.838 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 14.2 pttt -80.84 -38.16 28.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.096 -1.003 . . . . 0.0 110.952 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HD2' ' HG3' ' A' ' 33' ' ' GLU . 39.2 mtt180 -57.38 -16.59 9.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.824 ' HB ' HD21 ' A' ' 40' ' ' LEU . 2.1 m -108.98 -15.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.14 37.0 5.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.828 HD22 HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -149.19 160.97 42.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.954 -1.321 . . . . 0.0 110.559 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.486 ' C ' ' HB2' ' A' ' 35' ' ' SER . 20.5 m -66.69 159.41 74.69 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 108.766 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.056 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.46 -45.38 0.42 Allowed 'Trans proline' 0 C--N 1.286 -2.718 0 O-C-N 123.934 1.492 . . . . 0.0 110.551 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.98 -60.8 0.9 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.792 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.3 Cg_endo -73.9 -37.63 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.825 1.434 . . . . 0.0 110.175 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.4 t -38.63 -50.13 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.057 HD23 ' HG ' ' A' ' 65' ' ' LEU . 1.2 mp -59.12 -52.8 64.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -43.65 -36.96 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.03 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.705 ' CD ' HG21 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -72.87 -60.1 2.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 52' ' ' LEU . 2.2 t -54.29 -44.44 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 6.5 mmt85 -48.89 -50.04 36.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 109.636 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -50.57 -36.76 36.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.451 -0.78 . . . . 0.0 109.043 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.78 HD21 ' HB3' ' A' ' 16' ' ' ASP . 70.4 mt -73.14 -19.37 61.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.482 -0.762 . . . . 0.0 110.028 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -74.97 -58.93 2.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 0.0 110.394 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.491 ' CD ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -51.78 -21.74 3.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.383 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 29.4 mm100 -91.27 17.25 8.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 110.268 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.21 49.77 54.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' CE2' ' HD3' ' A' ' 8' ' ' PRO . 7.3 m-85 -127.93 8.71 6.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.255 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.728 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.9 mm -136.85 32.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.12 -8.73 57.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -132.93 -39.99 0.2 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.556 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 15.9 m-30 -58.36 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -1.137 . . . . 0.0 110.022 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.591 ' HB ' HD21 ' A' ' 23' ' ' LEU . 8.0 t -89.31 35.1 0.8 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.02 -1.05 . . . . 0.0 110.031 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.572 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -35.32 -32.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -71.74 -140.92 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.669 -0.645 . . . . 0.0 109.428 177.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.057 ' HG ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER 54.59 12.02 0.5 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.073 -1.017 . . . . 0.0 110.23 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.8 t30 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.883 -1.135 . . . . 0.0 110.304 179.298 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 2' ' ' VAL . 36.0 m -60.21 118.44 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.285 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -79.41 125.08 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 1.1 t -143.36 162.65 35.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.404 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER 69.22 -58.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 17.2 mtpt 64.07 -66.05 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.967 . . . . 0.0 110.548 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.662 ' HB3' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER 45.62 -167.09 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.657 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 40.7 Cg_endo -72.74 58.7 3.3 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.358 1.189 . . . . 0.0 109.754 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . -40.51 -48.52 3.86 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -70.35 124.74 24.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 110.182 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 52.04 94.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 0.0 110.204 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -133.79 145.97 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.461 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER -91.95 133.81 35.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -43.21 -34.69 1.19 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.897 HG23 HD22 ' A' ' 40' ' ' LEU . 5.0 mm -74.4 -21.99 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 110.642 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.675 ' HB3' HD21 ' A' ' 52' ' ' LEU . 66.4 m-20 -87.19 -56.96 3.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.109 -0.994 . . . . 0.0 110.522 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.74 -37.4 73.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.08 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 17' ' ' ARG . 17.7 t-20 -72.27 -42.67 65.32 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.356 -0.84 . . . . 0.0 109.132 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.051 HG21 HG23 ' A' ' 49' ' ' VAL . 9.0 mt -68.26 -31.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.282 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.795 HD11 HD22 ' A' ' 52' ' ' LEU . 15.5 mt -73.38 -40.64 64.18 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.314 -0.866 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.36 -27.96 66.71 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.312 -0.867 . . . . 0.0 109.295 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' OE1' ' NE ' ' A' ' 37' ' ' ARG . 22.4 mm-40 -80.34 -27.57 38.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.47 -0.769 . . . . 0.0 109.685 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.043 HD21 HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -72.0 -34.29 68.76 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.276 -0.89 . . . . 0.0 109.288 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -73.81 -40.85 63.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.756 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -74.26 -30.19 62.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.828 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -125.54 71.13 1.21 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.105 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -67.66 57.05 0.34 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -179.73 38.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 110.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 1.8 tt -119.42 135.4 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.428 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -81.81 158.74 23.98 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 16.3 m120 -50.09 -47.67 53.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 93.5 t -41.92 -63.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.079 -1.013 . . . . 0.0 109.495 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -62.55 -33.02 74.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.043 HD11 HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -68.09 -14.59 63.09 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.416 0.627 . . . . 0.0 109.765 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 12.5 p -86.55 -51.16 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.456 -0.777 . . . . 0.0 110.785 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' OG ' ' A' ' 35' ' ' SER . 12.6 mttt -77.05 -16.38 59.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 0.0 111.227 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -79.75 -16.05 56.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.109 . . . . 0.0 110.513 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.904 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -110.21 -4.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.205 -0.934 . . . . 0.0 110.054 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.65 42.48 5.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.904 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -154.52 163.72 39.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.117 -1.225 . . . . 0.0 110.557 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.9 159.12 86.36 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.247 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.08 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.2 Cg_endo -74.46 -46.89 0.25 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 123.969 1.51 . . . . 0.0 110.467 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.04 -54.67 4.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.988 . . . . 0.0 109.458 178.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.7 Cg_endo -76.1 -42.27 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.027 1.541 . . . . 0.0 110.26 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.765 ' HB2' HD12 ' A' ' 40' ' ' LEU . 47.1 t -38.88 -48.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 108.7 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.08 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -61.22 -50.77 71.74 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.2 mt-10 -45.19 -34.26 2.67 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.876 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -73.83 -52.16 13.96 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.679 0.752 . . . . 0.0 109.172 177.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.051 HG23 HG21 ' A' ' 19' ' ' ILE . 1.2 t -63.42 -47.56 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.925 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -48.32 -45.64 35.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.27 -41.15 68.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 177.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.795 HD22 HD11 ' A' ' 20' ' ' LEU . 95.9 mt -67.01 -27.01 67.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.438 -0.789 . . . . 0.0 109.866 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -63.08 -59.89 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.274 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.9 -24.46 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 15.1 mm-40 -92.2 11.43 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 110.292 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 61.12 54.98 32.14 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 1.069 ' O ' HD13 ' A' ' 58' ' ' ILE . 11.9 m-85 -130.7 2.84 4.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 110.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.069 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.8 mm -132.04 34.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 110.24 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -80.6 -7.78 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.754 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -140.04 -37.21 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.561 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 15.3 m-30 -55.83 -111.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.028 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.677 HG22 ' CG2' ' A' ' 58' ' ' ILE . 4.8 t -87.59 27.79 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.037 -1.039 . . . . 0.0 109.928 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -38.85 -31.3 0.06 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.235 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -53.64 -28.41 32.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.687 0.756 . . . . 0.0 109.954 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.606 ' HG ' ' N ' ' A' ' 66' ' ' ASN . 0.7 OUTLIER -41.42 -24.14 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.739 -0.601 . . . . 0.0 110.781 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.606 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 33.7 t-20 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.983 . . . . 0.0 110.283 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.266 0.555 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.05 -11.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.162 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 4' ' ' SER . 28.8 t0 -46.62 140.65 4.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.3 OUTLIER 66.1 111.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.36 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.493 ' CD ' ' HG2' ' A' ' 24' ' ' GLN . 1.8 mtpp -77.58 -63.63 1.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.291 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 2.3 ttmt -176.92 -129.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 110.244 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.631 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 63.29 -170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 120.991 -1.068 . . . . 0.0 108.991 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.631 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.9 Cg_endo -68.42 55.99 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.295 1.155 . . . . 0.0 109.941 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -48.66 -42.84 28.46 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 33.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.1 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.526 ' O ' ' NH1' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -159.3 62.59 0.39 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 12' ' ' LEU . 3.7 pp 175.46 -177.91 0.12 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.488 -0.757 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' CB ' ' OD1' ' A' ' 16' ' ' ASP . 2.9 t0 -96.06 161.22 14.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.323 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -57.08 -24.2 52.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 110.314 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 ' HD3' ' A' ' 48' ' ' ARG . 4.6 mm -74.47 -33.98 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.943 . . . . 0.0 110.527 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.566 ' C ' HD11 ' A' ' 52' ' ' LEU . 4.3 m-20 -71.66 -59.95 2.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.472 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.449 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -55.27 -43.74 75.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.023 . . . . 0.0 110.543 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 2.8 m120 -64.86 -37.61 88.22 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.17 -0.956 . . . . 0.0 109.276 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.059 HG21 HG23 ' A' ' 49' ' ' VAL . 9.5 mt -63.06 -38.91 83.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.39 -0.819 . . . . 0.0 109.356 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.746 ' CG ' HD13 ' A' ' 52' ' ' LEU . 90.4 mt -65.29 -41.2 94.37 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.11 -34.95 78.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.336 -0.852 . . . . 0.0 109.377 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 60.3 mm-40 -73.03 -41.83 63.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 109.601 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.677 HD13 ' HB3' ' A' ' 61' ' ' TYR . 37.2 mt -66.85 -30.86 71.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 109.334 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG2' ' CD ' ' A' ' 5' ' ' LYS . 4.0 tp60 -66.18 -39.29 89.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 4.1 mtmp? -81.05 -18.61 46.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.54 ' O ' HG22 ' A' ' 29' ' ' ILE . 7.2 m-20 -140.85 94.5 2.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.81 . . . . 0.0 109.951 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.86 29.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -130.37 39.86 3.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 110.157 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 26' ' ' ASP . 5.4 tt -126.49 130.72 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 110.39 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.763 ' HA ' HD11 ' A' ' 64' ' ' LEU . 20.9 p -72.15 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.619 ' ND2' ' HG ' ' A' ' 46' ' ' LEU . 2.3 m120 -112.61 -30.9 6.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.926 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 48.7 t -50.27 -63.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.173 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tp10 -62.21 -29.0 70.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.194 -0.941 . . . . 0.0 108.82 177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.617 HD22 HG12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -73.71 -14.78 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.459 0.647 . . . . 0.0 109.818 178.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.544 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 18.3 p -87.79 -45.81 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.497 -0.752 . . . . 0.0 111.004 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -82.55 -22.91 34.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 0.0 111.223 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.56 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -74.32 -15.68 60.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.014 -1.054 . . . . 0.0 110.552 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.854 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.4 m -106.49 -13.12 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.424 -0.798 . . . . 0.0 109.969 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.93 40.09 3.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.854 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.52 168.83 24.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.037 -1.273 . . . . 0.0 110.654 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -76.05 158.88 81.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 108.876 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.075 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.3 Cg_endo -74.59 -43.8 0.44 Allowed 'Trans proline' 0 C--N 1.288 -2.616 0 O-C-N 123.964 1.507 . . . . 0.0 110.464 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.35 -55.51 4.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.973 . . . . 0.0 109.471 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.4 Cg_endo -76.29 -42.94 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.894 1.471 . . . . 0.0 110.126 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.1 t -39.8 -46.0 1.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.95 -1.094 . . . . 0.0 108.626 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -64.63 -49.54 70.63 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 17.3 mt-10 -46.22 -43.03 15.07 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.482 -0.887 . . . . 0.0 108.894 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.775 ' HD3' HG21 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -68.43 -45.76 71.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.367 -0.833 . . . . 0.0 109.153 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.059 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -63.87 -47.69 89.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.432 -0.793 . . . . 0.0 109.604 178.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.619 ' N ' HG12 ' A' ' 49' ' ' VAL . 12.4 mmt85 -43.46 -55.69 4.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.838 . . . . 0.0 109.443 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -47.57 -43.48 25.41 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.869 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.746 HD13 ' CG ' ' A' ' 20' ' ' LEU . 30.2 mt -70.98 -41.97 70.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.758 . . . . 0.0 109.796 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.47 -57.66 9.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 110.138 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -54.81 -17.87 4.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.051 179.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.501 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 1.1 mm-40 -89.77 9.91 25.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.94 44.16 47.22 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.891 ' O ' HD13 ' A' ' 58' ' ' ILE . 14.1 m-85 -135.28 12.03 3.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -1.165 . . . . 0.0 110.261 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.891 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.8 mm -141.99 48.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 110.316 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -92.26 -6.03 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.921 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -134.5 -41.25 0.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.677 ' HB3' HD13 ' A' ' 23' ' ' LEU . 19.9 m-85 -57.05 -111.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 109.914 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.974 HG23 HD23 ' A' ' 65' ' ' LEU . 11.0 t -86.59 18.95 3.06 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.0 -1.062 . . . . 0.0 109.703 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -38.54 -30.04 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.763 HD11 ' HA ' ' A' ' 30' ' ' SER . 1.7 pp -55.12 -33.76 63.14 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.974 HD23 HG23 ' A' ' 62' ' ' THR . 1.9 pp -39.82 -26.39 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.709 -0.619 . . . . 0.0 110.596 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.8 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.277 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.06 169.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -154.25 19.75 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.359 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.33 -63.4 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HZ1' ' HB2' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -60.49 145.4 48.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 2.7 mmtp -135.82 -89.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.453 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.648 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 50.77 -165.37 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.648 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.3 Cg_endo -74.21 58.43 4.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.303 1.159 . . . . 0.0 109.978 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.83 63.98 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -65.44 -8.3 18.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -1.19 . . . . 0.0 109.98 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.6 OUTLIER -164.12 77.47 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.87 HD21 HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -129.22 144.94 51.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.657 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' H ' HD23 ' A' ' 12' ' ' LEU . 24.4 t0 -66.04 137.44 57.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.92 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 3.5 mmt180 -52.62 -29.03 23.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.344 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 HD22 ' A' ' 40' ' ' LEU . 9.0 mm -80.37 -29.88 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.616 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.706 ' HB3' HD11 ' A' ' 52' ' ' LEU . 5.2 m-20 -82.19 -36.92 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 2.9 ptt180 -70.62 -44.21 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 22.6 m-20 -67.78 -36.22 80.08 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.921 HG21 ' CG2' ' A' ' 49' ' ' VAL . 24.7 mt -68.76 -37.79 77.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.825 ' HG ' HD13 ' A' ' 52' ' ' LEU . 11.9 mt -65.67 -36.87 84.89 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.349 -0.845 . . . . 0.0 109.249 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.502 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 8.0 t30 -67.56 -35.48 79.12 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.394 -0.816 . . . . 0.0 109.198 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.806 ' OE1' HG13 ' A' ' 38' ' ' VAL . 7.1 mt-10 -72.87 -40.15 65.88 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.452 -0.78 . . . . 0.0 109.764 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 61' ' ' TYR . 34.7 mt -66.89 -37.05 83.66 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.22 -0.925 . . . . 0.0 109.306 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.415 ' OE1' ' OH ' ' A' ' 61' ' ' TYR . 64.7 tp60 -63.44 -40.67 97.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.399 -0.813 . . . . 0.0 109.235 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 -25.3 44.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.32 96.36 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.63 39.48 3.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -153.74 21.35 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -1.114 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.668 HD13 HD12 ' A' ' 34' ' ' LEU . 4.5 tt -101.84 140.22 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.515 ' HA ' HD11 ' A' ' 64' ' ' LEU . 13.5 t -84.92 -120.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.653 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 7.6 p30 -120.8 -46.44 2.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.0 t -45.22 -60.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.283 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.3 tt0 -62.04 -30.34 70.91 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.216 -0.928 . . . . 0.0 108.989 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.668 HD12 HD13 ' A' ' 29' ' ' ILE . 6.4 tp -74.67 -16.19 60.77 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.58 -0.7 . . . . 0.0 110.063 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' ASN . 11.6 p -84.37 -37.97 20.89 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.412 -0.805 . . . . 0.0 110.279 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -87.13 -17.9 31.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.449 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -75.1 -18.02 60.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.503 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -111.46 -11.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 121.405 -0.81 . . . . 0.0 109.731 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.62 41.36 4.77 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.878 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -148.02 168.57 21.98 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.998 -1.295 . . . . 0.0 110.466 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 3.5 m -72.75 154.82 91.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 108.872 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.073 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.3 Cg_endo -72.53 -48.31 0.33 Allowed 'Trans proline' 0 C--N 1.288 -2.642 0 O-C-N 123.961 1.506 . . . . 0.0 110.733 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.27 -54.22 4.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.179 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.3 Cg_endo -76.02 -41.01 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.977 1.514 . . . . 0.0 110.134 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 50.6 t -39.89 -46.19 1.96 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.043 . . . . 0.0 108.731 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.073 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.04 -49.28 75.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -46.3 -41.84 13.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.898 177.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.576 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -67.57 -56.62 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.921 ' CG2' HG21 ' A' ' 19' ' ' ILE . 1.4 t -55.71 -51.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 3.0 mmt85 -40.94 -49.92 3.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.533 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -49.82 -44.25 49.18 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.87 HD21 HD21 ' A' ' 12' ' ' LEU . 49.3 mt -67.22 -20.29 65.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.769 . . . . 0.0 109.881 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.72 -64.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -46.31 -23.92 0.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.299 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 20.7 mm-40 -85.97 11.06 12.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 59.5 54.38 38.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.82 ' O ' HD13 ' A' ' 58' ' ' ILE . 12.4 m-85 -139.53 9.82 2.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -1.2 . . . . 0.0 110.339 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.3 mm -136.72 29.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.29 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.44 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 16.3 pt20 -83.1 -9.4 59.23 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.402 -0.811 . . . . 0.0 109.666 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -125.4 -41.74 0.35 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.858 ' HB3' HD13 ' A' ' 23' ' ' LEU . 8.7 m-30 -57.32 -113.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.956 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.6 t -89.9 27.28 1.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -38.46 -29.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.407 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 65' ' ' LEU . 3.6 pp -53.47 -34.28 57.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 110.043 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.071 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -66.75 -6.46 15.94 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.604 -0.685 . . . . 0.0 110.497 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 1.071 ' N ' HD13 ' A' ' 65' ' ' LEU . 8.0 t30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.191 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.192 0.52 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.4 144.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.28 107.06 3.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.2 102.58 6.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -171.6 58.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.263 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG2' ' CD1' ' A' ' 12' ' ' LEU . 7.1 ttmt -177.06 58.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -54.03 -60.95 6.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.127 -0.983 . . . . 0.0 109.944 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 47.1 Cg_endo -74.16 53.6 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.935 1.492 . . . . 0.0 110.022 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . -52.85 -168.65 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 2.1 tttm 66.24 -129.51 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 109.974 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.85 89.48 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 110.264 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -117.05 133.11 56.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -59.53 128.33 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -47.11 -46.01 22.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 110.351 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.673 HG23 HD22 ' A' ' 40' ' ' LEU . 20.5 mm -65.88 -17.1 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 110.66 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.55 ' C ' HD11 ' A' ' 52' ' ' LEU . 20.4 m-20 -84.04 -62.71 1.5 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.059 -1.026 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.84 -45.23 67.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.128 -0.982 . . . . 0.0 110.022 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.505 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 9.9 t-20 -64.66 -42.36 95.46 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 109.285 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.825 HD13 HG23 ' A' ' 49' ' ' VAL . 1.3 mt -58.74 -35.0 53.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.36 -0.838 . . . . 0.0 109.347 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 52' ' ' LEU . 67.2 mt -67.06 -45.24 77.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.45 -27.06 68.73 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.219 -0.926 . . . . 0.0 109.245 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 11.9 mm-40 -85.37 -43.67 13.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.516 -0.74 . . . . 0.0 110.147 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -65.77 -20.28 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 109.558 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.471 ' HB2' ' HE3' ' A' ' 5' ' ' LYS . 3.6 tp60 -85.58 -41.32 15.36 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 1.3 ptmt -60.5 -30.78 69.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.522 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 27.0 p30 -150.87 71.23 1.02 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.09 -23.42 1.65 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.08 9.31 4.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.366 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 37' ' ' ARG . 7.1 tt -76.53 153.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.878 . . . . 0.0 110.454 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.556 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 2.3 m -104.6 155.58 18.72 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' SER . 6.2 p30 -46.25 -47.36 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.128 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' A' ' 35' ' ' SER . 4.7 t -49.65 -55.45 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.935 -1.103 . . . . 0.0 108.881 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.4 tt0 -67.21 -32.38 73.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -68.53 -20.04 64.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.59 0.71 . . . . 0.0 109.486 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.537 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 25.3 p -83.47 -46.2 12.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.557 -0.714 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -82.25 -27.1 32.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.68 ' HG3' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -58.37 -24.54 60.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.224 -0.923 . . . . 0.0 109.736 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.767 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.0 -3.87 10.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 178.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.29 46.76 5.73 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.767 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -150.24 156.65 41.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.273 . . . . 0.0 111.019 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.51 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -62.65 153.31 78.69 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.07 ' O ' HD12 ' A' ' 46' ' ' LEU . 46.2 Cg_endo -72.86 -41.93 1.27 Allowed 'Trans proline' 0 C--N 1.283 -2.887 0 O-C-N 123.842 1.443 . . . . 0.0 110.682 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -56.03 2.75 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.606 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.8 Cg_endo -74.74 -37.76 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.9 1.473 . . . . 0.0 110.121 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.675 ' HA ' HD11 ' A' ' 40' ' ' LEU . 48.5 t -41.85 -45.89 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.029 -1.044 . . . . 0.0 108.651 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.07 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.96 -43.27 93.23 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' PRO . 58.2 mt-10 -55.0 -43.69 73.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.572 ' CD ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.83 -44.65 76.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.636 0.731 . . . . 0.0 109.189 178.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.825 HG23 HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -62.8 -50.41 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -0.833 . . . . 0.0 109.599 178.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.613 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -41.85 -51.37 4.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.495 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -51.35 -45.1 62.22 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.134 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.828 ' HB3' HD11 ' A' ' 58' ' ' ILE . 16.5 mt -72.19 -23.5 61.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' CG ' ' HA ' ' A' ' 61' ' ' TYR . 13.0 tm-20 -58.14 -48.94 78.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -0.791 . . . . 0.0 110.098 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.514 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -65.18 -17.24 64.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 77.2 mm-40 -79.81 8.61 6.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.73 31.35 71.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -112.86 4.05 16.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -1.142 . . . . 0.0 109.999 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 52' ' ' LEU . 1.1 mt -150.24 124.18 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.36 -0.838 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -86.94 84.74 7.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.113 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 62' ' ' THR . . . 111.32 52.91 0.54 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.767 ' O ' HG21 ' A' ' 58' ' ' ILE . 96.1 m-85 57.58 -82.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.324 -1.104 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.759 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 1.4 p -91.12 1.11 57.33 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.107 -0.996 . . . . 0.0 109.274 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 62' ' ' THR . . . 71.11 29.17 2.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.456 0.646 . . . . 0.0 109.949 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 176.12 -30.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.905 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -50.44 -19.16 0.78 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.668 -0.645 . . . . 0.0 110.254 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.759 ' N ' HD23 ' A' ' 65' ' ' LEU . 2.3 t-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.338 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' VAL . 6.1 ttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.271 0.558 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' MET . 47.3 t -42.47 -43.67 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER 62.36 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.9 m -88.36 30.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.551 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 5.3 ttpt -62.46 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -119.32 -40.03 2.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HG2' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 41.64 -162.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.403 -0.811 . . . . 0.0 109.142 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.665 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.7 Cg_endo -75.14 58.08 4.86 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.235 1.124 . . . . 0.0 109.788 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' HA2' HD12 ' A' ' 12' ' ' LEU . . . -38.52 -29.81 0.08 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -60.16 -131.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.948 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.73 87.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.042 -1.036 . . . . 0.0 110.014 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.529 HD12 ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -110.59 149.58 30.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ASP . 10.4 t70 -85.85 131.64 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -40.88 -45.59 2.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.36 -0.837 . . . . 0.0 110.565 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.78 HG21 ' CD2' ' A' ' 40' ' ' LEU . 6.4 mm -70.19 -26.34 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 28.1 m-20 -72.51 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 0.0 110.303 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -35.92 68.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 109.985 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.74 ' HB3' HG13 ' A' ' 38' ' ' VAL . 3.5 t-20 -71.32 -42.86 68.06 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.783 . . . . 0.0 109.095 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.115 HG21 HG23 ' A' ' 49' ' ' VAL . 14.0 mt -66.31 -34.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.913 HD11 ' CD2' ' A' ' 52' ' ' LEU . 49.0 mt -72.18 -39.89 68.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.401 -0.812 . . . . 0.0 109.433 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.67 -37.07 84.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.989 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.88 -33.08 63.91 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.466 -0.771 . . . . 0.0 109.473 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 61' ' ' TYR . 17.5 mt -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.551 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 3.5 tm0? -73.66 -44.74 55.94 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.521 -0.737 . . . . 0.0 109.739 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -70.21 -32.33 70.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.603 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.541 ' O ' HG22 ' A' ' 29' ' ' ILE . 5.9 m-20 -130.05 86.17 2.37 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.84 0.71 50.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -111.03 31.9 5.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.165 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.989 HG21 ' OE2' ' A' ' 22' ' ' GLU . 14.9 tt -115.84 144.88 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.034 ' HA ' HD11 ' A' ' 64' ' ' LEU . 44.8 t -87.96 -110.92 0.06 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 110.408 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.689 ' CB ' HD21 ' A' ' 46' ' ' LEU . 4.5 p-10 -124.88 -50.33 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 31' ' ' ASN . 69.5 t -41.17 -64.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 37' ' ' ARG . 4.1 tp10 -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.224 -0.922 . . . . 0.0 108.851 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 30' ' ' SER . 1.1 tt -67.8 -23.57 65.21 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.557 -0.714 . . . . 0.0 109.609 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -78.57 -41.88 30.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.437 -0.789 . . . . 0.0 110.286 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -67.09 -28.31 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 1.1 mmt180 -73.03 -17.81 61.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 18' ' ' ASN . 3.6 t -107.23 11.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.914 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.47 18.05 21.3 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.78 ' CD2' HG21 ' A' ' 15' ' ' ILE . 15.0 tp -123.4 134.95 53.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -1.003 . . . . 0.0 110.203 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.563 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.8 m -47.0 158.7 0.42 Allowed Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.735 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.061 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.6 -42.58 0.82 Allowed 'Trans proline' 0 C--N 1.285 -2.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.39 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.41 -55.54 3.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.32 178.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.711 ' CG ' HD11 ' A' ' 40' ' ' LEU . 44.4 Cg_endo -74.26 -50.37 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.91 1.479 . . . . 0.0 110.136 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 39.4 t -38.19 -46.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 108.873 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.061 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -63.42 -53.05 58.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 1.3 mt-10 -46.29 -46.01 17.73 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.955 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -68.22 -43.83 77.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.576 -0.702 . . . . 0.0 109.33 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.115 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -62.87 -43.81 99.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' N ' HG12 ' A' ' 49' ' ' VAL . 18.7 mmm-85 -51.36 -46.48 62.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.566 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.59 -34.08 64.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.862 178.015 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.913 ' CD2' HD11 ' A' ' 20' ' ' LEU . 5.2 mt -76.68 -19.05 58.17 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.743 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.55 -59.92 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 110.197 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -54.19 -22.97 12.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.56 11.44 7.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 51.43 59.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.917 ' O ' HD13 ' A' ' 58' ' ' ILE . 13.4 m-85 -134.29 6.58 3.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -1.129 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.917 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.3 mm -137.17 38.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.266 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -1.27 57.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 109.611 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -138.32 -39.89 0.11 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.812 ' HB3' HD13 ' A' ' 23' ' ' LEU . 14.0 m-30 -58.59 -114.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -1.12 . . . . 0.0 109.898 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.065 ' O ' HD23 ' A' ' 65' ' ' LEU . 14.2 t -87.1 23.03 1.89 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -34.53 -32.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.548 0.689 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.034 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -58.67 -110.92 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.574 -0.704 . . . . 0.0 109.434 177.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.065 HD23 ' O ' ' A' ' 62' ' ' THR . 0.3 OUTLIER 34.95 30.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 110.46 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.556 ' N ' ' O ' ' A' ' 64' ' ' LEU . 7.2 t30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.287 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.292 0.568 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.8 139.9 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 4' ' ' SER . 2.7 p30 -69.52 -33.33 72.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.262 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER 55.51 77.51 0.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.325 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -135.04 32.42 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 110.193 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.09 63.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.506 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.565 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 2.1 ttt180 -64.46 -56.95 19.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 109.796 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 48.4 Cg_endo -74.95 44.64 1.19 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.427 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.27 -37.46 31.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 10' ' ' LYS . 17.6 ttpt -66.54 -8.3 25.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.179 . . . . 0.0 110.145 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.92 84.91 1.02 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -0.788 . . . . 0.0 110.012 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.72 HD22 ' HG3' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -140.61 86.05 2.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 110.363 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -42.63 145.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.109 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 8.4 mmt180 -47.3 -22.81 0.45 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.333 -0.855 . . . . 0.0 110.284 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.754 HG21 ' CD2' ' A' ' 40' ' ' LEU . 1.2 mp -80.51 -44.35 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 110.129 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.601 ' CB ' HD23 ' A' ' 12' ' ' LEU . 2.7 m-20 -58.55 -44.87 89.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.161 -0.962 . . . . 0.0 109.901 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HG3' HD22 ' A' ' 12' ' ' LEU . 3.8 mtt180 -65.93 -47.82 73.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.915 . . . . 0.0 109.799 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.584 ' HB3' HG13 ' A' ' 38' ' ' VAL . 1.5 m-20 -61.87 -41.79 98.27 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.388 -0.82 . . . . 0.0 108.879 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.997 HG21 HG23 ' A' ' 49' ' ' VAL . 7.6 mt -62.09 -41.06 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.462 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.095 HD11 HD22 ' A' ' 52' ' ' LEU . 13.8 mt -70.34 -40.94 73.82 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.1 t-20 -66.41 -34.39 77.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 6.2 mm-40 -76.32 -29.49 57.34 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.424 -0.797 . . . . 0.0 109.696 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.767 HD21 ' CD1' ' A' ' 34' ' ' LEU . 21.5 mt -72.48 -32.7 66.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.536 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 1.4 tp60 -79.24 -42.52 25.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -67.03 -33.69 76.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.552 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -141.34 63.37 1.44 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.911 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.01 -161.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.06 30.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -1.194 . . . . 0.0 109.946 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 26' ' ' ASP . 4.9 tt -117.43 131.9 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.361 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.571 ' HA ' HD11 ' A' ' 64' ' ' LEU . 37.0 t -67.73 168.88 10.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.954 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.6 OUTLIER -65.37 -39.91 92.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.36 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 31' ' ' ASN . 46.6 t -44.54 -61.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 109.221 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.99 -33.66 74.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.307 -0.87 . . . . 0.0 108.751 177.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.767 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -67.95 -20.39 65.05 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.525 0.678 . . . . 0.0 109.674 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.4 p -87.77 -24.39 23.8 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.41 -0.806 . . . . 0.0 110.488 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 4.7 mtmt -79.25 -33.14 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.71 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.591 ' CD ' ' HA ' ' A' ' 34' ' ' LEU . 4.4 ptm180 -81.67 -16.04 52.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.074 -1.016 . . . . 0.0 110.745 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 34' ' ' LEU . 4.5 t -97.66 12.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.207 -0.933 . . . . 0.0 110.144 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.98 21.76 8.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.754 ' CD2' HG21 ' A' ' 15' ' ' ILE . 15.2 tp -127.83 133.37 49.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.52 -0.988 . . . . 0.0 110.253 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.593 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -47.81 160.63 0.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 120.993 -1.067 . . . . 0.0 108.536 177.359 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.042 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.9 Cg_endo -73.92 -45.57 0.37 Allowed 'Trans proline' 0 C--N 1.282 -2.935 0 O-C-N 123.651 1.343 . . . . 0.0 110.654 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.554 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -38.73 -53.18 3.44 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 109.643 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.587 ' HB2' HD11 ' A' ' 40' ' ' LEU . 44.6 Cg_endo -75.45 -49.01 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.044 1.549 . . . . 0.0 109.77 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HA ' HD11 ' A' ' 19' ' ' ILE . 12.8 t -43.62 -37.87 2.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.047 -1.033 . . . . 0.0 108.494 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.042 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -70.77 -45.87 63.95 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 70.8 mt-10 -49.79 -46.3 50.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.088 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' CB ' HG22 ' A' ' 15' ' ' ILE . 3.6 mpt_? -69.69 -36.48 76.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.997 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -71.66 -47.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.272 -0.893 . . . . 0.0 110.017 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.608 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -48.25 -48.06 35.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 2.4 tpp180 -53.38 -45.91 69.41 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.903 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.095 HD22 HD11 ' A' ' 20' ' ' LEU . 78.1 mt -67.59 -16.59 64.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -58.89 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 110.254 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.445 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 61.4 mtt85 -73.75 -21.81 60.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 110.372 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' HG2' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -148.51 53.74 1.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -161.71 -123.58 0.67 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 1.061 ' O ' HD13 ' A' ' 58' ' ' ILE . 63.4 m-85 -146.96 76.16 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.061 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.5 mm -137.0 24.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.63 1.47 38.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.506 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -145.5 -39.91 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.762 ' HB3' HD22 ' A' ' 23' ' ' LEU . 93.0 m-85 -56.18 -110.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -1.081 . . . . 0.0 109.904 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.949 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.7 t -85.28 21.06 1.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.893 -1.129 . . . . 0.0 109.695 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -39.32 -28.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.484 -0.76 . . . . 0.0 109.224 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 30' ' ' SER . 2.0 pp -54.28 -34.21 60.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.615 0.721 . . . . 0.0 110.035 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.09 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -65.35 -5.81 8.37 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.632 -0.668 . . . . 0.0 110.656 -179.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 1.09 ' N ' HD13 ' A' ' 65' ' ' LEU . 3.7 p30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.218 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.212 0.53 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -108.28 146.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.376 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.35 107.6 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.4 p -121.87 40.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.307 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -106.62 22.96 15.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 110.329 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' ARG . 38.9 mtpt -89.91 -11.54 41.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.691 ' NE ' HD13 ' A' ' 20' ' ' LEU . 15.9 mmm180 43.83 -156.03 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.122 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.687 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 43.0 Cg_endo -77.83 20.41 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.129 1.068 . . . . 0.0 110.305 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . 41.51 -98.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.46 79.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 110.402 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 12' ' ' LEU . 0.6 OUTLIER 175.0 32.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 17' ' ' ARG . 2.4 pp 179.99 156.88 0.66 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.423 -0.798 . . . . 0.0 110.312 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 5.1 t70 -89.92 156.0 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.547 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 9.4 mmt180 -48.18 -25.64 1.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.322 -0.861 . . . . 0.0 110.346 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.875 HD12 HD22 ' A' ' 40' ' ' LEU . 19.2 mm -69.93 -33.57 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.265 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 52' ' ' LEU . 1.4 m-20 -73.81 -59.45 2.71 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.547 ' CD ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -53.6 -33.4 54.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.812 179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.579 ' CG ' HG12 ' A' ' 38' ' ' VAL . 59.8 t-20 -70.27 -43.12 71.12 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.384 -0.822 . . . . 0.0 109.192 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.043 HG21 HG23 ' A' ' 49' ' ' VAL . 40.4 mt -61.75 -35.92 70.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.937 HD11 HD22 ' A' ' 52' ' ' LEU . 20.2 mt -67.33 -43.63 81.11 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.285 -0.885 . . . . 0.0 109.286 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.504 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 11.1 t30 -58.67 -32.83 69.48 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 22.3 mm-40 -75.42 -45.09 41.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.853 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 19' ' ' ILE . 2.1 mm? -57.6 -44.14 85.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.659 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -68.04 -40.42 82.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.377 -0.827 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 27.6 mtpt -68.66 -20.16 64.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.909 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' ARG . 35.1 m-20 -147.4 79.23 1.49 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 110.188 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.88 58.36 0.21 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.26 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -1.181 . . . . 0.0 110.008 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.7 tt -122.35 147.04 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.602 ' HA ' HD11 ' A' ' 64' ' ' LEU . 9.1 p -87.83 -167.11 1.78 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.108 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 12.9 m-80 -78.78 -49.97 12.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -0.919 . . . . 0.0 110.333 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.6 t -40.02 -57.78 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 109.706 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -61.66 -33.5 74.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.186 -0.946 . . . . 0.0 108.759 177.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.749 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -67.16 -57.86 5.95 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 178.082 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.577 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 3.1 p -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.608 -0.682 . . . . 0.0 110.29 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -80.11 -22.99 41.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 34' ' ' LEU . 12.5 mmt180 -78.33 -17.86 55.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.855 HG23 ' HG ' ' A' ' 40' ' ' LEU . 3.2 m -105.88 -12.33 9.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 39.85 5.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.875 HD22 HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -153.76 169.19 23.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.016 -1.284 . . . . 0.0 110.775 179.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.2 154.09 94.01 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.058 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.4 Cg_endo -73.58 -44.0 0.57 Allowed 'Trans proline' 0 C--N 1.287 -2.698 0 O-C-N 124.004 1.529 . . . . 0.0 110.802 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.602 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.94 -56.26 1.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.8 Cg_endo -77.52 -42.57 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.93 1.49 . . . . 0.0 110.174 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 36.9 t -37.4 -50.39 1.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 108.877 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.058 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.34 -51.77 68.11 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.7 mm-40 -44.89 -41.22 6.96 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.303 -0.873 . . . . 0.0 108.949 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.69 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.97 -45.33 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.043 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -62.54 -44.59 99.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 178.207 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.552 ' N ' HG12 ' A' ' 49' ' ' VAL . 8.2 mmm180 -48.96 -47.39 44.02 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.339 -0.851 . . . . 0.0 109.019 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -50.5 -40.66 51.88 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.937 HD22 HD11 ' A' ' 20' ' ' LEU . 90.1 mt -75.44 -37.52 60.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.577 -0.702 . . . . 0.0 109.667 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 58' ' ' ILE . 7.1 tp10 -73.25 -26.6 61.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 110.337 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -68.66 -42.12 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.209 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' OE1' ' CG ' ' A' ' 57' ' ' PHE . 6.2 pt20 -76.99 2.09 15.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.64 8.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.721 ' O ' HD13 ' A' ' 58' ' ' ILE . 1.3 m-85 -119.28 11.01 12.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -1.183 . . . . 0.0 110.152 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 52' ' ' LEU . 15.0 mm -136.04 26.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.097 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.4 0.21 20.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.365 -0.834 . . . . 0.0 109.917 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -140.97 -42.86 0.07 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.521 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 94.2 m-85 -57.41 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -1.109 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.023 HG21 HG21 ' A' ' 49' ' ' VAL . 5.1 t -87.33 26.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.903 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -37.97 -32.1 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.521 -0.737 . . . . 0.0 109.444 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -53.83 -27.49 29.93 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.741 0.781 . . . . 0.0 109.872 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.667 ' CD2' HG21 ' A' ' 58' ' ' ILE . 1.1 pp -40.03 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.741 -0.599 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.579 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 2.0 t-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.588 ' C ' HG23 ' A' ' 2' ' ' VAL . 4.6 tmm? . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.186 0.517 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.588 HG23 ' C ' ' A' ' 1' ' ' MET . 2.0 t 61.27 -139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.364 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.519 ' H ' HG12 ' A' ' 2' ' ' VAL . 0.8 OUTLIER 56.59 -157.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 10.3 m -112.05 175.54 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.584 ' HD3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER 57.78 101.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 7' ' ' ARG . 1.8 ptpt -133.37 4.7 3.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.243 -0.911 . . . . 0.0 110.419 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.712 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 41.85 -159.33 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 108.932 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.712 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 41.2 Cg_endo -73.75 4.46 4.08 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.065 1.034 . . . . 0.0 109.658 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 10' ' ' LYS . . . 54.01 167.12 0.02 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 1.7 tttt 58.86 127.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -1.097 . . . . 0.0 110.495 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' LYS . 1.5 t70 40.5 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.482 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.808 HD22 ' HG3' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -136.77 113.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.273 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 15' ' ' ILE . 1.4 m-20 -64.05 130.18 42.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.943 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 6.7 mmt-85 -46.03 -22.33 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 110.358 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' HD2' ' A' ' 48' ' ' ARG . 6.6 mm -73.48 -34.43 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.462 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.812 ' HB3' HD11 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -78.0 -45.02 24.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.808 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -63.52 -51.87 63.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.954 . . . . 0.0 110.0 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.555 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 7.8 t-20 -60.85 -40.45 92.91 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.385 -0.822 . . . . 0.0 109.332 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.072 HG21 HG23 ' A' ' 49' ' ' VAL . 10.5 mt -64.77 -38.5 82.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.282 -0.887 . . . . 0.0 109.559 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.883 ' HG ' HD13 ' A' ' 52' ' ' LEU . 14.4 mt -73.38 -35.24 65.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.351 -0.843 . . . . 0.0 109.307 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.584 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 49.5 t30 -72.69 -31.15 64.82 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.43 -0.794 . . . . 0.0 109.453 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 5.6 mm-40 -72.13 -32.85 67.32 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.402 -0.811 . . . . 0.0 109.86 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' A' ' 61' ' ' TYR . 4.3 mt -69.89 -36.41 75.41 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.203 -0.936 . . . . 0.0 109.488 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HB2' ' HE3' ' A' ' 5' ' ' LYS . 2.8 tp-100 -64.07 -42.97 96.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.49 -28.9 66.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.435 178.575 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.517 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -133.41 76.12 1.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 110.055 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.76 58.82 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.57 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -1.114 . . . . 0.0 110.182 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 tt -112.17 141.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.621 ' O ' HD12 ' A' ' 34' ' ' LEU . 17.6 m -77.9 -138.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.417 -0.802 . . . . 0.0 110.138 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.606 ' OD1' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -108.86 -41.1 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' ASN . 76.2 t -44.43 -62.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 109.355 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.481 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 1.1 tp10 -61.84 -26.44 68.13 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -78.54 -15.28 58.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.697 -0.627 . . . . 0.0 110.071 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ASN . 23.6 p -87.93 -44.67 10.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.819 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 7.8 pttt -79.84 -41.05 27.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 111.126 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 13.9 ptm180 -63.01 -16.2 58.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.065 -1.022 . . . . 0.0 110.628 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.782 HG23 ' HG ' ' A' ' 40' ' ' LEU . 14.5 m -98.51 -22.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.358 -0.838 . . . . 0.0 110.005 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 103.97 35.38 3.46 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.782 ' HG ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -153.36 169.02 24.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.019 -1.283 . . . . 0.0 110.624 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.0 m -74.17 158.75 85.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.747 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.085 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.9 Cg_endo -74.16 -49.75 0.18 Allowed 'Trans proline' 0 C--N 1.286 -2.72 0 O-C-N 123.9 1.473 . . . . 0.0 110.565 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.92 -53.67 3.43 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.428 179.142 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.634 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.3 Cg_endo -76.46 -41.69 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.898 1.473 . . . . 0.0 110.219 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 53.8 t -40.33 -51.19 2.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 108.718 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.085 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.25 -47.4 81.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -46.4 -38.83 9.52 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.864 177.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.815 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.36 -46.91 53.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.535 -0.728 . . . . 0.0 109.266 178.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.072 HG23 HG21 ' A' ' 19' ' ' ILE . 0.6 OUTLIER -65.77 -51.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.473 -0.767 . . . . 0.0 109.96 178.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.815 ' HD2' HD11 ' A' ' 65' ' ' LEU . 2.4 mmm180 -46.07 -44.11 15.18 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -54.44 -44.75 72.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' A' ' 58' ' ' ILE . 61.0 mt -65.08 -16.69 63.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.99 -58.56 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.243 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 2.6 ptp180 -49.19 -27.94 4.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.438 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.472 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 73.5 mm-40 -81.77 10.87 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.74 93.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.818 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -129.85 15.44 5.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.353 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.922 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.0 mm -138.41 47.48 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.563 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -85.9 -13.41 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.143 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.12 -43.75 0.1 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.782 ' HB3' HD13 ' A' ' 23' ' ' LEU . 62.9 m-85 -55.97 -100.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -1.061 . . . . 0.0 109.959 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.052 HG21 HG21 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -85.33 13.02 7.06 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.947 -1.096 . . . . 0.0 110.199 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.785 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -39.71 -29.95 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.779 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -63.77 -120.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.812 . . . . 0.0 109.98 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.898 HD23 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER 40.06 28.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 110.319 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.1 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.288 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.159 0.504 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.23 -26.88 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 110.257 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' CB ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -165.79 -77.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 3.0 p 175.1 128.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.417 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -84.77 50.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' C ' ' HD3' ' A' ' 7' ' ' ARG . 12.0 mtpp -98.32 -58.48 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.552 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 43.22 -161.98 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.389 -0.819 . . . . 0.0 108.887 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 7' ' ' ARG . 43.7 Cg_endo -77.33 52.06 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.183 1.096 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.28 -36.39 10.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -58.3 -15.26 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 0.0 110.041 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.39 79.17 1.39 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.993 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.589 HD13 ' NH2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -147.48 140.42 24.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.316 -0.865 . . . . 0.0 110.401 -179.239 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.72 173.29 6.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -80.01 -22.3 42.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.264 -0.897 . . . . 0.0 110.362 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.788 HG23 HD22 ' A' ' 40' ' ' LEU . 13.4 mm -78.87 -29.68 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.798 ' HB3' HD21 ' A' ' 52' ' ' LEU . 85.3 m-20 -81.56 -39.91 23.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.073 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -51.68 56.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.214 -0.929 . . . . 0.0 110.032 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.559 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 9.5 m-20 -62.84 -39.43 94.34 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.404 -0.81 . . . . 0.0 109.363 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 34' ' ' LEU . 8.0 mt -64.07 -38.25 81.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.453 -0.779 . . . . 0.0 109.56 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.021 HD11 HD22 ' A' ' 52' ' ' LEU . 12.9 mt -70.03 -37.42 75.59 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 26.2 m-20 -70.83 -29.32 65.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.845 . . . . 0.0 109.603 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 37' ' ' ARG . 6.2 mm-40 -82.23 -29.14 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.445 -0.785 . . . . 0.0 109.848 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.96 -37.36 84.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -42.48 33.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 1.5 pttt -75.17 -29.71 60.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.995 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -133.14 53.31 2.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.134 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -53.54 -169.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.32 16.84 1.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -1.143 . . . . 0.0 110.197 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.982 HD13 ' NH1' ' A' ' 37' ' ' ARG . 12.9 tt -102.64 134.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 110.124 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 34' ' ' LEU . 36.5 m -75.02 -131.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.403 -0.81 . . . . 0.0 110.502 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 35' ' ' SER . 26.5 p-10 -111.78 -47.02 3.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.217 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t -43.1 -67.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.976 -1.078 . . . . 0.0 109.276 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 3.4 tp10 -56.34 -25.95 50.84 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.203 -0.936 . . . . 0.0 108.665 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.849 HD11 HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -77.64 -18.73 56.46 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.41 0.624 . . . . 0.0 109.906 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' ASN . 6.4 p -90.33 -47.75 7.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.532 -0.73 . . . . 0.0 110.864 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 35' ' ' SER . 10.6 ttmt -79.21 -24.83 42.85 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 111.288 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.982 ' NH1' HD13 ' A' ' 29' ' ' ILE . 28.4 ptt180 -75.8 -14.91 60.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 110.62 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.8 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -107.64 -11.02 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 110.071 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 42.12 4.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.8 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.79 167.38 30.58 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.064 -1.256 . . . . 0.0 110.852 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.2 m -72.98 156.71 89.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.02 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.059 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -74.18 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.635 0 O-C-N 123.972 1.512 . . . . 0.0 110.826 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -39.38 -53.86 3.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 109.421 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.641 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.1 Cg_endo -77.24 -42.53 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.021 1.537 . . . . 0.0 110.335 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.767 ' HB2' HD12 ' A' ' 40' ' ' LEU . 44.6 t -38.47 -53.38 1.55 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 0.0 108.866 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.059 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -55.25 -49.63 71.54 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.25 -38.04 1.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.958 177.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.584 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.51 -49.29 27.34 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.627 0.727 . . . . 0.0 109.173 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -63.49 -40.49 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 4.2 mmm180 -53.86 -46.17 71.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.081 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -52.04 -42.16 62.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.021 HD22 HD11 ' A' ' 20' ' ' LEU . 64.4 mt -70.77 -22.4 62.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.546 -0.721 . . . . 0.0 109.781 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 2.8 tm-20 -68.5 -69.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.6 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -52.95 -19.38 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 110.639 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.574 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 8.7 mm100 -86.54 13.41 8.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.01 . . . . 0.0 110.481 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 61.84 51.42 57.39 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.922 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.3 m-85 -139.94 9.38 2.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -1.218 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 57' ' ' PHE . 8.5 mm -140.79 31.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.267 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -84.44 -3.8 58.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -138.27 -42.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 14.5 m-30 -55.86 -108.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -1.088 . . . . 0.0 109.885 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.007 ' O ' HD12 ' A' ' 65' ' ' LEU . 4.7 t -88.15 22.46 2.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.931 -1.106 . . . . 0.0 109.807 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -37.87 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -54.41 -30.91 53.9 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.596 0.713 . . . . 0.0 110.008 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.031 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.02 -3.19 4.92 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.561 -0.712 . . . . 0.0 110.545 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 1.014 ' N ' HD13 ' A' ' 65' ' ' LEU . 5.2 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.256 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 tpt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.243 0.544 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.456 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 21.7 t -76.25 -27.34 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 10.4 t0 66.65 117.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.388 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.41 -163.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -88.46 41.86 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.221 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 3.3 mtpm? 58.03 -113.87 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.88 . . . . 0.0 110.572 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.653 ' HD3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER 64.47 -171.5 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.988 -1.07 . . . . 0.0 109.112 -178.847 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.1 Cg_endo -70.28 55.24 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.398 1.209 . . . . 0.0 109.774 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.84 -33.66 6.7 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -59.14 -17.04 23.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -1.166 . . . . 0.0 110.01 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -149.68 81.01 1.39 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 109.957 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.653 HD11 ' HD3' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -146.98 144.36 29.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 -179.319 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -80.59 127.76 32.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.208 -0.933 . . . . 0.0 109.661 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -40.54 -27.49 0.05 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.361 -0.837 . . . . 0.0 110.41 -179.133 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.906 HG23 HD22 ' A' ' 40' ' ' LEU . 8.5 mm -72.97 -46.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 110.421 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 13' ' ' ASP . 1.4 m-20 -68.93 -26.24 64.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.545 ' CG ' ' HB3' ' A' ' 12' ' ' LEU . 9.3 mtp180 -75.88 -66.43 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.443 ' HB3' HG12 ' A' ' 38' ' ' VAL . 9.2 t-20 -53.45 -28.28 29.35 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 108.988 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.791 HG13 HG11 ' A' ' 38' ' ' VAL . 3.4 mt -64.79 -50.66 74.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.091 178.046 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.914 HD11 HD22 ' A' ' 52' ' ' LEU . 72.0 mt -55.55 -42.19 74.3 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.491 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 10.8 t30 -59.02 -38.77 80.05 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.746 ' OE2' HG13 ' A' ' 38' ' ' VAL . 25.5 mt-10 -63.61 -39.65 94.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.45 -0.782 . . . . 0.0 109.744 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 34' ' ' LEU . 2.1 mm? -66.58 -40.6 89.02 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.549 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 7.0 tp-100 -65.69 -36.45 83.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.317 -0.864 . . . . 0.0 109.303 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 1.6 pttp -79.1 -29.38 43.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -136.67 95.27 3.11 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 110.024 179.123 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.86 13.37 43.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.527 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.01 34.92 4.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -1.217 . . . . 0.0 110.381 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 26' ' ' ASP . 11.3 tt -116.48 139.84 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.615 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.782 ' HA ' HD21 ' A' ' 64' ' ' LEU . 2.7 t -76.19 -129.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.364 -0.835 . . . . 0.0 110.027 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -117.89 -38.25 3.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.019 -1.05 . . . . 0.0 110.29 179.347 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' ASN . 98.0 t -45.39 -56.65 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.041 -1.037 . . . . 0.0 109.068 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 1.7 tp10 -66.99 -32.88 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.336 -0.853 . . . . 0.0 108.844 177.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -69.46 -15.8 63.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.558 -0.714 . . . . 0.0 109.492 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 16.2 p -86.27 -47.08 9.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.495 -0.753 . . . . 0.0 110.355 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.99 -16.8 52.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.181 -0.95 . . . . 0.0 110.724 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -74.64 -19.94 60.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.859 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.94 -5.97 10.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.396 -0.815 . . . . 0.0 109.756 179.102 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.92 40.65 5.51 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -152.18 160.38 43.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.294 . . . . 0.0 110.72 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.485 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -69.59 160.12 80.89 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.069 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.6 Cg_endo -73.06 -45.21 0.47 Allowed 'Trans proline' 0 C--N 1.284 -2.859 0 O-C-N 123.926 1.487 . . . . 0.0 110.489 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.39 -57.79 1.36 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.177 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 52.1 Cg_endo -76.5 -41.49 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.898 1.473 . . . . 0.0 110.135 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.714 ' HB2' HD12 ' A' ' 40' ' ' LEU . 53.6 t -39.13 -53.05 1.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 108.661 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.069 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -52.82 -51.98 58.76 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 176.42 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.0 -43.06 4.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.265 177.7 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.863 ' CD ' HG21 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -72.21 -56.25 5.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -0.815 . . . . 0.0 109.492 178.581 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.71 HG11 ' HG ' ' A' ' 65' ' ' LEU . 1.6 t -54.72 -48.93 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.331 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmt180 -43.33 -52.27 5.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.369 178.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.04 -41.41 16.68 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.922 178.064 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.914 HD22 HD11 ' A' ' 20' ' ' LEU . 92.8 mt -68.07 -28.33 67.27 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.452 -0.78 . . . . 0.0 109.715 178.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' ARG . 1.9 tm-20 -64.62 -63.63 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.825 . . . . 0.0 110.161 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -50.27 -27.04 5.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.147 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 7' ' ' ARG . 28.6 mm-40 -83.42 5.59 23.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.57 59.97 7.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.953 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.53 10.81 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.953 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.7 mm -140.41 32.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -4.1 59.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.69 178.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.54 -41.35 0.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.672 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 11.4 m-85 -61.31 -115.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.054 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.956 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.8 t -82.41 23.96 0.72 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.999 -1.063 . . . . 0.0 109.911 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -38.57 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 30' ' ' SER . 4.2 pp -51.61 -34.5 37.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.649 0.737 . . . . 0.0 109.819 178.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.053 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -66.91 -5.87 14.29 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.646 -0.659 . . . . 0.0 110.274 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 1.053 ' N ' HD13 ' A' ' 65' ' ' LEU . 21.5 t30 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.193 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.215 0.531 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 2' ' ' VAL . 16.2 m -71.48 69.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.291 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' SER . 2.7 m-20 -62.93 -64.15 1.0 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 79.7 p -179.31 166.85 1.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.545 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -88.87 155.15 19.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.917 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -94.54 -128.71 0.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.641 -179.354 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.67 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 64.28 -168.69 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.066 -1.021 . . . . 0.0 109.131 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 7' ' ' ARG . 37.6 Cg_endo -68.07 58.37 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.244 1.128 . . . . 0.0 110.012 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -49.2 -25.14 5.43 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' LEU . 4.3 pttm -62.36 -134.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.507 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 5.4 m-20 -45.18 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -128.44 139.07 52.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.672 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.6 127.2 30.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -43.65 -33.9 1.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.406 -0.808 . . . . 0.0 110.264 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.028 HG23 HD22 ' A' ' 40' ' ' LEU . 7.1 mm -73.65 -33.74 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.53 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.663 ' HB3' HD21 ' A' ' 52' ' ' LEU . 93.4 m-20 -76.67 -45.82 28.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.599 ' CD ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -62.81 -44.2 96.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.072 -1.018 . . . . 0.0 110.217 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.788 ' HB3' HG12 ' A' ' 38' ' ' VAL . 9.1 m-20 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 178.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.685 HD13 HG23 ' A' ' 49' ' ' VAL . 7.2 mt -69.79 -33.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 178.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.964 HD11 HD22 ' A' ' 52' ' ' LEU . 65.9 mt -70.9 -38.25 72.99 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.247 -0.908 . . . . 0.0 109.388 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -31.9 70.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.024 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -78.5 -32.12 48.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.382 -0.824 . . . . 0.0 109.605 178.98 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.828 HD22 ' HB3' ' A' ' 61' ' ' TYR . 12.6 mt -71.13 -37.34 72.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.306 -0.871 . . . . 0.0 109.475 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.545 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 2.9 tp-100 -67.6 -38.63 84.27 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 178.451 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 24.5 pttt -79.73 -38.16 33.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.481 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -116.49 91.84 3.7 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 110.093 179.363 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.8 22.48 13.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.46 9.85 4.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -1.115 . . . . 0.0 110.073 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.024 HG21 ' OE2' ' A' ' 22' ' ' GLU . 13.6 tt -85.72 143.67 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 110.405 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.058 ' HA ' HD11 ' A' ' 64' ' ' LEU . 21.0 m -92.38 -73.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 110.537 -179.309 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.702 ' OD1' HD11 ' A' ' 46' ' ' LEU . 10.7 t-20 -164.3 -54.6 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.478 ' C ' ' O ' ' A' ' 31' ' ' ASN . 3.2 t -42.64 -52.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.998 -1.064 . . . . 0.0 109.081 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -69.08 -29.23 67.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.147 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.652 HD21 HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -73.66 -16.61 61.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.608 -0.683 . . . . 0.0 109.749 178.508 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.564 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 19.3 p -88.07 -47.76 8.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -81.96 -17.11 48.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -77.43 -16.03 59.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.013 -1.055 . . . . 0.0 110.611 -179.359 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.898 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.48 -6.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.985 179.489 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.27 42.75 5.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.028 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -153.31 164.06 38.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.987 -1.302 . . . . 0.0 110.643 178.852 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -71.51 160.93 81.14 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.97 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.078 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.3 Cg_endo -74.28 -54.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.285 -2.794 0 O-C-N 123.953 1.502 . . . . 0.0 110.649 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 m -35.14 -54.25 1.1 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.1 Cg_endo -74.83 -42.6 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.88 1.463 . . . . 0.0 109.867 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.692 ' HB2' HD12 ' A' ' 40' ' ' LEU . 40.8 t -39.15 -49.15 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.785 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.078 HD12 ' O ' ' A' ' 42' ' ' PRO . 2.1 mp -56.93 -52.77 63.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -42.87 -41.03 3.14 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.73 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.612 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -73.14 -53.78 10.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.615 -0.678 . . . . 0.0 109.683 178.614 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.685 HG23 HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -56.7 -43.83 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 1.5 mmm-85 -50.72 -48.4 58.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.203 -0.936 . . . . 0.0 109.131 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -50.6 -39.2 49.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.964 HD22 HD11 ' A' ' 20' ' ' LEU . 93.0 mt -70.63 -19.84 62.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.689 178.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.493 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 1.3 mt-10 -78.21 -55.07 5.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 110.062 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -44.64 -49.33 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.394 -0.816 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.436 HE22 ' CG ' ' A' ' 8' ' ' PRO . 3.8 pt20 -70.61 -1.96 12.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.325 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 75.17 66.27 1.94 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.823 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -141.84 9.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 110.131 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.962 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.2 mm -135.26 11.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -64.52 -12.47 44.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 109.691 179.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.77 -37.39 0.62 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.828 ' HB3' HD22 ' A' ' 23' ' ' LEU . 14.2 m-30 -63.46 -116.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -1.052 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.622 ' HB ' HD21 ' A' ' 23' ' ' LEU . 6.4 t -89.16 31.3 0.89 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.007 -1.058 . . . . 0.0 109.927 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -33.91 -33.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.645 0.736 . . . . 0.0 109.041 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.058 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -62.36 -128.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.593 -0.692 . . . . 0.0 109.532 177.64 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.981 ' HG ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER 41.39 21.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.896 . . . . 0.0 110.464 178.856 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 64' ' ' LEU . 29.3 t30 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.138 . . . . 0.0 110.199 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' ' HB ' ' A' ' 2' ' ' VAL . 1.5 ptt? . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.323 0.583 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 1' ' ' MET . 3.7 p 178.76 143.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.93 . . . . 0.0 110.198 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 59.8 m-20 -133.88 -0.22 3.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.379 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.34 -62.26 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 24' ' ' GLN . 7.0 mtpp -114.76 105.57 13.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -117.45 -116.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.635 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 61.37 -169.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.933 -1.104 . . . . 0.0 109.117 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.635 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 38.4 Cg_endo -70.02 57.07 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.286 1.15 . . . . 0.0 109.943 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.6 -42.21 57.85 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.91 142.26 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.155 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 12' ' ' LEU . 68.9 m-20 53.82 -117.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 0.0 110.017 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' CB ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER 67.81 141.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.335 179.72 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.07 160.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.473 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 4.8 mmt85 -69.56 -35.49 75.44 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.297 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.898 HG21 HD12 ' A' ' 40' ' ' LEU . 1.2 mp -70.96 -35.22 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 110.273 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.758 ' CA ' HD11 ' A' ' 52' ' ' LEU . 63.8 m-20 -62.24 -67.17 0.44 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.545 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 3.1 ptm85 -50.76 -44.86 58.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.242 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.434 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 97.2 m-20 -66.21 -37.52 85.76 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.947 HG21 HG23 ' A' ' 49' ' ' VAL . 3.2 mt -66.91 -34.3 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 109.228 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.011 HD11 HD22 ' A' ' 52' ' ' LEU . 12.6 mt -68.74 -43.26 76.26 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.09 -30.88 71.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.292 -0.88 . . . . 0.0 109.511 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 24.6 mm-40 -76.84 -30.46 56.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.826 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 34' ' ' LEU . 2.4 mm? -75.46 -30.98 60.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 178.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.524 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 1.4 mm-40 -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.704 178.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.51 -40.39 57.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.836 179.185 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.532 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -136.51 64.05 1.56 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.328 -0.857 . . . . 0.0 110.073 179.182 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.05 -164.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 48.8 23.81 0.73 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 110.274 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 2.6 tt -106.65 142.14 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.164 -0.96 . . . . 0.0 110.341 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.592 ' HA ' HD11 ' A' ' 64' ' ' LEU . 4.4 p -80.91 179.87 7.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.387 -0.821 . . . . 0.0 110.197 -179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.604 HD22 HD11 ' A' ' 46' ' ' LEU . 9.3 p-10 -71.92 -50.02 32.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' ASN . 48.4 t -40.91 -48.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.453 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.0 -36.73 82.82 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.324 -0.86 . . . . 0.0 108.868 177.51 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.042 HD11 HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -67.78 -54.56 18.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.441 178.162 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.629 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 4.5 p -44.84 -44.89 9.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 32' ' ' VAL . 4.1 mtpp -73.82 -36.11 64.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.697 -178.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.12 -42.96 99.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 34' ' ' LEU . 9.1 m -92.1 20.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.977 179.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 48.98 23.66 3.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.898 HD12 HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -110.51 133.91 52.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.009 . . . . 0.0 110.82 -179.094 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -50.38 152.07 3.41 Favored Pre-proline 0 C--N 1.3 -1.554 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.971 176.177 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.087 ' O ' HD12 ' A' ' 46' ' ' LEU . 44.4 Cg_endo -70.51 -47.26 0.73 Allowed 'Trans proline' 0 C--N 1.283 -2.89 0 O-C-N 123.703 1.37 . . . . 0.0 110.573 -177.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.27 -54.66 5.82 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.048 -1.033 . . . . 0.0 109.125 178.336 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.649 ' HG2' HD22 ' A' ' 40' ' ' LEU . 42.3 Cg_endo -74.37 -48.39 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.95 1.5 . . . . 0.0 110.592 177.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' HA ' HD13 ' A' ' 40' ' ' LEU . 37.0 t -40.34 -42.05 1.48 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 108.742 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.087 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mt -67.87 -47.06 69.95 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.9 mm-40 -49.73 -46.14 49.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.139 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.26 -46.04 74.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.3 178.26 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.947 HG23 HG21 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -59.48 -46.89 92.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.469 -0.769 . . . . 0.0 109.786 178.591 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.605 ' N ' HG12 ' A' ' 49' ' ' VAL . 9.5 mmm180 -48.02 -50.61 27.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.4 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -48.83 -40.36 29.01 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.606 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 20' ' ' LEU . 70.9 mt -74.02 -30.46 62.45 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.446 -0.783 . . . . 0.0 109.623 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' N ' HG13 ' A' ' 58' ' ' ILE . 5.8 tp10 -74.49 -62.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.479 -0.763 . . . . 0.0 110.298 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -46.92 -26.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' NE2' ' HG3' ' A' ' 8' ' ' PRO . 11.9 mm100 -82.77 7.55 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 7' ' ' ARG . . . 73.68 40.03 47.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.869 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -128.83 10.3 5.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.184 -1.186 . . . . 0.0 110.277 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 57' ' ' PHE . 7.5 mm -140.93 35.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.02 -5.33 59.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.418 -0.801 . . . . 0.0 109.843 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -133.94 -41.23 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.647 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 16.8 m-30 -57.48 -114.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 0.0 109.933 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.689 HG21 HG21 ' A' ' 49' ' ' VAL . 3.7 t -85.76 24.44 1.25 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.896 -1.128 . . . . 0.0 109.975 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -37.4 -33.62 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -51.87 -27.1 11.63 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.73 0.776 . . . . 0.0 109.856 178.593 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.751 HD22 HG13 ' A' ' 49' ' ' VAL . 1.2 pp -41.94 -24.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.66 -0.65 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.582 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 43.6 p30 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.296 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 3' ' ' ASP . 5.7 t -112.52 49.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER 41.87 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.308 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 5' ' ' LYS . 33.5 p -70.73 -126.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 110.125 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' N ' ' OG ' ' A' ' 4' ' ' SER . 12.2 mtmt 52.94 60.4 3.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 110.272 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 5.3 mmtt -68.58 -96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.391 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.608 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 61.36 -173.22 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 109.231 -179.358 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.3 Cg_endo -67.06 60.45 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.417 1.22 . . . . 0.0 109.797 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -50.95 -174.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 12' ' ' LEU . 41.7 tttt 53.28 -130.62 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -1.194 . . . . 0.0 109.856 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' LYS . 3.4 p-10 -43.57 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.138 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -151.07 129.17 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 -179.637 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' CG ' ' A' ' 16' ' ' ASP . 6.4 m-20 -43.13 132.08 4.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.101 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 22.2 mmt-85 -53.0 -34.92 58.49 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 110.357 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.878 HD12 HD22 ' A' ' 40' ' ' LEU . 13.6 mm -75.8 -24.39 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' HD22 ' A' ' 12' ' ' LEU . 18.0 m-20 -80.6 -55.64 4.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.129 -0.982 . . . . 0.0 110.292 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -57.08 -43.87 82.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 2.7 m120 -66.32 -41.52 89.53 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.376 -0.827 . . . . 0.0 109.206 178.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 49' ' ' VAL . 6.8 mt -65.06 -34.76 72.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 178.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.872 HD11 HD22 ' A' ' 52' ' ' LEU . 25.8 mt -70.8 -39.2 73.26 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.378 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.598 ' ND2' ' O ' ' A' ' 17' ' ' ARG . 1.5 m-80 -68.91 -30.86 69.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.488 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 66.2 mm-40 -78.34 -32.34 49.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.431 -0.793 . . . . 0.0 109.763 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 HD11 ' A' ' 34' ' ' LEU . 2.5 mm? -73.37 -32.23 64.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 178.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 19.1 tp60 -74.13 -33.93 63.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.919 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 12.9 pttt -77.58 -34.27 53.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -128.07 76.56 1.7 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.111 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.07 59.59 0.15 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.41 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.299 179.85 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.5 tt -105.74 141.81 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.62 154.97 19.89 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.363 -0.836 . . . . 0.0 110.435 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.98 ' ND2' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -44.55 -55.3 5.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 0.0 110.369 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' ASN . 86.6 t -38.61 -58.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.175 -0.953 . . . . 0.0 109.552 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -65.12 -39.03 92.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.212 -0.93 . . . . 0.0 108.576 177.088 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.67 -15.07 50.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 178.39 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.562 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 12.7 p -88.0 -50.44 6.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.403 -0.811 . . . . 0.0 111.412 -178.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 13.2 mttt -81.89 -24.1 35.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 111.614 -177.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.596 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -73.66 -15.41 61.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.906 -1.121 . . . . 0.0 110.351 -179.191 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.879 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -104.61 -16.91 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.333 -0.854 . . . . 0.0 109.895 178.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.32 38.8 3.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.879 HD21 ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.67 170.3 20.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.276 . . . . 0.0 110.736 179.262 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.7 m -75.6 160.68 78.75 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.01 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.5 Cg_endo -73.8 -54.51 0.1 Allowed 'Trans proline' 0 C--N 1.287 -2.7 0 O-C-N 123.998 1.525 . . . . 0.0 110.845 -178.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -38.06 -51.64 3.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.752 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 43' ' ' THR . 48.8 Cg_endo -76.12 -43.22 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.756 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 41.8 t -41.6 -43.72 2.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.075 -1.016 . . . . 0.0 108.469 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.01 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.63 -51.3 60.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 2.5 mt-10 -43.24 -38.46 2.57 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.142 -0.973 . . . . 0.0 108.594 177.411 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.631 ' HG3' HG21 ' A' ' 15' ' ' ILE . 3.5 mmt85 -71.69 -54.52 10.04 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.031 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -60.41 -49.7 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 109.758 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.897 ' CD ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -41.73 -51.41 4.13 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -51.19 -44.11 61.5 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.679 -0.808 . . . . 0.0 108.836 177.928 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 20' ' ' LEU . 86.8 mt -66.64 -17.5 64.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.44 -0.787 . . . . 0.0 109.868 178.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.874 ' HG3' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -74.36 -64.7 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.246 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -46.95 -26.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.9 . . . . 0.0 110.4 -179.869 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.551 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mm-40 -82.73 7.68 14.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.02 91.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.987 ' O ' HD13 ' A' ' 58' ' ' ILE . 19.3 m-85 -128.43 10.57 6.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.987 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.7 mm -140.88 48.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.331 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.596 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 2.2 pp0? -79.58 -15.92 56.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.024 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -134.46 -45.67 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.667 ' CA ' HD12 ' A' ' 23' ' ' LEU . 25.7 m-85 -51.16 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -1.005 . . . . 0.0 110.112 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.892 HG21 HG21 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -85.3 13.73 6.16 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 109.889 179.773 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.843 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -42.07 -27.26 0.12 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -54.84 -32.73 60.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.465 -0.772 . . . . 0.0 110.25 179.642 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.119 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -59.73 -8.16 1.94 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.536 -0.728 . . . . 0.0 110.587 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 1.119 ' N ' HD13 ' A' ' 65' ' ' LEU . 44.3 t-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.254 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtp . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.236 0.541 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.07 -163.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.32 -11.25 7.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.84 134.83 57.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.278 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HD3' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -95.48 6.61 48.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.258 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 6.3 mtpt 60.72 -121.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.147 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.629 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tpp180 59.14 -171.27 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.886 -1.134 . . . . 0.0 109.02 -179.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.732 ' HB2' HD23 ' A' ' 12' ' ' LEU . 37.6 Cg_endo -67.66 57.77 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.338 1.178 . . . . 0.0 109.885 179.206 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -47.48 -64.2 2.99 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -42.2 146.78 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -1.164 . . . . 0.0 110.188 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 12' ' ' LEU . 64.8 m-20 45.11 -127.49 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.92 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.732 HD23 ' HB2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 67.08 134.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 0.0 110.393 179.617 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.82 136.79 57.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.166 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -54.86 -29.77 56.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.926 HD12 HD22 ' A' ' 40' ' ' LEU . 22.2 mm -67.22 -24.09 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.785 ' HB3' HD11 ' A' ' 52' ' ' LEU . 69.3 m-20 -83.07 -53.63 5.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 110.259 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -53.15 -50.19 65.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.33 -40.06 96.25 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 109.269 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.881 HG21 HG23 ' A' ' 49' ' ' VAL . 7.3 mt -64.52 -34.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.402 -0.811 . . . . 0.0 109.323 178.4 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.862 ' HG ' HD13 ' A' ' 52' ' ' LEU . 9.3 mt -68.91 -42.35 76.94 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 178.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 m-80 -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.471 ' OE1' HG12 ' A' ' 38' ' ' VAL . 11.3 mt-10 -72.57 -31.8 65.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.401 -0.812 . . . . 0.0 109.599 178.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.031 HD21 HD11 ' A' ' 34' ' ' LEU . 2.4 mm? -68.34 -31.68 71.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 178.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.482 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.92 -43.5 24.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.525 -0.734 . . . . 0.0 109.888 179.076 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -72.22 -49.21 36.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.968 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 27' ' ' GLY . 6.1 m-20 -121.98 71.04 0.98 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.244 -0.91 . . . . 0.0 110.071 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 28' ' ' ARG . . . -58.77 -151.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER 27.93 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.64 -0.918 . . . . 0.0 110.953 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 27' ' ' GLY . 8.8 tt -114.59 128.15 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -75.9 155.75 34.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.867 . . . . 0.0 110.281 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' SER . 7.4 p30 -46.24 -44.45 16.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 31' ' ' ASN . 58.8 t -40.37 -72.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 109.825 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -57.67 -25.01 59.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.865 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.031 HD11 HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.584 -0.697 . . . . 0.0 109.913 179.003 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 31' ' ' ASN . 23.4 p -88.17 -44.14 11.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.541 -0.724 . . . . 0.0 110.967 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -42.1 22.33 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 111.425 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -61.26 -15.81 38.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.512 -178.713 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.79 HG23 ' HG ' ' A' ' 40' ' ' LEU . 15.1 m -100.41 -23.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 121.266 -0.896 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.99 32.25 4.76 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.926 HD22 HD12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -148.06 168.99 20.94 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.008 -1.289 . . . . 0.0 110.647 179.005 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -72.75 158.41 87.32 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 108.977 177.34 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.055 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.1 Cg_endo -73.93 -46.59 0.31 Allowed 'Trans proline' 0 C--N 1.287 -2.703 0 O-C-N 123.928 1.488 . . . . 0.0 110.744 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.3 -54.81 4.51 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 109.548 179.254 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.1 Cg_endo -77.25 -40.02 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.887 1.467 . . . . 0.0 110.267 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.0 t -38.71 -45.78 1.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.025 . . . . 0.0 108.809 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.055 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -65.3 -50.36 65.97 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 6.1 mm-40 -42.86 -39.29 2.47 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.592 177.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' HG13 ' A' ' 15' ' ' ILE . 1.4 mmt85 -69.47 -55.6 9.79 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.663 0.745 . . . . 0.0 109.071 177.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -55.57 -43.04 71.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.32 -0.862 . . . . 0.0 109.479 178.292 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 10.1 mmt85 -45.86 -56.22 5.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.331 -0.856 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -46.74 -40.36 13.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 177.952 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.862 HD13 ' HG ' ' A' ' 20' ' ' LEU . 21.4 mt -77.4 -19.14 56.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.404 -0.81 . . . . 0.0 109.889 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.572 ' HG3' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.31 -59.32 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 0.0 110.384 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -57.52 -21.13 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 68.8 mm-40 -79.3 7.63 7.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 64.43 49.74 63.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.924 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.7 m-85 -139.07 17.77 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.279 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.965 ' CG2' HG22 ' A' ' 62' ' ' THR . 7.8 mm -142.75 23.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.412 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -74.68 -3.22 30.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.892 179.171 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -137.44 -43.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.641 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 64.3 m-85 -55.61 -108.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 0.0 109.893 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . 1.023 ' O ' HD12 ' A' ' 65' ' ' LEU . 3.0 t -85.98 23.26 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.913 -1.117 . . . . 0.0 109.662 178.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -37.94 -30.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.518 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 62' ' ' THR . 1.0 OUTLIER -51.51 -32.98 29.68 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.605 178.515 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.023 HD12 ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -59.09 151.07 23.3 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.67 -0.644 . . . . 0.0 110.341 179.549 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.81 ' CB ' HD22 ' A' ' 65' ' ' LEU . 21.0 t-20 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.214 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.236 0.541 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 2' ' ' VAL . 8.4 p -80.97 133.81 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.249 -0.907 . . . . 0.0 110.269 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 38.7 p-10 -84.75 47.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.333 -0.855 . . . . 0.0 110.265 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -70.62 177.77 3.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 4.3 mtpm? -58.3 144.75 40.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.94 . . . . 0.0 110.321 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' ARG . 3.9 mtmt -113.02 -17.12 12.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.317 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.709 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 39.59 -156.43 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.879 . . . . 0.0 109.113 179.577 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.784 ' HD2' HD11 ' A' ' 12' ' ' LEU . 43.2 Cg_endo -76.15 5.87 4.26 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.063 1.033 . . . . 0.0 109.914 179.188 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.649 ' CA ' HD12 ' A' ' 12' ' ' LEU . . . 41.7 -146.07 0.61 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 43.09 -133.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 0.0 110.231 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.511 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 1.2 m-20 -64.76 103.64 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.972 . . . . 0.0 110.407 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.784 HD11 ' HD2' ' A' ' 8' ' ' PRO . 1.4 mt -143.95 96.22 2.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -47.41 141.89 4.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -51.74 -24.45 5.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.298 -0.876 . . . . 0.0 110.306 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.866 HG23 HD22 ' A' ' 40' ' ' LEU . 10.5 mm -75.37 -34.28 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 110.237 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.727 ' HB3' HD11 ' A' ' 52' ' ' LEU . 72.5 m-20 -74.99 -38.25 61.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 110.266 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' HG3' HD22 ' A' ' 12' ' ' LEU . 15.5 mtt180 -67.39 -59.73 3.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.294 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.3 -31.75 65.97 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.357 -0.839 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.935 HG21 HG23 ' A' ' 49' ' ' VAL . 8.3 mt -69.49 -39.87 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 58' ' ' ILE . 26.1 mt -69.88 -37.37 76.02 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.488 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 35.8 t-20 -67.69 -29.06 68.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 178.403 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 4.6 mm-40 -73.36 -38.02 65.85 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.433 -0.792 . . . . 0.0 109.678 178.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.888 HD13 ' HB3' ' A' ' 61' ' ' TYR . 63.7 mt -68.48 -32.91 73.23 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.229 -0.92 . . . . 0.0 109.256 178.639 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 3.7 tt0 -70.69 -39.34 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.113 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -82.02 -26.9 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 0.0 109.635 178.688 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.571 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -142.0 63.83 1.41 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.47 -0.768 . . . . 0.0 109.932 178.883 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -49.43 -26.5 7.17 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 7.7 mpt_? -92.71 81.1 4.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -1.173 . . . . 0.0 110.493 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 10.0 tt -159.09 138.86 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.341 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.635 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -86.8 162.0 18.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.973 179.768 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -53.45 -30.75 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 110.449 -179.582 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.73 -66.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 109.156 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.2 tp10 -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.27 -0.894 . . . . 0.0 108.671 177.36 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.6 -14.58 62.12 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 178.286 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 23.5 p -87.04 -43.44 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.499 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -84.78 -17.28 38.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 12.8 mtt-85 -77.75 -16.63 58.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.018 -1.051 . . . . 0.0 110.67 -179.411 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.906 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -109.5 -7.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.482 -0.761 . . . . 0.0 110.01 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.97 42.88 5.21 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.906 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.64 167.6 28.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.046 -1.267 . . . . 0.0 110.685 179.034 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -73.54 160.76 81.52 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.97 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 1.037 ' O ' HD12 ' A' ' 46' ' ' LEU . 52.3 Cg_endo -75.56 -49.64 0.13 Allowed 'Trans proline' 0 C--N 1.286 -2.738 0 O-C-N 123.932 1.491 . . . . 0.0 110.725 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -39.47 -51.55 4.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.795 179.405 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.3 Cg_endo -76.53 -43.12 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.915 1.481 . . . . 0.0 109.727 178.223 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.738 ' HB2' HD12 ' A' ' 40' ' ' LEU . 51.9 t -41.67 -42.36 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.037 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -67.72 -48.66 65.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.588 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 44' ' ' PRO . 66.6 mm-40 -48.05 -39.4 19.91 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.837 177.236 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 1.3 mmt180 -70.02 -51.84 28.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.13 178.049 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.935 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -59.67 -50.62 79.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.42 -0.8 . . . . 0.0 109.63 178.587 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.675 ' N ' HG12 ' A' ' 49' ' ' VAL . 3.9 mmm180 -45.89 -42.15 12.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -57.31 -38.11 73.5 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.408 -0.807 . . . . 0.0 108.977 178.277 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 16' ' ' ASP . 79.8 mt -74.77 -17.89 60.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.912 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -69.2 -53.82 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.133 -0.979 . . . . 0.0 109.739 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -75.03 -29.1 60.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 110.031 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 4.8 pt20 -140.92 56.06 1.57 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.893 . . . . 0.0 110.421 179.783 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -166.57 -137.6 2.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 1.074 ' O ' HD13 ' A' ' 58' ' ' ILE . 56.2 m-85 -139.78 83.08 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -1.12 . . . . 0.0 110.284 -179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.074 HD13 ' O ' ' A' ' 57' ' ' PHE . 4.6 mm -134.97 17.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.193 -0.942 . . . . 0.0 110.531 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -3.12 30.11 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 178.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -144.23 -41.79 0.05 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.888 ' HB3' HD13 ' A' ' 23' ' ' LEU . 15.8 m-30 -52.84 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -1.11 . . . . 0.0 110.047 179.337 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.803 HG22 ' CG2' ' A' ' 58' ' ' ILE . 3.9 t -89.56 26.93 1.59 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.049 -1.032 . . . . 0.0 109.826 179.169 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -39.01 -29.96 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.485 -0.76 . . . . 0.0 109.269 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.635 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -55.29 -25.15 32.39 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.678 0.751 . . . . 0.0 109.838 178.616 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -43.43 -22.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.718 -0.614 . . . . 0.0 110.569 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.594 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.255 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.618 0.723 . . . . 1.8300000000000001 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 9.6 mmt180 -46.52 -32.02 3.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.93 -0.708 . . . . 2.8300000000000001 110.631 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.743 HG23 HD22 ' A' ' 40' ' ' LEU . 6.6 mm -70.12 -37.24 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.46999999999999997 111.63 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.707 ' CA ' HD11 ' A' ' 52' ' ' LEU . 73.3 m-20 -74.67 -54.37 7.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.916 -1.115 . . . . 1.25 111.417 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 1.3 ptm180 -57.08 -46.68 82.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 2.3999999999999999 111.204 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.574 ' HB3' HG12 ' A' ' 38' ' ' VAL . 2.5 m-20 -65.75 -32.79 74.53 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.124 -1.03 . . . . 1.99 108.689 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.908 HG21 HG23 ' A' ' 49' ' ' VAL . 9.1 mt -69.38 -38.04 76.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.41999999999999998 108.548 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.06 HD11 HD22 ' A' ' 52' ' ' LEU . 41.4 mt -67.5 -39.02 85.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.332 -0.988 . . . . 0.90000000000000002 108.332 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -65.31 -30.97 71.88 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.983 -0.747 . . . . 1.8400000000000001 108.983 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.775 ' OE1' HG13 ' A' ' 38' ' ' VAL . 7.3 mt-10 -79.45 -32.87 42.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.543 -0.723 . . . . 2.0699999999999998 109.419 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.053 HD21 HD11 ' A' ' 34' ' ' LEU . 2.5 mm? -69.21 -41.61 76.84 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.365 -0.934 . . . . 1.3700000000000001 108.666 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.488 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 2.2 tp60 -64.67 -38.35 90.71 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 2.0699999999999998 108.909 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -78.08 -20.73 51.71 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.319 -0.993 . . . . 2.1400000000000001 108.319 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.2 m-20 -141.69 91.02 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.478 -0.889 . . . . 1.52 109.506 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.54 14.11 37.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.351 -1.099 . . . . 1.5600000000000001 110.351 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 28.19 5.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.293 . . . . 3.6400000000000001 110.015 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 26' ' ' ASP . 12.2 tt -105.64 137.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.64000000000000001 110.294 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.462 ' O ' HD12 ' A' ' 34' ' ' LEU . 7.8 t -77.91 -123.45 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.826 -0.749 . . . . 1.76 110.128 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.684 HD22 HD21 ' A' ' 46' ' ' LEU . 14.2 p30 -122.44 -44.48 2.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.056 -1.028 . . . . 2.2799999999999998 110.086 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 74.1 t -45.51 -55.45 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.902 -1.124 . . . . 0.51000000000000001 108.428 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -64.32 -47.11 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.073 -1.454 . . . . 1.77 107.073 177.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.053 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.3 -19.17 3.01 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.568 0.699 . . . . 0.90000000000000002 109.839 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.55 ' HA ' ' HG ' ' A' ' 45' ' ' CYS . 3.7 p -87.45 -31.13 20.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.47999999999999998 110.586 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -87.19 -31.62 20.25 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.272 -0.893 . . . . 2.1899999999999999 112.586 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 13.3 mtp180 -68.85 -17.81 64.05 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.507 -1.371 . . . . 2.3799999999999999 110.759 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.848 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.8 m -104.94 -11.33 9.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 C-N-CA 119.626 -0.83 . . . . 0.91000000000000003 110.047 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.2 40.11 6.65 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.351 -0.928 . . . . 0.46999999999999997 111.362 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.848 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -146.09 171.79 14.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.779 -1.424 . . . . 1.4299999999999999 110.654 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 38.4 m -76.39 158.94 80.85 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.392 -1.336 . . . . 0.94999999999999996 107.392 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.103 ' O ' HD12 ' A' ' 46' ' ' LEU . 55.9 Cg_endo -77.13 -44.61 0.19 Allowed 'Trans proline' 0 C--N 1.282 -2.96 0 O-C-N 124.189 1.626 . . . . 0.28000000000000003 111.27 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.34 -52.56 5.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.67000000000000004 109.099 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.0 Cg_endo -79.76 -38.03 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.32000000000000001 110.107 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' HD12 ' A' ' 40' ' ' LEU . 42.1 t -42.93 -46.75 5.51 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.749 -1.204 . . . . 0.47999999999999998 107.749 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.103 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -62.02 -51.7 66.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.328 -1.36 . . . . 0.38 107.328 177.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -44.75 -37.39 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.099 -1.04 . . . . 2.0299999999999998 108.212 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.581 ' HG3' HG21 ' A' ' 15' ' ' ILE . 2.6 mmt180 -73.64 -46.17 48.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.951 0.881 . . . . 1.8300000000000001 108.717 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.908 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -65.86 -38.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.411 -0.806 . . . . 0.46999999999999997 109.94 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.545 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 0.9 OUTLIER -56.74 -45.48 81.96 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.389 -0.967 . . . . 2.0800000000000001 108.389 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -39.45 64.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.138 -1.43 . . . . 2.4100000000000001 107.138 177.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 20' ' ' LEU . 59.3 mt -73.06 -19.97 61.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.584 0.707 . . . . 0.57999999999999996 109.31 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.33 -51.44 13.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 1.8500000000000001 109.869 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -52.96 -30.15 33.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.527 -0.733 . . . . 3.6200000000000001 110.364 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 13.0 mm-40 -84.33 11.05 9.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 2.5800000000000001 109.843 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.26 48.57 73.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.13 -1.188 . . . . 1.6499999999999999 110.13 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 1.041 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.8 m-85 -129.15 7.8 5.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.059 -1.259 . . . . 2.6400000000000001 110.214 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.041 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.5 mm . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.64000000000000001 109.448 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.436 ' HB2' ' NH2' ' A' ' 51' ' ' ARG . 3.7 t70 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.353 0.597 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 7.1 tpp85 -44.68 -33.89 2.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.854 HG23 HD22 ' A' ' 40' ' ' LEU . 9.3 mm -73.67 -20.91 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.697 ' CB ' HD11 ' A' ' 52' ' ' LEU . 2.9 m-20 -85.17 -59.53 2.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 0.0 110.142 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.501 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -53.99 -40.21 66.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.536 ' HB3' HG12 ' A' ' 38' ' ' VAL . 10.1 m120 -69.56 -41.37 75.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.945 HG21 ' CG2' ' A' ' 49' ' ' VAL . 18.6 mt -67.87 -33.75 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.28 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.764 HD11 HD22 ' A' ' 52' ' ' LEU . 14.3 mt -68.78 -36.47 78.34 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -66.2 -37.62 86.01 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.685 ' CD ' HG13 ' A' ' 38' ' ' VAL . 98.9 mt-10 -68.78 -39.24 80.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.707 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 23' ' ' LEU . 43.7 mt -64.38 -24.93 67.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.351 -0.843 . . . . 0.0 109.592 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -75.97 -39.13 56.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -84.01 -24.56 30.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 1.5 m-20 -133.85 90.57 2.72 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.04 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 9.8 51.88 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -123.07 39.36 3.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -1.131 . . . . 0.0 110.294 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.491 HG13 ' HB3' ' A' ' 33' ' ' GLU . 7.5 tt -117.86 139.8 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.379 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 31' ' ' ASN . 9.1 t -86.96 -108.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.347 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' SER . 1.8 p-10 -128.58 -45.72 1.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.27 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.434 HG23 ' ND2' ' A' ' 31' ' ' ASN . 93.8 t -46.03 -61.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.954 -1.091 . . . . 0.0 109.119 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HB3' HG13 ' A' ' 29' ' ' ILE . 1.6 tp10 -64.05 -28.13 69.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.224 -0.923 . . . . 0.0 108.944 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.808 HD21 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -75.09 -15.3 60.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.713 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASN . 28.0 p -86.57 -44.18 12.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.567 -0.708 . . . . 0.0 110.597 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -82.0 -21.86 36.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 31.8 mtt-85 -70.74 -19.25 62.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.364 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.873 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -110.12 -9.24 11.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.15 40.56 5.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.873 HD21 ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -150.74 159.31 44.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.984 -1.304 . . . . 0.0 110.526 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.528 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.0 OUTLIER -67.0 156.32 88.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 108.858 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.119 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.6 Cg_endo -72.01 -49.59 0.3 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 124.022 1.538 . . . . 0.0 110.496 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -35.98 -55.39 1.3 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.1 Cg_endo -75.83 -41.85 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.962 1.507 . . . . 0.0 110.007 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 35.9 t -39.9 -52.6 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.662 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.119 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -55.18 -49.03 72.92 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.51 -44.96 13.0 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.431 -0.793 . . . . 0.0 109.134 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HD3' ' HB ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.48 -51.89 31.7 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.594 0.711 . . . . 0.0 109.665 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.945 ' CG2' HG21 ' A' ' 19' ' ' ILE . 2.9 t -64.44 -59.2 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.552 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -40.5 -45.71 2.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -51.75 -46.9 64.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.852 177.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 20' ' ' LEU . 12.9 mt -62.95 -27.66 69.55 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.414 -0.804 . . . . 0.0 109.665 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.466 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -66.69 -56.82 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 47.2 mtp180 -45.96 -24.43 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.355 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.648 ' CB ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mm-40 -95.7 3.95 53.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.307 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.91 44.35 19.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.999 ' O ' HD13 ' A' ' 58' ' ' ILE . 19.0 m-30 -116.65 0.93 12.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -1.231 . . . . 0.0 110.177 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.999 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.9 mm . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 16' ' ' ASP . 4.6 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.295 0.569 . . . . 0.0 110.033 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.8 tpt180 -48.42 -20.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.37 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.885 HD12 HD22 ' A' ' 40' ' ' LEU . 7.6 mm -73.92 -45.2 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD2' ' NE ' ' A' ' 51' ' ' ARG . 47.7 m-20 -70.62 -35.74 73.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -69.22 -65.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 1.6 t-20 -52.61 -26.52 13.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 15' ' ' ILE . 3.2 mt -70.07 -47.26 69.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.604 ' CG ' HD13 ' A' ' 52' ' ' LEU . 40.7 mt -64.27 -33.15 75.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.117 -0.989 . . . . 0.0 109.19 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -70.43 -28.45 65.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.359 -0.838 . . . . 0.0 109.408 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' OE1' ' CB ' ' A' ' 37' ' ' ARG . 3.6 mm-40 -78.55 -35.46 46.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.469 -0.769 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.093 HD21 HD11 ' A' ' 34' ' ' LEU . 2.9 mm? -68.67 -35.84 77.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -74.75 -36.82 62.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.778 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -76.82 -36.59 56.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.82 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -122.22 76.5 1.31 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.164 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' A' ' 28' ' ' ARG . . . -67.8 58.14 0.35 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -173.77 36.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 0.0 110.007 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -123.51 153.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.466 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.805 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -100.06 -94.03 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 3.3 p30 -138.76 -46.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.483 ' N ' ' CG ' ' A' ' 31' ' ' ASN . 31.0 t -44.99 -64.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.992 -1.067 . . . . 0.0 109.412 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 5.7 tp10 -62.01 -27.39 68.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 108.816 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.093 HD11 HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -73.71 -16.04 61.21 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.524 -0.735 . . . . 0.0 109.401 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -88.98 -36.49 15.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.721 -0.612 . . . . 0.0 110.679 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.9 -50.25 8.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.246 -0.909 . . . . 0.0 111.188 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.539 ' CB ' ' OE1' ' A' ' 22' ' ' GLU . 7.3 mtp85 -54.84 -17.06 3.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.126 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.812 ' HB ' HD21 ' A' ' 40' ' ' LEU . 15.7 m -100.42 -21.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.26 39.04 4.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.885 HD22 HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.905 -1.35 . . . . 0.0 110.744 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -68.65 155.08 93.75 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.868 177.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.083 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.8 Cg_endo -74.06 -45.65 0.35 Allowed 'Trans proline' 0 C--N 1.286 -2.713 0 O-C-N 123.992 1.522 . . . . 0.0 110.737 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.96 -55.61 3.69 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.9 Cg_endo -75.64 -39.74 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.915 1.482 . . . . 0.0 110.026 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 51.6 t -39.43 -47.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 108.731 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.083 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.19 -49.97 72.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 14.5 mt-10 -46.97 -37.91 9.82 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.219 -0.925 . . . . 0.0 108.817 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -70.77 -58.0 4.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.464 -0.772 . . . . 0.0 109.101 177.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.657 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -54.03 -50.45 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.23 -0.919 . . . . 0.0 109.17 177.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 18.1 mmt180 -41.76 -53.81 3.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.384 -0.822 . . . . 0.0 109.533 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NE ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -46.61 -44.15 17.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.735 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' ' 58' ' ' ILE . 66.4 mt -69.95 -26.02 63.92 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -71.13 -66.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 110.134 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -56.34 -24.51 44.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.194 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.604 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.8 mm100 -79.45 5.13 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 68.4 48.69 49.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.605 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.0 m-85 -134.06 8.54 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 52' ' ' LEU . 17.0 mm . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.402 0.62 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 15.2 mmt180 -53.15 -39.3 63.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 110.496 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.768 HG23 HD22 ' A' ' 40' ' ' LEU . 4.4 mm -72.8 -21.17 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.735 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.782 ' HB3' HD21 ' A' ' 52' ' ' LEU . 96.2 m-20 -86.33 -56.62 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.639 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 8.3 ptt85 -57.18 -42.55 81.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 110.271 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -68.3 -41.87 80.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.409 -0.807 . . . . 0.0 109.384 178.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.924 HG21 ' CG2' ' A' ' 49' ' ' VAL . 6.1 mt -65.72 -30.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.23 -0.918 . . . . 0.0 109.357 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.532 HD11 HD22 ' A' ' 52' ' ' LEU . 14.3 mt -74.01 -44.62 53.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -64.78 -28.16 69.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.588 ' OE1' HG13 ' A' ' 38' ' ' VAL . 8.9 mt-10 -76.46 -38.94 54.61 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.368 -0.832 . . . . 0.0 109.943 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 34' ' ' LEU . 14.7 mt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.46 -43.93 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -25.61 56.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.517 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -137.69 87.94 2.29 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.911 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.55 7.69 46.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.602 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -114.67 28.21 8.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 26' ' ' ASP . 6.9 tt -108.9 137.33 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.4 p -94.72 157.68 15.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 110.222 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -42.26 -49.19 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.456 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 31' ' ' ASN . 78.7 t -44.05 -65.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.958 -1.089 . . . . 0.0 109.402 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -61.89 -28.7 69.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.22 -0.925 . . . . 0.0 108.782 177.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -72.69 -14.63 61.62 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 178.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 25.1 p -86.74 -43.34 12.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.461 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -16.53 46.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.254 -0.904 . . . . 0.0 111.221 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -81.29 -15.54 55.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.977 -1.077 . . . . 0.0 110.773 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.882 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -108.35 -8.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.223 -0.923 . . . . 0.0 109.874 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 40.63 4.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.882 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -151.77 165.63 33.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -1.23 . . . . 0.0 110.549 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.25 157.07 85.33 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.786 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.111 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.5 Cg_endo -72.25 -44.8 0.74 Allowed 'Trans proline' 0 C--N 1.286 -2.729 0 O-C-N 124.005 1.529 . . . . 0.0 110.539 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.06 -55.87 4.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.363 178.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -75.35 -42.2 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.901 1.474 . . . . 0.0 110.202 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.701 ' HB2' HD12 ' A' ' 40' ' ' LEU . 42.5 t -40.14 -51.02 2.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 108.708 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.111 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -58.26 -46.4 86.07 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -48.47 -42.59 33.15 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.318 -0.864 . . . . 0.0 108.959 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.21 -55.32 10.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.695 0.76 . . . . 0.0 109.555 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.924 ' CG2' HG21 ' A' ' 19' ' ' ILE . 1.6 t -59.06 -55.51 23.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.976 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.563 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -39.8 -50.02 2.37 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.405 -0.81 . . . . 0.0 109.645 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.03 -47.2 33.72 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.697 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.795 ' HB3' HD11 ' A' ' 58' ' ' ILE . 97.0 mt -59.61 -26.26 65.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -68.22 -57.58 5.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 110.248 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -46.58 -36.63 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 7.8 mm-40 -81.82 8.38 10.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.28 60.11 7.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 1.013 ' O ' HD13 ' A' ' 58' ' ' ILE . 14.8 m-85 -135.38 12.54 3.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 110.312 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.013 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.2 mm . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 110.24 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 7.7 t70 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.333 0.587 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -45.5 -30.17 1.35 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.913 HG21 ' HD3' ' A' ' 48' ' ' ARG . 17.9 mm -73.54 -18.76 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.685 ' CA ' HD11 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -84.27 -48.61 9.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.179 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -61.07 -47.82 84.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 33.9 p-10 -66.18 -37.64 86.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.016 -1.052 . . . . 0.0 109.283 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.973 HG21 HG23 ' A' ' 49' ' ' VAL . 5.8 mt -64.38 -29.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.234 -0.916 . . . . 0.0 109.23 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.081 HD11 HD22 ' A' ' 52' ' ' LEU . 40.7 mt -72.23 -46.77 54.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.662 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 7.3 t30 -61.41 -29.15 69.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.382 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 3.4 mm-40 -74.87 -36.93 62.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.433 -0.792 . . . . 0.0 109.705 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 34' ' ' LEU . 2.9 mm? -66.17 -37.77 86.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.338 -0.851 . . . . 0.0 109.669 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.83 -35.92 67.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.784 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -81.45 -24.49 36.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.882 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ARG . 1.4 m-20 -125.06 69.72 1.14 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.58 61.74 0.11 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.69 32.02 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.367 -1.078 . . . . 0.0 109.83 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.528 HG13 ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -124.71 151.6 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.812 ' O ' HD12 ' A' ' 34' ' ' LEU . 35.7 m -102.9 -92.96 0.33 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.214 -0.929 . . . . 0.0 110.333 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.861 HD22 HD11 ' A' ' 46' ' ' LEU . 16.2 p-10 -139.37 -47.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -0.938 . . . . 0.0 110.26 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' ASN . 78.8 t -45.91 -65.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.961 -1.087 . . . . 0.0 109.129 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 29' ' ' ILE . 11.9 tp10 -61.27 -27.71 68.66 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.94 . . . . 0.0 108.756 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.929 HD11 HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.518 -0.739 . . . . 0.0 109.543 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.567 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 24.6 p -88.25 -39.87 14.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -82.58 -27.28 31.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.923 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 8.1 mtt180 -69.17 -17.37 63.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.12 -0.988 . . . . 0.0 110.379 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.846 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -110.05 -6.02 11.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.49 -0.756 . . . . 0.0 109.913 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.65 44.96 5.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.846 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -156.19 167.77 29.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.002 -1.293 . . . . 0.0 110.84 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.54 ' C ' ' HB2' ' A' ' 35' ' ' SER . 4.6 m -72.89 154.41 90.99 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.528 -0.732 . . . . 0.0 109.149 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.067 ' O ' HD12 ' A' ' 46' ' ' LEU . 50.1 Cg_endo -73.85 -49.2 0.21 Allowed 'Trans proline' 0 C--N 1.288 -2.621 0 O-C-N 124.06 1.558 . . . . 0.0 110.733 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.575 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -36.52 -53.46 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 48.8 Cg_endo -75.85 -45.28 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.915 1.482 . . . . 0.0 109.969 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.525 ' HB2' HD12 ' A' ' 40' ' ' LEU . 18.3 t -38.68 -52.01 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 108.898 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.067 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.71 -49.88 75.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.01 -43.87 4.43 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.913 ' HD3' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.06 -42.04 63.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.546 -0.721 . . . . 0.0 109.629 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.973 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -67.37 -46.97 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.756 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.596 ' N ' HG12 ' A' ' 49' ' ' VAL . 1.3 mtm180 -47.84 -51.3 23.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.174 -0.954 . . . . 0.0 109.118 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -48.85 -45.95 41.58 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 108.853 177.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.081 HD22 HD11 ' A' ' 20' ' ' LEU . 86.5 mt -63.31 -17.69 62.81 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.785 . . . . 0.0 109.448 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -75.66 -53.2 8.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.471 -0.768 . . . . 0.0 110.215 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -55.3 -33.22 63.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -76.22 -0.96 24.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.36 40.64 23.12 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.941 ' CE2' HD13 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -119.72 -0.08 10.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.161 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.892 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.2 mm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 38.0 m-20 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.404 0.621 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' ASN . 18.3 mmt-85 -62.04 -16.9 55.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 110.318 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 40' ' ' LEU . 7.9 mm -84.87 -49.75 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 0.0 109.833 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' HA ' HD11 ' A' ' 52' ' ' LEU . 2.6 m-20 -71.67 -40.02 69.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.92 . . . . 0.0 110.145 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.5 OUTLIER -71.68 -46.16 59.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 110.027 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 52.1 t30 -67.29 -34.31 77.14 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.22 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.881 HG21 HG23 ' A' ' 49' ' ' VAL . 8.0 mt -63.68 -39.64 86.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.458 -0.777 . . . . 0.0 109.186 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.053 HD11 HD22 ' A' ' 52' ' ' LEU . 80.3 mt -68.31 -45.93 71.64 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.151 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -60.15 -37.41 80.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.183 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.69 -40.96 76.03 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 34' ' ' LEU . 2.7 mm? -64.44 -37.84 88.94 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.288 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -69.32 -44.9 70.76 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 109.508 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -74.36 -19.85 60.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.959 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -148.98 61.68 1.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 110.112 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -52.84 -28.67 32.06 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -76.8 51.7 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -1.138 . . . . 0.0 110.345 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 26' ' ' ASP . 18.9 tt -138.73 154.07 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.31 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.77 ' O ' HD12 ' A' ' 34' ' ' LEU . 42.1 t -99.93 -115.61 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.317 -0.864 . . . . 0.0 110.352 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.666 ' CB ' HD21 ' A' ' 46' ' ' LEU . 9.6 p30 -121.21 -46.4 2.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.3 t -44.58 -62.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.995 -1.066 . . . . 0.0 109.416 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.255 -0.903 . . . . 0.0 108.786 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -76.77 -15.65 59.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.55 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 16.5 p -88.08 -38.81 15.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.538 -0.726 . . . . 0.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -31.38 23.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.295 -0.878 . . . . 0.0 110.916 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -65.12 -16.63 63.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.351 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.884 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.2 m -109.65 -11.99 11.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 110.036 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.81 42.55 5.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.884 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.75 166.28 32.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.956 -1.32 . . . . 0.0 110.734 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.502 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -70.32 155.55 93.26 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 108.786 177.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.069 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.3 Cg_endo -74.29 -42.91 0.59 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 O-C-N 123.808 1.425 . . . . 0.0 110.556 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.97 -57.51 2.06 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.731 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 50.0 Cg_endo -76.47 -41.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.843 1.444 . . . . 0.0 110.205 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.721 ' HB2' HD12 ' A' ' 40' ' ' LEU . 53.8 t -39.21 -45.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 108.825 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.069 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.49 -47.99 74.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -48.06 -39.35 19.77 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.685 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' CD ' HG21 ' A' ' 15' ' ' ILE . 5.4 mmt180 -70.64 -46.86 62.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.665 0.745 . . . . 0.0 109.16 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -64.33 -45.29 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.374 -0.829 . . . . 0.0 109.847 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.577 ' N ' HG12 ' A' ' 49' ' ' VAL . 12.6 mmm-85 -47.59 -49.35 26.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.449 -0.782 . . . . 0.0 109.465 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -51.16 -43.43 61.25 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.882 178.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 20' ' ' LEU . 93.8 mt -66.61 -16.67 64.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.432 -0.793 . . . . 0.0 109.891 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -78.08 -61.19 2.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.523 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -49.87 -29.68 8.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.649 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.765 ' NE2' HD23 ' A' ' 52' ' ' LEU . 4.1 pt20 -82.51 12.23 4.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.39 52.78 44.0 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.949 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -131.42 8.41 4.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -1.151 . . . . 0.0 110.15 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.949 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.7 mm . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.323 0.582 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.471 ' HD2' ' NE ' ' A' ' 17' ' ' ARG . 17.1 mmt-85 -49.59 -20.58 0.8 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.318 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.918 HG23 HD22 ' A' ' 40' ' ' LEU . 10.2 mm -74.66 -24.33 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.436 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' CA ' HD11 ' A' ' 52' ' ' LEU . 50.2 m-20 -84.36 -56.52 3.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 110.372 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -56.75 -43.94 81.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.035 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.532 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 16.4 m120 -64.78 -41.2 96.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.011 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.871 HG21 HG23 ' A' ' 49' ' ' VAL . 3.5 mt -62.0 -39.59 84.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.444 -0.785 . . . . 0.0 109.264 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.827 HD11 HD22 ' A' ' 52' ' ' LEU . 16.0 mt -66.56 -40.91 89.25 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.66 -32.4 73.7 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.385 -0.822 . . . . 0.0 109.446 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.739 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -78.61 -31.22 46.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 109.62 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.802 ' CD2' HD11 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -73.33 -31.91 64.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.371 -0.83 . . . . 0.0 109.571 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -78.15 -36.63 47.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.395 -0.816 . . . . 0.0 109.769 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 30.0 pttt -74.67 -33.56 62.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.67 68.21 0.86 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.087 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.09 60.66 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -175.37 28.67 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.384 -1.068 . . . . 0.0 109.658 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.739 HG21 ' OE2' ' A' ' 22' ' ' GLU . 16.1 tt -116.6 146.56 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.408 -0.808 . . . . 0.0 110.218 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 t -91.66 -91.42 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 110.275 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 2.3 p-10 -143.74 -47.4 0.28 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 59.3 t -44.25 -61.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.013 -1.054 . . . . 0.0 109.177 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HB3' HG13 ' A' ' 29' ' ' ILE . 4.2 tp10 -62.81 -31.95 73.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.278 -0.888 . . . . 0.0 108.805 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.802 HD11 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -70.28 -15.25 62.87 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.603 -0.686 . . . . 0.0 109.487 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.7 p -87.76 -37.6 16.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.723 . . . . 0.0 110.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -32.36 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.9 . . . . 0.0 111.273 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -66.27 -16.99 64.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.687 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.925 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -109.46 -8.06 11.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 44.59 5.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.925 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -152.54 165.82 33.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.0 -1.294 . . . . 0.0 110.71 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.488 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.61 156.83 90.98 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 108.807 177.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.098 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.6 Cg_endo -74.5 -48.69 0.19 Allowed 'Trans proline' 0 C--N 1.287 -2.681 0 O-C-N 123.83 1.437 . . . . 0.0 110.543 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -54.13 3.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.011 . . . . 0.0 109.434 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.7 Cg_endo -75.85 -40.66 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.001 1.527 . . . . 0.0 110.135 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.692 ' HB2' HD12 ' A' ' 40' ' ' LEU . 50.3 t -40.56 -44.74 2.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.085 . . . . 0.0 108.718 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.098 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.86 -45.16 87.26 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 1.6 mm-40 -50.12 -35.48 25.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.81 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -74.49 -48.37 27.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.701 . . . . 0.0 109.288 177.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.871 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -65.74 -56.71 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 178.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.689 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -43.59 -42.95 5.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.54 -43.83 68.72 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.827 HD22 HD11 ' A' ' 20' ' ' LEU . 71.7 mt -69.29 -16.96 63.68 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.629 -0.669 . . . . 0.0 109.785 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 1.9 mt-10 -75.7 -56.29 4.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -53.82 -27.72 31.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.393 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.607 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 66.1 mm-40 -85.38 17.13 3.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.001 . . . . 0.0 110.251 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.44 56.94 21.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.614 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.6 m-85 -137.2 6.74 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.13 -1.217 . . . . 0.0 110.239 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 52' ' ' LEU . 13.5 mm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.022 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.383 0.611 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.6 -22.65 5.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.869 HG23 HD22 ' A' ' 40' ' ' LEU . 13.8 mm -71.74 -30.51 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.903 . . . . 0.0 110.5 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.817 ' C ' HD11 ' A' ' 52' ' ' LEU . 50.5 m-20 -76.02 -61.3 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 110.539 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.81 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.64 -39.99 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.493 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 6.7 t30 -67.74 -35.72 79.26 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 109.226 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.909 HG21 HG23 ' A' ' 49' ' ' VAL . 18.6 mt -63.14 -41.96 94.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.362 -0.836 . . . . 0.0 109.094 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 17' ' ' ARG . 25.8 mt -56.21 -42.15 76.74 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.129 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -59.36 -49.65 77.01 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.288 -0.882 . . . . 0.0 109.027 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -61.93 -37.68 85.58 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 178.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.941 HD21 ' CD1' ' A' ' 34' ' ' LEU . 2.3 mm? -67.36 -35.67 79.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.385 -0.822 . . . . 0.0 109.434 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -39.82 39.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.408 -0.808 . . . . 0.0 109.656 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HD3' ' OE1' ' A' ' 22' ' ' GLU . 2.4 pttt -77.55 -30.27 52.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 109.747 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.6 m-20 -140.33 61.07 1.53 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 110.317 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -56.22 -163.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.32 25.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -1.195 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 37' ' ' ARG . 10.3 tt -108.88 137.62 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' HD12 ' A' ' 34' ' ' LEU . 20.4 m -72.04 -137.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.852 . . . . 0.0 110.4 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.1 p30 -110.86 -43.12 3.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.319 -0.863 . . . . 0.0 109.907 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 32.8 t -44.8 -56.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.13 -0.981 . . . . 0.0 109.153 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.64 -34.41 78.17 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.34 -0.85 . . . . 0.0 108.887 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.941 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -70.3 -14.97 62.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.717 . . . . 0.0 109.777 178.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.548 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 8.3 p -85.64 -49.7 7.79 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 110.59 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.404 ' N ' ' OG ' ' A' ' 35' ' ' SER . 1.9 mtpp -78.68 -22.11 47.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 110.801 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 29' ' ' ILE . 15.9 mtt-85 -70.02 -17.21 63.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.093 -1.004 . . . . 0.0 110.163 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.86 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.66 -9.56 12.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.672 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.99 42.0 4.81 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.869 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -152.41 161.21 42.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.961 -1.317 . . . . 0.0 110.72 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -66.28 157.07 83.21 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 108.8 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.091 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.8 Cg_endo -73.5 -44.61 0.5 Allowed 'Trans proline' 0 C--N 1.287 -2.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.456 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.567 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.24 -56.12 2.79 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.93 . . . . 0.0 109.551 179.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.7 Cg_endo -74.96 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.99 1.521 . . . . 0.0 109.907 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' HD12 ' A' ' 40' ' ' LEU . 45.0 t -37.32 -53.01 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.091 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -54.95 -54.29 44.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -43.87 -43.53 6.4 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.386 -0.821 . . . . 0.0 109.298 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HD2' HG21 ' A' ' 15' ' ' ILE . 1.4 mmt180 -66.57 -48.67 68.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.791 . . . . 0.0 109.16 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.909 HG23 HG21 ' A' ' 19' ' ' ILE . 1.1 t -61.61 -43.48 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.411 -0.806 . . . . 0.0 109.507 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 5.8 mmm180 -45.78 -52.19 11.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.389 -0.819 . . . . 0.0 109.396 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.489 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -53.24 -40.57 64.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.065 178.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.893 ' HB3' HD11 ' A' ' 58' ' ' ILE . 16.2 mt -73.48 -31.3 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -0.764 . . . . 0.0 109.753 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -82.09 -30.15 31.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -74.0 -18.56 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.71 15.53 23.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.258 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.62 58.68 6.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.867 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -145.41 11.93 1.33 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -1.121 . . . . 0.0 110.296 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.893 HD11 ' HB3' ' A' ' 52' ' ' LEU . 8.0 mm . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.276 0.56 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 12.0 mmt85 -56.02 -24.88 41.96 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.354 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.862 HG23 HD22 ' A' ' 40' ' ' LEU . 10.6 mm -74.93 -35.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.751 ' HB3' HD21 ' A' ' 52' ' ' LEU . 6.2 m-20 -74.84 -56.6 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.574 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.718 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.6 ptt85 -55.53 -45.1 77.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.306 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.482 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 11.1 m120 -64.8 -34.12 77.61 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.095 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.648 HD12 ' O ' ' A' ' 15' ' ' ILE . 5.9 mt -64.79 -44.33 96.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.946 HD11 HD22 ' A' ' 52' ' ' LEU . 12.2 mt -63.29 -41.24 98.97 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 109.261 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -62.76 -31.2 72.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.266 -0.896 . . . . 0.0 109.258 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.697 ' OE2' HG13 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -77.49 -43.24 32.84 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.45 -0.781 . . . . 0.0 109.835 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 HD11 ' A' ' 34' ' ' LEU . 2.2 mm? -62.17 -36.31 81.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 109.38 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' OE1' ' C ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -68.71 -44.88 72.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.742 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -71.77 -37.5 70.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.925 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -135.87 92.04 2.77 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.56 -10.06 86.47 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.577 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.8 mpt_? -85.89 26.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -1.164 . . . . 0.0 110.467 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.487 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 4.0 tt -111.45 155.04 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.944 . . . . 0.0 110.329 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.652 ' O ' HD12 ' A' ' 34' ' ' LEU . 73.8 m -108.17 -94.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 110.414 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' SER . 18.7 p-10 -136.69 -50.96 0.67 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.481 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 77.7 t -43.29 -58.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.246 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.42 -27.48 68.56 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.864 . . . . 0.0 108.864 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.066 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -75.67 -15.38 60.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.565 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.8 p -88.09 -48.99 7.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 111.031 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.67 -22.37 34.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.067 -1.021 . . . . 0.0 111.184 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 7.8 mtp180 -72.59 -16.09 61.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.554 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.811 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -109.76 -9.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.311 -0.868 . . . . 0.0 110.062 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.65 41.51 4.42 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.862 HD22 HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -153.55 165.45 35.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.107 -1.231 . . . . 0.0 110.667 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.4 m -72.21 159.76 84.56 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 108.865 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.074 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.3 Cg_endo -73.39 -51.36 0.16 Allowed 'Trans proline' 0 C--N 1.285 -2.769 0 O-C-N 123.87 1.458 . . . . 0.0 110.609 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.31 -55.18 1.87 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 109.705 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.9 Cg_endo -75.83 -40.58 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.998 1.525 . . . . 0.0 110.064 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.2 t -39.45 -48.59 1.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.105 -0.997 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.074 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.3 mp -58.49 -52.41 65.77 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.82 -38.38 2.12 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.356 -0.84 . . . . 0.0 108.997 177.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' HG21 ' A' ' 15' ' ' ILE . 4.6 mmp_? -71.54 -56.31 6.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.233 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.606 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -56.01 -40.05 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 178.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 7.5 mmt85 -52.78 -48.67 66.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 109.699 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.552 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -53.15 -37.21 61.64 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.971 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.946 HD22 HD11 ' A' ' 20' ' ' LEU . 94.4 mt -67.93 -23.12 65.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.444 -0.785 . . . . 0.0 109.887 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 40.8 mt-10 -77.65 -51.23 10.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.886 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -48.48 -39.71 24.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.026 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.462 ' NE2' ' HD2' ' A' ' 51' ' ' ARG . 3.3 pt20 -86.37 27.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.85 76.25 0.14 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.898 ' CE2' HD13 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -151.29 13.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.505 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.849 HD11 ' HB3' ' A' ' 52' ' ' LEU . 15.1 mm . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.267 0.556 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 18' ' ' ASN . 9.2 mmt85 -60.97 -29.97 69.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.269 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.743 HD12 HD22 ' A' ' 40' ' ' LEU . 4.9 mm -81.38 -27.66 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.702 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.543 ' CA ' HD11 ' A' ' 52' ' ' LEU . 3.1 m-20 -84.54 -31.37 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.253 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -75.56 -46.59 31.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 110.157 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 39.4 p-10 -69.14 -32.48 71.87 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.189 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG12 HG11 ' A' ' 38' ' ' VAL . 6.3 mt -69.18 -38.31 77.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.879 HD11 ' CD2' ' A' ' 52' ' ' LEU . 22.9 mt -68.82 -40.49 79.45 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 29.9 t-20 -67.56 -26.42 66.28 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.205 -0.934 . . . . 0.0 109.267 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -87.04 -40.96 14.23 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.749 HD13 HG23 ' A' ' 58' ' ' ILE . 1.3 mt -69.18 -24.29 64.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -84.37 -37.84 21.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.451 -0.781 . . . . 0.0 109.969 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 4.0 pttt -83.09 -32.34 26.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.818 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 29' ' ' ILE . 19.4 t0 -129.56 55.49 1.76 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.34 -25.61 2.03 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -82.21 9.84 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -1.143 . . . . 0.0 110.185 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 26' ' ' ASP . 5.8 tt -74.15 154.96 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -104.4 147.06 27.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 110.15 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.829 ' OD1' HD11 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -39.98 -52.51 2.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.262 -0.899 . . . . 0.0 109.809 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 31' ' ' ASN . 18.0 t -44.79 -57.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 108.939 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 tp10 -65.29 -29.5 70.26 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 108.727 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.616 HD21 HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -72.81 -16.6 61.61 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 109.512 178.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 21.1 p -88.69 -44.99 10.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.594 -0.691 . . . . 0.0 110.604 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 6.1 mtpp -82.44 -43.97 16.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 3.7 mtt-85 -56.99 -16.65 7.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 0.0 110.23 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.784 HG23 ' CD2' ' A' ' 40' ' ' LEU . 18.7 m -101.3 -21.05 5.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.403 -0.811 . . . . 0.0 110.019 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 101.14 37.8 3.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.784 ' CD2' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -154.92 171.66 19.32 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.879 -1.365 . . . . 0.0 110.793 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.57 158.82 82.79 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 108.877 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.043 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.7 Cg_endo -73.54 -45.22 0.43 Allowed 'Trans proline' 0 C--N 1.287 -2.709 0 O-C-N 123.987 1.52 . . . . 0.0 110.646 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -42.03 -55.64 6.03 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 109.443 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.2 Cg_endo -76.02 -36.9 1.76 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.88 1.463 . . . . 0.0 110.281 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 40.9 t -43.47 -47.71 7.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.064 . . . . 0.0 108.652 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.043 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.54 -39.51 88.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -55.97 -41.99 75.6 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.709 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -70.58 -47.98 57.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.592 -0.692 . . . . 0.0 109.284 178.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.627 HG12 ' N ' ' A' ' 50' ' ' ARG . 1.2 t -58.89 -51.89 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.483 -0.761 . . . . 0.0 109.343 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -41.97 -53.7 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.455 -0.778 . . . . 0.0 109.325 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -48.05 -42.7 29.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.432 -0.792 . . . . 0.0 109.052 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.879 ' CD2' HD11 ' A' ' 20' ' ' LEU . 12.7 mt -72.13 -23.38 61.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 0.0 109.775 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -63.04 -59.92 4.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.233 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.7 -28.64 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.329 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.608 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mm-40 -74.75 0.51 15.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 66.93 51.6 38.84 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.608 ' CE2' ' HB3' ' A' ' 55' ' ' GLN . 22.0 m-85 -131.15 9.43 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -1.159 . . . . 0.0 110.28 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.776 HD11 ' HB3' ' A' ' 52' ' ' LEU . 1.2 mt . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.294 -0.879 . . . . 0.0 110.022 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.287 0.565 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.532 ' HD3' ' NH1' ' A' ' 17' ' ' ARG . 25.0 mmt-85 -54.86 -19.18 5.97 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.828 HG23 HD22 ' A' ' 40' ' ' LEU . 3.0 mm -83.86 -49.82 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.78 ' HB3' HD21 ' A' ' 52' ' ' LEU . 7.0 m-20 -66.65 -33.41 75.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' NH1' ' HD3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -74.42 -55.45 5.97 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 17.3 t-20 -58.53 -29.65 66.48 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 109.092 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.622 HG21 HG22 ' A' ' 49' ' ' VAL . 12.7 mt -67.52 -43.92 86.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.536 -0.728 . . . . 0.0 109.308 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.753 HD11 HD22 ' A' ' 52' ' ' LEU . 34.4 mt -66.14 -40.13 90.38 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.216 -0.927 . . . . 0.0 109.345 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.2 t-20 -67.77 -31.1 70.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.296 -0.877 . . . . 0.0 109.235 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -80.04 -36.01 36.36 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.493 -0.754 . . . . 0.0 109.614 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 HD11 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.18 -35.13 75.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.539 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.43 -39.27 67.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 2.3 tttt -82.0 -20.26 38.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 29' ' ' ILE . 13.0 m-20 -144.88 53.06 1.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.019 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -47.01 -37.44 9.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -70.49 57.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 26' ' ' ASP . 2.3 tt -141.6 135.9 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.413 ' O ' HD12 ' A' ' 34' ' ' LEU . 33.2 t -82.35 -94.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.376 -0.828 . . . . 0.0 110.356 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 10.8 p-10 -140.1 -48.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.145 -0.972 . . . . 0.0 110.432 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' ASN . 77.9 t -42.0 -64.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.525 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.506 ' HB3' HG13 ' A' ' 29' ' ' ILE . 5.3 tp10 -63.24 -22.84 67.13 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.176 -0.953 . . . . 0.0 108.979 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -79.54 -15.12 58.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.637 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 13.8 p -87.89 -45.53 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 110.838 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 14.2 pttt -80.84 -38.16 28.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.096 -1.003 . . . . 0.0 110.952 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HD2' ' HG3' ' A' ' 33' ' ' GLU . 39.2 mtt180 -57.38 -16.59 9.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.824 ' HB ' HD21 ' A' ' 40' ' ' LEU . 2.1 m -108.98 -15.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.14 37.0 5.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.828 HD22 HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -149.19 160.97 42.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.954 -1.321 . . . . 0.0 110.559 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.486 ' C ' ' HB2' ' A' ' 35' ' ' SER . 20.5 m -66.69 159.41 74.69 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 108.766 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.056 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.46 -45.38 0.42 Allowed 'Trans proline' 0 C--N 1.286 -2.718 0 O-C-N 123.934 1.492 . . . . 0.0 110.551 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.98 -60.8 0.9 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.792 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.3 Cg_endo -73.9 -37.63 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.825 1.434 . . . . 0.0 110.175 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.4 t -38.63 -50.13 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.056 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -59.12 -52.8 64.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -43.65 -36.96 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.03 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.705 ' CD ' HG21 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -72.87 -60.1 2.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 52' ' ' LEU . 2.2 t -54.29 -44.44 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 6.5 mmt85 -48.89 -50.04 36.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 109.636 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -50.57 -36.76 36.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.451 -0.78 . . . . 0.0 109.043 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.78 HD21 ' HB3' ' A' ' 16' ' ' ASP . 70.4 mt -73.14 -19.37 61.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.482 -0.762 . . . . 0.0 110.028 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -74.97 -58.93 2.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 0.0 110.394 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.491 ' CD ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -51.78 -21.74 3.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.383 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 29.4 mm100 -91.27 17.25 8.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 110.268 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.21 49.77 54.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' O ' HD13 ' A' ' 58' ' ' ILE . 7.3 m-85 -127.93 8.71 6.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.255 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.728 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.9 mm . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.41 0.624 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -43.21 -34.69 1.19 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.897 HG23 HD22 ' A' ' 40' ' ' LEU . 5.0 mm -74.4 -21.99 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 110.642 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.675 ' HB3' HD21 ' A' ' 52' ' ' LEU . 66.4 m-20 -87.19 -56.96 3.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.109 -0.994 . . . . 0.0 110.522 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.74 -37.4 73.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.08 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 17' ' ' ARG . 17.7 t-20 -72.27 -42.67 65.32 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.356 -0.84 . . . . 0.0 109.132 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.051 HG21 HG23 ' A' ' 49' ' ' VAL . 9.0 mt -68.26 -31.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.282 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.795 HD11 HD22 ' A' ' 52' ' ' LEU . 15.5 mt -73.38 -40.64 64.18 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.314 -0.866 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.36 -27.96 66.71 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.312 -0.867 . . . . 0.0 109.295 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.521 ' OE1' ' NE ' ' A' ' 37' ' ' ARG . 22.4 mm-40 -80.34 -27.57 38.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.47 -0.769 . . . . 0.0 109.685 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.043 HD21 HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -72.0 -34.29 68.76 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.276 -0.89 . . . . 0.0 109.288 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -73.81 -40.85 63.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.756 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -74.26 -30.19 62.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.828 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -125.54 71.13 1.21 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.105 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -67.66 57.05 0.34 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -179.73 38.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 110.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 1.8 tt -119.42 135.4 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.428 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -81.81 158.74 23.98 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 16.3 m120 -50.09 -47.67 53.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 93.5 t -41.92 -63.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.079 -1.013 . . . . 0.0 109.495 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -62.55 -33.02 74.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.043 HD11 HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -68.09 -14.59 63.09 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.416 0.627 . . . . 0.0 109.765 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 12.5 p -86.55 -51.16 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.456 -0.777 . . . . 0.0 110.785 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' OG ' ' A' ' 35' ' ' SER . 12.6 mttt -77.05 -16.38 59.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 0.0 111.227 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -79.75 -16.05 56.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.109 . . . . 0.0 110.513 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.904 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -110.21 -4.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.205 -0.934 . . . . 0.0 110.054 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.65 42.48 5.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.904 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -154.52 163.72 39.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.117 -1.225 . . . . 0.0 110.557 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.9 159.12 86.36 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.08 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.2 Cg_endo -74.46 -46.89 0.25 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 123.969 1.51 . . . . 0.0 110.467 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.04 -54.67 4.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.988 . . . . 0.0 109.458 178.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.7 Cg_endo -76.1 -42.27 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.027 1.541 . . . . 0.0 110.26 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.765 ' HB2' HD12 ' A' ' 40' ' ' LEU . 47.1 t -38.88 -48.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 108.7 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.08 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -61.22 -50.77 71.74 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.2 mt-10 -45.19 -34.26 2.67 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.876 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -73.83 -52.16 13.96 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.679 0.752 . . . . 0.0 109.172 177.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.051 HG23 HG21 ' A' ' 19' ' ' ILE . 1.2 t -63.42 -47.56 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.925 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -48.32 -45.64 35.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.27 -41.15 68.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 177.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.795 HD22 HD11 ' A' ' 20' ' ' LEU . 95.9 mt -67.01 -27.01 67.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.438 -0.789 . . . . 0.0 109.866 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -63.08 -59.89 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.274 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.9 -24.46 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 15.1 mm-40 -92.2 11.43 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 110.292 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 61.12 54.98 32.14 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 1.069 ' O ' HD13 ' A' ' 58' ' ' ILE . 11.9 m-85 -130.7 2.84 4.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 110.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.069 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.8 mm . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 110.24 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' CB ' ' OD1' ' A' ' 16' ' ' ASP . 2.9 t0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.351 0.596 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -57.08 -24.2 52.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 110.314 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 ' HD3' ' A' ' 48' ' ' ARG . 4.6 mm -74.47 -33.98 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.943 . . . . 0.0 110.527 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.566 ' C ' HD11 ' A' ' 52' ' ' LEU . 4.3 m-20 -71.66 -59.95 2.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.472 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.449 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -55.27 -43.74 75.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.023 . . . . 0.0 110.543 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 2.8 m120 -64.86 -37.61 88.22 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.17 -0.956 . . . . 0.0 109.276 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.059 HG21 HG23 ' A' ' 49' ' ' VAL . 9.5 mt -63.06 -38.91 83.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.39 -0.819 . . . . 0.0 109.356 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.746 ' CG ' HD13 ' A' ' 52' ' ' LEU . 90.4 mt -65.29 -41.2 94.37 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.11 -34.95 78.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.336 -0.852 . . . . 0.0 109.377 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 60.3 mm-40 -73.03 -41.83 63.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 109.601 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.2 mt -66.85 -30.86 71.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 109.334 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -66.18 -39.29 89.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 4.1 mtmp? -81.05 -18.61 46.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.54 ' O ' HG22 ' A' ' 29' ' ' ILE . 7.2 m-20 -140.85 94.5 2.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.81 . . . . 0.0 109.951 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.86 29.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -130.37 39.86 3.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 110.157 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 26' ' ' ASP . 5.4 tt -126.49 130.72 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 110.39 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 20.9 p -72.15 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' SER . 6.2 m-80 -112.61 -30.9 6.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.926 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 48.7 t -50.27 -63.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.173 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tp10 -62.21 -29.0 70.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.194 -0.941 . . . . 0.0 108.82 177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.617 HD22 HG12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -73.71 -14.78 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.459 0.647 . . . . 0.0 109.818 178.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.544 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 18.3 p -87.79 -45.81 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.497 -0.752 . . . . 0.0 111.004 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -82.55 -22.91 34.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 0.0 111.223 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.56 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -74.32 -15.68 60.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.014 -1.054 . . . . 0.0 110.552 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.854 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.4 m -106.49 -13.12 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.424 -0.798 . . . . 0.0 109.969 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.93 40.09 3.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.854 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.52 168.83 24.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.037 -1.273 . . . . 0.0 110.654 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -76.05 158.88 81.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 108.876 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.075 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.3 Cg_endo -74.59 -43.8 0.44 Allowed 'Trans proline' 0 C--N 1.288 -2.616 0 O-C-N 123.964 1.507 . . . . 0.0 110.464 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.35 -55.51 4.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.973 . . . . 0.0 109.471 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.4 Cg_endo -76.29 -42.94 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.894 1.471 . . . . 0.0 110.126 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.1 t -39.8 -46.0 1.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.95 -1.094 . . . . 0.0 108.626 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -64.63 -49.54 70.63 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 17.3 mt-10 -46.22 -43.03 15.07 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.482 -0.887 . . . . 0.0 108.894 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.775 ' HD3' HG21 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -68.43 -45.76 71.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.367 -0.833 . . . . 0.0 109.153 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.059 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -63.87 -47.69 89.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.432 -0.793 . . . . 0.0 109.604 178.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.619 ' N ' HG12 ' A' ' 49' ' ' VAL . 12.4 mmt85 -43.46 -55.69 4.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.838 . . . . 0.0 109.443 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.57 -43.48 25.41 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.869 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.746 HD13 ' CG ' ' A' ' 20' ' ' LEU . 30.2 mt -70.98 -41.97 70.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.758 . . . . 0.0 109.796 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.47 -57.66 9.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 110.138 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -54.81 -17.87 4.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.051 179.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.501 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -89.77 9.91 25.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.94 44.16 47.22 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.891 ' O ' HD13 ' A' ' 58' ' ' ILE . 14.1 m-85 -135.28 12.03 3.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -1.165 . . . . 0.0 110.261 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.891 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.8 mm . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 110.316 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.4 t0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.257 0.551 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 3.5 mmt180 -52.62 -29.03 23.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.344 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 HD22 ' A' ' 40' ' ' LEU . 9.0 mm -80.37 -29.88 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.616 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.706 ' HB3' HD11 ' A' ' 52' ' ' LEU . 5.2 m-20 -82.19 -36.92 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 2.9 ptt180 -70.62 -44.21 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 22.6 m-20 -67.78 -36.22 80.08 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.921 HG21 ' CG2' ' A' ' 49' ' ' VAL . 24.7 mt -68.76 -37.79 77.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.825 ' HG ' HD13 ' A' ' 52' ' ' LEU . 11.9 mt -65.67 -36.87 84.89 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.349 -0.845 . . . . 0.0 109.249 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -67.56 -35.48 79.12 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.394 -0.816 . . . . 0.0 109.198 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.806 ' OE1' HG13 ' A' ' 38' ' ' VAL . 7.1 mt-10 -72.87 -40.15 65.88 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.452 -0.78 . . . . 0.0 109.764 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.458 HD23 ' CG2' ' A' ' 29' ' ' ILE . 34.7 mt -66.89 -37.05 83.66 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.22 -0.925 . . . . 0.0 109.306 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -63.44 -40.67 97.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.399 -0.813 . . . . 0.0 109.235 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 -25.3 44.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.32 96.36 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.63 39.48 3.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -153.74 21.35 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -1.114 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.668 HD13 HD12 ' A' ' 34' ' ' LEU . 4.5 tt -101.84 140.22 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 31' ' ' ASN . 13.5 t -84.92 -120.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.653 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 7.6 p30 -120.8 -46.44 2.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.0 t -45.22 -60.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.283 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.3 tt0 -62.04 -30.34 70.91 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.216 -0.928 . . . . 0.0 108.989 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.668 HD12 HD13 ' A' ' 29' ' ' ILE . 6.4 tp -74.67 -16.19 60.77 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.58 -0.7 . . . . 0.0 110.063 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' ASN . 11.6 p -84.37 -37.97 20.89 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.412 -0.805 . . . . 0.0 110.279 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -87.13 -17.9 31.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.449 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -75.1 -18.02 60.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.503 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -111.46 -11.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 121.405 -0.81 . . . . 0.0 109.731 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.62 41.36 4.77 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.878 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -148.02 168.57 21.98 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.998 -1.295 . . . . 0.0 110.466 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 3.5 m -72.75 154.82 91.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 108.872 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.073 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.3 Cg_endo -72.53 -48.31 0.33 Allowed 'Trans proline' 0 C--N 1.288 -2.642 0 O-C-N 123.961 1.506 . . . . 0.0 110.733 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.27 -54.22 4.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.3 Cg_endo -76.02 -41.01 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.977 1.514 . . . . 0.0 110.134 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 50.6 t -39.89 -46.19 1.96 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.043 . . . . 0.0 108.731 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.073 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.04 -49.28 75.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -46.3 -41.84 13.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.898 177.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.576 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -67.57 -56.62 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.921 ' CG2' HG21 ' A' ' 19' ' ' ILE . 1.4 t -55.71 -51.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 3.0 mmt85 -40.94 -49.92 3.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.533 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -49.82 -44.25 49.18 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.825 HD13 ' HG ' ' A' ' 20' ' ' LEU . 49.3 mt -67.22 -20.29 65.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.769 . . . . 0.0 109.881 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.72 -64.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -46.31 -23.92 0.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.299 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 20.7 mm-40 -85.97 11.06 12.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 59.5 54.38 38.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.82 ' O ' HD13 ' A' ' 58' ' ' ILE . 12.4 m-85 -139.53 9.82 2.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -1.2 . . . . 0.0 110.339 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.3 mm . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.29 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.324 0.583 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -47.11 -46.01 22.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 110.351 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.673 HG23 HD22 ' A' ' 40' ' ' LEU . 20.5 mm -65.88 -17.1 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 110.66 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.55 ' C ' HD11 ' A' ' 52' ' ' LEU . 20.4 m-20 -84.04 -62.71 1.5 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.059 -1.026 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.84 -45.23 67.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.128 -0.982 . . . . 0.0 110.022 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.505 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -64.66 -42.36 95.46 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 109.285 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.825 HD13 HG23 ' A' ' 49' ' ' VAL . 1.3 mt -58.74 -35.0 53.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.36 -0.838 . . . . 0.0 109.347 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 52' ' ' LEU . 67.2 mt -67.06 -45.24 77.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.45 -27.06 68.73 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.219 -0.926 . . . . 0.0 109.245 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 11.9 mm-40 -85.37 -43.67 13.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.516 -0.74 . . . . 0.0 110.147 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -65.77 -20.28 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 109.558 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -85.58 -41.32 15.36 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 1.3 ptmt -60.5 -30.78 69.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.522 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 27.0 p30 -150.87 71.23 1.02 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.09 -23.42 1.65 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.08 9.31 4.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.366 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 37' ' ' ARG . 7.1 tt -76.53 153.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.878 . . . . 0.0 110.454 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 34' ' ' LEU . 2.3 m -104.6 155.58 18.72 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' SER . 5.3 p-10 -46.25 -47.36 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.128 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' A' ' 35' ' ' SER . 4.7 t -49.65 -55.45 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.935 -1.103 . . . . 0.0 108.881 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.4 tt0 -67.21 -32.38 73.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -68.53 -20.04 64.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.59 0.71 . . . . 0.0 109.486 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.537 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 25.3 p -83.47 -46.2 12.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.557 -0.714 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -82.25 -27.1 32.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.68 ' HG3' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -58.37 -24.54 60.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.224 -0.923 . . . . 0.0 109.736 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.767 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.0 -3.87 10.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 178.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.29 46.76 5.73 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.767 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -150.24 156.65 41.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.273 . . . . 0.0 111.019 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.51 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -62.65 153.31 78.69 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.07 ' O ' HD12 ' A' ' 46' ' ' LEU . 46.2 Cg_endo -72.86 -41.93 1.27 Allowed 'Trans proline' 0 C--N 1.283 -2.887 0 O-C-N 123.842 1.443 . . . . 0.0 110.682 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -56.03 2.75 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.606 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.8 Cg_endo -74.74 -37.76 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.9 1.473 . . . . 0.0 110.121 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.675 ' HA ' HD11 ' A' ' 40' ' ' LEU . 48.5 t -41.85 -45.89 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.029 -1.044 . . . . 0.0 108.651 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.07 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.96 -43.27 93.23 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' PRO . 58.2 mt-10 -55.0 -43.69 73.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.572 ' CD ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.83 -44.65 76.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.636 0.731 . . . . 0.0 109.189 178.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.825 HG23 HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -62.8 -50.41 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -0.833 . . . . 0.0 109.599 178.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -41.85 -51.37 4.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.495 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -51.35 -45.1 62.22 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.134 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.828 ' HB3' HD11 ' A' ' 58' ' ' ILE . 16.5 mt -72.19 -23.5 61.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.14 -48.94 78.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -0.791 . . . . 0.0 110.098 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.514 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -65.18 -17.24 64.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 77.2 mm-40 -79.81 8.61 6.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.73 31.35 71.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -112.86 4.05 16.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -1.142 . . . . 0.0 109.999 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 52' ' ' LEU . 1.1 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.36 -0.838 . . . . 0.0 110.167 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ASP . 10.4 t70 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.357 0.599 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -40.88 -45.59 2.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.36 -0.837 . . . . 0.0 110.565 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.78 HG21 ' CD2' ' A' ' 40' ' ' LEU . 6.4 mm -70.19 -26.34 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 28.1 m-20 -72.51 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 0.0 110.303 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -35.92 68.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 109.985 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.74 ' HB3' HG13 ' A' ' 38' ' ' VAL . 3.5 t-20 -71.32 -42.86 68.06 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.783 . . . . 0.0 109.095 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.115 HG21 HG23 ' A' ' 49' ' ' VAL . 14.0 mt -66.31 -34.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.913 HD11 ' CD2' ' A' ' 52' ' ' LEU . 49.0 mt -72.18 -39.89 68.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.401 -0.812 . . . . 0.0 109.433 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.67 -37.07 84.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.989 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.88 -33.08 63.91 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.466 -0.771 . . . . 0.0 109.473 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.52 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 17.5 mt -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -73.66 -44.74 55.94 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.521 -0.737 . . . . 0.0 109.739 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -70.21 -32.33 70.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.603 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.541 ' O ' HG22 ' A' ' 29' ' ' ILE . 5.9 m-20 -130.05 86.17 2.37 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.84 0.71 50.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -111.03 31.9 5.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.165 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.989 HG21 ' OE2' ' A' ' 22' ' ' GLU . 14.9 tt -115.84 144.88 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.739 ' O ' HD12 ' A' ' 34' ' ' LEU . 44.8 t -87.96 -110.92 0.06 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 110.408 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.689 ' CB ' HD21 ' A' ' 46' ' ' LEU . 4.5 p-10 -124.88 -50.33 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 31' ' ' ASN . 69.5 t -41.17 -64.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 37' ' ' ARG . 4.1 tp10 -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.224 -0.922 . . . . 0.0 108.851 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 30' ' ' SER . 1.1 tt -67.8 -23.57 65.21 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.557 -0.714 . . . . 0.0 109.609 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -78.57 -41.88 30.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.437 -0.789 . . . . 0.0 110.286 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -67.09 -28.31 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 1.1 mmt180 -73.03 -17.81 61.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 18' ' ' ASN . 3.6 t -107.23 11.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.914 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.47 18.05 21.3 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.78 ' CD2' HG21 ' A' ' 15' ' ' ILE . 15.0 tp -123.4 134.95 53.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -1.003 . . . . 0.0 110.203 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.563 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.8 m -47.0 158.7 0.42 Allowed Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.735 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.061 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.6 -42.58 0.82 Allowed 'Trans proline' 0 C--N 1.285 -2.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.39 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.41 -55.54 3.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.32 178.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.711 ' CG ' HD11 ' A' ' 40' ' ' LEU . 44.4 Cg_endo -74.26 -50.37 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.91 1.479 . . . . 0.0 110.136 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 39.4 t -38.19 -46.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 108.873 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.061 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -63.42 -53.05 58.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 1.3 mt-10 -46.29 -46.01 17.73 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.955 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -68.22 -43.83 77.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.576 -0.702 . . . . 0.0 109.33 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.115 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -62.87 -43.81 99.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.55 ' N ' HG12 ' A' ' 49' ' ' VAL . 18.7 mmm-85 -51.36 -46.48 62.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.566 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.59 -34.08 64.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.862 178.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.913 ' CD2' HD11 ' A' ' 20' ' ' LEU . 5.2 mt -76.68 -19.05 58.17 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.743 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.55 -59.92 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 110.197 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -54.19 -22.97 12.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.56 11.44 7.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 51.43 59.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.917 ' O ' HD13 ' A' ' 58' ' ' ILE . 13.4 m-85 -134.29 6.58 3.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -1.129 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.917 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.3 mm . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.266 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.327 0.584 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 8.4 mmt180 -47.3 -22.81 0.45 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.333 -0.855 . . . . 0.0 110.284 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.754 HG21 ' CD2' ' A' ' 40' ' ' LEU . 1.2 mp -80.51 -44.35 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 110.129 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.541 ' HB3' HD11 ' A' ' 52' ' ' LEU . 2.7 m-20 -58.55 -44.87 89.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.161 -0.962 . . . . 0.0 109.901 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -65.93 -47.82 73.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.915 . . . . 0.0 109.799 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.584 ' HB3' HG13 ' A' ' 38' ' ' VAL . 1.5 m-20 -61.87 -41.79 98.27 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.388 -0.82 . . . . 0.0 108.879 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.997 HG21 HG23 ' A' ' 49' ' ' VAL . 7.6 mt -62.09 -41.06 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.462 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.095 HD11 HD22 ' A' ' 52' ' ' LEU . 13.8 mt -70.34 -40.94 73.82 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.1 t-20 -66.41 -34.39 77.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 6.2 mm-40 -76.32 -29.49 57.34 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.424 -0.797 . . . . 0.0 109.696 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.767 HD21 ' CD1' ' A' ' 34' ' ' LEU . 21.5 mt -72.48 -32.7 66.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -79.24 -42.52 25.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.518 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -67.03 -33.69 76.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.552 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -141.34 63.37 1.44 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.911 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.01 -161.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.06 30.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -1.194 . . . . 0.0 109.946 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 26' ' ' ASP . 4.9 tt -117.43 131.9 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.361 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 37.0 t -67.73 168.88 10.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.954 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.6 OUTLIER -65.37 -39.91 92.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.36 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 31' ' ' ASN . 46.6 t -44.54 -61.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 109.221 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.99 -33.66 74.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.307 -0.87 . . . . 0.0 108.751 177.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.767 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -67.95 -20.39 65.05 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.525 0.678 . . . . 0.0 109.674 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.4 p -87.77 -24.39 23.8 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.41 -0.806 . . . . 0.0 110.488 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 4.7 mtmt -79.25 -33.14 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.71 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.591 ' CD ' ' HA ' ' A' ' 34' ' ' LEU . 4.4 ptm180 -81.67 -16.04 52.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.074 -1.016 . . . . 0.0 110.745 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 34' ' ' LEU . 4.5 t -97.66 12.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.207 -0.933 . . . . 0.0 110.144 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.98 21.76 8.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.754 ' CD2' HG21 ' A' ' 15' ' ' ILE . 15.2 tp -127.83 133.37 49.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.52 -0.988 . . . . 0.0 110.253 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.593 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -47.81 160.63 0.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 120.993 -1.067 . . . . 0.0 108.536 177.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.042 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.9 Cg_endo -73.92 -45.57 0.37 Allowed 'Trans proline' 0 C--N 1.282 -2.935 0 O-C-N 123.651 1.343 . . . . 0.0 110.654 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.554 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -38.73 -53.18 3.44 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 109.643 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.587 ' HB2' HD11 ' A' ' 40' ' ' LEU . 44.6 Cg_endo -75.45 -49.01 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.044 1.549 . . . . 0.0 109.77 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HA ' HD11 ' A' ' 19' ' ' ILE . 12.8 t -43.62 -37.87 2.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.047 -1.033 . . . . 0.0 108.494 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.042 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -70.77 -45.87 63.95 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 70.8 mt-10 -49.79 -46.3 50.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.088 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.598 ' CB ' HG22 ' A' ' 15' ' ' ILE . 3.6 mpt_? -69.69 -36.48 76.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.997 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -71.66 -47.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.272 -0.893 . . . . 0.0 110.017 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.608 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -48.25 -48.06 35.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 2.4 tpp180 -53.38 -45.91 69.41 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.903 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.095 HD22 HD11 ' A' ' 20' ' ' LEU . 78.1 mt -67.59 -16.59 64.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -58.89 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 110.254 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.445 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 61.4 mtt85 -73.75 -21.81 60.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 110.372 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' HG2' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -148.51 53.74 1.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -161.71 -123.58 0.67 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 1.061 ' O ' HD13 ' A' ' 58' ' ' ILE . 63.4 m-85 -146.96 76.16 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.061 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.5 mm . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 5.1 t70 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.342 0.591 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.547 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 9.4 mmt180 -48.18 -25.64 1.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.322 -0.861 . . . . 0.0 110.346 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.875 HD12 HD22 ' A' ' 40' ' ' LEU . 19.2 mm -69.93 -33.57 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.265 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 52' ' ' LEU . 1.4 m-20 -73.81 -59.45 2.71 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.547 ' CD ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -53.6 -33.4 54.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.812 179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.579 ' CG ' HG12 ' A' ' 38' ' ' VAL . 59.8 t-20 -70.27 -43.12 71.12 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.384 -0.822 . . . . 0.0 109.192 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.043 HG21 HG23 ' A' ' 49' ' ' VAL . 40.4 mt -61.75 -35.92 70.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.937 HD11 HD22 ' A' ' 52' ' ' LEU . 20.2 mt -67.33 -43.63 81.11 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.285 -0.885 . . . . 0.0 109.286 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.67 -32.83 69.48 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 22.3 mm-40 -75.42 -45.09 41.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.853 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 19' ' ' ILE . 2.1 mm? -57.6 -44.14 85.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.659 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -68.04 -40.42 82.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.377 -0.827 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 27.6 mtpt -68.66 -20.16 64.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.909 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' ARG . 35.1 m-20 -147.4 79.23 1.49 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 110.188 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.88 58.36 0.21 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.26 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -1.181 . . . . 0.0 110.008 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.578 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.7 tt -122.35 147.04 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 9.1 p -87.83 -167.11 1.78 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.108 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 12.9 m-80 -78.78 -49.97 12.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -0.919 . . . . 0.0 110.333 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.6 t -40.02 -57.78 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 109.706 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -61.66 -33.5 74.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.186 -0.946 . . . . 0.0 108.759 177.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.749 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -67.16 -57.86 5.95 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 178.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.577 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 3.1 p -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.608 -0.682 . . . . 0.0 110.29 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -80.11 -22.99 41.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 34' ' ' LEU . 12.5 mmt180 -78.33 -17.86 55.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.855 HG23 ' HG ' ' A' ' 40' ' ' LEU . 3.2 m -105.88 -12.33 9.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 39.85 5.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.875 HD22 HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -153.76 169.19 23.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.016 -1.284 . . . . 0.0 110.775 179.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.2 154.09 94.01 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.058 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.4 Cg_endo -73.58 -44.0 0.57 Allowed 'Trans proline' 0 C--N 1.287 -2.698 0 O-C-N 124.004 1.529 . . . . 0.0 110.802 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.602 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.94 -56.26 1.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.8 Cg_endo -77.52 -42.57 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.93 1.49 . . . . 0.0 110.174 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 36.9 t -37.4 -50.39 1.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 108.877 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.058 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.34 -51.77 68.11 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.7 mm-40 -44.89 -41.22 6.96 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.303 -0.873 . . . . 0.0 108.949 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.69 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.97 -45.33 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.043 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -62.54 -44.59 99.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 178.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.552 ' N ' HG12 ' A' ' 49' ' ' VAL . 8.2 mmm180 -48.96 -47.39 44.02 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.339 -0.851 . . . . 0.0 109.019 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -50.5 -40.66 51.88 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.937 HD22 HD11 ' A' ' 20' ' ' LEU . 90.1 mt -75.44 -37.52 60.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.577 -0.702 . . . . 0.0 109.667 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 58' ' ' ILE . 7.1 tp10 -73.25 -26.6 61.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 110.337 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -68.66 -42.12 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.209 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' OE1' ' CG ' ' A' ' 57' ' ' PHE . 6.2 pt20 -76.99 2.09 15.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.64 8.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.721 ' O ' HD13 ' A' ' 58' ' ' ILE . 1.3 m-85 -119.28 11.01 12.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -1.183 . . . . 0.0 110.152 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 52' ' ' LEU . 15.0 mm . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.097 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 15' ' ' ILE . 1.4 m-20 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.235 0.54 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 6.7 mmt-85 -46.03 -22.33 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 110.358 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' HD2' ' A' ' 48' ' ' ARG . 6.6 mm -73.48 -34.43 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.462 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.812 ' HB3' HD11 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -78.0 -45.02 24.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -51.87 63.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.954 . . . . 0.0 110.0 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.555 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 7.8 t-20 -60.85 -40.45 92.91 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.385 -0.822 . . . . 0.0 109.332 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.072 HG21 HG23 ' A' ' 49' ' ' VAL . 10.5 mt -64.77 -38.5 82.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.282 -0.887 . . . . 0.0 109.559 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.883 ' HG ' HD13 ' A' ' 52' ' ' LEU . 14.4 mt -73.38 -35.24 65.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.351 -0.843 . . . . 0.0 109.307 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.69 -31.15 64.82 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.43 -0.794 . . . . 0.0 109.453 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 5.6 mm-40 -72.13 -32.85 67.32 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.402 -0.811 . . . . 0.0 109.86 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mt -69.89 -36.41 75.41 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.203 -0.936 . . . . 0.0 109.488 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -64.07 -42.97 96.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.49 -28.9 66.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.435 178.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.517 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -133.41 76.12 1.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 110.055 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.76 58.82 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.57 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -1.114 . . . . 0.0 110.182 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 tt -112.17 141.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.621 ' O ' HD12 ' A' ' 34' ' ' LEU . 17.6 m -77.9 -138.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.417 -0.802 . . . . 0.0 110.138 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.606 ' OD1' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -108.86 -41.1 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' ASN . 76.2 t -44.43 -62.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 109.355 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.481 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 1.1 tp10 -61.84 -26.44 68.13 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -78.54 -15.28 58.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.697 -0.627 . . . . 0.0 110.071 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ASN . 23.6 p -87.93 -44.67 10.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.819 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 7.8 pttt -79.84 -41.05 27.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 111.126 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 13.9 ptm180 -63.01 -16.2 58.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.065 -1.022 . . . . 0.0 110.628 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.782 HG23 ' HG ' ' A' ' 40' ' ' LEU . 14.5 m -98.51 -22.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.358 -0.838 . . . . 0.0 110.005 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 103.97 35.38 3.46 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.782 ' HG ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -153.36 169.02 24.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.019 -1.283 . . . . 0.0 110.624 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.0 m -74.17 158.75 85.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.747 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.085 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.9 Cg_endo -74.16 -49.75 0.18 Allowed 'Trans proline' 0 C--N 1.286 -2.72 0 O-C-N 123.9 1.473 . . . . 0.0 110.565 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.92 -53.67 3.43 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.428 179.142 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.634 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.3 Cg_endo -76.46 -41.69 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.898 1.473 . . . . 0.0 110.219 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 53.8 t -40.33 -51.19 2.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 108.718 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.085 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.25 -47.4 81.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -46.4 -38.83 9.52 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.864 177.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.815 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.36 -46.91 53.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.535 -0.728 . . . . 0.0 109.266 178.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.072 HG23 HG21 ' A' ' 19' ' ' ILE . 0.6 OUTLIER -65.77 -51.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.473 -0.767 . . . . 0.0 109.96 178.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.703 ' N ' HG12 ' A' ' 49' ' ' VAL . 2.4 mmm180 -46.07 -44.11 15.18 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -54.44 -44.75 72.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' A' ' 58' ' ' ILE . 61.0 mt -65.08 -16.69 63.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.99 -58.56 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.243 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 2.6 ptp180 -49.19 -27.94 4.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.438 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.472 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 73.5 mm-40 -81.77 10.87 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.74 93.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.818 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -129.85 15.44 5.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.353 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.922 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.0 mm . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -80.01 -22.3 42.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.264 -0.897 . . . . 0.0 110.362 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.788 HG23 HD22 ' A' ' 40' ' ' LEU . 13.4 mm -78.87 -29.68 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.798 ' HB3' HD21 ' A' ' 52' ' ' LEU . 85.3 m-20 -81.56 -39.91 23.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.073 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -51.68 56.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.214 -0.929 . . . . 0.0 110.032 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.559 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -62.84 -39.43 94.34 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.404 -0.81 . . . . 0.0 109.363 178.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 34' ' ' LEU . 8.0 mt -64.07 -38.25 81.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.453 -0.779 . . . . 0.0 109.56 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.021 HD11 HD22 ' A' ' 52' ' ' LEU . 12.9 mt -70.03 -37.42 75.59 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 26.2 m-20 -70.83 -29.32 65.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.845 . . . . 0.0 109.603 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 37' ' ' ARG . 6.2 mm-40 -82.23 -29.14 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.445 -0.785 . . . . 0.0 109.848 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.96 -37.36 84.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -42.48 33.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 1.5 pttt -75.17 -29.71 60.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.995 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -133.14 53.31 2.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.134 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -53.54 -169.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.32 16.84 1.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -1.143 . . . . 0.0 110.197 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.982 HD13 ' NH1' ' A' ' 37' ' ' ARG . 12.9 tt -102.64 134.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 110.124 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 34' ' ' LEU . 36.5 m -75.02 -131.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.403 -0.81 . . . . 0.0 110.502 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 35' ' ' SER . 26.5 p-10 -111.78 -47.02 3.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.217 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t -43.1 -67.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.976 -1.078 . . . . 0.0 109.276 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 3.4 tp10 -56.34 -25.95 50.84 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.203 -0.936 . . . . 0.0 108.665 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.849 HD11 HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -77.64 -18.73 56.46 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.41 0.624 . . . . 0.0 109.906 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' ASN . 6.4 p -90.33 -47.75 7.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.532 -0.73 . . . . 0.0 110.864 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 35' ' ' SER . 10.6 ttmt -79.21 -24.83 42.85 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 111.288 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.982 ' NH1' HD13 ' A' ' 29' ' ' ILE . 28.4 ptt180 -75.8 -14.91 60.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 110.62 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.8 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -107.64 -11.02 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 110.071 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 42.12 4.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.8 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.79 167.38 30.58 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.064 -1.256 . . . . 0.0 110.852 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.2 m -72.98 156.71 89.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.02 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.059 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -74.18 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.635 0 O-C-N 123.972 1.512 . . . . 0.0 110.826 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -39.38 -53.86 3.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 109.421 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.641 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.1 Cg_endo -77.24 -42.53 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.021 1.537 . . . . 0.0 110.335 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.767 ' HB2' HD12 ' A' ' 40' ' ' LEU . 44.6 t -38.47 -53.38 1.55 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 0.0 108.866 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.059 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -55.25 -49.63 71.54 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.25 -38.04 1.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.958 177.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.584 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.51 -49.29 27.34 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.627 0.727 . . . . 0.0 109.173 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -63.49 -40.49 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 4.2 mmm180 -53.86 -46.17 71.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.081 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -52.04 -42.16 62.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.021 HD22 HD11 ' A' ' 20' ' ' LEU . 64.4 mt -70.77 -22.4 62.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.546 -0.721 . . . . 0.0 109.781 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 2.8 tm-20 -68.5 -69.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.6 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -52.95 -19.38 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 110.639 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.574 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 8.7 mm100 -86.54 13.41 8.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.01 . . . . 0.0 110.481 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 61.84 51.42 57.39 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.922 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.3 m-85 -139.94 9.38 2.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -1.218 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 57' ' ' PHE . 8.5 mm . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.267 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 121.203 0.525 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -40.54 -27.49 0.05 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.361 -0.837 . . . . 0.0 110.41 -179.133 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.906 HG23 HD22 ' A' ' 40' ' ' LEU . 8.5 mm -72.97 -46.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 110.421 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 13' ' ' ASP . 1.4 m-20 -68.93 -26.24 64.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -75.88 -66.43 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.443 ' HB3' HG12 ' A' ' 38' ' ' VAL . 9.2 t-20 -53.45 -28.28 29.35 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 108.988 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.791 HG13 HG11 ' A' ' 38' ' ' VAL . 3.4 mt -64.79 -50.66 74.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.091 178.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.914 HD11 HD22 ' A' ' 52' ' ' LEU . 72.0 mt -55.55 -42.19 74.3 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -59.02 -38.77 80.05 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.746 ' OE2' HG13 ' A' ' 38' ' ' VAL . 25.5 mt-10 -63.61 -39.65 94.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.45 -0.782 . . . . 0.0 109.744 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 34' ' ' LEU . 2.1 mm? -66.58 -40.6 89.02 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -65.69 -36.45 83.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.317 -0.864 . . . . 0.0 109.303 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 1.6 pttp -79.1 -29.38 43.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -136.67 95.27 3.11 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 110.024 179.123 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.86 13.37 43.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.527 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.01 34.92 4.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -1.217 . . . . 0.0 110.381 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 26' ' ' ASP . 11.3 tt -116.48 139.84 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.615 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.546 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.7 t -76.19 -129.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.364 -0.835 . . . . 0.0 110.027 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.555 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -117.89 -38.25 3.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.019 -1.05 . . . . 0.0 110.29 179.347 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' ASN . 98.0 t -45.39 -56.65 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.041 -1.037 . . . . 0.0 109.068 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 1.7 tp10 -66.99 -32.88 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.336 -0.853 . . . . 0.0 108.844 177.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -69.46 -15.8 63.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.558 -0.714 . . . . 0.0 109.492 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 16.2 p -86.27 -47.08 9.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.495 -0.753 . . . . 0.0 110.355 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.99 -16.8 52.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.181 -0.95 . . . . 0.0 110.724 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -74.64 -19.94 60.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.859 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.94 -5.97 10.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.396 -0.815 . . . . 0.0 109.756 179.102 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.92 40.65 5.51 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -152.18 160.38 43.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.294 . . . . 0.0 110.72 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.485 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -69.59 160.12 80.89 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.069 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.6 Cg_endo -73.06 -45.21 0.47 Allowed 'Trans proline' 0 C--N 1.284 -2.859 0 O-C-N 123.926 1.487 . . . . 0.0 110.489 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.39 -57.79 1.36 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.177 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 52.1 Cg_endo -76.5 -41.49 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.898 1.473 . . . . 0.0 110.135 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.714 ' HB2' HD12 ' A' ' 40' ' ' LEU . 53.6 t -39.13 -53.05 1.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 108.661 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.069 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -52.82 -51.98 58.76 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 176.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.0 -43.06 4.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.265 177.7 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.863 ' CD ' HG21 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -72.21 -56.25 5.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -0.815 . . . . 0.0 109.492 178.581 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG23 HD13 ' A' ' 19' ' ' ILE . 1.6 t -54.72 -48.93 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.331 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmt180 -43.33 -52.27 5.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.369 178.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.04 -41.41 16.68 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.922 178.064 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.914 HD22 HD11 ' A' ' 20' ' ' LEU . 92.8 mt -68.07 -28.33 67.27 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.452 -0.78 . . . . 0.0 109.715 178.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' ARG . 1.9 tm-20 -64.62 -63.63 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.825 . . . . 0.0 110.161 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -50.27 -27.04 5.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.147 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HA ' ' OE1' ' A' ' 55' ' ' GLN . 28.6 mm-40 -83.42 5.59 23.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.57 59.97 7.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.953 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.53 10.81 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.953 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.7 mm . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.348 0.594 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -43.65 -33.9 1.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.406 -0.808 . . . . 0.0 110.264 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 1.028 HG23 HD22 ' A' ' 40' ' ' LEU . 7.1 mm -73.65 -33.74 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.53 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.663 ' HB3' HD21 ' A' ' 52' ' ' LEU . 93.4 m-20 -76.67 -45.82 28.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.599 ' CD ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -62.81 -44.2 96.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.072 -1.018 . . . . 0.0 110.217 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.788 ' HB3' HG12 ' A' ' 38' ' ' VAL . 9.1 m-20 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 178.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.685 HD13 HG23 ' A' ' 49' ' ' VAL . 7.2 mt -69.79 -33.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 178.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.964 HD11 HD22 ' A' ' 52' ' ' LEU . 65.9 mt -70.9 -38.25 72.99 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.247 -0.908 . . . . 0.0 109.388 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -31.9 70.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.024 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -78.5 -32.12 48.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.382 -0.824 . . . . 0.0 109.605 178.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' ' HG3' ' A' ' 22' ' ' GLU . 12.6 mt -71.13 -37.34 72.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.306 -0.871 . . . . 0.0 109.475 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.6 -38.63 84.27 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 178.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 24.5 pttt -79.73 -38.16 33.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.481 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -116.49 91.84 3.7 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 110.093 179.363 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.8 22.48 13.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.46 9.85 4.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -1.115 . . . . 0.0 110.073 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.024 HG21 ' OE2' ' A' ' 22' ' ' GLU . 13.6 tt -85.72 143.67 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 110.405 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 m -92.38 -73.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 110.537 -179.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.702 ' OD1' HD11 ' A' ' 46' ' ' LEU . 10.7 t-20 -164.3 -54.6 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.478 ' C ' ' O ' ' A' ' 31' ' ' ASN . 3.2 t -42.64 -52.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.998 -1.064 . . . . 0.0 109.081 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -69.08 -29.23 67.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.147 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.652 HD21 HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -73.66 -16.61 61.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.608 -0.683 . . . . 0.0 109.749 178.508 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.564 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 19.3 p -88.07 -47.76 8.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -81.96 -17.11 48.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -77.43 -16.03 59.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.013 -1.055 . . . . 0.0 110.611 -179.359 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.898 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.48 -6.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.985 179.489 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.27 42.75 5.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.028 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -153.31 164.06 38.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.987 -1.302 . . . . 0.0 110.643 178.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -71.51 160.93 81.14 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.078 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.3 Cg_endo -74.28 -54.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.285 -2.794 0 O-C-N 123.953 1.502 . . . . 0.0 110.649 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 m -35.14 -54.25 1.1 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.1 Cg_endo -74.83 -42.6 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.88 1.463 . . . . 0.0 109.867 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.692 ' HB2' HD12 ' A' ' 40' ' ' LEU . 40.8 t -39.15 -49.15 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.785 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.078 HD12 ' O ' ' A' ' 42' ' ' PRO . 2.1 mp -56.93 -52.77 63.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -42.87 -41.03 3.14 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.73 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.612 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -73.14 -53.78 10.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.615 -0.678 . . . . 0.0 109.683 178.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.685 HG23 HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -56.7 -43.83 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 1.5 mmm-85 -50.72 -48.4 58.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.203 -0.936 . . . . 0.0 109.131 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -50.6 -39.2 49.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.964 HD22 HD11 ' A' ' 20' ' ' LEU . 93.0 mt -70.63 -19.84 62.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.689 178.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.493 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 1.3 mt-10 -78.21 -55.07 5.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 110.062 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -44.64 -49.33 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.394 -0.816 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 52' ' ' LEU . 11.0 pt20 -70.61 -1.96 12.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.325 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 75.17 66.27 1.94 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.823 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -141.84 9.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 110.131 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.962 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.2 mm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.277 0.56 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.473 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 4.8 mmt85 -69.56 -35.49 75.44 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.297 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.898 HG21 HD12 ' A' ' 40' ' ' LEU . 1.2 mp -70.96 -35.22 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 110.273 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.758 ' CA ' HD11 ' A' ' 52' ' ' LEU . 63.8 m-20 -62.24 -67.17 0.44 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.545 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 3.1 ptm85 -50.76 -44.86 58.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.242 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.434 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 97.2 m-20 -66.21 -37.52 85.76 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.947 HG21 HG23 ' A' ' 49' ' ' VAL . 3.2 mt -66.91 -34.3 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 109.228 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.011 HD11 HD22 ' A' ' 52' ' ' LEU . 12.6 mt -68.74 -43.26 76.26 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.09 -30.88 71.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.292 -0.88 . . . . 0.0 109.511 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 24.6 mm-40 -76.84 -30.46 56.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.826 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 34' ' ' LEU . 2.4 mm? -75.46 -30.98 60.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 178.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.704 178.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.51 -40.39 57.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.836 179.185 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.532 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -136.51 64.05 1.56 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.328 -0.857 . . . . 0.0 110.073 179.182 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.05 -164.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 48.8 23.81 0.73 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 110.274 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 2.6 tt -106.65 142.14 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.164 -0.96 . . . . 0.0 110.341 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 p -80.91 179.87 7.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.387 -0.821 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.604 HD22 HD11 ' A' ' 46' ' ' LEU . 9.3 p-10 -71.92 -50.02 32.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' ASN . 48.4 t -40.91 -48.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.453 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.0 -36.73 82.82 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.324 -0.86 . . . . 0.0 108.868 177.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.042 HD11 HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -67.78 -54.56 18.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.441 178.162 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.629 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 4.5 p -44.84 -44.89 9.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 32' ' ' VAL . 4.1 mtpp -73.82 -36.11 64.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.697 -178.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.12 -42.96 99.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 34' ' ' LEU . 9.1 m -92.1 20.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.977 179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 48.98 23.66 3.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.898 HD12 HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -110.51 133.91 52.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.009 . . . . 0.0 110.82 -179.094 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -50.38 152.07 3.41 Favored Pre-proline 0 C--N 1.3 -1.554 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.971 176.177 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.087 ' O ' HD12 ' A' ' 46' ' ' LEU . 44.4 Cg_endo -70.51 -47.26 0.73 Allowed 'Trans proline' 0 C--N 1.283 -2.89 0 O-C-N 123.703 1.37 . . . . 0.0 110.573 -177.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.27 -54.66 5.82 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.048 -1.033 . . . . 0.0 109.125 178.336 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.649 ' HG2' HD22 ' A' ' 40' ' ' LEU . 42.3 Cg_endo -74.37 -48.39 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.95 1.5 . . . . 0.0 110.592 177.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' HA ' HD13 ' A' ' 40' ' ' LEU . 37.0 t -40.34 -42.05 1.48 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 108.742 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.087 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mt -67.87 -47.06 69.95 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.9 mm-40 -49.73 -46.14 49.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.139 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.26 -46.04 74.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.3 178.26 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.947 HG23 HG21 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -59.48 -46.89 92.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.469 -0.769 . . . . 0.0 109.786 178.591 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.605 ' N ' HG12 ' A' ' 49' ' ' VAL . 9.5 mmm180 -48.02 -50.61 27.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.4 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -48.83 -40.36 29.01 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.606 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 20' ' ' LEU . 70.9 mt -74.02 -30.46 62.45 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.446 -0.783 . . . . 0.0 109.623 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.603 ' N ' HG13 ' A' ' 58' ' ' ILE . 5.8 tp10 -74.49 -62.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.479 -0.763 . . . . 0.0 110.298 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -46.92 -26.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -82.77 7.55 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 73.68 40.03 47.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.869 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -128.83 10.3 5.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.184 -1.186 . . . . 0.0 110.277 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 57' ' ' PHE . 7.5 mm . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 110.212 179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' CG ' ' A' ' 16' ' ' ASP . 6.4 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.339 0.59 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 22.2 mmt-85 -53.0 -34.92 58.49 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 110.357 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.878 HD12 HD22 ' A' ' 40' ' ' LEU . 13.6 mm -75.8 -24.39 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 13' ' ' ASP . 18.0 m-20 -80.6 -55.64 4.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.129 -0.982 . . . . 0.0 110.292 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.08 -43.87 82.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 2.7 m120 -66.32 -41.52 89.53 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.376 -0.827 . . . . 0.0 109.206 178.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 49' ' ' VAL . 6.8 mt -65.06 -34.76 72.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 178.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.872 HD11 HD22 ' A' ' 52' ' ' LEU . 25.8 mt -70.8 -39.2 73.26 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.378 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 17' ' ' ARG . 3.3 m120 -68.91 -30.86 69.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.488 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 66.2 mm-40 -78.34 -32.34 49.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.431 -0.793 . . . . 0.0 109.763 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 HD11 ' A' ' 34' ' ' LEU . 2.5 mm? -73.37 -32.23 64.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 178.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.486 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 19.1 tp60 -74.13 -33.93 63.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.919 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 12.9 pttt -77.58 -34.27 53.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -128.07 76.56 1.7 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.111 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.07 59.59 0.15 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.41 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.299 179.85 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.5 tt -105.74 141.81 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.62 154.97 19.89 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.363 -0.836 . . . . 0.0 110.435 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.847 ' OD1' HD11 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -44.55 -55.3 5.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 0.0 110.369 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' ASN . 86.6 t -38.61 -58.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.175 -0.953 . . . . 0.0 109.552 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -65.12 -39.03 92.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.212 -0.93 . . . . 0.0 108.576 177.088 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.67 -15.07 50.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 178.39 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.562 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 12.7 p -88.0 -50.44 6.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.403 -0.811 . . . . 0.0 111.412 -178.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 13.2 mttt -81.89 -24.1 35.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 111.614 -177.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.596 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -73.66 -15.41 61.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.906 -1.121 . . . . 0.0 110.351 -179.191 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.879 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -104.61 -16.91 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.333 -0.854 . . . . 0.0 109.895 178.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.32 38.8 3.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.879 HD21 ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.67 170.3 20.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.276 . . . . 0.0 110.736 179.262 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.7 m -75.6 160.68 78.75 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.01 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.5 Cg_endo -73.8 -54.51 0.1 Allowed 'Trans proline' 0 C--N 1.287 -2.7 0 O-C-N 123.998 1.525 . . . . 0.0 110.845 -178.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -38.06 -51.64 3.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.752 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 43' ' ' THR . 48.8 Cg_endo -76.12 -43.22 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.756 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 41.8 t -41.6 -43.72 2.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.075 -1.016 . . . . 0.0 108.469 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.01 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.63 -51.3 60.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 2.5 mt-10 -43.24 -38.46 2.57 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.142 -0.973 . . . . 0.0 108.594 177.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.631 ' HG3' HG21 ' A' ' 15' ' ' ILE . 3.5 mmt85 -71.69 -54.52 10.04 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.031 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -60.41 -49.7 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 109.758 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.651 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -41.73 -51.41 4.13 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -51.19 -44.11 61.5 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.679 -0.808 . . . . 0.0 108.836 177.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 20' ' ' LEU . 86.8 mt -66.64 -17.5 64.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.44 -0.787 . . . . 0.0 109.868 178.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' CA ' ' OE1' ' A' ' 53' ' ' GLU . 0.0 OUTLIER -74.36 -64.7 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.246 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -46.95 -26.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.9 . . . . 0.0 110.4 -179.869 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.551 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mm-40 -82.73 7.68 14.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.02 91.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.987 ' O ' HD13 ' A' ' 58' ' ' ILE . 19.3 m-85 -128.43 10.57 6.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.987 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.7 mm . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.331 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.373 0.606 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -54.86 -29.77 56.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.926 HD12 HD22 ' A' ' 40' ' ' LEU . 22.2 mm -67.22 -24.09 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.785 ' HB3' HD11 ' A' ' 52' ' ' LEU . 69.3 m-20 -83.07 -53.63 5.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 110.259 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -53.15 -50.19 65.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.33 -40.06 96.25 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 109.269 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.881 HG21 HG23 ' A' ' 49' ' ' VAL . 7.3 mt -64.52 -34.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.402 -0.811 . . . . 0.0 109.323 178.4 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.862 ' HG ' HD13 ' A' ' 52' ' ' LEU . 9.3 mt -68.91 -42.35 76.94 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 178.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 178.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.471 ' OE1' HG12 ' A' ' 38' ' ' VAL . 11.3 mt-10 -72.57 -31.8 65.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.401 -0.812 . . . . 0.0 109.599 178.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.031 HD21 HD11 ' A' ' 34' ' ' LEU . 2.4 mm? -68.34 -31.68 71.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 178.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -43.5 24.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.525 -0.734 . . . . 0.0 109.888 179.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -72.22 -49.21 36.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.968 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 27' ' ' GLY . 6.1 m-20 -121.98 71.04 0.98 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.244 -0.91 . . . . 0.0 110.071 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 28' ' ' ARG . . . -58.77 -151.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.604 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER 27.93 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.64 -0.918 . . . . 0.0 110.953 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 27' ' ' GLY . 8.8 tt -114.59 128.15 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -75.9 155.75 34.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.867 . . . . 0.0 110.281 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' SER . 7.4 p30 -46.24 -44.45 16.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 31' ' ' ASN . 58.8 t -40.37 -72.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 109.825 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -57.67 -25.01 59.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.865 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.031 HD11 HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.584 -0.697 . . . . 0.0 109.913 179.003 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 31' ' ' ASN . 23.4 p -88.17 -44.14 11.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.541 -0.724 . . . . 0.0 110.967 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -42.1 22.33 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 111.425 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -61.26 -15.81 38.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.512 -178.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.79 HG23 ' HG ' ' A' ' 40' ' ' LEU . 15.1 m -100.41 -23.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 121.266 -0.896 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.99 32.25 4.76 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.926 HD22 HD12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -148.06 168.99 20.94 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.008 -1.289 . . . . 0.0 110.647 179.005 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -72.75 158.41 87.32 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 108.977 177.34 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.055 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.1 Cg_endo -73.93 -46.59 0.31 Allowed 'Trans proline' 0 C--N 1.287 -2.703 0 O-C-N 123.928 1.488 . . . . 0.0 110.744 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.3 -54.81 4.51 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 109.548 179.254 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.1 Cg_endo -77.25 -40.02 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.887 1.467 . . . . 0.0 110.267 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.0 t -38.71 -45.78 1.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.025 . . . . 0.0 108.809 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.055 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -65.3 -50.36 65.97 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 6.1 mm-40 -42.86 -39.29 2.47 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.592 177.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' HG13 ' A' ' 15' ' ' ILE . 1.4 mmt85 -69.47 -55.6 9.79 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.663 0.745 . . . . 0.0 109.071 177.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -55.57 -43.04 71.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.32 -0.862 . . . . 0.0 109.479 178.292 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 10.1 mmt85 -45.86 -56.22 5.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.331 -0.856 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -46.74 -40.36 13.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 177.952 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.862 HD13 ' HG ' ' A' ' 20' ' ' LEU . 21.4 mt -77.4 -19.14 56.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.404 -0.81 . . . . 0.0 109.889 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -72.31 -59.32 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 0.0 110.384 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -57.52 -21.13 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 68.8 mm-40 -79.3 7.63 7.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 64.43 49.74 63.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.924 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.7 m-85 -139.07 17.77 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.279 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.924 HD13 ' O ' ' A' ' 57' ' ' PHE . 7.8 mm . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.338 0.59 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -51.74 -24.45 5.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.298 -0.876 . . . . 0.0 110.306 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.866 HG23 HD22 ' A' ' 40' ' ' LEU . 10.5 mm -75.37 -34.28 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 110.237 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.727 ' HB3' HD11 ' A' ' 52' ' ' LEU . 72.5 m-20 -74.99 -38.25 61.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 110.266 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.5 mtt180 -67.39 -59.73 3.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.3 -31.75 65.97 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.357 -0.839 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.935 HG21 HG23 ' A' ' 49' ' ' VAL . 8.3 mt -69.49 -39.87 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 58' ' ' ILE . 26.1 mt -69.88 -37.37 76.02 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -67.69 -29.06 68.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 178.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 4.6 mm-40 -73.36 -38.02 65.85 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.433 -0.792 . . . . 0.0 109.678 178.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 27' ' ' GLY . 63.7 mt -68.48 -32.91 73.23 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.229 -0.92 . . . . 0.0 109.256 178.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.69 -39.34 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.113 177.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -82.02 -26.9 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 0.0 109.635 178.688 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.571 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -142.0 63.83 1.41 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.47 -0.768 . . . . 0.0 109.932 178.883 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -49.43 -26.5 7.17 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 7.7 mpt_? -92.71 81.1 4.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -1.173 . . . . 0.0 110.493 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 10.0 tt -159.09 138.86 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.341 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -86.8 162.0 18.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.973 179.768 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.686 ' ND2' HD23 ' A' ' 46' ' ' LEU . 2.3 m-80 -53.45 -30.75 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 110.449 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.73 -66.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 109.156 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.2 tp10 -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.27 -0.894 . . . . 0.0 108.671 177.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.6 -14.58 62.12 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 178.286 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 23.5 p -87.04 -43.44 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.499 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -84.78 -17.28 38.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 12.8 mtt-85 -77.75 -16.63 58.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.018 -1.051 . . . . 0.0 110.67 -179.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.906 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -109.5 -7.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.482 -0.761 . . . . 0.0 110.01 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.97 42.88 5.21 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.906 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.64 167.6 28.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.046 -1.267 . . . . 0.0 110.685 179.034 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -73.54 160.76 81.52 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 1.037 ' O ' HD12 ' A' ' 46' ' ' LEU . 52.3 Cg_endo -75.56 -49.64 0.13 Allowed 'Trans proline' 0 C--N 1.286 -2.738 0 O-C-N 123.932 1.491 . . . . 0.0 110.725 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -39.47 -51.55 4.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.795 179.405 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.3 Cg_endo -76.53 -43.12 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.915 1.481 . . . . 0.0 109.727 178.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.738 ' HB2' HD12 ' A' ' 40' ' ' LEU . 51.9 t -41.67 -42.36 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.037 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -67.72 -48.66 65.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 44' ' ' PRO . 66.6 mm-40 -48.05 -39.4 19.91 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.837 177.236 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 1.3 mmt180 -70.02 -51.84 28.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.13 178.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.935 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -59.67 -50.62 79.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.42 -0.8 . . . . 0.0 109.63 178.587 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.675 ' N ' HG12 ' A' ' 49' ' ' VAL . 3.9 mmm180 -45.89 -42.15 12.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -57.31 -38.11 73.5 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.408 -0.807 . . . . 0.0 108.977 178.277 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 16' ' ' ASP . 79.8 mt -74.77 -17.89 60.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.912 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -69.2 -53.82 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.133 -0.979 . . . . 0.0 109.739 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -75.03 -29.1 60.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 110.031 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 4.8 pt20 -140.92 56.06 1.57 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.893 . . . . 0.0 110.421 179.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -166.57 -137.6 2.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 1.074 ' O ' HD13 ' A' ' 58' ' ' ILE . 56.2 m-85 -139.78 83.08 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -1.12 . . . . 0.0 110.284 -179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.074 HD13 ' O ' ' A' ' 57' ' ' PHE . 4.6 mm . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.193 -0.942 . . . . 0.0 110.531 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HE2' ' CA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.815 0.34 . . . . 9.8100000000000005 110.45 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 3' ' ' ASP . 1.2 p -172.61 -165.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.815 -1.178 . . . . 7.7400000000000002 111.274 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.704 ' H ' HG22 ' A' ' 2' ' ' VAL . 54.1 m-20 60.46 -75.06 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.462 -0.774 . . . . 5.7800000000000002 110.813 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 74.45 11.55 4.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.507 -0.746 . . . . 4.5300000000000002 111.304 179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 23.0 mtmt -87.82 35.02 0.72 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.815 -1.178 . . . . 2.79 109.577 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -52.77 -64.12 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 4.96 110.39 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.616 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 6.0 mmt-85 49.39 -154.86 0.01 OUTLIER Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.501 -1.296 . . . . 5.8300000000000001 107.501 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.616 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 41.8 Cg_endo -74.59 58.39 4.58 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.97 -0.819 . . . . 1.9099999999999999 109.97 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 12' ' ' LEU . . . -60.06 -51.02 61.44 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.426 -1.47 . . . . 1.95 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -44.81 -25.83 0.34 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -1.114 . . . . 4.5099999999999998 109.145 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' GLY . 1.8 m-20 -144.05 71.91 1.33 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.58 0.705 . . . . 3.02 109.213 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' A' ' 16' ' ' ASP . 0.7 OUTLIER -130.85 133.07 45.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.602 -0.686 . . . . 1.5900000000000001 110.48 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.85 140.42 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.958 . . . . 1.8300000000000001 110.096 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 9.6 mmt180 -46.52 -32.02 3.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.93 -0.708 . . . . 2.8300000000000001 110.631 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.743 HG23 HD22 ' A' ' 40' ' ' LEU . 6.6 mm -70.12 -37.24 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.46999999999999997 111.63 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.719 ' HB2' HD22 ' A' ' 12' ' ' LEU . 73.3 m-20 -74.67 -54.37 7.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.916 -1.115 . . . . 1.25 111.417 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 1.3 ptm180 -57.08 -46.68 82.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.933 -1.104 . . . . 2.3999999999999999 111.204 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.574 ' HB3' HG12 ' A' ' 38' ' ' VAL . 2.5 m-20 -65.75 -32.79 74.53 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 119.124 -1.03 . . . . 1.99 108.689 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.908 HG21 HG23 ' A' ' 49' ' ' VAL . 9.1 mt -69.38 -38.04 76.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.41999999999999998 108.548 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.06 HD11 HD22 ' A' ' 52' ' ' LEU . 41.4 mt -67.5 -39.02 85.16 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.332 -0.988 . . . . 0.90000000000000002 108.332 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.505 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 36.8 t-20 -65.31 -30.97 71.88 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.983 -0.747 . . . . 1.8400000000000001 108.983 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.775 ' OE1' HG13 ' A' ' 38' ' ' VAL . 7.3 mt-10 -79.45 -32.87 42.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.543 -0.723 . . . . 2.0699999999999998 109.419 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.053 HD21 HD11 ' A' ' 34' ' ' LEU . 2.5 mm? -69.21 -41.61 76.84 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.365 -0.934 . . . . 1.3700000000000001 108.666 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.488 ' HA ' ' OE1' ' A' ' 24' ' ' GLN . 2.2 tp60 -64.67 -38.35 90.71 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.909 -0.774 . . . . 2.0699999999999998 108.909 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -78.08 -20.73 51.71 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.319 -0.993 . . . . 2.1400000000000001 108.319 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 29' ' ' ILE . 1.2 m-20 -141.69 91.02 2.33 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.478 -0.889 . . . . 1.52 109.506 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.54 14.11 37.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.351 -1.099 . . . . 1.5600000000000001 110.351 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.74 28.19 5.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.293 . . . . 3.6400000000000001 110.015 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 26' ' ' ASP . 12.2 tt -105.64 137.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.64000000000000001 110.294 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.828 ' HA ' HD11 ' A' ' 64' ' ' LEU . 7.8 t -77.91 -123.45 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.826 -0.749 . . . . 1.76 110.128 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.684 HD22 HD21 ' A' ' 46' ' ' LEU . 14.2 p30 -122.44 -44.48 2.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.056 -1.028 . . . . 2.2799999999999998 110.086 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.512 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 74.1 t -45.51 -55.45 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.902 -1.124 . . . . 0.51000000000000001 108.428 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -64.32 -47.11 80.66 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.073 -1.454 . . . . 1.77 107.073 177.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.053 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.3 -19.17 3.01 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 121.568 0.699 . . . . 0.90000000000000002 109.839 178.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.55 ' HA ' ' HG ' ' A' ' 45' ' ' CYS . 3.7 p -87.45 -31.13 20.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.47999999999999998 110.586 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -87.19 -31.62 20.25 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.272 -0.893 . . . . 2.1899999999999999 112.586 -178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.553 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 13.3 mtp180 -68.85 -17.81 64.05 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.507 -1.371 . . . . 2.3799999999999999 110.759 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.848 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.8 m -104.94 -11.33 9.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 C-N-CA 119.626 -0.83 . . . . 0.91000000000000003 110.047 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.2 40.11 6.65 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 120.351 -0.928 . . . . 0.46999999999999997 111.362 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.848 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -146.09 171.79 14.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.779 -1.424 . . . . 1.4299999999999999 110.654 179.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 38.4 m -76.39 158.94 80.85 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 107.392 -1.336 . . . . 0.94999999999999996 107.392 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.103 ' O ' HD12 ' A' ' 46' ' ' LEU . 55.9 Cg_endo -77.13 -44.61 0.19 Allowed 'Trans proline' 0 C--N 1.282 -2.96 0 O-C-N 124.189 1.626 . . . . 0.28000000000000003 111.27 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.556 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.34 -52.56 5.81 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.213 -0.929 . . . . 0.67000000000000004 109.099 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.0 Cg_endo -79.76 -38.03 0.41 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.921 1.485 . . . . 0.32000000000000001 110.107 178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' HD12 ' A' ' 40' ' ' LEU . 42.1 t -42.93 -46.75 5.51 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.749 -1.204 . . . . 0.47999999999999998 107.749 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.103 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -62.02 -51.7 66.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.328 -1.36 . . . . 0.38 107.328 177.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -44.75 -37.39 3.73 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.099 -1.04 . . . . 2.0299999999999998 108.212 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.581 ' HG3' HG21 ' A' ' 15' ' ' ILE . 2.6 mmt180 -73.64 -46.17 48.4 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.951 0.881 . . . . 1.8300000000000001 108.717 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.908 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -65.86 -38.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.411 -0.806 . . . . 0.46999999999999997 109.94 179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' HD3' ' CD1' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.74 -45.48 81.96 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.389 -0.967 . . . . 2.0800000000000001 108.389 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -39.45 64.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.138 -1.43 . . . . 2.4100000000000001 107.138 177.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 20' ' ' LEU . 59.3 mt -73.06 -19.97 61.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.584 0.707 . . . . 0.57999999999999996 109.31 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.33 -51.44 13.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 1.8500000000000001 109.869 179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -52.96 -30.15 33.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.527 -0.733 . . . . 3.6200000000000001 110.364 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 13.0 mm-40 -84.33 11.05 9.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 2.5800000000000001 109.843 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.26 48.57 73.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.13 -1.188 . . . . 1.6499999999999999 110.13 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 1.041 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.8 m-85 -129.15 7.8 5.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.059 -1.259 . . . . 2.6400000000000001 110.214 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.041 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.5 mm -135.45 40.71 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.64000000000000001 109.448 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -92.4 -5.9 51.12 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.793 0.806 . . . . 2.3799999999999999 109.166 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -136.56 -40.17 0.13 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.425 -1.87 . . . . 2.25 108.425 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 9.5 m-30 -57.73 -111.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -1.038 . . . . 5.5099999999999998 109.651 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.799 HG21 HG21 ' A' ' 49' ' ' VAL . 6.6 t -89.06 22.07 2.91 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.318 -1.353 . . . . 1.49 109.827 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -40.08 -30.74 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.058 0.933 . . . . 1.9299999999999999 108.489 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.828 HD11 ' HA ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -54.89 -32.41 60.92 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.049 0.928 . . . . 1.96 110.949 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.834 HD22 ' CG1' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -40.94 -24.94 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.436 0.636 . . . . 2.29 111.236 -179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.562 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 22.1 t-20 . . . . . 0 C--N 1.294 -1.809 0 CA-C-O 117.943 -1.027 . . . . 3.54 110.252 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.3 t -82.6 79.15 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.0 110.465 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 t0 44.44 86.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.229 -0.919 . . . . 0.0 110.316 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 66.8 m -152.16 -36.79 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.532 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 2.0 mttt 67.5 48.29 1.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.92 78.41 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 110.148 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.589 ' HB3' ' CG ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -71.9 -57.63 3.9 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.552 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HG2' HD11 ' A' ' 12' ' ' LEU . 41.6 Cg_endo -69.83 -48.95 0.6 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.973 1.512 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 72.24 170.82 15.69 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 11' ' ' ASP . 1.9 tttt 51.67 -141.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -1.157 . . . . 0.0 110.113 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 10' ' ' LYS . 5.0 m-20 -43.46 107.45 0.09 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.073 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.59 HD11 ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -138.12 130.88 29.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.959 . . . . 0.0 110.473 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.436 ' HB2' ' NH2' ' A' ' 51' ' ' ARG . 3.7 t70 -72.23 131.14 42.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 110.002 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 7.1 tpp85 -44.68 -33.89 2.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 0.0 110.382 -179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.854 HG23 HD22 ' A' ' 40' ' ' LEU . 9.3 mm -73.67 -20.91 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.697 ' CB ' HD11 ' A' ' 52' ' ' LEU . 2.9 m-20 -85.17 -59.53 2.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 0.0 110.142 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.501 ' HD2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -53.99 -40.21 66.71 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.128 -0.982 . . . . 0.0 110.099 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.536 ' HB3' HG12 ' A' ' 38' ' ' VAL . 10.1 m120 -69.56 -41.37 75.98 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.331 -0.856 . . . . 0.0 109.218 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.945 HG21 ' CG2' ' A' ' 49' ' ' VAL . 18.6 mt -67.87 -33.75 63.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.659 -0.816 . . . . 0.0 109.28 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.764 HD11 HD22 ' A' ' 52' ' ' LEU . 14.3 mt -68.78 -36.47 78.34 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.532 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 5.4 t-20 -66.2 -37.62 86.01 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.383 -0.823 . . . . 0.0 109.108 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.685 ' CD ' HG13 ' A' ' 38' ' ' VAL . 98.9 mt-10 -68.78 -39.24 80.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.422 -0.799 . . . . 0.0 109.707 178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.747 HD22 ' HB3' ' A' ' 61' ' ' TYR . 43.7 mt -64.38 -24.93 67.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.351 -0.843 . . . . 0.0 109.592 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -75.97 -39.13 56.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -84.01 -24.56 30.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.775 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD1' ' NE ' ' A' ' 28' ' ' ARG . 1.5 m-20 -133.85 90.57 2.72 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.04 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.12 9.8 51.88 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.485 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -123.07 39.36 3.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -1.131 . . . . 0.0 110.294 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.491 HG13 ' HB3' ' A' ' 33' ' ' GLU . 7.5 tt -117.86 139.8 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.379 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.036 ' HA ' HD11 ' A' ' 64' ' ' LEU . 9.1 t -86.96 -108.09 0.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.809 . . . . 0.0 110.347 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 35' ' ' SER . 1.8 p-10 -128.58 -45.72 1.32 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 0.0 110.27 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.434 HG23 ' ND2' ' A' ' 31' ' ' ASN . 93.8 t -46.03 -61.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.954 -1.091 . . . . 0.0 109.119 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HB3' HG13 ' A' ' 29' ' ' ILE . 1.6 tp10 -64.05 -28.13 69.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.224 -0.923 . . . . 0.0 108.944 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.808 HD21 HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -75.09 -15.3 60.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.496 -0.753 . . . . 0.0 109.713 178.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 31' ' ' ASN . 28.0 p -86.57 -44.18 12.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.567 -0.708 . . . . 0.0 110.597 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -82.0 -21.86 36.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.283 -0.886 . . . . 0.0 110.89 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 31.8 mtt-85 -70.74 -19.25 62.75 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.032 -1.042 . . . . 0.0 110.364 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.873 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -110.12 -9.24 11.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 O-C-N 121.488 -0.758 . . . . 0.0 109.879 179.206 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.15 40.56 5.46 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.873 HD21 ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -150.74 159.31 44.61 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.984 -1.304 . . . . 0.0 110.526 178.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.528 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.0 OUTLIER -67.0 156.32 88.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 O-C-N 121.33 -0.856 . . . . 0.0 108.858 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.119 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.6 Cg_endo -72.01 -49.59 0.3 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 124.022 1.538 . . . . 0.0 110.496 -178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -35.98 -55.39 1.3 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.237 -0.914 . . . . 0.0 109.61 179.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.1 Cg_endo -75.83 -41.85 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.962 1.507 . . . . 0.0 110.007 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.555 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 35.9 t -39.9 -52.6 2.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.116 -0.99 . . . . 0.0 108.662 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.119 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -55.18 -49.03 72.92 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -45.51 -44.96 13.0 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.431 -0.793 . . . . 0.0 109.134 177.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.543 ' HD3' ' HB ' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.48 -51.89 31.7 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.594 0.711 . . . . 0.0 109.665 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.945 ' CG2' HG21 ' A' ' 19' ' ' ILE . 2.9 t -64.44 -59.2 4.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.615 ' CD ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -40.5 -45.71 2.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -51.75 -46.9 64.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.54 -0.864 . . . . 0.0 108.852 177.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.764 HD22 HD11 ' A' ' 20' ' ' LEU . 12.9 mt -62.95 -27.66 69.55 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.414 -0.804 . . . . 0.0 109.665 178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' OE1' ' CB ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -66.69 -56.82 8.83 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 110.324 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 47.2 mtp180 -45.96 -24.43 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.355 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.648 ' CB ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mm-40 -95.7 3.95 53.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.905 . . . . 0.0 110.307 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.91 44.35 19.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.999 ' O ' HD13 ' A' ' 58' ' ' ILE . 19.0 m-30 -116.65 0.93 12.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.107 -1.231 . . . . 0.0 110.177 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.999 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.9 mm -138.8 53.41 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 110.327 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -94.62 -17.6 22.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.474 -0.766 . . . . 0.0 109.6 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -122.07 -37.98 0.63 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.747 ' HB3' HD22 ' A' ' 23' ' ' LEU . 21.5 m-85 -57.9 -116.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -1.074 . . . . 0.0 109.859 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.937 ' O ' HD12 ' A' ' 65' ' ' LEU . 9.4 t -89.79 26.75 1.7 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.95 -1.094 . . . . 0.0 109.781 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -38.19 -29.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.613 -0.679 . . . . 0.0 109.669 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.036 HD11 ' HA ' ' A' ' 30' ' ' SER . 1.7 pp -56.27 -33.8 65.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 110.205 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.11 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -67.07 -5.29 12.6 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.613 -0.68 . . . . 0.0 110.53 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 1.11 ' N ' HD13 ' A' ' 65' ' ' LEU . 43.2 p-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.315 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.201 0.524 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.4 m -130.84 9.41 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -146.63 44.92 1.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 110.343 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' ASP . 0.5 OUTLIER -46.46 174.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.208 -0.933 . . . . 0.0 110.255 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER 55.86 -140.12 0.91 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -35.69 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.313 -0.867 . . . . 0.0 110.331 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.593 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -69.26 -60.46 4.11 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.555 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 44.3 Cg_endo -72.95 -36.22 4.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.986 1.519 . . . . 0.0 110.437 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.558 ' CA ' HD12 ' A' ' 12' ' ' LEU . . . 57.2 -136.86 50.11 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 9' ' ' GLY . 2.7 tptp 41.37 -140.62 0.1 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.275 -1.133 . . . . 0.0 110.238 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 10.6 p30 -58.92 100.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.116 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.558 HD12 ' CA ' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -138.3 122.92 18.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 110.326 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' OD2' ' A' ' 16' ' ' ASP . 4.6 p-10 -59.29 135.33 57.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.286 -0.883 . . . . 0.0 110.033 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 3.8 tpt180 -48.42 -20.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.249 -0.907 . . . . 0.0 110.37 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.885 HD12 HD22 ' A' ' 40' ' ' LEU . 7.6 mm -73.92 -45.2 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' OD2' ' NE ' ' A' ' 51' ' ' ARG . 47.7 m-20 -70.62 -35.74 73.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -69.22 -65.16 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 1.6 t-20 -52.61 -26.52 13.74 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.399 -0.813 . . . . 0.0 109.321 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 15' ' ' ILE . 3.2 mt -70.07 -47.26 69.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.604 ' CG ' HD13 ' A' ' 52' ' ' LEU . 40.7 mt -64.27 -33.15 75.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.117 -0.989 . . . . 0.0 109.19 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 47.0 t30 -70.43 -28.45 65.05 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.359 -0.838 . . . . 0.0 109.408 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' OE1' ' CB ' ' A' ' 37' ' ' ARG . 3.6 mm-40 -78.55 -35.46 46.05 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.469 -0.769 . . . . 0.0 109.959 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.093 HD21 HD11 ' A' ' 34' ' ' LEU . 2.9 mm? -68.67 -35.84 77.74 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -74.75 -36.82 62.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.778 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -76.82 -36.59 56.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.82 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -122.22 76.5 1.31 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.334 -0.854 . . . . 0.0 110.164 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' A' ' 28' ' ' ARG . . . -67.8 58.14 0.35 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -173.77 36.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 0.0 110.007 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -123.51 153.38 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 110.466 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.805 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -100.06 -94.03 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 110.348 -179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 3.3 p30 -138.76 -46.0 0.49 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.19 -0.944 . . . . 0.0 110.299 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.483 ' N ' ' CG ' ' A' ' 31' ' ' ASN . 31.0 t -44.99 -64.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.992 -1.067 . . . . 0.0 109.412 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 5.7 tp10 -62.01 -27.39 68.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.207 -0.933 . . . . 0.0 108.816 177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.093 HD11 HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -73.71 -16.04 61.21 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.524 -0.735 . . . . 0.0 109.401 178.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -88.98 -36.49 15.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.721 -0.612 . . . . 0.0 110.679 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.9 -50.25 8.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.246 -0.909 . . . . 0.0 111.188 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.539 ' CB ' ' OE1' ' A' ' 22' ' ' GLU . 7.3 mtp85 -54.84 -17.06 3.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.126 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.812 ' HB ' HD21 ' A' ' 40' ' ' LEU . 15.7 m -100.42 -21.65 5.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.546 -0.721 . . . . 0.0 109.916 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.26 39.04 4.62 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.885 HD22 HD12 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -153.14 166.75 31.53 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.905 -1.35 . . . . 0.0 110.744 178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -68.65 155.08 93.75 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.868 177.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.083 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.8 Cg_endo -74.06 -45.65 0.35 Allowed 'Trans proline' 0 C--N 1.286 -2.713 0 O-C-N 123.992 1.522 . . . . 0.0 110.737 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.96 -55.61 3.69 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.9 Cg_endo -75.64 -39.74 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.915 1.482 . . . . 0.0 110.026 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 51.6 t -39.43 -47.25 1.79 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.167 -0.958 . . . . 0.0 108.731 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.083 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.19 -49.97 72.14 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 14.5 mt-10 -46.97 -37.91 9.82 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.219 -0.925 . . . . 0.0 108.817 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -70.77 -58.0 4.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.464 -0.772 . . . . 0.0 109.101 177.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.896 HG11 HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -54.03 -50.45 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.23 -0.919 . . . . 0.0 109.17 177.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.552 ' HA ' ' HB2' ' A' ' 53' ' ' GLU . 18.1 mmt180 -41.76 -53.81 3.54 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.384 -0.822 . . . . 0.0 109.533 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.511 ' NE ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -46.61 -44.15 17.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.735 177.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' ' 58' ' ' ILE . 66.4 mt -69.95 -26.02 63.92 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.475 -0.766 . . . . 0.0 109.516 178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -71.13 -66.42 0.62 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 110.134 179.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -56.34 -24.51 44.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.831 . . . . 0.0 110.194 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.604 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 8.8 mm100 -79.45 5.13 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.248 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 68.4 48.69 49.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.605 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.0 m-85 -134.06 8.54 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.756 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 17.0 mm -131.04 42.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.275 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -79.66 -3.26 46.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.38 -0.825 . . . . 0.0 109.762 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -144.42 -37.63 0.07 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.587 ' HB3' ' CB ' ' A' ' 23' ' ' LEU . 8.8 m-30 -56.21 -116.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -1.08 . . . . 0.0 110.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.969 ' O ' HD23 ' A' ' 65' ' ' LEU . 15.1 t -88.5 26.09 1.54 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.921 -1.112 . . . . 0.0 109.892 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -34.72 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.523 0.678 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -58.79 -110.55 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.498 -0.751 . . . . 0.0 109.445 178.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.969 HD23 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER 37.04 29.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.817 . . . . 0.0 110.419 179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.25 0.548 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.43 167.28 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.393 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -132.38 95.6 3.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m -149.86 -179.23 6.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.311 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HD3' ' HG3' ' A' ' 24' ' ' GLN . 1.3 mmpp? 50.71 88.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.186 -0.946 . . . . 0.0 110.186 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.37 -95.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.268 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.751 ' HG2' HD13 ' A' ' 20' ' ' LEU . 2.5 mpp_? 53.34 -171.96 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.043 -1.036 . . . . 0.0 109.187 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 38.1 Cg_endo -67.86 56.85 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.42 1.221 . . . . 0.0 109.95 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -45.61 -36.74 6.37 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 12' ' ' LEU . 7.3 pttt -60.09 -130.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -1.121 . . . . 0.0 110.013 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 5.0 m-20 -52.06 90.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.088 -1.007 . . . . 0.0 110.182 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.5 OUTLIER -129.14 150.05 50.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 110.263 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.8 145.17 26.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.159 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 15.2 mmt180 -53.15 -39.3 63.45 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.281 -0.887 . . . . 0.0 110.496 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.768 HG23 HD22 ' A' ' 40' ' ' LEU . 4.4 mm -72.8 -21.17 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.735 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.782 ' HB3' HD21 ' A' ' 52' ' ' LEU . 96.2 m-20 -86.33 -56.62 3.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.019 -1.051 . . . . 0.0 110.639 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.531 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 8.3 ptt85 -57.18 -42.55 81.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.162 -0.961 . . . . 0.0 110.271 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -68.3 -41.87 80.27 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.409 -0.807 . . . . 0.0 109.384 178.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.924 HG21 ' CG2' ' A' ' 49' ' ' VAL . 6.1 mt -65.72 -30.27 49.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.23 -0.918 . . . . 0.0 109.357 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.751 HD13 ' HG2' ' A' ' 7' ' ' ARG . 14.3 mt -74.01 -44.62 53.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.186 -0.946 . . . . 0.0 109.614 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 18.3 t30 -64.78 -28.16 69.38 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.588 ' OE1' HG13 ' A' ' 38' ' ' VAL . 8.9 mt-10 -76.46 -38.94 54.61 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.368 -0.832 . . . . 0.0 109.943 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.929 HD13 ' HB3' ' A' ' 61' ' ' TYR . 14.7 mt -68.67 -26.89 65.54 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.487 ' HG3' ' HD3' ' A' ' 5' ' ' LYS . 1.0 OUTLIER -70.46 -43.93 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.39 -0.819 . . . . 0.0 109.264 178.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.77 -25.61 56.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 109.517 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -137.69 87.94 2.29 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.43 -0.794 . . . . 0.0 109.911 179.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.55 7.69 46.43 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.602 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -114.67 28.21 8.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.214 -1.168 . . . . 0.0 110.147 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 26' ' ' ASP . 6.9 tt -108.9 137.33 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.385 -0.822 . . . . 0.0 110.296 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 3.4 p -94.72 157.68 15.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.384 -0.822 . . . . 0.0 110.222 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.5 OUTLIER -42.26 -49.19 5.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.456 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 31' ' ' ASN . 78.7 t -44.05 -65.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.958 -1.089 . . . . 0.0 109.402 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.9 OUTLIER -61.89 -28.7 69.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.22 -0.925 . . . . 0.0 108.782 177.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -72.69 -14.63 61.62 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.434 0.635 . . . . 0.0 109.794 178.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 25.1 p -86.74 -43.34 12.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.423 -0.798 . . . . 0.0 110.461 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -16.53 46.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.254 -0.904 . . . . 0.0 111.221 -178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -81.29 -15.54 55.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.977 -1.077 . . . . 0.0 110.773 -179.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.882 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -108.35 -8.44 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.223 -0.923 . . . . 0.0 109.874 179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.78 40.63 4.91 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.882 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -151.77 165.63 33.84 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -1.23 . . . . 0.0 110.549 179.17 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.25 157.07 85.33 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.303 -0.873 . . . . 0.0 108.786 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.111 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.5 Cg_endo -72.25 -44.8 0.74 Allowed 'Trans proline' 0 C--N 1.286 -2.729 0 O-C-N 124.005 1.529 . . . . 0.0 110.539 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.06 -55.87 4.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.037 -1.039 . . . . 0.0 109.363 178.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.4 Cg_endo -75.35 -42.2 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.901 1.474 . . . . 0.0 110.202 178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.701 ' HB2' HD12 ' A' ' 40' ' ' LEU . 42.5 t -40.14 -51.02 2.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 0.0 108.708 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.111 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -58.26 -46.4 86.07 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -48.47 -42.59 33.15 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.318 -0.864 . . . . 0.0 108.959 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -69.21 -55.32 10.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.695 0.76 . . . . 0.0 109.555 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.924 ' CG2' HG21 ' A' ' 19' ' ' ILE . 1.6 t -59.06 -55.51 23.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.976 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.563 ' CD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -39.8 -50.02 2.37 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.405 -0.81 . . . . 0.0 109.645 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.03 -47.2 33.72 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.697 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.795 ' HB3' HD11 ' A' ' 58' ' ' ILE . 97.0 mt -59.61 -26.26 65.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.455 -0.778 . . . . 0.0 109.569 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.1 OUTLIER -68.22 -57.58 5.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.341 -0.849 . . . . 0.0 110.248 179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -46.58 -36.63 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.247 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 7.8 mm-40 -81.82 8.38 10.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.28 60.11 7.54 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 1.013 ' O ' HD13 ' A' ' 58' ' ' ILE . 14.8 m-85 -135.38 12.54 3.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 110.312 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.013 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.2 mm -137.23 52.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.217 -0.927 . . . . 0.0 110.24 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -88.08 -10.96 48.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.458 -0.776 . . . . 0.0 109.604 178.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.51 -37.75 0.15 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.929 ' HB3' HD13 ' A' ' 23' ' ' LEU . 22.0 m-85 -64.44 -102.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.411 -1.052 . . . . 0.0 110.11 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.908 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -80.42 6.96 10.79 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 109.97 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.928 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -40.58 -27.71 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.405 -0.809 . . . . 0.0 110.036 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 65' ' ' LEU . 1.6 pp -57.7 -41.1 81.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.361 -0.837 . . . . 0.0 110.656 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.908 HD23 ' O ' ' A' ' 62' ' ' THR . 1.8 pp -41.96 97.06 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.417 -0.802 . . . . 0.0 110.148 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.057 . . . . 0.0 110.33 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptt? . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.241 0.544 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 2' ' ' VAL . 16.0 m -105.43 0.61 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 110.21 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 1.3 p30 -150.52 86.69 1.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 0.0 110.196 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 5' ' ' LYS . 2.1 m -168.24 137.19 2.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 15.7 mtmt 42.95 81.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 0.0 110.305 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -174.18 82.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.377 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.552 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -75.95 -59.06 1.21 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.207 -0.933 . . . . 0.0 110.456 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 43.0 Cg_endo -71.7 -46.89 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.871 1.458 . . . . 0.0 110.453 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 64.04 -74.66 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.55 10.12 16.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.211 -1.17 . . . . 0.0 110.186 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 12' ' ' LEU . 31.0 m-20 -132.87 72.19 1.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 110.334 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 3.0 pp 179.82 140.24 0.13 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.371 -0.831 . . . . 0.0 110.483 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 7.7 t70 -79.81 156.12 27.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.214 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -45.5 -30.17 1.35 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.316 -0.865 . . . . 0.0 110.248 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.913 HG21 ' HD3' ' A' ' 48' ' ' ARG . 17.9 mm -73.54 -18.76 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.877 . . . . 0.0 110.569 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.685 ' CA ' HD11 ' A' ' 52' ' ' LEU . 0.7 OUTLIER -84.27 -48.61 9.57 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.121 -0.987 . . . . 0.0 110.179 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -61.07 -47.82 84.59 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.222 -0.924 . . . . 0.0 110.583 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 19' ' ' ILE . 33.9 p-10 -66.18 -37.64 86.09 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.016 -1.052 . . . . 0.0 109.283 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.973 HG21 HG23 ' A' ' 49' ' ' VAL . 5.8 mt -64.38 -29.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.234 -0.916 . . . . 0.0 109.23 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.081 HD11 HD22 ' A' ' 52' ' ' LEU . 40.7 mt -72.23 -46.77 54.66 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.662 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.49 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.3 t30 -61.41 -29.15 69.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.382 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 3.4 mm-40 -74.87 -36.93 62.28 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.433 -0.792 . . . . 0.0 109.705 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.929 HD21 HD11 ' A' ' 34' ' ' LEU . 2.9 mm? -66.17 -37.77 86.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.338 -0.851 . . . . 0.0 109.669 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.546 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -72.83 -35.92 67.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.784 178.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -81.45 -24.49 36.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.835 . . . . 0.0 109.882 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ARG . 1.4 m-20 -125.06 69.72 1.14 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 110.291 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.58 61.74 0.11 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.69 32.02 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.367 -1.078 . . . . 0.0 109.83 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.528 HG13 ' HB3' ' A' ' 33' ' ' GLU . 16.4 tt -124.71 151.6 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.355 -0.841 . . . . 0.0 110.256 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.812 ' O ' HD12 ' A' ' 34' ' ' LEU . 35.7 m -102.9 -92.96 0.33 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.214 -0.929 . . . . 0.0 110.333 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.861 HD22 HD11 ' A' ' 46' ' ' LEU . 16.2 p-10 -139.37 -47.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.2 -0.938 . . . . 0.0 110.26 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' ASN . 78.8 t -45.91 -65.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.961 -1.087 . . . . 0.0 109.129 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB3' HG13 ' A' ' 29' ' ' ILE . 11.9 tp10 -61.27 -27.71 68.66 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.195 -0.94 . . . . 0.0 108.756 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.929 HD11 HD21 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -72.86 -16.26 61.59 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.518 -0.739 . . . . 0.0 109.543 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.567 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 24.6 p -88.25 -39.87 14.1 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.527 -0.733 . . . . 0.0 110.712 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 mtmm -82.58 -27.28 31.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.212 -0.93 . . . . 0.0 110.923 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 8.1 mtt180 -69.17 -17.37 63.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.12 -0.988 . . . . 0.0 110.379 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.846 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -110.05 -6.02 11.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 O-C-N 121.49 -0.756 . . . . 0.0 109.913 179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.65 44.96 5.93 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.846 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -156.19 167.77 29.39 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.002 -1.293 . . . . 0.0 110.84 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.54 ' C ' ' HB2' ' A' ' 35' ' ' SER . 4.6 m -72.89 154.41 90.99 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.528 -0.732 . . . . 0.0 109.149 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.067 ' O ' HD12 ' A' ' 46' ' ' LEU . 50.1 Cg_endo -73.85 -49.2 0.21 Allowed 'Trans proline' 0 C--N 1.288 -2.621 0 O-C-N 124.06 1.558 . . . . 0.0 110.733 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.575 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -36.52 -53.46 1.74 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 48.8 Cg_endo -75.85 -45.28 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.915 1.482 . . . . 0.0 109.969 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.525 ' HB2' HD12 ' A' ' 40' ' ' LEU . 18.3 t -38.68 -52.01 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 108.898 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.067 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.71 -49.88 75.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.01 -43.87 4.43 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.367 -0.833 . . . . 0.0 109.01 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.913 ' HD3' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.06 -42.04 63.5 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.546 -0.721 . . . . 0.0 109.629 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.98 HG13 HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -67.37 -46.97 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.304 -0.873 . . . . 0.0 109.756 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.596 ' N ' HG12 ' A' ' 49' ' ' VAL . 1.3 mtm180 -47.84 -51.3 23.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.174 -0.954 . . . . 0.0 109.118 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -48.85 -45.95 41.58 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.42 -0.8 . . . . 0.0 108.853 177.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.081 HD22 HD11 ' A' ' 20' ' ' LEU . 86.5 mt -63.31 -17.69 62.81 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.443 -0.785 . . . . 0.0 109.448 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.825 ' HG3' HD21 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -75.66 -53.2 8.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.471 -0.768 . . . . 0.0 110.215 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -55.3 -33.22 63.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -76.22 -0.96 24.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.36 40.64 23.12 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.941 ' CE2' HD13 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -119.72 -0.08 10.82 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.165 -1.197 . . . . 0.0 110.161 179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.892 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.2 mm -134.59 46.57 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.287 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.516 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 6.8 pt20 -82.9 -6.61 59.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.302 -0.874 . . . . 0.0 109.622 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.431 ' N ' ' HB2' ' A' ' 63' ' ' ALA . . . -143.4 -44.48 0.05 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.595 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 25.1 m-85 -54.88 -101.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -1.141 . . . . 0.0 110.008 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.006 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -82.27 8.47 11.08 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.944 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.877 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -39.36 -28.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.456 -0.778 . . . . 0.0 109.808 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' A' ' 66' ' ' ASN . 1.0 OUTLIER -57.35 -34.87 69.23 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.392 -0.817 . . . . 0.0 110.526 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.006 HD23 ' O ' ' A' ' 62' ' ' THR . 1.4 pp -41.26 90.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.502 -0.749 . . . . 0.0 110.312 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.5 t-20 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.283 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.253 0.549 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.69 104.66 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -100.69 72.64 1.55 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 110.175 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER -149.13 -78.41 0.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.347 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HE3' ' HG3' ' A' ' 24' ' ' GLN . 5.6 mmpt? 54.77 33.32 19.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 110.017 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -177.75 63.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.992 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.573 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 4.2 mtt180 -86.55 -50.84 0.46 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 110.523 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD3' ' CB ' ' A' ' 7' ' ' ARG . 49.6 Cg_endo -84.48 24.02 0.79 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.953 1.502 . . . . 0.0 110.617 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.502 ' HA3' ' HG ' ' A' ' 12' ' ' LEU . . . -165.72 81.08 0.11 Allowed Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 2.6 tptt -43.71 125.08 3.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -1.197 . . . . 0.0 109.425 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' O ' ' C ' ' A' ' 12' ' ' LEU . 61.1 m-20 55.61 37.75 29.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.406 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.717 HD21 ' NH1' ' A' ' 51' ' ' ARG . 1.1 mt -32.36 149.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.64 -0.663 . . . . 0.0 110.924 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 38.0 m-20 -45.51 153.01 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.327 -0.858 . . . . 0.0 110.005 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' CB ' ' A' ' 18' ' ' ASN . 18.3 mmt-85 -62.04 -16.9 55.24 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 110.318 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 40' ' ' LEU . 7.9 mm -84.87 -49.75 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 0.0 109.833 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.542 ' HB2' HD22 ' A' ' 12' ' ' LEU . 2.6 m-20 -71.67 -40.02 69.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.92 . . . . 0.0 110.145 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.5 OUTLIER -71.68 -46.16 59.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 110.027 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.583 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 52.1 t30 -67.29 -34.31 77.14 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.271 -0.893 . . . . 0.0 109.22 178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.881 HG21 HG23 ' A' ' 49' ' ' VAL . 8.0 mt -63.68 -39.64 86.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.458 -0.777 . . . . 0.0 109.186 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.053 HD11 HD22 ' A' ' 52' ' ' LEU . 80.3 mt -68.31 -45.93 71.64 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.251 -0.906 . . . . 0.0 109.151 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -60.15 -37.41 80.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.332 -0.855 . . . . 0.0 109.183 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.69 -40.96 76.03 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.378 -0.826 . . . . 0.0 109.466 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.035 HD21 HD11 ' A' ' 34' ' ' LEU . 2.7 mm? -64.44 -37.84 88.94 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.307 -0.871 . . . . 0.0 109.288 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.487 ' HG3' ' HE3' ' A' ' 5' ' ' LYS . 8.5 tm0? -69.32 -44.9 70.76 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 109.508 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -74.36 -19.85 60.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.959 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -148.98 61.68 1.05 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.395 -0.815 . . . . 0.0 110.112 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -52.84 -28.67 32.06 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -76.8 51.7 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -1.138 . . . . 0.0 110.345 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 26' ' ' ASP . 18.9 tt -138.73 154.07 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.31 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.931 ' HA ' HD11 ' A' ' 64' ' ' LEU . 42.1 t -99.93 -115.61 0.16 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.317 -0.864 . . . . 0.0 110.352 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.666 ' CB ' HD21 ' A' ' 46' ' ' LEU . 9.6 p30 -121.21 -46.4 2.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 0.0 110.282 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.3 t -44.58 -62.27 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 120.995 -1.066 . . . . 0.0 109.416 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.05 -24.91 67.88 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.255 -0.903 . . . . 0.0 108.786 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.035 HD11 HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -76.77 -15.65 59.69 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.567 -0.708 . . . . 0.0 109.499 178.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.55 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 16.5 p -88.08 -38.81 15.11 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.538 -0.726 . . . . 0.0 110.629 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -31.38 23.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.295 -0.878 . . . . 0.0 110.916 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -65.12 -16.63 63.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.132 -0.98 . . . . 0.0 110.351 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.884 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.2 m -109.65 -11.99 11.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 110.036 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.81 42.55 5.04 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.884 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.75 166.28 32.68 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.956 -1.32 . . . . 0.0 110.734 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.502 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -70.32 155.55 93.26 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 108.786 177.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.069 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.3 Cg_endo -74.29 -42.91 0.59 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 O-C-N 123.808 1.425 . . . . 0.0 110.556 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.97 -57.51 2.06 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.731 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 50.0 Cg_endo -76.47 -41.57 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.843 1.444 . . . . 0.0 110.205 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.721 ' HB2' HD12 ' A' ' 40' ' ' LEU . 53.8 t -39.21 -45.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.996 -1.065 . . . . 0.0 108.825 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.069 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.49 -47.99 74.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.5 OUTLIER -48.06 -39.35 19.77 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.685 177.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' CD ' HG21 ' A' ' 15' ' ' ILE . 5.4 mmt180 -70.64 -46.86 62.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.665 0.745 . . . . 0.0 109.16 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.931 HG21 HG21 ' A' ' 62' ' ' THR . 0.5 OUTLIER -64.33 -45.29 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.374 -0.829 . . . . 0.0 109.847 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.874 ' HD2' HD11 ' A' ' 65' ' ' LEU . 12.6 mmm-85 -47.59 -49.35 26.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.449 -0.782 . . . . 0.0 109.465 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.717 ' NH1' HD21 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -51.16 -43.43 61.25 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.882 178.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.053 HD22 HD11 ' A' ' 20' ' ' LEU . 93.8 mt -66.61 -16.67 64.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.432 -0.793 . . . . 0.0 109.891 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -78.08 -61.19 2.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 0.0 110.523 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -49.87 -29.68 8.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.649 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.765 ' NE2' HD23 ' A' ' 52' ' ' LEU . 4.1 pt20 -82.51 12.23 4.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.392 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.39 52.78 44.0 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.949 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -131.42 8.41 4.63 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.243 -1.151 . . . . 0.0 110.15 179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.949 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.7 mm -140.8 51.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.46 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -83.03 -11.71 57.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.925 . . . . 0.0 109.956 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.01 -40.14 0.1 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.658 ' CA ' HD12 ' A' ' 23' ' ' LEU . 20.4 m-85 -58.75 -102.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -1.078 . . . . 0.0 110.111 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.931 HG21 HG21 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -84.15 11.58 7.87 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.034 -1.041 . . . . 0.0 110.08 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.938 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -38.28 -29.73 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.389 -0.819 . . . . 0.0 109.856 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.931 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -62.91 -115.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.403 -0.811 . . . . 0.0 110.022 179.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.874 HD11 ' HD2' ' A' ' 50' ' ' ARG . 0.3 OUTLIER 37.89 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 64' ' ' LEU . 7.4 t30 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.329 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.189 0.518 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 31.9 t -77.52 158.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 110.363 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 2' ' ' VAL . 86.2 m-20 53.64 55.93 7.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.258 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 t -139.0 142.59 38.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.539 ' HE3' ' NE2' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -107.43 74.4 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 110.166 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -103.7 -60.02 1.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.378 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.626 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 45.23 -168.64 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 121.301 -0.874 . . . . 0.0 109.064 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 7' ' ' ARG . 39.7 Cg_endo -72.53 56.83 2.85 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.261 1.138 . . . . 0.0 109.811 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . -60.41 -134.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 11' ' ' ASP . 9.8 ttmt 42.12 -105.39 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.233 -1.157 . . . . 0.0 109.944 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.47 ' N ' ' HG2' ' A' ' 10' ' ' LYS . 33.7 p-10 -73.3 79.61 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.155 -0.966 . . . . 0.0 109.965 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 16' ' ' ASP . 13.5 tp -151.83 140.36 20.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 110.32 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.07 135.21 56.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.471 ' HD2' ' NE ' ' A' ' 17' ' ' ARG . 17.1 mmt-85 -49.59 -20.58 0.8 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 110.318 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.918 HG23 HD22 ' A' ' 40' ' ' LEU . 10.2 mm -74.66 -24.33 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.269 -0.894 . . . . 0.0 110.436 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' CA ' HD11 ' A' ' 52' ' ' LEU . 50.2 m-20 -84.36 -56.52 3.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.0 110.372 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -56.75 -43.94 81.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.035 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.532 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 16.4 m120 -64.78 -41.2 96.02 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.397 -0.814 . . . . 0.0 109.011 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.871 HG21 HG23 ' A' ' 49' ' ' VAL . 3.5 mt -62.0 -39.59 84.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.444 -0.785 . . . . 0.0 109.264 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.827 HD11 HD22 ' A' ' 52' ' ' LEU . 16.0 mt -66.56 -40.91 89.25 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.235 -0.916 . . . . 0.0 109.358 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -66.66 -32.4 73.7 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.385 -0.822 . . . . 0.0 109.446 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.739 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -78.61 -31.22 46.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.441 -0.787 . . . . 0.0 109.62 178.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.802 ' CD2' HD11 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -73.33 -31.91 64.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.371 -0.83 . . . . 0.0 109.571 178.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.539 ' NE2' ' HE3' ' A' ' 5' ' ' LYS . 3.5 tp-100 -78.15 -36.63 47.45 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.395 -0.816 . . . . 0.0 109.769 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 30.0 pttt -74.67 -33.56 62.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.719 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.67 68.21 0.86 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.087 179.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.09 60.66 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -175.37 28.67 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.384 -1.068 . . . . 0.0 109.658 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.739 HG21 ' OE2' ' A' ' 22' ' ' GLU . 16.1 tt -116.6 146.56 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.408 -0.808 . . . . 0.0 110.218 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.5 t -91.66 -91.42 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 110.275 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 35' ' ' SER . 2.3 p-10 -143.74 -47.4 0.28 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 59.3 t -44.25 -61.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.013 -1.054 . . . . 0.0 109.177 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HB3' HG13 ' A' ' 29' ' ' ILE . 4.2 tp10 -62.81 -31.95 73.04 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.278 -0.888 . . . . 0.0 108.805 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.802 HD11 ' CD2' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -70.28 -15.25 62.87 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.603 -0.686 . . . . 0.0 109.487 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.7 p -87.76 -37.6 16.49 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.723 . . . . 0.0 110.762 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -32.36 24.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.9 . . . . 0.0 111.273 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 mtt180 -66.27 -16.99 64.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.687 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.925 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -109.46 -8.06 11.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 O-C-N 121.393 -0.817 . . . . 0.0 110.121 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.35 44.59 5.84 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.925 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -152.54 165.82 33.95 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.0 -1.294 . . . . 0.0 110.71 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.488 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -69.61 156.83 90.98 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.374 -0.829 . . . . 0.0 108.807 177.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.098 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.6 Cg_endo -74.5 -48.69 0.19 Allowed 'Trans proline' 0 C--N 1.287 -2.681 0 O-C-N 123.83 1.437 . . . . 0.0 110.543 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.572 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -54.13 3.49 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.083 -1.011 . . . . 0.0 109.434 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 49.7 Cg_endo -75.85 -40.66 0.66 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 124.001 1.527 . . . . 0.0 110.135 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.692 ' HB2' HD12 ' A' ' 40' ' ' LEU . 50.3 t -40.56 -44.74 2.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.963 -1.085 . . . . 0.0 108.718 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.098 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.86 -45.16 87.26 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 1.6 mm-40 -50.12 -35.48 25.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.81 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -74.49 -48.37 27.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.578 -0.701 . . . . 0.0 109.288 177.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.871 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -65.74 -56.71 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.319 -0.863 . . . . 0.0 109.541 178.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.689 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -43.59 -42.95 5.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.293 -0.879 . . . . 0.0 109.446 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.54 -43.83 68.72 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.827 HD22 HD11 ' A' ' 20' ' ' LEU . 71.7 mt -69.29 -16.96 63.68 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.629 -0.669 . . . . 0.0 109.785 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 1.9 mt-10 -75.7 -56.29 4.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 110.321 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -53.82 -27.72 31.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 110.393 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.607 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 66.1 mm-40 -85.38 17.13 3.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.001 . . . . 0.0 110.251 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.44 56.94 21.01 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.614 ' O ' HD13 ' A' ' 58' ' ' ILE . 20.6 m-85 -137.2 6.74 2.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.13 -1.217 . . . . 0.0 110.239 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.674 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 13.5 mm -132.41 33.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.351 -0.843 . . . . 0.0 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -82.25 3.95 25.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.773 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -143.23 -44.1 0.05 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.487 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 60.6 m-85 -56.9 -112.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 110.184 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.954 ' O ' HD23 ' A' ' 65' ' ' LEU . 15.4 t -89.63 24.51 2.29 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.935 -1.103 . . . . 0.0 110.116 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -32.38 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.588 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -55.9 -110.18 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.63 -0.669 . . . . 0.0 109.494 177.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.954 HD23 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER 36.42 29.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.379 -0.825 . . . . 0.0 110.612 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.257 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.64 ' O ' HG12 ' A' ' 2' ' ' VAL . 1.9 ttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.227 0.537 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 1' ' ' MET . 8.7 p 37.3 35.47 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.335 -0.853 . . . . 0.0 110.499 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -74.81 -165.16 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.339 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 p -141.35 154.33 45.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -109.34 94.31 4.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.309 -0.869 . . . . 0.0 110.173 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -166.53 88.51 0.35 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.252 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.566 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -61.5 -55.91 38.32 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.394 -0.816 . . . . 0.0 110.227 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 7' ' ' ARG . 42.2 Cg_endo -71.25 -46.76 0.61 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.949 1.5 . . . . 0.0 110.397 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.549 ' O ' ' CD2' ' A' ' 12' ' ' LEU . . . 68.18 -57.01 0.42 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 1.4 tpmt? -90.34 2.1 55.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -1.183 . . . . 0.0 110.038 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -127.03 53.6 1.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 110.078 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' A' ' 17' ' ' ARG . 1.8 pt? -176.2 130.42 0.22 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 0.0 110.097 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.6 162.11 29.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.295 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.6 -22.65 5.25 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.29 -0.881 . . . . 0.0 110.387 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.869 HG23 HD22 ' A' ' 40' ' ' LEU . 13.8 mm -71.74 -30.51 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.903 . . . . 0.0 110.5 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.817 ' C ' HD11 ' A' ' 52' ' ' LEU . 50.5 m-20 -76.02 -61.3 1.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 110.539 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.81 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.64 -39.99 62.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 110.493 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 14' ' ' ARG . 6.7 t30 -67.74 -35.72 79.26 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.163 -0.961 . . . . 0.0 109.226 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.909 HG21 HG23 ' A' ' 49' ' ' VAL . 18.6 mt -63.14 -41.96 94.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.362 -0.836 . . . . 0.0 109.094 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 17' ' ' ARG . 25.8 mt -56.21 -42.15 76.74 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.129 178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.52 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 61.7 t-20 -59.36 -49.65 77.01 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.288 -0.882 . . . . 0.0 109.027 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -61.93 -37.68 85.58 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 178.201 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.941 HD21 ' CD1' ' A' ' 34' ' ' LEU . 2.3 mm? -67.36 -35.67 79.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.385 -0.822 . . . . 0.0 109.434 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -39.82 39.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.408 -0.808 . . . . 0.0 109.656 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HD3' ' OE1' ' A' ' 22' ' ' GLU . 2.4 pttt -77.55 -30.27 52.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -0.873 . . . . 0.0 109.747 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' GLY . 3.6 m-20 -140.33 61.07 1.53 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.407 -0.808 . . . . 0.0 110.317 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -56.22 -163.54 0.03 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.32 25.37 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -1.195 . . . . 0.0 110.315 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.504 ' CD1' ' HD2' ' A' ' 37' ' ' ARG . 10.3 tt -108.88 137.62 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.203 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.675 ' HA ' HD11 ' A' ' 64' ' ' LEU . 20.4 m -72.04 -137.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.852 . . . . 0.0 110.4 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 3.1 p30 -110.86 -43.12 3.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.319 -0.863 . . . . 0.0 109.907 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 32.8 t -44.8 -56.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.13 -0.981 . . . . 0.0 109.153 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.488 ' HB3' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.64 -34.41 78.17 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.34 -0.85 . . . . 0.0 108.887 177.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.941 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -70.3 -14.97 62.82 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.717 . . . . 0.0 109.777 178.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.548 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 8.3 p -85.64 -49.7 7.79 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.458 -0.776 . . . . 0.0 110.59 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.404 ' N ' ' OG ' ' A' ' 35' ' ' SER . 1.9 mtpp -78.68 -22.11 47.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 110.801 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.504 ' HD2' ' CD1' ' A' ' 29' ' ' ILE . 15.9 mtt-85 -70.02 -17.21 63.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.093 -1.004 . . . . 0.0 110.163 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.86 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -112.66 -9.56 12.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 121.501 -0.749 . . . . 0.0 109.672 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.99 42.0 4.81 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.869 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -152.41 161.21 42.92 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.961 -1.317 . . . . 0.0 110.72 178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -66.28 157.07 83.21 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 108.8 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.091 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.8 Cg_endo -73.5 -44.61 0.5 Allowed 'Trans proline' 0 C--N 1.287 -2.671 0 O-C-N 123.978 1.515 . . . . 0.0 110.456 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.567 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.24 -56.12 2.79 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.213 -0.93 . . . . 0.0 109.551 179.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.7 Cg_endo -74.96 -43.9 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.99 1.521 . . . . 0.0 109.907 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' HD12 ' A' ' 40' ' ' LEU . 45.0 t -37.32 -53.01 1.1 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.091 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -54.95 -54.29 44.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.4 OUTLIER -43.87 -43.53 6.4 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.386 -0.821 . . . . 0.0 109.298 177.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.618 ' HD2' HG21 ' A' ' 15' ' ' ILE . 1.4 mmt180 -66.57 -48.67 68.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.435 -0.791 . . . . 0.0 109.16 178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.909 HG23 HG21 ' A' ' 19' ' ' ILE . 1.1 t -61.61 -43.48 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.411 -0.806 . . . . 0.0 109.507 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 5.8 mmm180 -45.78 -52.19 11.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.389 -0.819 . . . . 0.0 109.396 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.489 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.8 OUTLIER -53.24 -40.57 64.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 109.065 178.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.893 ' HB3' HD11 ' A' ' 58' ' ' ILE . 16.2 mt -73.48 -31.3 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -0.764 . . . . 0.0 109.753 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -82.09 -30.15 31.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -74.0 -18.56 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 110.173 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.71 15.53 23.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.258 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.62 58.68 6.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.867 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -145.41 11.93 1.33 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -1.121 . . . . 0.0 110.296 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.893 HD11 ' HB3' ' A' ' 52' ' ' LEU . 8.0 mm -140.62 37.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.173 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -14.58 58.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 0.0 109.855 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -125.0 -40.84 0.4 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.574 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 18.5 m-30 -56.64 -115.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.39 -1.065 . . . . 0.0 110.062 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.002 ' O ' HD23 ' A' ' 65' ' ' LEU . 9.4 t -87.1 24.77 1.47 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.956 -1.09 . . . . 0.0 110.08 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -34.16 -34.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.565 -0.709 . . . . 0.0 109.328 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.675 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -56.29 -108.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.577 -0.702 . . . . 0.0 109.421 177.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.002 HD23 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER 36.85 28.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.306 -0.871 . . . . 0.0 110.49 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.554 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.269 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.296 0.57 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.23 48.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -85.09 -34.7 22.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 0.0 110.176 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -165.61 -177.92 4.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 110.173 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HB2' ' HE2' ' A' ' 5' ' ' LYS . 35.5 mtmm -106.77 80.43 1.45 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 110.18 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 11.6 tttm -87.55 -117.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.0 110.372 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.674 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER 59.97 -159.06 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.973 -1.08 . . . . 0.0 109.053 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.674 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 42.5 Cg_endo -75.33 57.73 4.86 Favored 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.064 1.034 . . . . 0.0 110.17 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.18 -25.6 51.24 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -75.76 1.93 13.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -1.177 . . . . 0.0 110.098 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.85 74.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.399 -0.813 . . . . 0.0 109.694 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.693 HD22 ' CB ' ' A' ' 16' ' ' ASP . 0.6 OUTLIER -142.4 147.76 36.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.397 -178.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -50.22 142.57 9.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 110.047 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 12.0 mmt85 -56.02 -24.88 41.96 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.324 -0.86 . . . . 0.0 110.354 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.862 HG23 HD22 ' A' ' 40' ' ' LEU . 10.6 mm -74.93 -35.33 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.751 ' HB3' HD21 ' A' ' 52' ' ' LEU . 6.2 m-20 -74.84 -56.6 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.574 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.718 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.6 ptt85 -55.53 -45.1 77.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 110.306 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.482 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 11.1 m120 -64.8 -34.12 77.61 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.095 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.648 HD12 ' O ' ' A' ' 15' ' ' ILE . 5.9 mt -64.79 -44.33 96.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.501 -0.749 . . . . 0.0 109.271 178.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.946 HD11 HD22 ' A' ' 52' ' ' LEU . 12.2 mt -63.29 -41.24 98.97 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.313 -0.867 . . . . 0.0 109.261 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.403 ' HA ' ' HE3' ' A' ' 5' ' ' LYS . 2.7 t-20 -62.76 -31.2 72.1 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.266 -0.896 . . . . 0.0 109.258 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.697 ' OE2' HG13 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -77.49 -43.24 32.84 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.45 -0.781 . . . . 0.0 109.835 179.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.066 HD21 HD11 ' A' ' 34' ' ' LEU . 2.2 mm? -62.17 -36.31 81.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.177 -0.952 . . . . 0.0 109.38 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' OE1' ' C ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -68.71 -44.88 72.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.742 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -71.77 -37.5 70.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.257 -0.902 . . . . 0.0 109.925 179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -135.87 92.04 2.77 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.383 -0.823 . . . . 0.0 110.078 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.56 -10.06 86.47 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.577 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 1.8 mpt_? -85.89 26.81 0.94 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -1.164 . . . . 0.0 110.467 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.487 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 4.0 tt -111.45 155.04 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.189 -0.944 . . . . 0.0 110.329 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.757 ' HA ' HD11 ' A' ' 64' ' ' LEU . 73.8 m -108.17 -94.99 0.39 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.85 . . . . 0.0 110.414 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' SER . 18.7 p-10 -136.69 -50.96 0.67 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.241 -0.912 . . . . 0.0 110.313 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.481 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 77.7 t -43.29 -58.74 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.246 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -65.42 -27.48 68.56 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.317 -0.864 . . . . 0.0 108.864 177.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.066 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -75.67 -15.38 60.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.539 -0.726 . . . . 0.0 109.649 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.565 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 20.8 p -88.09 -48.99 7.32 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 0.0 111.031 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp -82.67 -22.37 34.61 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.067 -1.021 . . . . 0.0 111.184 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 7.8 mtp180 -72.59 -16.09 61.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.974 -1.079 . . . . 0.0 110.554 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.811 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -109.76 -9.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.311 -0.868 . . . . 0.0 110.062 179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.65 41.51 4.42 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.862 HD22 HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -153.55 165.45 35.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.107 -1.231 . . . . 0.0 110.667 178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.4 m -72.21 159.76 84.56 Favored Pre-proline 0 C--N 1.301 -1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 108.865 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.074 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.3 Cg_endo -73.39 -51.36 0.16 Allowed 'Trans proline' 0 C--N 1.285 -2.769 0 O-C-N 123.87 1.458 . . . . 0.0 110.609 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.31 -55.18 1.87 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.178 -0.951 . . . . 0.0 109.705 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.9 Cg_endo -75.83 -40.58 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.998 1.525 . . . . 0.0 110.064 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.2 t -39.45 -48.59 1.98 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.105 -0.997 . . . . 0.0 108.738 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.074 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.3 mp -58.49 -52.41 65.77 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.82 -38.38 2.12 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.356 -0.84 . . . . 0.0 108.997 177.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HG3' HG21 ' A' ' 15' ' ' ILE . 4.6 mmp_? -71.54 -56.31 6.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.233 178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.606 ' CG2' HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -56.01 -40.05 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.35 -0.844 . . . . 0.0 109.458 178.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 7.5 mmt85 -52.78 -48.67 66.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 109.699 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.552 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -53.15 -37.21 61.64 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.971 178.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.946 HD22 HD11 ' A' ' 20' ' ' LEU . 94.4 mt -67.93 -23.12 65.04 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.444 -0.785 . . . . 0.0 109.887 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.517 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 40.8 mt-10 -77.65 -51.23 10.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.886 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -48.48 -39.71 24.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -0.885 . . . . 0.0 110.026 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.462 ' NE2' ' HD2' ' A' ' 51' ' ' ARG . 3.3 pt20 -86.37 27.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.294 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.85 76.25 0.14 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.898 ' CE2' HD13 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -151.29 13.32 0.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -1.149 . . . . 0.0 110.505 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.849 HD11 ' HB3' ' A' ' 52' ' ' LEU . 15.1 mm -137.95 24.51 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.236 -0.915 . . . . 0.0 110.41 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.53 -8.13 53.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -135.55 -38.09 0.18 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.559 ' HB3' ' CB ' ' A' ' 23' ' ' LEU . 91.8 m-85 -57.71 -113.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -1.113 . . . . 0.0 109.829 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.573 ' O ' ' N ' ' A' ' 64' ' ' LEU . 6.9 t -90.43 32.0 0.98 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.855 -1.153 . . . . 0.0 109.912 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -34.96 -32.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.708 0.766 . . . . 0.0 109.072 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.757 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -75.81 -139.48 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.674 -0.641 . . . . 0.0 109.418 177.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.673 ' HG ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER 58.93 9.0 1.07 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.053 -1.03 . . . . 0.0 110.277 178.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 110.314 179.634 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.291 0.567 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.9 t 48.93 86.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -0.883 . . . . 0.0 110.3 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.82 80.22 3.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 110.186 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.0 p -104.75 87.54 2.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.465 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.501 ' HG3' ' CG ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -78.54 72.81 5.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 110.059 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 17.6 mmtt -63.55 -90.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.731 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.906 ' HG3' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 54.59 -163.13 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 108.974 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.668 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 42.3 Cg_endo -74.39 57.73 4.25 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 O-C-N 123.125 1.066 . . . . 0.0 110.069 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . -39.08 -37.32 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 12' ' ' LEU . 1.1 tptp -60.74 -135.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -1.196 . . . . 0.0 110.159 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.53 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 0.0 110.226 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -113.38 111.58 22.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.69 151.98 0.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 110.01 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 18' ' ' ASN . 9.2 mmt85 -60.97 -29.97 69.98 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.269 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.743 HD12 HD22 ' A' ' 40' ' ' LEU . 4.9 mm -81.38 -27.66 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.311 -0.868 . . . . 0.0 110.702 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.543 ' CA ' HD11 ' A' ' 52' ' ' LEU . 3.1 m-20 -84.54 -31.37 24.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.253 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -75.56 -46.59 31.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 110.157 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.598 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 39.4 p-10 -69.14 -32.48 71.87 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.189 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG12 HG11 ' A' ' 38' ' ' VAL . 6.3 mt -69.18 -38.31 77.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.906 HD22 ' HG3' ' A' ' 7' ' ' ARG . 22.9 mt -68.82 -40.49 79.45 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.29 -0.881 . . . . 0.0 109.501 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 29.9 t-20 -67.56 -26.42 66.28 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.205 -0.934 . . . . 0.0 109.267 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -87.04 -40.96 14.23 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.002 HD21 HD23 ' A' ' 64' ' ' LEU . 1.3 mt -69.18 -24.29 64.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.466 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.501 ' CG ' ' HG3' ' A' ' 5' ' ' LYS . 5.6 tp60 -84.37 -37.84 21.04 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.451 -0.781 . . . . 0.0 109.969 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 4.0 pttt -83.09 -32.34 26.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.818 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 29' ' ' ILE . 19.4 t0 -129.56 55.49 1.76 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -46.34 -25.61 2.03 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -82.21 9.84 7.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -1.143 . . . . 0.0 110.185 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.891 ' O ' HD13 ' A' ' 64' ' ' LEU . 5.8 tt -74.15 154.96 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.904 . . . . 0.0 110.291 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.866 ' HA ' HD13 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -104.4 147.06 27.97 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.778 . . . . 0.0 110.15 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.829 ' OD1' HD11 ' A' ' 46' ' ' LEU . 1.0 OUTLIER -39.98 -52.51 2.45 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.262 -0.899 . . . . 0.0 109.809 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 31' ' ' ASN . 18.0 t -44.79 -57.47 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 108.939 178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 2.2 tp10 -65.29 -29.5 70.26 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.278 -0.889 . . . . 0.0 108.727 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.776 HD12 HD21 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -72.81 -16.6 61.61 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.473 -0.767 . . . . 0.0 109.512 178.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 21.1 p -88.69 -44.99 10.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.594 -0.691 . . . . 0.0 110.604 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 6.1 mtpp -82.44 -43.97 16.63 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 111.13 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 3.7 mtt-85 -56.99 -16.65 7.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.027 -1.046 . . . . 0.0 110.23 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.784 HG23 ' CD2' ' A' ' 40' ' ' LEU . 18.7 m -101.3 -21.05 5.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 O-C-N 121.403 -0.811 . . . . 0.0 110.019 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 101.14 37.8 3.5 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.784 ' CD2' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -154.92 171.66 19.32 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.879 -1.365 . . . . 0.0 110.793 179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -75.57 158.82 82.79 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 108.877 177.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.043 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.7 Cg_endo -73.54 -45.22 0.43 Allowed 'Trans proline' 0 C--N 1.287 -2.709 0 O-C-N 123.987 1.52 . . . . 0.0 110.646 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -42.03 -55.64 6.03 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.975 . . . . 0.0 109.443 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.2 Cg_endo -76.02 -36.9 1.76 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.88 1.463 . . . . 0.0 110.281 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 40.9 t -43.47 -47.71 7.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.997 -1.064 . . . . 0.0 108.652 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.043 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.54 -39.51 88.16 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -55.97 -41.99 75.6 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.709 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -70.58 -47.98 57.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.592 -0.692 . . . . 0.0 109.284 178.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.627 HG12 ' N ' ' A' ' 50' ' ' ARG . 1.2 t -58.89 -51.89 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.483 -0.761 . . . . 0.0 109.343 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -41.97 -53.7 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.455 -0.778 . . . . 0.0 109.325 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -48.05 -42.7 29.14 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.432 -0.792 . . . . 0.0 109.052 178.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.879 ' CD2' HD11 ' A' ' 20' ' ' LEU . 12.7 mt -72.13 -23.38 61.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 0.0 109.775 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' CG ' ' HA ' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -63.04 -59.92 4.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.424 -0.797 . . . . 0.0 110.233 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.7 -28.64 3.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.329 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.608 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 2.2 mm-40 -74.75 0.51 15.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.178 -0.951 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 66.93 51.6 38.84 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.621 ' CE2' ' HA ' ' A' ' 7' ' ' ARG . 22.0 m-85 -131.15 9.43 4.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.23 -1.159 . . . . 0.0 110.28 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.95 HG22 ' HB2' ' A' ' 63' ' ' ALA . 1.2 mt -149.56 118.36 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.294 -0.879 . . . . 0.0 110.022 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' A' ' 63' ' ' ALA . 2.1 pt20 -73.26 78.82 1.31 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.841 . . . . 0.0 110.337 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 62' ' ' THR . . . 111.87 50.89 0.58 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.784 ' O ' HG21 ' A' ' 58' ' ' ILE . 64.5 m-85 60.22 -74.71 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 110.511 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.911 ' HG1' HD12 ' A' ' 65' ' ' LEU . 2.5 p -90.12 -8.69 50.73 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.225 -0.922 . . . . 0.0 109.942 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.95 ' HB2' HG22 ' A' ' 58' ' ' ILE . . . 55.72 32.14 18.82 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.507 -0.746 . . . . 0.0 109.617 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.002 HD23 HD21 ' A' ' 23' ' ' LEU . 4.1 pp -175.13 -38.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 110.269 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.114 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -63.57 -7.14 6.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.461 -0.775 . . . . 0.0 110.632 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 1.114 ' N ' HD13 ' A' ' 65' ' ' LEU . 14.9 p-10 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.191 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t -132.65 114.89 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.244 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -101.8 75.67 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.299 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -150.45 83.41 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.182 -0.949 . . . . 0.0 110.28 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' CE ' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER 55.75 176.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.228 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -102.59 -105.15 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.243 -0.911 . . . . 0.0 110.345 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.613 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 58.94 -173.67 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.029 -1.044 . . . . 0.0 109.216 -179.124 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.4 Cg_endo -67.41 58.31 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.437 1.23 . . . . 0.0 109.845 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -54.98 -24.84 36.09 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 13.6 pttp -64.39 -9.62 19.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.126 -1.22 . . . . 0.0 110.2 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -175.58 89.79 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.972 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -134.4 121.89 21.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 110.359 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.68 145.94 6.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 110.029 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.532 ' HD3' ' NH1' ' A' ' 17' ' ' ARG . 25.0 mmt-85 -54.86 -19.18 5.97 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.828 HG23 HD22 ' A' ' 40' ' ' LEU . 3.0 mm -83.86 -49.82 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.78 ' HB3' HD21 ' A' ' 52' ' ' LEU . 7.0 m-20 -66.65 -33.41 75.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 110.178 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' NH1' ' HD3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -74.42 -55.45 5.97 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -0.942 . . . . 0.0 109.73 179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.523 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 17.3 t-20 -58.53 -29.65 66.48 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.325 -0.859 . . . . 0.0 109.092 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.622 HG21 HG22 ' A' ' 49' ' ' VAL . 12.7 mt -67.52 -43.92 86.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.536 -0.728 . . . . 0.0 109.308 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.753 HD11 HD22 ' A' ' 52' ' ' LEU . 34.4 mt -66.14 -40.13 90.38 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.216 -0.927 . . . . 0.0 109.345 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 6.2 t-20 -67.77 -31.1 70.77 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.296 -0.877 . . . . 0.0 109.235 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -80.04 -36.01 36.36 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.493 -0.754 . . . . 0.0 109.614 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 HD11 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -69.18 -35.13 75.95 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.539 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.43 -39.27 67.99 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 2.3 tttt -82.0 -20.26 38.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.626 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 29' ' ' ILE . 13.0 m-20 -144.88 53.06 1.22 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.416 -0.803 . . . . 0.0 110.019 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -47.01 -37.44 9.71 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -70.49 57.55 0.18 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.24 -1.153 . . . . 0.0 110.4 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 26' ' ' ASP . 2.3 tt -141.6 135.9 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 0.0 110.238 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.701 ' HA ' HD11 ' A' ' 64' ' ' LEU . 33.2 t -82.35 -94.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.376 -0.828 . . . . 0.0 110.356 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' SER . 10.8 p-10 -140.1 -48.36 0.45 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.145 -0.972 . . . . 0.0 110.432 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' ASN . 77.9 t -42.0 -64.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.059 -1.026 . . . . 0.0 109.525 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.506 ' HB3' HG13 ' A' ' 29' ' ' ILE . 5.3 tp10 -63.24 -22.84 67.13 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.176 -0.953 . . . . 0.0 108.979 177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -79.54 -15.12 58.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.553 -0.717 . . . . 0.0 109.637 178.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 31' ' ' ASN . 13.8 p -87.89 -45.53 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.558 -0.714 . . . . 0.0 110.838 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 14.2 pttt -80.84 -38.16 28.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.096 -1.003 . . . . 0.0 110.952 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HD2' ' HG3' ' A' ' 33' ' ' GLU . 39.2 mtt180 -57.38 -16.59 9.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 110.558 -178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.824 ' HB ' HD21 ' A' ' 40' ' ' LEU . 2.1 m -108.98 -15.03 9.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.333 -0.854 . . . . 0.0 109.992 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.14 37.0 5.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.828 HD22 HG23 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -149.19 160.97 42.89 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.954 -1.321 . . . . 0.0 110.559 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.486 ' C ' ' HB2' ' A' ' 35' ' ' SER . 20.5 m -66.69 159.41 74.69 Favored Pre-proline 0 C--N 1.3 -1.574 0 O-C-N 121.3 -0.875 . . . . 0.0 108.766 177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.056 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.46 -45.38 0.42 Allowed 'Trans proline' 0 C--N 1.286 -2.718 0 O-C-N 123.934 1.492 . . . . 0.0 110.551 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.98 -60.8 0.9 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.915 . . . . 0.0 109.792 179.071 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 47.3 Cg_endo -73.9 -37.63 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.825 1.434 . . . . 0.0 110.175 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.4 t -38.63 -50.13 1.59 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.057 HD23 ' HG ' ' A' ' 65' ' ' LEU . 1.2 mp -59.12 -52.8 64.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -43.65 -36.96 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.25 -0.906 . . . . 0.0 109.03 177.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.705 ' CD ' HG21 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -72.87 -60.1 2.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.494 -0.754 . . . . 0.0 109.399 178.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 52' ' ' LEU . 2.2 t -54.29 -44.44 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 6.5 mmt85 -48.89 -50.04 36.86 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.32 -0.863 . . . . 0.0 109.636 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -50.57 -36.76 36.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.451 -0.78 . . . . 0.0 109.043 178.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.78 HD21 ' HB3' ' A' ' 16' ' ' ASP . 70.4 mt -73.14 -19.37 61.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.482 -0.762 . . . . 0.0 110.028 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.8 OUTLIER -74.97 -58.93 2.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.908 . . . . 0.0 110.394 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.491 ' CD ' ' HG2' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -51.78 -21.74 3.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.383 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 29.4 mm100 -91.27 17.25 8.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 110.268 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.21 49.77 54.76 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.592 ' CE2' ' HD3' ' A' ' 8' ' ' PRO . 7.3 m-85 -127.93 8.71 6.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.255 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.728 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.9 mm -136.85 32.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.201 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.12 -8.73 57.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.887 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -132.93 -39.99 0.2 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.556 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 15.9 m-30 -58.36 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -1.137 . . . . 0.0 110.022 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.591 ' HB ' HD21 ' A' ' 23' ' ' LEU . 8.0 t -89.31 35.1 0.8 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.02 -1.05 . . . . 0.0 110.031 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.572 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -35.32 -32.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -71.74 -140.92 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.669 -0.645 . . . . 0.0 109.428 177.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.057 ' HG ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER 54.59 12.02 0.5 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.073 -1.017 . . . . 0.0 110.23 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 120.883 -1.135 . . . . 0.0 110.304 179.298 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.279 0.561 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 2' ' ' VAL . 36.0 m -60.21 118.44 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.285 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -79.41 125.08 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.188 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 1.1 t -143.36 162.65 35.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.404 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 7' ' ' ARG . 0.5 OUTLIER 69.22 -58.83 0.5 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.357 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 17.2 mtpt 64.07 -66.05 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.152 -0.967 . . . . 0.0 110.548 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.662 ' HB3' HD13 ' A' ' 20' ' ' LEU . 0.1 OUTLIER 45.62 -167.09 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 109.079 -179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.657 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 40.7 Cg_endo -72.74 58.7 3.3 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.358 1.189 . . . . 0.0 109.754 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . -40.51 -48.52 3.86 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -70.35 124.74 24.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.223 -1.163 . . . . 0.0 110.182 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 52.04 94.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -0.934 . . . . 0.0 110.204 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.54 HD21 ' HG2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -133.79 145.97 50.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.461 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 16' ' ' ASP . 0.9 OUTLIER -91.95 133.81 35.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -43.21 -34.69 1.19 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.353 -0.842 . . . . 0.0 110.393 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.897 HG23 HD22 ' A' ' 40' ' ' LEU . 5.0 mm -74.4 -21.99 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 0.0 110.642 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.675 ' HB3' HD21 ' A' ' 52' ' ' LEU . 66.4 m-20 -87.19 -56.96 3.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.109 -0.994 . . . . 0.0 110.522 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.74 -37.4 73.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 110.08 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 17' ' ' ARG . 17.7 t-20 -72.27 -42.67 65.32 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.356 -0.84 . . . . 0.0 109.132 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.051 HG21 HG23 ' A' ' 49' ' ' VAL . 9.0 mt -68.26 -31.49 51.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.367 -0.833 . . . . 0.0 109.282 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.795 HD11 HD22 ' A' ' 52' ' ' LEU . 15.5 mt -73.38 -40.64 64.18 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.314 -0.866 . . . . 0.0 109.486 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -68.36 -27.96 66.71 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.312 -0.867 . . . . 0.0 109.295 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' OE1' ' NE ' ' A' ' 37' ' ' ARG . 22.4 mm-40 -80.34 -27.57 38.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.47 -0.769 . . . . 0.0 109.685 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.043 HD21 HD11 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -72.0 -34.29 68.76 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.276 -0.89 . . . . 0.0 109.288 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -73.81 -40.85 63.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.491 -0.756 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -74.26 -30.19 62.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.828 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.2 OUTLIER -125.54 71.13 1.21 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.105 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -67.66 57.05 0.34 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -179.73 38.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 110.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 1.8 tt -119.42 135.4 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.428 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -81.81 158.74 23.98 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 110.113 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.535 ' HA ' ' CB ' ' A' ' 34' ' ' LEU . 16.3 m120 -50.09 -47.67 53.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.225 -0.922 . . . . 0.0 110.36 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 93.5 t -41.92 -63.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.079 -1.013 . . . . 0.0 109.495 179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -62.55 -33.02 74.1 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.043 HD11 HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -68.09 -14.59 63.09 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.416 0.627 . . . . 0.0 109.765 178.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.534 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 12.5 p -86.55 -51.16 6.34 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.456 -0.777 . . . . 0.0 110.785 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' OG ' ' A' ' 35' ' ' SER . 12.6 mttt -77.05 -16.38 59.28 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.22 -0.925 . . . . 0.0 111.227 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -79.75 -16.05 56.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.925 -1.109 . . . . 0.0 110.513 -179.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.904 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -110.21 -4.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 121.205 -0.934 . . . . 0.0 110.054 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.65 42.48 5.42 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.904 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -154.52 163.72 39.77 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.117 -1.225 . . . . 0.0 110.557 179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.9 159.12 86.36 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.08 ' O ' HD12 ' A' ' 46' ' ' LEU . 51.2 Cg_endo -74.46 -46.89 0.25 Allowed 'Trans proline' 0 C--N 1.286 -2.75 0 O-C-N 123.969 1.51 . . . . 0.0 110.467 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.577 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.04 -54.67 4.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.118 -0.988 . . . . 0.0 109.458 178.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.7 Cg_endo -76.1 -42.27 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 124.027 1.541 . . . . 0.0 110.26 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.765 ' HB2' HD12 ' A' ' 40' ' ' LEU . 47.1 t -38.88 -48.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 108.7 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.08 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -61.22 -50.77 71.74 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.2 mt-10 -45.19 -34.26 2.67 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.876 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.8 OUTLIER -73.83 -52.16 13.96 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.679 0.752 . . . . 0.0 109.172 177.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.051 HG23 HG21 ' A' ' 19' ' ' ILE . 1.2 t -63.42 -47.56 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.558 -0.714 . . . . 0.0 109.925 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.572 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -48.32 -45.64 35.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HD2' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -54.27 -41.15 68.52 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 108.916 177.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.795 HD22 HD11 ' A' ' 20' ' ' LEU . 95.9 mt -67.01 -27.01 67.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.438 -0.789 . . . . 0.0 109.866 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -63.08 -59.89 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.373 -0.829 . . . . 0.0 110.274 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -45.9 -24.46 0.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.189 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 15.1 mm-40 -92.2 11.43 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.897 . . . . 0.0 110.292 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 61.12 54.98 32.14 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 1.069 ' O ' HD13 ' A' ' 58' ' ' ILE . 11.9 m-85 -130.7 2.84 4.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.17 . . . . 0.0 110.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.069 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.8 mm -132.04 34.41 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.376 -0.827 . . . . 0.0 110.24 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -80.6 -7.78 59.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.754 178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -140.04 -37.21 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.561 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 15.3 m-30 -55.83 -111.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -1.074 . . . . 0.0 110.028 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.677 HG22 ' CG2' ' A' ' 58' ' ' ILE . 4.8 t -87.59 27.79 1.07 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.037 -1.039 . . . . 0.0 109.928 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -38.85 -31.3 0.06 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.235 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 62' ' ' THR . 0.3 OUTLIER -53.64 -28.41 32.8 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.687 0.756 . . . . 0.0 109.954 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.606 ' HG ' ' N ' ' A' ' 66' ' ' ASN . 0.7 OUTLIER -41.42 -24.14 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.739 -0.601 . . . . 0.0 110.781 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.606 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 33.7 t-20 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.983 . . . . 0.0 110.283 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.266 0.555 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.05 -11.82 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.0 110.162 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 4' ' ' SER . 28.8 t0 -46.62 140.65 4.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 110.398 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 0.3 OUTLIER 66.1 111.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.36 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.493 ' CD ' ' HG2' ' A' ' 24' ' ' GLN . 1.8 mtpp -77.58 -63.63 1.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.895 . . . . 0.0 110.291 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 2.3 ttmt -176.92 -129.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.935 . . . . 0.0 110.244 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.631 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 63.29 -170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 120.991 -1.068 . . . . 0.0 108.991 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.631 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.9 Cg_endo -68.42 55.99 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.295 1.155 . . . . 0.0 109.941 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -48.66 -42.84 28.46 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 33.69 0.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.1 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.526 ' O ' ' NH1' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -159.3 62.59 0.39 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 12' ' ' LEU . 3.7 pp 175.46 -177.91 0.12 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.488 -0.757 . . . . 0.0 110.225 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' CB ' ' OD1' ' A' ' 16' ' ' ASP . 2.9 t0 -96.06 161.22 14.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.323 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.499 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.9 OUTLIER -57.08 -24.2 52.26 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.345 -0.847 . . . . 0.0 110.314 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 ' HD3' ' A' ' 48' ' ' ARG . 4.6 mm -74.47 -33.98 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.943 . . . . 0.0 110.527 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.566 ' C ' HD11 ' A' ' 52' ' ' LEU . 4.3 m-20 -71.66 -59.95 2.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.192 -0.942 . . . . 0.0 110.472 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.449 ' HD3' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -55.27 -43.74 75.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.023 . . . . 0.0 110.543 -179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.503 ' O ' ' HG2' ' A' ' 22' ' ' GLU . 2.8 m120 -64.86 -37.61 88.22 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.17 -0.956 . . . . 0.0 109.276 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.059 HG21 HG23 ' A' ' 49' ' ' VAL . 9.5 mt -63.06 -38.91 83.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.39 -0.819 . . . . 0.0 109.356 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.746 ' CG ' HD13 ' A' ' 52' ' ' LEU . 90.4 mt -65.29 -41.2 94.37 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.11 -34.95 78.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.336 -0.852 . . . . 0.0 109.377 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 60.3 mm-40 -73.03 -41.83 63.81 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 109.601 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.677 HD13 ' HB3' ' A' ' 61' ' ' TYR . 37.2 mt -66.85 -30.86 71.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.299 -0.876 . . . . 0.0 109.334 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HG2' ' CD ' ' A' ' 5' ' ' LYS . 4.0 tp60 -66.18 -39.29 89.61 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 4.1 mtmp? -81.05 -18.61 46.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.54 ' O ' HG22 ' A' ' 29' ' ' ILE . 7.2 m-20 -140.85 94.5 2.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.403 -0.81 . . . . 0.0 109.951 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.83 15.86 29.61 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -130.37 39.86 3.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -1.16 . . . . 0.0 110.157 179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 26' ' ' ASP . 5.4 tt -126.49 130.72 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 110.39 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.763 ' HA ' HD11 ' A' ' 64' ' ' LEU . 20.9 p -72.15 -133.7 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.057 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 35' ' ' SER . 6.2 m-80 -112.61 -30.9 6.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.926 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 48.7 t -50.27 -63.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.145 -0.972 . . . . 0.0 109.173 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 11.3 tp10 -62.21 -29.0 70.08 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.194 -0.941 . . . . 0.0 108.82 177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.617 HD22 HG12 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -73.71 -14.78 61.2 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.459 0.647 . . . . 0.0 109.818 178.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.544 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 18.3 p -87.79 -45.81 10.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.497 -0.752 . . . . 0.0 111.004 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -82.55 -22.91 34.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 0.0 111.223 -178.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.56 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -74.32 -15.68 60.95 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.014 -1.054 . . . . 0.0 110.552 -179.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.854 ' CG2' HD21 ' A' ' 40' ' ' LEU . 1.4 m -106.49 -13.12 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.424 -0.798 . . . . 0.0 109.969 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.93 40.09 3.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.854 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.52 168.83 24.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.037 -1.273 . . . . 0.0 110.654 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -76.05 158.88 81.68 Favored Pre-proline 0 C--N 1.301 -1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 108.876 177.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.075 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.3 Cg_endo -74.59 -43.8 0.44 Allowed 'Trans proline' 0 C--N 1.288 -2.616 0 O-C-N 123.964 1.507 . . . . 0.0 110.464 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.35 -55.51 4.13 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.973 . . . . 0.0 109.471 178.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.4 Cg_endo -76.29 -42.94 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.894 1.471 . . . . 0.0 110.126 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.1 t -39.8 -46.0 1.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.95 -1.094 . . . . 0.0 108.626 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.075 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -64.63 -49.54 70.63 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 17.3 mt-10 -46.22 -43.03 15.07 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.482 -0.887 . . . . 0.0 108.894 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.775 ' HD3' HG21 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -68.43 -45.76 71.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.367 -0.833 . . . . 0.0 109.153 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.059 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -63.87 -47.69 89.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.432 -0.793 . . . . 0.0 109.604 178.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.619 ' N ' HG12 ' A' ' 49' ' ' VAL . 12.4 mmt85 -43.46 -55.69 4.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.358 -0.838 . . . . 0.0 109.443 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' NH1' ' O ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -47.57 -43.48 25.41 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.612 -0.835 . . . . 0.0 108.869 178.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.746 HD13 ' CG ' ' A' ' 20' ' ' LEU . 30.2 mt -70.98 -41.97 70.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.488 -0.758 . . . . 0.0 109.796 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' HG13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.47 -57.66 9.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.856 . . . . 0.0 110.138 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -54.81 -17.87 4.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 110.051 179.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.501 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -89.77 9.91 25.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 110.246 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.94 44.16 47.22 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.891 ' O ' HD13 ' A' ' 58' ' ' ILE . 14.1 m-85 -135.28 12.03 3.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -1.165 . . . . 0.0 110.261 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.891 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.8 mm -141.99 48.47 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 110.316 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -92.26 -6.03 51.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.411 -0.806 . . . . 0.0 109.921 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -134.5 -41.25 0.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.677 ' HB3' HD13 ' A' ' 23' ' ' LEU . 19.9 m-85 -57.05 -111.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -1.11 . . . . 0.0 109.914 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.974 HG23 HD23 ' A' ' 65' ' ' LEU . 11.0 t -86.59 18.95 3.06 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.0 -1.062 . . . . 0.0 109.703 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -38.54 -30.04 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.543 -0.723 . . . . 0.0 109.174 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.763 HD11 ' HA ' ' A' ' 30' ' ' SER . 1.7 pp -55.12 -33.76 63.14 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.974 HD23 HG23 ' A' ' 62' ' ' THR . 1.9 pp -39.82 -26.39 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.709 -0.619 . . . . 0.0 110.596 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.8 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.277 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.272 0.558 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.06 169.15 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -154.25 19.75 0.49 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.246 -0.909 . . . . 0.0 110.359 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.33 -63.4 0.46 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.943 . . . . 0.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.502 ' HZ1' ' HB2' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -60.49 145.4 48.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.14 179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' C ' ' HG2' ' A' ' 7' ' ' ARG . 2.7 mmtp -135.82 -89.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.293 -0.879 . . . . 0.0 110.453 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.648 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 50.77 -165.37 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.648 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.3 Cg_endo -74.21 58.43 4.31 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.303 1.159 . . . . 0.0 109.978 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.37 -36.83 63.98 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -65.44 -8.3 18.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -1.19 . . . . 0.0 109.98 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.6 OUTLIER -164.12 77.47 0.36 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.425 -0.797 . . . . 0.0 109.83 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.87 HD21 HD21 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -129.22 144.94 51.4 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.365 -0.834 . . . . 0.0 110.657 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.519 ' H ' HD23 ' A' ' 12' ' ' LEU . 24.4 t0 -66.04 137.44 57.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 109.92 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 3.5 mmt180 -52.62 -29.03 23.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 110.344 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG23 HD22 ' A' ' 40' ' ' LEU . 9.0 mm -80.37 -29.88 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.616 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.706 ' HB3' HD11 ' A' ' 52' ' ' LEU . 5.2 m-20 -82.19 -36.92 26.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 2.9 ptt180 -70.62 -44.21 67.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.928 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.58 ' N ' ' CG ' ' A' ' 17' ' ' ARG . 22.6 m-20 -67.78 -36.22 80.08 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.425 -0.797 . . . . 0.0 109.27 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.921 HG21 ' CG2' ' A' ' 49' ' ' VAL . 24.7 mt -68.76 -37.79 77.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.353 -0.842 . . . . 0.0 109.213 178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.825 ' HG ' HD13 ' A' ' 52' ' ' LEU . 11.9 mt -65.67 -36.87 84.89 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.349 -0.845 . . . . 0.0 109.249 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.502 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 8.0 t30 -67.56 -35.48 79.12 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.394 -0.816 . . . . 0.0 109.198 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.806 ' OE1' HG13 ' A' ' 38' ' ' VAL . 7.1 mt-10 -72.87 -40.15 65.88 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.452 -0.78 . . . . 0.0 109.764 178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.858 HD13 ' HB3' ' A' ' 61' ' ' TYR . 34.7 mt -66.89 -37.05 83.66 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.22 -0.925 . . . . 0.0 109.306 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.415 ' OE1' ' OH ' ' A' ' 61' ' ' TYR . 64.7 tp60 -63.44 -40.67 97.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.399 -0.813 . . . . 0.0 109.235 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 -25.3 44.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.359 -0.838 . . . . 0.0 109.82 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.32 96.36 3.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.63 39.48 3.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -153.74 21.35 0.53 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.306 -1.114 . . . . 0.0 110.017 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.668 HD13 HD12 ' A' ' 34' ' ' LEU . 4.5 tt -101.84 140.22 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.515 ' HA ' HD11 ' A' ' 64' ' ' LEU . 13.5 t -84.92 -120.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.379 -0.826 . . . . 0.0 110.194 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.653 ' HA ' ' HB3' ' A' ' 34' ' ' LEU . 7.6 p30 -120.8 -46.44 2.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.083 -1.01 . . . . 0.0 110.423 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.0 t -45.22 -60.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.283 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 3.3 tt0 -62.04 -30.34 70.91 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.216 -0.928 . . . . 0.0 108.989 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.668 HD12 HD13 ' A' ' 29' ' ' ILE . 6.4 tp -74.67 -16.19 60.77 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.58 -0.7 . . . . 0.0 110.063 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' ASN . 11.6 p -84.37 -37.97 20.89 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.412 -0.805 . . . . 0.0 110.279 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mttm -87.13 -17.9 31.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.449 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -75.1 -18.02 60.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.153 -0.967 . . . . 0.0 110.503 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -111.46 -11.53 11.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 O-C-N 121.405 -0.81 . . . . 0.0 109.731 179.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.62 41.36 4.77 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.878 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -148.02 168.57 21.98 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.998 -1.295 . . . . 0.0 110.466 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.517 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 3.5 m -72.75 154.82 91.19 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.4 -0.812 . . . . 0.0 108.872 177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.073 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.3 Cg_endo -72.53 -48.31 0.33 Allowed 'Trans proline' 0 C--N 1.288 -2.642 0 O-C-N 123.961 1.506 . . . . 0.0 110.733 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -40.27 -54.22 4.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.063 -1.023 . . . . 0.0 109.475 179.179 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.3 Cg_endo -76.02 -41.01 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.977 1.514 . . . . 0.0 110.134 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.576 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 50.6 t -39.89 -46.19 1.96 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.043 . . . . 0.0 108.731 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.073 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -63.04 -49.28 75.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -46.3 -41.84 13.77 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.898 177.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.576 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -67.57 -56.62 8.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.494 -0.754 . . . . 0.0 109.387 178.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.921 ' CG2' HG21 ' A' ' 19' ' ' ILE . 1.4 t -55.71 -51.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 3.0 mmt85 -40.94 -49.92 3.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.369 -0.832 . . . . 0.0 109.392 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.533 ' CG ' ' OD2' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -49.82 -44.25 49.18 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 177.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.87 HD21 HD21 ' A' ' 12' ' ' LEU . 49.3 mt -67.22 -20.29 65.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.469 -0.769 . . . . 0.0 109.881 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.502 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.72 -64.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.318 -0.864 . . . . 0.0 110.278 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -46.31 -23.92 0.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 0.0 110.299 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 20.7 mm-40 -85.97 11.06 12.29 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 59.5 54.38 38.19 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.82 ' O ' HD13 ' A' ' 58' ' ' ILE . 12.4 m-85 -139.53 9.82 2.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.16 -1.2 . . . . 0.0 110.339 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.82 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.3 mm -136.72 29.71 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.29 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.44 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 16.3 pt20 -83.1 -9.4 59.23 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.402 -0.811 . . . . 0.0 109.666 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -125.4 -41.74 0.35 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.858 ' HB3' HD13 ' A' ' 23' ' ' LEU . 8.7 m-30 -57.32 -113.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.813 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.956 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.6 t -89.9 27.28 1.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -38.46 -29.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.407 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 65' ' ' LEU . 3.6 pp -53.47 -34.28 57.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 110.043 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.071 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -66.75 -6.46 15.94 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.604 -0.685 . . . . 0.0 110.497 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 1.071 ' N ' HD13 ' A' ' 65' ' ' LEU . 8.0 t30 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.191 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.192 0.52 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.4 144.16 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.28 107.06 3.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.2 102.58 6.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' HE3' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -171.6 58.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.263 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG2' ' CD1' ' A' ' 12' ' ' LEU . 7.1 ttmt -177.06 58.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -54.03 -60.95 6.11 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.127 -0.983 . . . . 0.0 109.944 179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 7' ' ' ARG . 47.1 Cg_endo -74.16 53.6 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.935 1.492 . . . . 0.0 110.022 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 8' ' ' PRO . . . -52.85 -168.65 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 2.1 tttm 66.24 -129.51 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -1.143 . . . . 0.0 109.974 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.85 89.48 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 110.264 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -117.05 133.11 56.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.245 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 16' ' ' ASP . 0.4 OUTLIER -59.53 128.33 36.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 0.6 OUTLIER -47.11 -46.01 22.61 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.308 -0.87 . . . . 0.0 110.351 -179.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.673 HG23 HD22 ' A' ' 40' ' ' LEU . 20.5 mm -65.88 -17.1 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.817 . . . . 0.0 110.66 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.55 ' C ' HD11 ' A' ' 52' ' ' LEU . 20.4 m-20 -84.04 -62.71 1.5 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.059 -1.026 . . . . 0.0 110.439 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -52.84 -45.23 67.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.128 -0.982 . . . . 0.0 110.022 -179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.505 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -64.66 -42.36 95.46 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 109.285 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.825 HD13 HG23 ' A' ' 49' ' ' VAL . 1.3 mt -58.74 -35.0 53.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.36 -0.838 . . . . 0.0 109.347 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.718 HD11 HD22 ' A' ' 52' ' ' LEU . 67.2 mt -67.06 -45.24 77.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.242 -0.911 . . . . 0.0 109.581 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -64.45 -27.06 68.73 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.219 -0.926 . . . . 0.0 109.245 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 11.9 mm-40 -85.37 -43.67 13.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.516 -0.74 . . . . 0.0 110.147 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -65.77 -20.28 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.085 -1.009 . . . . 0.0 109.558 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.471 ' HB2' ' HE3' ' A' ' 5' ' ' LYS . 3.6 tp60 -85.58 -41.32 15.36 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 26' ' ' ASP . 1.3 ptmt -60.5 -30.78 69.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.723 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.522 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 27.0 p30 -150.87 71.23 1.02 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.09 -23.42 1.65 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' CD ' ' H ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -79.08 9.31 4.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.242 -1.152 . . . . 0.0 110.366 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.68 HD11 ' HG3' ' A' ' 37' ' ' ARG . 7.1 tt -76.53 153.31 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.878 . . . . 0.0 110.454 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.556 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 2.3 m -104.6 155.58 18.72 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.839 . . . . 0.0 110.331 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' SER . 5.3 p-10 -46.25 -47.36 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.128 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.406 ' O ' ' OG ' ' A' ' 35' ' ' SER . 4.7 t -49.65 -55.45 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.935 -1.103 . . . . 0.0 108.881 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.4 tt0 -67.21 -32.38 73.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.292 -0.88 . . . . 0.0 108.762 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -68.53 -20.04 64.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.59 0.71 . . . . 0.0 109.486 178.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.537 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 25.3 p -83.47 -46.2 12.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.557 -0.714 . . . . 0.0 110.155 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -82.25 -27.1 32.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 110.234 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.68 ' HG3' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -58.37 -24.54 60.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.224 -0.923 . . . . 0.0 109.736 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.767 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -111.0 -3.87 10.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 178.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.29 46.76 5.73 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.767 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.6 OUTLIER -150.24 156.65 41.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.036 -1.273 . . . . 0.0 111.019 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.51 ' C ' ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -62.65 153.31 78.69 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.07 ' O ' HD12 ' A' ' 46' ' ' LEU . 46.2 Cg_endo -72.86 -41.93 1.27 Allowed 'Trans proline' 0 C--N 1.283 -2.887 0 O-C-N 123.842 1.443 . . . . 0.0 110.682 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.573 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.13 -56.03 2.75 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.606 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.8 Cg_endo -74.74 -37.76 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.9 1.473 . . . . 0.0 110.121 178.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.675 ' HA ' HD11 ' A' ' 40' ' ' LEU . 48.5 t -41.85 -45.89 3.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.029 -1.044 . . . . 0.0 108.651 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.07 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mp -64.96 -43.27 93.23 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 176.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 44' ' ' PRO . 58.2 mt-10 -55.0 -43.69 73.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.572 ' CD ' ' HB ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -67.83 -44.65 76.71 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.636 0.731 . . . . 0.0 109.189 178.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.825 HG23 HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -62.8 -50.41 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -0.833 . . . . 0.0 109.599 178.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.613 ' HD2' ' CD1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -41.85 -51.37 4.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.495 ' HG2' ' OD2' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -51.35 -45.1 62.22 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.134 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.828 ' HB3' HD11 ' A' ' 58' ' ' ILE . 16.5 mt -72.19 -23.5 61.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.872 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' CG ' ' HA ' ' A' ' 61' ' ' TYR . 13.0 tm-20 -58.14 -48.94 78.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -0.791 . . . . 0.0 110.098 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.514 ' HG3' ' N ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -65.18 -17.24 64.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 110.323 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.514 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 77.2 mm-40 -79.81 8.61 6.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 110.278 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.73 31.35 71.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -112.86 4.05 16.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -1.142 . . . . 0.0 109.999 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 52' ' ' LEU . 1.1 mt -150.24 124.18 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.36 -0.838 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -86.94 84.74 7.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 110.113 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 62' ' ' THR . . . 111.32 52.91 0.54 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.767 ' O ' HG21 ' A' ' 58' ' ' ILE . 96.1 m-85 57.58 -82.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.324 -1.104 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.759 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 1.4 p -91.12 1.11 57.33 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.107 -0.996 . . . . 0.0 109.274 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 62' ' ' THR . . . 71.11 29.17 2.96 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.456 0.646 . . . . 0.0 109.949 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 29' ' ' ILE . 0.8 OUTLIER 176.12 -30.81 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.905 -179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -50.44 -19.16 0.78 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.668 -0.645 . . . . 0.0 110.254 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.759 ' N ' HD23 ' A' ' 65' ' ' LEU . 2.3 t-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.338 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' VAL . 6.1 ttt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.271 0.558 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' MET . 47.3 t -42.47 -43.67 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -0.894 . . . . 0.0 110.274 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 0.6 OUTLIER 62.36 105.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.338 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' LYS . 28.9 m -88.36 30.28 0.9 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.551 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 5.3 ttpt -62.46 81.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 7' ' ' ARG . 0.2 OUTLIER -119.32 -40.03 2.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.239 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HG2' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER 41.64 -162.26 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.403 -0.811 . . . . 0.0 109.142 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.665 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.7 Cg_endo -75.14 58.08 4.86 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.235 1.124 . . . . 0.0 109.788 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' HA2' HD12 ' A' ' 12' ' ' LEU . . . -38.52 -29.81 0.08 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -60.16 -131.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -1.17 . . . . 0.0 109.948 179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.73 87.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.042 -1.036 . . . . 0.0 110.014 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.529 HD12 ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -110.59 149.58 30.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ASP . 10.4 t70 -85.85 131.64 34.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 0.0 109.939 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -40.88 -45.59 2.55 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.36 -0.837 . . . . 0.0 110.565 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.78 HG21 ' CD2' ' A' ' 40' ' ' LEU . 6.4 mm -70.19 -26.34 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.82 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 51' ' ' ARG . 28.1 m-20 -72.51 -59.31 2.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 0.0 110.303 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -35.92 68.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 109.985 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.74 ' HB3' HG13 ' A' ' 38' ' ' VAL . 3.5 t-20 -71.32 -42.86 68.06 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.448 -0.783 . . . . 0.0 109.095 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.115 HG21 HG23 ' A' ' 49' ' ' VAL . 14.0 mt -66.31 -34.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.46 -0.775 . . . . 0.0 109.206 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.913 HD11 ' CD2' ' A' ' 52' ' ' LEU . 49.0 mt -72.18 -39.89 68.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.401 -0.812 . . . . 0.0 109.433 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.67 -37.07 84.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.989 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.88 -33.08 63.91 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.466 -0.771 . . . . 0.0 109.473 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 61' ' ' TYR . 17.5 mt -72.0 -25.0 61.66 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.551 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 3.5 tm0? -73.66 -44.74 55.94 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.521 -0.737 . . . . 0.0 109.739 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -70.21 -32.33 70.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.907 . . . . 0.0 109.603 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.541 ' O ' HG22 ' A' ' 29' ' ' ILE . 5.9 m-20 -130.05 86.17 2.37 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.84 0.71 50.11 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -111.03 31.9 5.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.163 -1.198 . . . . 0.0 110.165 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.989 HG21 ' OE2' ' A' ' 22' ' ' GLU . 14.9 tt -115.84 144.88 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.875 . . . . 0.0 110.327 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.034 ' HA ' HD11 ' A' ' 64' ' ' LEU . 44.8 t -87.96 -110.92 0.06 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 110.408 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.689 ' CB ' HD21 ' A' ' 46' ' ' LEU . 4.5 p-10 -124.88 -50.33 1.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 31' ' ' ASN . 69.5 t -41.17 -64.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.0 109.48 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 37' ' ' ARG . 4.1 tp10 -61.33 -31.93 71.8 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.224 -0.922 . . . . 0.0 108.851 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 30' ' ' SER . 1.1 tt -67.8 -23.57 65.21 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.557 -0.714 . . . . 0.0 109.609 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 31' ' ' ASN . 9.7 p -78.57 -41.88 30.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.437 -0.789 . . . . 0.0 110.286 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -67.09 -28.31 68.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.856 . . . . 0.0 110.115 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 33' ' ' GLU . 1.1 mmt180 -73.03 -17.81 61.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 18' ' ' ASN . 3.6 t -107.23 11.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.399 -0.813 . . . . 0.0 109.914 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.47 18.05 21.3 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.78 ' CD2' HG21 ' A' ' 15' ' ' ILE . 15.0 tp -123.4 134.95 53.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -1.003 . . . . 0.0 110.203 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.563 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 22.8 m -47.0 158.7 0.42 Allowed Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.07 -1.052 . . . . 0.0 108.735 177.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.061 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -73.6 -42.58 0.82 Allowed 'Trans proline' 0 C--N 1.285 -2.772 0 O-C-N 123.825 1.434 . . . . 0.0 110.39 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -39.41 -55.54 3.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 109.32 178.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.711 ' CG ' HD11 ' A' ' 40' ' ' LEU . 44.4 Cg_endo -74.26 -50.37 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.91 1.479 . . . . 0.0 110.136 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 39.4 t -38.19 -46.65 1.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.201 -0.937 . . . . 0.0 108.873 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.061 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -63.42 -53.05 58.42 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 1.3 mt-10 -46.29 -46.01 17.73 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.955 177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD2' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -68.22 -43.83 77.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.576 -0.702 . . . . 0.0 109.33 178.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.115 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -62.87 -43.81 99.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' N ' HG12 ' A' ' 49' ' ' VAL . 18.7 mmm-85 -51.36 -46.48 62.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.303 -0.873 . . . . 0.0 109.475 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.566 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.59 -34.08 64.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.862 178.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.913 ' CD2' HD11 ' A' ' 20' ' ' LEU . 5.2 mt -76.68 -19.05 58.17 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.444 -0.785 . . . . 0.0 109.743 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.512 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -70.55 -59.92 2.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 110.197 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -54.19 -22.97 12.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 110.212 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.56 11.44 7.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.7 51.43 59.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.917 ' O ' HD13 ' A' ' 58' ' ' ILE . 13.4 m-85 -134.29 6.58 3.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -1.129 . . . . 0.0 110.245 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.917 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.3 mm -137.17 38.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.266 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -1.27 57.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.39 -0.819 . . . . 0.0 109.611 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -138.32 -39.89 0.11 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.812 ' HB3' HD13 ' A' ' 23' ' ' LEU . 14.0 m-30 -58.59 -114.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.296 -1.12 . . . . 0.0 109.898 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.065 ' O ' HD23 ' A' ' 65' ' ' LEU . 14.2 t -87.1 23.03 1.89 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.054 -1.029 . . . . 0.0 109.906 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -34.53 -32.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.548 0.689 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.034 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -58.67 -110.92 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.574 -0.704 . . . . 0.0 109.434 177.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.065 HD23 ' O ' ' A' ' 62' ' ' THR . 0.3 OUTLIER 34.95 30.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 110.46 179.099 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.556 ' N ' ' O ' ' A' ' 64' ' ' LEU . 7.2 t30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.287 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 121.292 0.568 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.8 139.9 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.186 -0.946 . . . . 0.0 110.239 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 4' ' ' SER . 2.7 p30 -69.52 -33.33 72.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.269 -0.894 . . . . 0.0 110.262 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.523 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 0.6 OUTLIER 55.51 77.51 0.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.325 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.536 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -135.04 32.42 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 0.0 110.193 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -177.09 63.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.226 -0.921 . . . . 0.0 110.506 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.565 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 2.1 ttt180 -64.46 -56.95 19.14 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.034 -1.041 . . . . 0.0 109.796 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 7' ' ' ARG . 48.4 Cg_endo -74.95 44.64 1.19 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.427 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -50.27 -37.46 31.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 10' ' ' LYS . 17.6 ttpt -66.54 -8.3 25.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -1.179 . . . . 0.0 110.145 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.92 84.91 1.02 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.439 -0.788 . . . . 0.0 110.012 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.72 HD22 ' HG3' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -140.61 86.05 2.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 110.363 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -42.63 145.95 0.4 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.109 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 8.4 mmt180 -47.3 -22.81 0.45 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.333 -0.855 . . . . 0.0 110.284 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.754 HG21 ' CD2' ' A' ' 40' ' ' LEU . 1.2 mp -80.51 -44.35 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 110.129 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.601 ' CB ' HD23 ' A' ' 12' ' ' LEU . 2.7 m-20 -58.55 -44.87 89.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.161 -0.962 . . . . 0.0 109.901 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.72 ' HG3' HD22 ' A' ' 12' ' ' LEU . 3.8 mtt180 -65.93 -47.82 73.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.915 . . . . 0.0 109.799 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.584 ' HB3' HG13 ' A' ' 38' ' ' VAL . 1.5 m-20 -61.87 -41.79 98.27 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.388 -0.82 . . . . 0.0 108.879 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.997 HG21 HG23 ' A' ' 49' ' ' VAL . 7.6 mt -62.09 -41.06 89.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.524 -0.735 . . . . 0.0 109.462 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.095 HD11 HD22 ' A' ' 52' ' ' LEU . 13.8 mt -70.34 -40.94 73.82 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.1 t-20 -66.41 -34.39 77.84 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.287 -0.883 . . . . 0.0 109.354 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.539 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 6.2 mm-40 -76.32 -29.49 57.34 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.424 -0.797 . . . . 0.0 109.696 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.767 HD21 ' CD1' ' A' ' 34' ' ' LEU . 21.5 mt -72.48 -32.7 66.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.348 -0.845 . . . . 0.0 109.375 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.536 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 1.4 tp60 -79.24 -42.52 25.73 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -67.03 -33.69 76.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 179.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.552 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -141.34 63.37 1.44 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.845 . . . . 0.0 109.911 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.01 -161.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.488 ' CD ' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 44.06 30.1 0.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.17 -1.194 . . . . 0.0 109.946 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 26' ' ' ASP . 4.9 tt -117.43 131.9 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.292 -0.88 . . . . 0.0 110.361 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.571 ' HA ' HD11 ' A' ' 64' ' ' LEU . 37.0 t -67.73 168.88 10.53 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.291 -0.881 . . . . 0.0 109.954 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' SER . 0.6 OUTLIER -65.37 -39.91 92.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 110.36 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 31' ' ' ASN . 46.6 t -44.54 -61.12 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 109.221 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.99 -33.66 74.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.307 -0.87 . . . . 0.0 108.751 177.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.767 ' CD1' HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -67.95 -20.39 65.05 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.525 0.678 . . . . 0.0 109.674 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' ASN . 8.4 p -87.77 -24.39 23.8 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.41 -0.806 . . . . 0.0 110.488 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 4.7 mtmt -79.25 -33.14 43.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 110.71 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.591 ' CD ' ' HA ' ' A' ' 34' ' ' LEU . 4.4 ptm180 -81.67 -16.04 52.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.074 -1.016 . . . . 0.0 110.745 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 34' ' ' LEU . 4.5 t -97.66 12.39 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.207 -0.933 . . . . 0.0 110.144 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 51.98 21.76 8.24 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.754 ' CD2' HG21 ' A' ' 15' ' ' ILE . 15.2 tp -127.83 133.37 49.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.52 -0.988 . . . . 0.0 110.253 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.593 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -47.81 160.63 0.39 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 120.993 -1.067 . . . . 0.0 108.536 177.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.042 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.9 Cg_endo -73.92 -45.57 0.37 Allowed 'Trans proline' 0 C--N 1.282 -2.935 0 O-C-N 123.651 1.343 . . . . 0.0 110.654 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.554 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.2 OUTLIER -38.73 -53.18 3.44 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.077 -1.014 . . . . 0.0 109.643 178.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.587 ' HB2' HD11 ' A' ' 40' ' ' LEU . 44.6 Cg_endo -75.45 -49.01 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.044 1.549 . . . . 0.0 109.77 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HA ' HD11 ' A' ' 19' ' ' ILE . 12.8 t -43.62 -37.87 2.77 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.047 -1.033 . . . . 0.0 108.494 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.042 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.5 mt -70.77 -45.87 63.95 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 70.8 mt-10 -49.79 -46.3 50.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 109.088 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' CB ' HG22 ' A' ' 15' ' ' ILE . 3.6 mpt_? -69.69 -36.48 76.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.515 -0.741 . . . . 0.0 109.57 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.997 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -71.66 -47.79 55.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.272 -0.893 . . . . 0.0 110.017 179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.608 ' N ' HG12 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -48.25 -48.06 35.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.236 -0.915 . . . . 0.0 109.31 179.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 2.4 tpp180 -53.38 -45.91 69.41 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.73 -0.788 . . . . 0.0 108.903 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.095 HD22 HD11 ' A' ' 20' ' ' LEU . 78.1 mt -67.59 -16.59 64.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.463 -0.773 . . . . 0.0 109.898 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -58.89 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.421 -0.8 . . . . 0.0 110.254 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.445 ' C ' ' HG2' ' A' ' 55' ' ' GLN . 61.4 mtt85 -73.75 -21.81 60.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.335 -0.853 . . . . 0.0 110.372 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' HG2' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -148.51 53.74 1.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -161.71 -123.58 0.67 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 1.061 ' O ' HD13 ' A' ' 58' ' ' ILE . 63.4 m-85 -146.96 76.16 1.41 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -1.158 . . . . 0.0 110.282 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.061 HD13 ' O ' ' A' ' 57' ' ' PHE . 5.5 mm -137.0 24.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.63 1.47 38.17 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.506 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -145.5 -39.91 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.762 ' HB3' HD22 ' A' ' 23' ' ' LEU . 93.0 m-85 -56.18 -110.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.363 -1.081 . . . . 0.0 109.904 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.949 ' O ' HD12 ' A' ' 65' ' ' LEU . 2.7 t -85.28 21.06 1.8 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.893 -1.129 . . . . 0.0 109.695 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -39.32 -28.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.484 -0.76 . . . . 0.0 109.224 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 30' ' ' SER . 2.0 pp -54.28 -34.21 60.35 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.615 0.721 . . . . 0.0 110.035 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.09 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -65.35 -5.81 8.37 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.632 -0.668 . . . . 0.0 110.656 -179.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 1.09 ' N ' HD13 ' A' ' 65' ' ' LEU . 3.7 p30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.218 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.212 0.53 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -108.28 146.56 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.376 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.35 107.6 0.12 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.4 p -121.87 40.79 3.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.307 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' CD ' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER -106.62 22.96 15.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.21 -0.931 . . . . 0.0 110.329 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 7' ' ' ARG . 38.9 mtpt -89.91 -11.54 41.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.24 -0.913 . . . . 0.0 110.251 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.691 ' NE ' HD13 ' A' ' 20' ' ' LEU . 15.9 mmm180 43.83 -156.03 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 109.122 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.687 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 43.0 Cg_endo -77.83 20.41 0.71 Allowed 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.129 1.068 . . . . 0.0 110.305 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 8' ' ' PRO . . . 41.51 -98.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -63.46 79.58 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 110.402 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 12' ' ' LEU . 0.6 OUTLIER 175.0 32.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 110.218 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 17' ' ' ARG . 2.4 pp 179.99 156.88 0.66 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.423 -0.798 . . . . 0.0 110.312 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' HB3' ' OD1' ' A' ' 16' ' ' ASP . 5.1 t70 -89.92 156.0 18.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 110.285 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.547 ' HA ' ' CD ' ' A' ' 17' ' ' ARG . 9.4 mmt180 -48.18 -25.64 1.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.322 -0.861 . . . . 0.0 110.346 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.875 HD12 HD22 ' A' ' 40' ' ' LEU . 19.2 mm -69.93 -33.57 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.265 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 52' ' ' LEU . 1.4 m-20 -73.81 -59.45 2.71 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 110.017 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.547 ' CD ' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -53.6 -33.4 54.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.812 179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.579 ' CG ' HG12 ' A' ' 38' ' ' VAL . 59.8 t-20 -70.27 -43.12 71.12 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.384 -0.822 . . . . 0.0 109.192 178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.043 HG21 HG23 ' A' ' 49' ' ' VAL . 40.4 mt -61.75 -35.92 70.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.37 -0.831 . . . . 0.0 109.224 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.937 HD11 HD22 ' A' ' 52' ' ' LEU . 20.2 mt -67.33 -43.63 81.11 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.285 -0.885 . . . . 0.0 109.286 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.504 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 11.1 t30 -58.67 -32.83 69.48 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.369 -0.832 . . . . 0.0 109.088 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 22.3 mm-40 -75.42 -45.09 41.0 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.5 -0.75 . . . . 0.0 109.853 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 19' ' ' ILE . 2.1 mm? -57.6 -44.14 85.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.659 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -68.04 -40.42 82.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.377 -0.827 . . . . 0.0 109.83 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 27.6 mtpt -68.66 -20.16 64.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.0 109.909 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' ARG . 35.1 m-20 -147.4 79.23 1.49 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.306 -0.872 . . . . 0.0 110.188 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.88 58.36 0.21 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.26 31.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.193 -1.181 . . . . 0.0 110.008 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.578 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.7 tt -122.35 147.04 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 110.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.602 ' HA ' HD11 ' A' ' 64' ' ' LEU . 9.1 p -87.83 -167.11 1.78 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.353 -0.842 . . . . 0.0 110.108 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 12.9 m-80 -78.78 -49.97 12.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -0.919 . . . . 0.0 110.333 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' ASN . 20.6 t -40.02 -57.78 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.053 -1.029 . . . . 0.0 109.706 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -61.66 -33.5 74.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.186 -0.946 . . . . 0.0 108.759 177.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.749 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -67.16 -57.86 5.95 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.555 -0.716 . . . . 0.0 109.467 178.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.577 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 3.1 p -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.608 -0.682 . . . . 0.0 110.29 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -80.11 -22.99 41.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.821 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 34' ' ' LEU . 12.5 mmt180 -78.33 -17.86 55.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 110.28 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.855 HG23 ' HG ' ' A' ' 40' ' ' LEU . 3.2 m -105.88 -12.33 9.78 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.23 39.85 5.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.875 HD22 HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -153.76 169.19 23.94 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.016 -1.284 . . . . 0.0 110.775 179.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -71.2 154.09 94.01 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 108.969 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.058 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.4 Cg_endo -73.58 -44.0 0.57 Allowed 'Trans proline' 0 C--N 1.287 -2.698 0 O-C-N 124.004 1.529 . . . . 0.0 110.802 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.602 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.94 -56.26 1.98 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.696 179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.623 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 53.8 Cg_endo -77.52 -42.57 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.93 1.49 . . . . 0.0 110.174 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 36.9 t -37.4 -50.39 1.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.124 -0.985 . . . . 0.0 108.877 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.058 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -60.34 -51.77 68.11 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 4.7 mm-40 -44.89 -41.22 6.96 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.303 -0.873 . . . . 0.0 108.949 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.69 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -69.97 -45.33 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.043 HG23 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -62.54 -44.59 99.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 178.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.552 ' N ' HG12 ' A' ' 49' ' ' VAL . 8.2 mmm180 -48.96 -47.39 44.02 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.339 -0.851 . . . . 0.0 109.019 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.522 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -50.5 -40.66 51.88 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.937 HD22 HD11 ' A' ' 20' ' ' LEU . 90.1 mt -75.44 -37.52 60.31 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.577 -0.702 . . . . 0.0 109.667 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.558 ' N ' HG13 ' A' ' 58' ' ' ILE . 7.1 tp10 -73.25 -26.6 61.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.35 -0.843 . . . . 0.0 110.337 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -68.66 -42.12 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 110.209 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' OE1' ' CG ' ' A' ' 57' ' ' PHE . 6.2 pt20 -76.99 2.09 15.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.64 8.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.721 ' O ' HD13 ' A' ' 58' ' ' ILE . 1.3 m-85 -119.28 11.01 12.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.188 -1.183 . . . . 0.0 110.152 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 52' ' ' LEU . 15.0 mm -136.04 26.55 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.097 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.4 0.21 20.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.365 -0.834 . . . . 0.0 109.917 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -140.97 -42.86 0.07 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.521 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 94.2 m-85 -57.41 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.314 -1.109 . . . . 0.0 109.977 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.023 HG21 HG21 ' A' ' 49' ' ' VAL . 5.1 t -87.33 26.18 1.27 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.982 -1.074 . . . . 0.0 109.903 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -37.97 -32.1 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.521 -0.737 . . . . 0.0 109.444 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -53.83 -27.49 29.93 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.741 0.781 . . . . 0.0 109.872 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.667 ' CD2' HG21 ' A' ' 58' ' ' ILE . 1.1 pp -40.03 -24.84 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.883 0 O-C-N 121.741 -0.599 . . . . 0.0 110.726 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.579 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 2.0 t-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.167 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.588 ' C ' HG23 ' A' ' 2' ' ' VAL . 4.6 tmm? . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.186 0.517 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.588 HG23 ' C ' ' A' ' 1' ' ' MET . 2.0 t 61.27 -139.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.364 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.519 ' H ' HG12 ' A' ' 2' ' ' VAL . 0.8 OUTLIER 56.59 -157.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.224 -0.923 . . . . 0.0 110.194 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 10.3 m -112.05 175.54 5.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.255 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.584 ' HD3' ' HA ' ' A' ' 21' ' ' ASN . 0.1 OUTLIER 57.78 101.64 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.309 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 7' ' ' ARG . 1.8 ptpt -133.37 4.7 3.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.243 -0.911 . . . . 0.0 110.419 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.712 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 41.85 -159.33 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 108.932 179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.712 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 41.2 Cg_endo -73.75 4.46 4.08 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 O-C-N 123.065 1.034 . . . . 0.0 109.658 178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 10' ' ' LYS . . . 54.01 167.12 0.02 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 9' ' ' GLY . 1.7 tttt 58.86 127.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.334 -1.097 . . . . 0.0 110.495 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' LYS . 1.5 t70 40.5 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.482 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.808 HD22 ' HG3' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -136.77 113.81 10.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.273 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 15' ' ' ILE . 1.4 m-20 -64.05 130.18 42.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.19 -0.943 . . . . 0.0 110.052 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 6.7 mmt-85 -46.03 -22.33 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 110.358 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' HD2' ' A' ' 48' ' ' ARG . 6.6 mm -73.48 -34.43 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.197 -0.94 . . . . 0.0 110.462 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.812 ' HB3' HD11 ' A' ' 52' ' ' LEU . 1.0 OUTLIER -78.0 -45.02 24.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.808 ' HG3' HD22 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -63.52 -51.87 63.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.954 . . . . 0.0 110.0 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.555 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 7.8 t-20 -60.85 -40.45 92.91 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.385 -0.822 . . . . 0.0 109.332 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.072 HG21 HG23 ' A' ' 49' ' ' VAL . 10.5 mt -64.77 -38.5 82.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.282 -0.887 . . . . 0.0 109.559 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.883 ' HG ' HD13 ' A' ' 52' ' ' LEU . 14.4 mt -73.38 -35.24 65.88 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.351 -0.843 . . . . 0.0 109.307 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.584 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 49.5 t30 -72.69 -31.15 64.82 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.43 -0.794 . . . . 0.0 109.453 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.555 ' CG ' ' O ' ' A' ' 18' ' ' ASN . 5.6 mm-40 -72.13 -32.85 67.32 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.402 -0.811 . . . . 0.0 109.86 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' A' ' 61' ' ' TYR . 4.3 mt -69.89 -36.41 75.41 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.203 -0.936 . . . . 0.0 109.488 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HB2' ' HE3' ' A' ' 5' ' ' LYS . 2.8 tp-100 -64.07 -42.97 96.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.49 -28.9 66.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -0.826 . . . . 0.0 109.435 178.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.517 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -133.41 76.12 1.65 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.486 -0.759 . . . . 0.0 110.055 179.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.76 58.82 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.57 29.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.306 -1.114 . . . . 0.0 110.182 179.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.5 tt -112.17 141.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.208 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.621 ' O ' HD12 ' A' ' 34' ' ' LEU . 17.6 m -77.9 -138.7 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.417 -0.802 . . . . 0.0 110.138 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.606 ' OD1' HD23 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -108.86 -41.1 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' ASN . 76.2 t -44.43 -62.48 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 109.355 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.481 ' O ' ' HD2' ' A' ' 37' ' ' ARG . 1.1 tp10 -61.84 -26.44 68.13 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.191 -0.943 . . . . 0.0 108.966 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -78.54 -15.28 58.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.697 -0.627 . . . . 0.0 110.071 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ASN . 23.6 p -87.93 -44.67 10.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.819 . . . . 0.0 110.789 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' CG ' ' N ' ' A' ' 37' ' ' ARG . 7.8 pttt -79.84 -41.05 27.14 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.233 -0.917 . . . . 0.0 111.126 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 13.9 ptm180 -63.01 -16.2 58.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.065 -1.022 . . . . 0.0 110.628 -178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.782 HG23 ' HG ' ' A' ' 40' ' ' LEU . 14.5 m -98.51 -22.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.358 -0.838 . . . . 0.0 110.005 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' C ' HD23 ' A' ' 40' ' ' LEU . . . 103.97 35.38 3.46 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.782 ' HG ' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -153.36 169.02 24.13 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.019 -1.283 . . . . 0.0 110.624 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 2.0 m -74.17 158.75 85.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.747 177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.085 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.9 Cg_endo -74.16 -49.75 0.18 Allowed 'Trans proline' 0 C--N 1.286 -2.72 0 O-C-N 123.9 1.473 . . . . 0.0 110.565 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.6 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -38.92 -53.67 3.43 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.428 179.142 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.634 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 50.3 Cg_endo -76.46 -41.69 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.898 1.473 . . . . 0.0 110.219 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 53.8 t -40.33 -51.19 2.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 108.718 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.085 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -57.25 -47.4 81.48 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -46.4 -38.83 9.52 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.864 177.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.815 ' HD2' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -72.36 -46.91 53.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.535 -0.728 . . . . 0.0 109.266 178.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.072 HG23 HG21 ' A' ' 19' ' ' ILE . 0.6 OUTLIER -65.77 -51.47 61.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.473 -0.767 . . . . 0.0 109.96 178.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.815 ' HD2' HD11 ' A' ' 65' ' ' LEU . 2.4 mmm180 -46.07 -44.11 15.18 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 109.216 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.503 ' O ' ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -54.44 -44.75 72.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' A' ' 58' ' ' ILE . 61.0 mt -65.08 -16.69 63.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.353 -0.842 . . . . 0.0 109.726 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.501 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -72.99 -58.56 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.243 179.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.503 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 2.6 ptp180 -49.19 -27.94 4.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.438 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.472 ' N ' ' HG3' ' A' ' 54' ' ' ARG . 73.5 mm-40 -81.77 10.87 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.06 46.74 93.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.818 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -129.85 15.44 5.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.13 . . . . 0.0 110.353 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.922 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.0 mm -138.41 47.48 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.235 -0.916 . . . . 0.0 110.167 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.563 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -85.9 -13.41 47.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.66 179.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.12 -43.75 0.1 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.782 ' HB3' HD13 ' A' ' 23' ' ' LEU . 62.9 m-85 -55.97 -100.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -1.061 . . . . 0.0 109.959 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.052 HG21 HG21 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -85.33 13.02 7.06 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.947 -1.096 . . . . 0.0 110.199 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.785 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -39.71 -29.95 0.07 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.371 -0.83 . . . . 0.0 109.779 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -63.77 -120.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.812 . . . . 0.0 109.98 179.352 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.898 HD23 ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER 40.06 28.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 110.319 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.1 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.288 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mtp . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.159 0.504 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.23 -26.88 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 0.0 110.257 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' CB ' ' A' ' 4' ' ' SER . 0.2 OUTLIER -165.79 -77.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.948 . . . . 0.0 110.308 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 3.0 p 175.1 128.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.417 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -84.77 50.33 1.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.172 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' C ' ' HD3' ' A' ' 7' ' ' ARG . 12.0 mtpp -98.32 -58.48 1.96 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.228 -0.92 . . . . 0.0 110.552 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.646 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 43.22 -161.98 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.687 0 O-C-N 121.389 -0.819 . . . . 0.0 108.887 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 7' ' ' ARG . 43.7 Cg_endo -77.33 52.06 3.74 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.183 1.096 . . . . 0.0 110.223 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -47.28 -36.39 10.44 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -58.3 -15.26 9.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -1.166 . . . . 0.0 110.041 179.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.39 79.17 1.39 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.993 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.589 HD13 ' NH2' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -147.48 140.42 24.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.316 -0.865 . . . . 0.0 110.401 -179.239 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -69.72 173.29 6.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 110.317 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -80.01 -22.3 42.62 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.264 -0.897 . . . . 0.0 110.362 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.788 HG23 HD22 ' A' ' 40' ' ' LEU . 13.4 mm -78.87 -29.68 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.213 -0.929 . . . . 0.0 110.478 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.798 ' HB3' HD21 ' A' ' 52' ' ' LEU . 85.3 m-20 -81.56 -39.91 23.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 110.073 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.87 -51.68 56.73 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.214 -0.929 . . . . 0.0 110.032 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.559 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -62.84 -39.43 94.34 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.404 -0.81 . . . . 0.0 109.363 178.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.796 HG23 HD21 ' A' ' 34' ' ' LEU . 8.0 mt -64.07 -38.25 81.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.453 -0.779 . . . . 0.0 109.56 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.021 HD11 HD22 ' A' ' 52' ' ' LEU . 12.9 mt -70.03 -37.42 75.59 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.23 -0.919 . . . . 0.0 109.344 178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 26.2 m-20 -70.83 -29.32 65.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.347 -0.845 . . . . 0.0 109.603 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 37' ' ' ARG . 6.2 mm-40 -82.23 -29.14 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.445 -0.785 . . . . 0.0 109.848 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -66.96 -37.36 84.13 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.236 -0.915 . . . . 0.0 109.458 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -42.48 33.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.414 -0.804 . . . . 0.0 109.695 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 1.5 pttt -75.17 -29.71 60.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.995 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.7 OUTLIER -133.14 53.31 2.02 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.134 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -53.54 -169.41 0.03 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 54.32 16.84 1.34 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -1.143 . . . . 0.0 110.197 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.982 HD13 ' NH1' ' A' ' 37' ' ' ARG . 12.9 tt -102.64 134.02 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 110.124 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.655 ' O ' HD12 ' A' ' 34' ' ' LEU . 36.5 m -75.02 -131.97 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.403 -0.81 . . . . 0.0 110.502 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.569 ' O ' ' N ' ' A' ' 35' ' ' SER . 26.5 p-10 -111.78 -47.02 3.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.217 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.475 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 5.6 t -43.1 -67.44 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.976 -1.078 . . . . 0.0 109.276 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 3.4 tp10 -56.34 -25.95 50.84 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.203 -0.936 . . . . 0.0 108.665 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.849 HD11 HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -77.64 -18.73 56.46 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.41 0.624 . . . . 0.0 109.906 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' ASN . 6.4 p -90.33 -47.75 7.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.532 -0.73 . . . . 0.0 110.864 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' N ' ' OG ' ' A' ' 35' ' ' SER . 10.6 ttmt -79.21 -24.83 42.85 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 111.288 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.982 ' NH1' HD13 ' A' ' 29' ' ' ILE . 28.4 ptt180 -75.8 -14.91 60.31 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 110.62 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.8 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -107.64 -11.02 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.331 -0.856 . . . . 0.0 110.071 179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.9 42.12 4.19 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.8 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -155.79 167.38 30.58 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.064 -1.256 . . . . 0.0 110.852 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.2 m -72.98 156.71 89.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.473 -0.767 . . . . 0.0 109.02 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.059 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.8 Cg_endo -74.18 -49.07 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.635 0 O-C-N 123.972 1.512 . . . . 0.0 110.826 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -39.38 -53.86 3.91 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.157 -0.964 . . . . 0.0 109.421 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.641 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 49.1 Cg_endo -77.24 -42.53 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 124.021 1.537 . . . . 0.0 110.335 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.767 ' HB2' HD12 ' A' ' 40' ' ' LEU . 44.6 t -38.47 -53.38 1.55 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.086 -1.009 . . . . 0.0 108.866 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.059 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -55.25 -49.63 71.54 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -42.25 -38.04 1.66 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.958 177.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.584 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -73.51 -49.29 27.34 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.627 0.727 . . . . 0.0 109.173 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -63.49 -40.49 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.504 -0.747 . . . . 0.0 109.822 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 4.2 mmm180 -53.86 -46.17 71.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.319 -0.863 . . . . 0.0 109.081 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -52.04 -42.16 62.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.021 HD22 HD11 ' A' ' 20' ' ' LEU . 64.4 mt -70.77 -22.4 62.39 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.546 -0.721 . . . . 0.0 109.781 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HG2' ' HB ' ' A' ' 58' ' ' ILE . 2.8 tm-20 -68.5 -69.5 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.6 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -52.95 -19.38 2.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.284 -0.885 . . . . 0.0 110.639 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.574 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 8.7 mm100 -86.54 13.41 8.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.083 -1.01 . . . . 0.0 110.481 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 61.84 51.42 57.39 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.922 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.3 m-85 -139.94 9.38 2.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -1.218 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.922 HD13 ' O ' ' A' ' 57' ' ' PHE . 8.5 mm -140.79 31.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.267 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -84.44 -3.8 58.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.733 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -138.27 -42.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 14.5 m-30 -55.86 -108.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.35 -1.088 . . . . 0.0 109.885 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.007 ' O ' HD12 ' A' ' 65' ' ' LEU . 4.7 t -88.15 22.46 2.43 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.931 -1.106 . . . . 0.0 109.807 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -37.87 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.545 -0.722 . . . . 0.0 109.472 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -54.41 -30.91 53.9 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.596 0.713 . . . . 0.0 110.008 178.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.031 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -66.02 -3.19 4.92 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.561 -0.712 . . . . 0.0 110.545 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 1.014 ' N ' HD13 ' A' ' 65' ' ' LEU . 5.2 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.256 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 tpt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.243 0.544 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.456 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 21.7 t -76.25 -27.34 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 110.206 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 2' ' ' VAL . 10.4 t0 66.65 117.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 110.388 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.41 -163.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.094 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HD3' ' CB ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -88.46 41.86 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.221 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 3.3 mtpm? 58.03 -113.87 0.74 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.291 -0.88 . . . . 0.0 110.572 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.653 ' HD3' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER 64.47 -171.5 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.988 -1.07 . . . . 0.0 109.112 -178.847 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.62 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 39.1 Cg_endo -70.28 55.24 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.398 1.209 . . . . 0.0 109.774 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -46.84 -33.66 6.7 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -59.14 -17.04 23.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.218 -1.166 . . . . 0.0 110.01 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -149.68 81.01 1.39 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.431 -0.793 . . . . 0.0 109.957 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.653 HD11 ' HD3' ' A' ' 7' ' ' ARG . 0.4 OUTLIER -146.98 144.36 29.13 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 -179.319 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -80.59 127.76 32.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.208 -0.933 . . . . 0.0 109.661 178.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -40.54 -27.49 0.05 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.361 -0.837 . . . . 0.0 110.41 -179.133 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.906 HG23 HD22 ' A' ' 40' ' ' LEU . 8.5 mm -72.97 -46.88 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.297 -0.877 . . . . 0.0 110.421 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 13' ' ' ASP . 1.4 m-20 -68.93 -26.24 64.97 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.545 ' CG ' ' HB3' ' A' ' 12' ' ' LEU . 9.3 mtp180 -75.88 -66.43 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.17 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.443 ' HB3' HG12 ' A' ' 38' ' ' VAL . 9.2 t-20 -53.45 -28.28 29.35 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 108.988 179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.791 HG13 HG11 ' A' ' 38' ' ' VAL . 3.4 mt -64.79 -50.66 74.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.091 178.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.914 HD11 HD22 ' A' ' 52' ' ' LEU . 72.0 mt -55.55 -42.19 74.3 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.535 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.491 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 10.8 t30 -59.02 -38.77 80.05 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 178.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.746 ' OE2' HG13 ' A' ' 38' ' ' VAL . 25.5 mt-10 -63.61 -39.65 94.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.45 -0.782 . . . . 0.0 109.744 179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 34' ' ' LEU . 2.1 mm? -66.58 -40.6 89.02 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.549 ' CB ' ' HD3' ' A' ' 5' ' ' LYS . 7.0 tp-100 -65.69 -36.45 83.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.317 -0.864 . . . . 0.0 109.303 178.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 1.6 pttp -79.1 -29.38 43.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 0.0 109.737 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -136.67 95.27 3.11 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.399 -0.813 . . . . 0.0 110.024 179.123 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.86 13.37 43.7 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.527 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.01 34.92 4.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.131 -1.217 . . . . 0.0 110.381 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 26' ' ' ASP . 11.3 tt -116.48 139.84 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 110.615 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.782 ' HA ' HD21 ' A' ' 64' ' ' LEU . 2.7 t -76.19 -129.77 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.364 -0.835 . . . . 0.0 110.027 179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.555 ' HA ' ' HB2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -117.89 -38.25 3.28 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.019 -1.05 . . . . 0.0 110.29 179.347 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 31' ' ' ASN . 98.0 t -45.39 -56.65 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.041 -1.037 . . . . 0.0 109.068 178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 1.7 tp10 -66.99 -32.88 74.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.336 -0.853 . . . . 0.0 108.844 177.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -69.46 -15.8 63.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.558 -0.714 . . . . 0.0 109.492 178.295 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.573 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 16.2 p -86.27 -47.08 9.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.495 -0.753 . . . . 0.0 110.355 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -80.99 -16.8 52.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.181 -0.95 . . . . 0.0 110.724 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -74.64 -19.94 60.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.148 -0.97 . . . . 0.0 110.432 -179.608 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.859 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -107.94 -5.97 10.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 O-C-N 121.396 -0.815 . . . . 0.0 109.756 179.102 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.92 40.65 5.51 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.906 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -152.18 160.38 43.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.0 -1.294 . . . . 0.0 110.72 178.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.485 ' C ' ' HB2' ' A' ' 35' ' ' SER . 3.8 m -69.59 160.12 80.89 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.069 ' O ' HD12 ' A' ' 46' ' ' LEU . 47.6 Cg_endo -73.06 -45.21 0.47 Allowed 'Trans proline' 0 C--N 1.284 -2.859 0 O-C-N 123.926 1.487 . . . . 0.0 110.489 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -37.39 -57.79 1.36 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 179.177 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 52.1 Cg_endo -76.5 -41.49 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.898 1.473 . . . . 0.0 110.135 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.714 ' HB2' HD12 ' A' ' 40' ' ' LEU . 53.6 t -39.13 -53.05 1.88 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.087 -1.008 . . . . 0.0 108.661 178.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.069 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -52.82 -51.98 58.76 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.318 -0.994 . . . . 0.0 108.318 176.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -43.0 -43.06 4.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.343 -0.848 . . . . 0.0 109.265 177.7 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.863 ' CD ' HG21 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -72.21 -56.25 5.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.397 -0.815 . . . . 0.0 109.492 178.581 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.71 HG11 ' HG ' ' A' ' 65' ' ' LEU . 1.6 t -54.72 -48.93 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.331 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 9.6 mmt180 -43.33 -52.27 5.92 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.286 -0.884 . . . . 0.0 109.369 178.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.04 -41.41 16.68 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.922 178.064 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.914 HD22 HD11 ' A' ' 20' ' ' LEU . 92.8 mt -68.07 -28.33 67.27 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.452 -0.78 . . . . 0.0 109.715 178.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' ARG . 1.9 tm-20 -64.62 -63.63 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.825 . . . . 0.0 110.161 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -50.27 -27.04 5.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 110.147 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 7' ' ' ARG . 28.6 mm-40 -83.42 5.59 23.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 110.262 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.57 59.97 7.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.953 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -146.53 10.81 1.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.169 -1.195 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.953 HD13 ' O ' ' A' ' 57' ' ' PHE . 10.7 mm -140.41 32.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 110.288 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.16 -4.1 59.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.308 -0.87 . . . . 0.0 109.69 178.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.54 -41.35 0.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.672 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 11.4 m-85 -61.31 -115.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.054 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.956 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.8 t -82.41 23.96 0.72 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.999 -1.063 . . . . 0.0 109.911 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -38.57 -29.31 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.782 HD21 ' HA ' ' A' ' 30' ' ' SER . 4.2 pp -51.61 -34.5 37.75 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.649 0.737 . . . . 0.0 109.819 178.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.053 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -66.91 -5.87 14.29 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.646 -0.659 . . . . 0.0 110.274 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 1.053 ' N ' HD13 ' A' ' 65' ' ' LEU . 21.5 t30 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.193 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.215 0.531 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.447 HG22 ' H ' ' A' ' 2' ' ' VAL . 16.2 m -71.48 69.32 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.291 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 4' ' ' SER . 2.7 m-20 -62.93 -64.15 1.0 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 79.7 p -179.31 166.85 1.51 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -0.922 . . . . 0.0 110.315 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.545 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -88.87 155.15 19.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.917 . . . . 0.0 110.013 179.65 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -94.54 -128.71 0.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.924 . . . . 0.0 110.641 -179.354 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.67 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 64.28 -168.69 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.066 -1.021 . . . . 0.0 109.131 -178.95 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 7' ' ' ARG . 37.6 Cg_endo -68.07 58.37 0.9 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.244 1.128 . . . . 0.0 110.012 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -49.2 -25.14 5.43 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' LEU . 4.3 pttm -62.36 -134.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -1.168 . . . . 0.0 110.072 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.507 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 5.4 m-20 -45.18 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.171 -0.955 . . . . 0.0 110.145 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -128.44 139.07 52.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.672 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.6 127.2 30.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -0.884 . . . . 0.0 110.177 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -43.65 -33.9 1.33 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.406 -0.808 . . . . 0.0 110.264 -179.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.028 HG23 HD22 ' A' ' 40' ' ' LEU . 7.1 mm -73.65 -33.74 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.53 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.663 ' HB3' HD21 ' A' ' 52' ' ' LEU . 93.4 m-20 -76.67 -45.82 28.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 110.476 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.599 ' CD ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -62.81 -44.2 96.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.072 -1.018 . . . . 0.0 110.217 -179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.788 ' HB3' HG12 ' A' ' 38' ' ' VAL . 9.1 m-20 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.275 -0.891 . . . . 0.0 109.347 178.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.685 HD13 HG23 ' A' ' 49' ' ' VAL . 7.2 mt -69.79 -33.07 54.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 178.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.964 HD11 HD22 ' A' ' 52' ' ' LEU . 65.9 mt -70.9 -38.25 72.99 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.247 -0.908 . . . . 0.0 109.388 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.66 -31.9 70.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.369 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.024 ' OE2' HG21 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -78.5 -32.12 48.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.382 -0.824 . . . . 0.0 109.605 178.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.828 HD22 ' HB3' ' A' ' 61' ' ' TYR . 12.6 mt -71.13 -37.34 72.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.306 -0.871 . . . . 0.0 109.475 178.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.545 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 2.9 tp-100 -67.6 -38.63 84.27 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 178.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 24.5 pttt -79.73 -38.16 33.97 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.321 -0.862 . . . . 0.0 109.762 178.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.481 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -116.49 91.84 3.7 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 0.0 110.093 179.363 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.8 22.48 13.89 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -131.46 9.85 4.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -1.115 . . . . 0.0 110.073 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.024 HG21 ' OE2' ' A' ' 22' ' ' GLU . 13.6 tt -85.72 143.67 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.336 -0.853 . . . . 0.0 110.405 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.058 ' HA ' HD11 ' A' ' 64' ' ' LEU . 21.0 m -92.38 -73.95 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.833 . . . . 0.0 110.537 -179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.702 ' OD1' HD11 ' A' ' 46' ' ' LEU . 10.7 t-20 -164.3 -54.6 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.204 -0.935 . . . . 0.0 110.504 -179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.478 ' C ' ' O ' ' A' ' 31' ' ' ASN . 3.2 t -42.64 -52.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.998 -1.064 . . . . 0.0 109.081 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -69.08 -29.23 67.29 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.147 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.652 HD21 HG23 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -73.66 -16.61 61.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.608 -0.683 . . . . 0.0 109.749 178.508 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.564 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 19.3 p -88.07 -47.76 8.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.0 110.954 -179.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -81.96 -17.11 48.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.955 -1.091 . . . . 0.0 111.129 -178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.594 ' HG2' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -77.43 -16.03 59.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.013 -1.055 . . . . 0.0 110.611 -179.359 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.898 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.48 -6.37 11.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 109.985 179.489 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.27 42.75 5.15 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.028 HD22 HG23 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -153.31 164.06 38.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.987 -1.302 . . . . 0.0 110.643 178.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.4 OUTLIER -71.51 160.93 81.14 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.078 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.3 Cg_endo -74.28 -54.22 0.1 OUTLIER 'Trans proline' 0 C--N 1.285 -2.794 0 O-C-N 123.953 1.502 . . . . 0.0 110.649 -178.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 m -35.14 -54.25 1.1 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.293 -0.879 . . . . 0.0 109.828 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.1 Cg_endo -74.83 -42.6 0.52 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.88 1.463 . . . . 0.0 109.867 178.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.692 ' HB2' HD12 ' A' ' 40' ' ' LEU . 40.8 t -39.15 -49.15 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 108.785 178.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.078 HD12 ' O ' ' A' ' 42' ' ' PRO . 2.1 mp -56.93 -52.77 63.87 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -42.87 -41.03 3.14 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.73 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.612 ' HG3' HG21 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -73.14 -53.78 10.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.615 -0.678 . . . . 0.0 109.683 178.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.685 HG23 HD13 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -56.7 -43.83 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 0.0 109.663 178.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.541 ' CG ' ' O ' ' A' ' 46' ' ' LEU . 1.5 mmm-85 -50.72 -48.4 58.91 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.203 -0.936 . . . . 0.0 109.131 179.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -50.6 -39.2 49.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.824 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.964 HD22 HD11 ' A' ' 20' ' ' LEU . 93.0 mt -70.63 -19.84 62.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.689 178.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.493 ' CG ' ' HB ' ' A' ' 58' ' ' ILE . 1.3 mt-10 -78.21 -55.07 5.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 110.062 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -44.64 -49.33 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.394 -0.816 . . . . 0.0 110.308 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 52' ' ' LEU . 11.0 pt20 -70.61 -1.96 12.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.291 -0.881 . . . . 0.0 110.325 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 53' ' ' GLU . . . 75.17 66.27 1.94 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.823 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -141.84 9.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 110.131 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.962 HD11 ' HB3' ' A' ' 52' ' ' LEU . 6.2 mm -135.26 11.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -64.52 -12.47 44.81 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 109.691 179.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.77 -37.39 0.62 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.828 ' HB3' HD22 ' A' ' 23' ' ' LEU . 14.2 m-30 -63.46 -116.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -1.052 . . . . 0.0 109.919 179.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.622 ' HB ' HD21 ' A' ' 23' ' ' LEU . 6.4 t -89.16 31.3 0.89 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.007 -1.058 . . . . 0.0 109.927 179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -33.91 -33.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.645 0.736 . . . . 0.0 109.041 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.058 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -62.36 -128.05 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.593 -0.692 . . . . 0.0 109.532 177.64 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.981 ' HG ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER 41.39 21.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.896 . . . . 0.0 110.464 178.856 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 64' ' ' LEU . 1.3 t-20 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.138 . . . . 0.0 110.199 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' ' HB ' ' A' ' 2' ' ' VAL . 1.5 ptt? . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.323 0.583 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 1' ' ' MET . 3.7 p 178.76 143.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.93 . . . . 0.0 110.198 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 59.8 m-20 -133.88 -0.22 3.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.186 -0.946 . . . . 0.0 110.379 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.34 -62.26 1.73 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.93 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 24' ' ' GLN . 7.0 mtpp -114.76 105.57 13.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -117.45 -116.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 -179.97 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.635 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 61.37 -169.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.933 -1.104 . . . . 0.0 109.117 -179.154 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.635 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 38.4 Cg_endo -70.02 57.07 1.56 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.286 1.15 . . . . 0.0 109.943 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -52.6 -42.21 57.85 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.91 142.26 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -1.138 . . . . 0.0 110.155 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 12' ' ' LEU . 68.9 m-20 53.82 -117.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 0.0 110.017 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' CB ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER 67.81 141.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.335 179.72 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.07 160.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.473 ' HA ' ' HD3' ' A' ' 17' ' ' ARG . 4.8 mmt85 -69.56 -35.49 75.44 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 110.297 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.898 HG21 HD12 ' A' ' 40' ' ' LEU . 1.2 mp -70.96 -35.22 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 110.273 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.758 ' CA ' HD11 ' A' ' 52' ' ' LEU . 63.8 m-20 -62.24 -67.17 0.44 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.204 -0.935 . . . . 0.0 110.545 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 3.1 ptm85 -50.76 -44.86 58.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.242 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.434 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 97.2 m-20 -66.21 -37.52 85.76 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.388 -0.82 . . . . 0.0 109.292 178.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.947 HG21 HG23 ' A' ' 49' ' ' VAL . 3.2 mt -66.91 -34.3 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 109.228 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.011 HD11 HD22 ' A' ' 52' ' ' LEU . 12.6 mt -68.74 -43.26 76.26 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.313 -0.867 . . . . 0.0 109.508 178.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -64.09 -30.88 71.92 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.292 -0.88 . . . . 0.0 109.511 179.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 24.6 mm-40 -76.84 -30.46 56.32 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.416 -0.802 . . . . 0.0 109.826 179.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.042 HD21 HD11 ' A' ' 34' ' ' LEU . 2.4 mm? -75.46 -30.98 60.13 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 178.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.524 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 1.1 mm100 -79.44 -35.4 40.49 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.422 -0.799 . . . . 0.0 109.704 178.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' CG ' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -75.51 -40.39 57.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.836 179.185 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.532 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -136.51 64.05 1.56 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.328 -0.857 . . . . 0.0 110.073 179.182 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 26' ' ' ASP . . . -55.05 -164.12 0.02 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 48.8 23.81 0.73 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 110.274 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.577 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 2.6 tt -106.65 142.14 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.164 -0.96 . . . . 0.0 110.341 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.592 ' HA ' HD11 ' A' ' 64' ' ' LEU . 4.4 p -80.91 179.87 7.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.387 -0.821 . . . . 0.0 110.197 -179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.604 HD22 HD11 ' A' ' 46' ' ' LEU . 9.3 p-10 -71.92 -50.02 32.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' ASN . 48.4 t -40.91 -48.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.453 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.0 -36.73 82.82 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.324 -0.86 . . . . 0.0 108.868 177.51 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.042 HD11 HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -67.78 -54.56 18.23 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.508 -0.745 . . . . 0.0 109.441 178.162 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.629 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 4.5 p -44.84 -44.89 9.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.619 -0.675 . . . . 0.0 110.515 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' CD ' ' O ' ' A' ' 32' ' ' VAL . 4.1 mtpp -73.82 -36.11 64.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.293 -0.879 . . . . 0.0 110.697 -178.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.12 -42.96 99.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.163 -0.961 . . . . 0.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 34' ' ' LEU . 9.1 m -92.1 20.48 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.977 179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 48.98 23.66 3.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 -179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.898 HD12 HG21 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -110.51 133.91 52.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.009 . . . . 0.0 110.82 -179.094 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -50.38 152.07 3.41 Favored Pre-proline 0 C--N 1.3 -1.554 0 C-N-CA 118.816 -1.154 . . . . 0.0 107.971 176.177 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.087 ' O ' HD12 ' A' ' 46' ' ' LEU . 44.4 Cg_endo -70.51 -47.26 0.73 Allowed 'Trans proline' 0 C--N 1.283 -2.89 0 O-C-N 123.703 1.37 . . . . 0.0 110.573 -177.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 1.0 OUTLIER -41.27 -54.66 5.82 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.048 -1.033 . . . . 0.0 109.125 178.336 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.649 ' HG2' HD22 ' A' ' 40' ' ' LEU . 42.3 Cg_endo -74.37 -48.39 0.21 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.95 1.5 . . . . 0.0 110.592 177.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' HA ' HD13 ' A' ' 40' ' ' LEU . 37.0 t -40.34 -42.05 1.48 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.085 . . . . 0.0 108.742 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.087 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.2 mt -67.87 -47.06 69.95 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.9 mm-40 -49.73 -46.14 49.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.139 177.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HG3' ' CD1' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -67.26 -46.04 74.86 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.475 -0.766 . . . . 0.0 109.3 178.26 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.947 HG23 HG21 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -59.48 -46.89 92.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.469 -0.769 . . . . 0.0 109.786 178.591 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.605 ' N ' HG12 ' A' ' 49' ' ' VAL . 9.5 mmm180 -48.02 -50.61 27.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.4 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 0.6 OUTLIER -48.83 -40.36 29.01 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.606 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.011 HD22 HD11 ' A' ' 20' ' ' LEU . 70.9 mt -74.02 -30.46 62.45 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.446 -0.783 . . . . 0.0 109.623 178.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' N ' HG13 ' A' ' 58' ' ' ILE . 5.8 tp10 -74.49 -62.2 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.479 -0.763 . . . . 0.0 110.298 -179.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -46.92 -26.27 0.96 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' NE2' ' HG3' ' A' ' 8' ' ' PRO . 11.9 mm100 -82.77 7.55 14.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.267 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.516 ' O ' ' NH1' ' A' ' 7' ' ' ARG . . . 73.68 40.03 47.04 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.869 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -128.83 10.3 5.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.184 -1.186 . . . . 0.0 110.277 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.869 HD13 ' O ' ' A' ' 57' ' ' PHE . 7.5 mm -140.93 35.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 110.212 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.02 -5.33 59.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.418 -0.801 . . . . 0.0 109.843 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -133.94 -41.23 0.17 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.647 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 16.8 m-30 -57.48 -114.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 0.0 109.933 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.689 HG21 HG21 ' A' ' 49' ' ' VAL . 3.7 t -85.76 24.44 1.25 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.896 -1.128 . . . . 0.0 109.975 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -37.4 -33.62 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.461 -0.774 . . . . 0.0 109.285 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -51.87 -27.1 11.63 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.73 0.776 . . . . 0.0 109.856 178.593 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.751 HD22 HG13 ' A' ' 49' ' ' VAL . 1.2 pp -41.94 -24.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.66 -0.65 . . . . 0.0 110.703 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.582 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 43.6 p30 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.296 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 3' ' ' ASP . 5.7 t -112.52 49.44 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER 41.87 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -0.863 . . . . 0.0 110.308 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 5' ' ' LYS . 33.5 p -70.73 -126.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 110.125 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' N ' ' OG ' ' A' ' 4' ' ' SER . 12.2 mtmt 52.94 60.4 3.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 110.272 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 5.3 mmtt -68.58 -96.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 110.391 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.608 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 61.36 -173.22 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 109.231 -179.358 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 7' ' ' ARG . 37.3 Cg_endo -67.06 60.45 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.417 1.22 . . . . 0.0 109.797 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -50.95 -174.55 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' A' ' 12' ' ' LEU . 41.7 tttt 53.28 -130.62 2.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -1.194 . . . . 0.0 109.856 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 10' ' ' LYS . 3.4 p-10 -43.57 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 110.138 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -151.07 129.17 11.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 110.307 -179.637 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' CG ' ' A' ' 16' ' ' ASP . 6.4 m-20 -43.13 132.08 4.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.295 -0.878 . . . . 0.0 110.101 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 18' ' ' ASN . 22.2 mmt-85 -53.0 -34.92 58.49 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.368 -0.832 . . . . 0.0 110.357 -179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.878 HD12 HD22 ' A' ' 40' ' ' LEU . 13.6 mm -75.8 -24.39 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.678 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB2' HD22 ' A' ' 12' ' ' LEU . 18.0 m-20 -80.6 -55.64 4.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.129 -0.982 . . . . 0.0 110.292 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -57.08 -43.87 82.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 2.7 m120 -66.32 -41.52 89.53 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.376 -0.827 . . . . 0.0 109.206 178.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HG23 ' A' ' 49' ' ' VAL . 6.8 mt -65.06 -34.76 72.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 178.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.872 HD11 HD22 ' A' ' 52' ' ' LEU . 25.8 mt -70.8 -39.2 73.26 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.378 178.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 17' ' ' ARG . 3.3 m120 -68.91 -30.86 69.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.785 . . . . 0.0 109.488 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 18' ' ' ASN . 66.2 mm-40 -78.34 -32.34 49.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.431 -0.793 . . . . 0.0 109.763 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.06 HD21 HD11 ' A' ' 34' ' ' LEU . 2.5 mm? -73.37 -32.23 64.39 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.339 -0.851 . . . . 0.0 109.457 178.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' ' CE1' ' A' ' 61' ' ' TYR . 19.1 tp60 -74.13 -33.93 63.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.484 -0.76 . . . . 0.0 109.919 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' CE ' ' OE1' ' A' ' 22' ' ' GLU . 12.9 pttt -77.58 -34.27 53.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -128.07 76.56 1.7 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.111 179.476 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 28' ' ' ARG . . . -66.07 59.59 0.15 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -178.41 29.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.338 -1.095 . . . . 0.0 110.299 179.85 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 5.5 tt -105.74 141.81 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.401 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.62 154.97 19.89 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.363 -0.836 . . . . 0.0 110.435 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.847 ' OD1' HD11 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -44.55 -55.3 5.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.332 -0.855 . . . . 0.0 110.369 179.86 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' ASN . 86.6 t -38.61 -58.38 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.175 -0.953 . . . . 0.0 109.552 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -65.12 -39.03 92.5 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.212 -0.93 . . . . 0.0 108.576 177.088 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 HD21 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.67 -15.07 50.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.58 -0.7 . . . . 0.0 110.021 178.39 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.562 ' HB2' ' N ' ' A' ' 42' ' ' PRO . 12.7 p -88.0 -50.44 6.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.403 -0.811 . . . . 0.0 111.412 -178.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HG3' ' OG ' ' A' ' 35' ' ' SER . 13.2 mttt -81.89 -24.1 35.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 111.614 -177.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.596 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -73.66 -15.41 61.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.906 -1.121 . . . . 0.0 110.351 -179.191 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.879 ' HB ' HD21 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -104.61 -16.91 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.333 -0.854 . . . . 0.0 109.895 178.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.32 38.8 3.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.879 HD21 ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.67 170.3 20.58 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.031 -1.276 . . . . 0.0 110.736 179.262 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 1.7 m -75.6 160.68 78.75 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.01 ' O ' HD12 ' A' ' 46' ' ' LEU . 49.5 Cg_endo -73.8 -54.51 0.1 Allowed 'Trans proline' 0 C--N 1.287 -2.7 0 O-C-N 123.998 1.525 . . . . 0.0 110.845 -178.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -38.06 -51.64 3.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.971 . . . . 0.0 109.752 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 43' ' ' THR . 48.8 Cg_endo -76.12 -43.22 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.909 1.478 . . . . 0.0 109.756 178.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 41.8 t -41.6 -43.72 2.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.075 -1.016 . . . . 0.0 108.469 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.01 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -65.63 -51.3 60.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 2.5 mt-10 -43.24 -38.46 2.57 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.142 -0.973 . . . . 0.0 108.594 177.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.631 ' HG3' HG21 ' A' ' 15' ' ' ILE . 3.5 mmt85 -71.69 -54.52 10.04 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.635 0.731 . . . . 0.0 109.205 177.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.031 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -60.41 -49.7 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 109.758 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.897 ' CD ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -41.73 -51.41 4.13 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.411 -0.806 . . . . 0.0 109.465 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.499 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -51.19 -44.11 61.5 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.679 -0.808 . . . . 0.0 108.836 177.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 20' ' ' LEU . 86.8 mt -66.64 -17.5 64.87 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.44 -0.787 . . . . 0.0 109.868 178.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.874 ' HG3' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -74.36 -64.7 0.97 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.246 179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -46.95 -26.01 0.91 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.9 . . . . 0.0 110.4 -179.869 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.551 ' HB3' ' CE2' ' A' ' 57' ' ' PHE . 1.8 mm-40 -82.73 7.68 14.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.925 . . . . 0.0 110.229 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.26 47.02 91.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.987 ' O ' HD13 ' A' ' 58' ' ' ILE . 19.3 m-85 -128.43 10.57 6.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -1.17 . . . . 0.0 110.181 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.987 HD13 ' O ' ' A' ' 57' ' ' PHE . 6.7 mm -140.88 48.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.331 179.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.596 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 2.2 pp0? -79.58 -15.92 56.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.264 -0.898 . . . . 0.0 110.024 179.37 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -134.46 -45.67 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.667 ' CA ' HD12 ' A' ' 23' ' ' LEU . 25.7 m-85 -51.16 -102.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -1.005 . . . . 0.0 110.112 179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.892 HG21 HG21 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -85.3 13.73 6.16 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.103 -0.998 . . . . 0.0 109.889 179.773 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.843 ' N ' HG22 ' A' ' 58' ' ' ILE . . . -42.07 -27.26 0.12 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 62' ' ' THR . 0.4 OUTLIER -54.84 -32.73 60.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.465 -0.772 . . . . 0.0 110.25 179.642 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.119 HD13 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -59.73 -8.16 1.94 Allowed 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.536 -0.728 . . . . 0.0 110.587 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 1.119 ' N ' HD13 ' A' ' 65' ' ' LEU . 44.3 t-20 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.254 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtp . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.236 0.541 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.07 -163.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.32 -11.25 7.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.267 -0.896 . . . . 0.0 110.282 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.84 134.83 57.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.275 -0.89 . . . . 0.0 110.278 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HD3' ' HB2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -95.48 6.61 48.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 110.258 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 5' ' ' LYS . 6.3 mtpt 60.72 -121.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 110.147 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.629 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tpp180 59.14 -171.27 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 120.886 -1.134 . . . . 0.0 109.02 -179.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.732 ' HB2' HD23 ' A' ' 12' ' ' LEU . 37.6 Cg_endo -67.66 57.77 0.75 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.338 1.178 . . . . 0.0 109.885 179.206 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 7' ' ' ARG . . . -47.48 -64.2 2.99 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 9' ' ' GLY . 0.3 OUTLIER -42.2 146.78 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -1.164 . . . . 0.0 110.188 179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 12' ' ' LEU . 64.8 m-20 45.11 -127.49 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.92 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.732 HD23 ' HB2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 67.08 134.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 0.0 110.393 179.617 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.82 136.79 57.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.166 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -54.86 -29.77 56.2 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.339 -0.851 . . . . 0.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.926 HD12 HD22 ' A' ' 40' ' ' LEU . 22.2 mm -67.22 -24.09 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.065 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.785 ' HB3' HD11 ' A' ' 52' ' ' LEU . 69.3 m-20 -83.07 -53.63 5.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -0.905 . . . . 0.0 110.259 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -53.15 -50.19 65.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -63.33 -40.06 96.25 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.353 -0.842 . . . . 0.0 109.269 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.881 HG21 HG23 ' A' ' 49' ' ' VAL . 7.3 mt -64.52 -34.76 71.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.402 -0.811 . . . . 0.0 109.323 178.4 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.862 ' HG ' HD13 ' A' ' 52' ' ' LEU . 9.3 mt -68.91 -42.35 76.94 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 178.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.462 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 1.5 m-80 -66.93 -34.08 77.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.471 ' OE1' HG12 ' A' ' 38' ' ' VAL . 11.3 mt-10 -72.57 -31.8 65.53 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.401 -0.812 . . . . 0.0 109.599 178.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.031 HD21 HD11 ' A' ' 34' ' ' LEU . 2.4 mm? -68.34 -31.68 71.26 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 178.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.482 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -78.92 -43.5 24.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.525 -0.734 . . . . 0.0 109.888 179.076 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -72.22 -49.21 36.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.285 -0.884 . . . . 0.0 109.968 179.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 27' ' ' GLY . 6.1 m-20 -121.98 71.04 0.98 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.244 -0.91 . . . . 0.0 110.071 179.405 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.561 ' O ' ' HG2' ' A' ' 28' ' ' ARG . . . -58.77 -151.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.604 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER 27.93 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.64 -0.918 . . . . 0.0 110.953 179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.559 ' N ' ' O ' ' A' ' 27' ' ' GLY . 8.8 tt -114.59 128.15 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.169 179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -75.9 155.75 34.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.312 -0.867 . . . . 0.0 110.281 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' SER . 7.4 p30 -46.24 -44.45 16.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.204 -0.935 . . . . 0.0 110.398 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 31' ' ' ASN . 58.8 t -40.37 -72.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 109.825 179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 1.4 tp10 -57.67 -25.01 59.62 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.865 178.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.031 HD11 HD21 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -77.2 -15.28 59.56 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.584 -0.697 . . . . 0.0 109.913 179.003 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 31' ' ' ASN . 23.4 p -88.17 -44.14 11.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.541 -0.724 . . . . 0.0 110.967 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.77 -42.1 22.33 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 111.425 -177.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -61.26 -15.81 38.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.512 -178.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.79 HG23 ' HG ' ' A' ' 40' ' ' LEU . 15.1 m -100.41 -23.44 4.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 O-C-N 121.266 -0.896 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.99 32.25 4.76 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.926 HD22 HD12 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -148.06 168.99 20.94 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.008 -1.289 . . . . 0.0 110.647 179.005 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -72.75 158.41 87.32 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.336 -0.852 . . . . 0.0 108.977 177.34 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.055 ' O ' HD12 ' A' ' 46' ' ' LEU . 48.1 Cg_endo -73.93 -46.59 0.31 Allowed 'Trans proline' 0 C--N 1.287 -2.703 0 O-C-N 123.928 1.488 . . . . 0.0 110.744 -178.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.585 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.9 OUTLIER -40.3 -54.81 4.51 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.045 -1.034 . . . . 0.0 109.548 179.254 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.585 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 49.1 Cg_endo -77.25 -40.02 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.887 1.467 . . . . 0.0 110.267 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . 42.0 t -38.71 -45.78 1.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.025 . . . . 0.0 108.809 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.055 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mp -65.3 -50.36 65.97 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.566 ' HB2' ' O ' ' A' ' 44' ' ' PRO . 6.1 mm-40 -42.86 -39.29 2.47 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.592 177.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' HG13 ' A' ' 15' ' ' ILE . 1.4 mmt85 -69.47 -55.6 9.79 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.663 0.745 . . . . 0.0 109.071 177.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 19' ' ' ILE . 0.5 OUTLIER -55.57 -43.04 71.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.32 -0.862 . . . . 0.0 109.479 178.292 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HG2' ' O ' ' A' ' 46' ' ' LEU . 10.1 mmt85 -45.86 -56.22 5.67 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.331 -0.856 . . . . 0.0 109.446 179.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -46.74 -40.36 13.31 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 177.952 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.862 HD13 ' HG ' ' A' ' 20' ' ' LEU . 21.4 mt -77.4 -19.14 56.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.404 -0.81 . . . . 0.0 109.889 178.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.572 ' HG3' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.31 -59.32 2.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.805 . . . . 0.0 110.384 -179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -57.52 -21.13 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.456 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.414 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 68.8 mm-40 -79.3 7.63 7.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 57' ' ' PHE . . . 64.43 49.74 63.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.924 ' O ' HD13 ' A' ' 58' ' ' ILE . 21.7 m-85 -139.07 17.77 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.279 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.965 ' CG2' HG22 ' A' ' 62' ' ' THR . 7.8 mm -142.75 23.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.327 -0.858 . . . . 0.0 110.275 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.412 ' C ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -74.68 -3.22 30.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.892 179.171 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -137.44 -43.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.552 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.641 ' HB3' ' CG ' ' A' ' 23' ' ' LEU . 64.3 m-85 -55.61 -108.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 0.0 109.893 179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 1.023 ' O ' HD12 ' A' ' 65' ' ' LEU . 3.0 t -85.98 23.26 1.52 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.913 -1.117 . . . . 0.0 109.662 178.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -37.94 -30.41 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.518 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 62' ' ' THR . 1.0 OUTLIER -51.51 -32.98 29.68 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.605 178.515 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.023 HD12 ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -59.09 151.07 23.3 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.67 -0.644 . . . . 0.0 110.341 179.549 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.81 ' CB ' HD22 ' A' ' 65' ' ' LEU . 21.0 t-20 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.214 -179.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.236 0.541 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 2' ' ' VAL . 8.4 p -80.97 133.81 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.249 -0.907 . . . . 0.0 110.269 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 38.7 p-10 -84.75 47.61 1.41 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.333 -0.855 . . . . 0.0 110.265 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -70.62 177.77 3.35 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.3 -0.875 . . . . 0.0 110.447 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HD2' ' CB ' ' A' ' 24' ' ' GLN . 4.3 mtpm? -58.3 144.75 40.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.94 . . . . 0.0 110.321 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 7' ' ' ARG . 3.9 mtmt -113.02 -17.12 12.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.317 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.709 ' CB ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 39.59 -156.43 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.879 . . . . 0.0 109.113 179.577 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.784 ' HD2' HD11 ' A' ' 12' ' ' LEU . 43.2 Cg_endo -76.15 5.87 4.26 Favored 'Trans proline' 0 C--N 1.318 -1.05 0 O-C-N 123.063 1.033 . . . . 0.0 109.914 179.188 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.649 ' CA ' HD12 ' A' ' 12' ' ' LEU . . . 41.7 -146.07 0.61 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 43.09 -133.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -1.131 . . . . 0.0 110.231 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.511 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 1.2 m-20 -64.76 103.64 0.73 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.146 -0.972 . . . . 0.0 110.407 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.784 HD11 ' HD2' ' A' ' 8' ' ' PRO . 1.4 mt -143.95 96.22 2.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 110.169 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -47.41 141.89 4.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.353 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -51.74 -24.45 5.85 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.298 -0.876 . . . . 0.0 110.306 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.866 HG23 HD22 ' A' ' 40' ' ' LEU . 10.5 mm -75.37 -34.28 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.855 . . . . 0.0 110.237 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.727 ' HB3' HD11 ' A' ' 52' ' ' LEU . 72.5 m-20 -74.99 -38.25 61.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -0.942 . . . . 0.0 110.266 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' HG3' HD22 ' A' ' 12' ' ' LEU . 15.5 mtt180 -67.39 -59.73 3.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.879 . . . . 0.0 110.294 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -57.3 -31.75 65.97 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.357 -0.839 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.935 HG21 HG23 ' A' ' 49' ' ' VAL . 8.3 mt -69.49 -39.87 79.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 178.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 58' ' ' ILE . 26.1 mt -69.88 -37.37 76.02 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 178.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.488 ' HA ' ' CD ' ' A' ' 5' ' ' LYS . 35.8 t-20 -67.69 -29.06 68.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.296 -0.877 . . . . 0.0 109.296 178.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 25' ' ' LYS . 4.6 mm-40 -73.36 -38.02 65.85 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.433 -0.792 . . . . 0.0 109.678 178.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.888 HD13 ' HB3' ' A' ' 61' ' ' TYR . 63.7 mt -68.48 -32.91 73.23 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.229 -0.92 . . . . 0.0 109.256 178.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 3.7 tt0 -70.69 -39.34 73.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.113 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -82.02 -26.9 33.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.411 -0.806 . . . . 0.0 109.635 178.688 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.571 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -142.0 63.83 1.41 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.47 -0.768 . . . . 0.0 109.932 178.883 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . -49.43 -26.5 7.17 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 7.7 mpt_? -92.71 81.1 4.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -1.173 . . . . 0.0 110.493 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.52 ' CG1' ' HB3' ' A' ' 33' ' ' GLU . 10.0 tt -159.09 138.86 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 110.341 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.635 ' HA ' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -86.8 162.0 18.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.369 -0.832 . . . . 0.0 109.973 179.768 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.686 ' ND2' HD23 ' A' ' 46' ' ' LEU . 2.3 m-80 -53.45 -30.75 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 0.0 110.449 -179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.73 -66.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.988 -1.07 . . . . 0.0 109.156 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 29' ' ' ILE . 1.2 tp10 -61.26 -29.41 69.83 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.27 -0.894 . . . . 0.0 108.671 177.36 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.6 -14.58 62.12 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.609 -0.682 . . . . 0.0 109.549 178.286 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.529 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 23.5 p -87.04 -43.44 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.431 -0.793 . . . . 0.0 110.499 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -84.78 -17.28 38.69 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.147 -0.97 . . . . 0.0 110.952 -178.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' NH1' ' HG2' ' A' ' 37' ' ' ARG . 12.8 mtt-85 -77.75 -16.63 58.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.018 -1.051 . . . . 0.0 110.67 -179.411 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.906 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -109.5 -7.37 11.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 121.482 -0.761 . . . . 0.0 110.01 179.383 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.97 42.88 5.21 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.906 HD21 ' CG2' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -152.64 167.6 28.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.046 -1.267 . . . . 0.0 110.685 179.034 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -73.54 160.76 81.52 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 1.037 ' O ' HD12 ' A' ' 46' ' ' LEU . 52.3 Cg_endo -75.56 -49.64 0.13 Allowed 'Trans proline' 0 C--N 1.286 -2.738 0 O-C-N 123.932 1.491 . . . . 0.0 110.725 -178.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 0.3 OUTLIER -39.47 -51.55 4.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.795 179.405 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 43' ' ' THR . 48.3 Cg_endo -76.53 -43.12 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.915 1.481 . . . . 0.0 109.727 178.223 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.738 ' HB2' HD12 ' A' ' 40' ' ' LEU . 51.9 t -41.67 -42.36 2.51 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.037 HD12 ' O ' ' A' ' 42' ' ' PRO . 1.1 mt -67.72 -48.66 65.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 44' ' ' PRO . 66.6 mm-40 -48.05 -39.4 19.91 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.837 177.236 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HD2' ' CB ' ' A' ' 15' ' ' ILE . 1.3 mmt180 -70.02 -51.84 28.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.729 . . . . 0.0 109.13 178.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.935 HG23 HG21 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -59.67 -50.62 79.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.42 -0.8 . . . . 0.0 109.63 178.587 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.675 ' N ' HG12 ' A' ' 49' ' ' VAL . 3.9 mmm180 -45.89 -42.15 12.24 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.414 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' HG3' ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -57.31 -38.11 73.5 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.408 -0.807 . . . . 0.0 108.977 178.277 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.727 HD11 ' HB3' ' A' ' 16' ' ' ASP . 79.8 mt -74.77 -17.89 60.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.355 -0.841 . . . . 0.0 109.912 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -69.2 -53.82 18.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.133 -0.979 . . . . 0.0 109.739 179.448 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -75.03 -29.1 60.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.326 -0.859 . . . . 0.0 110.031 179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 4.8 pt20 -140.92 56.06 1.57 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.893 . . . . 0.0 110.421 179.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 52' ' ' LEU . . . -166.57 -137.6 2.25 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 1.074 ' O ' HD13 ' A' ' 58' ' ' ILE . 56.2 m-85 -139.78 83.08 1.91 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -1.12 . . . . 0.0 110.284 -179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.074 HD13 ' O ' ' A' ' 57' ' ' PHE . 4.6 mm -134.97 17.43 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.193 -0.942 . . . . 0.0 110.531 -179.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -3.12 30.11 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.69 178.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . -144.23 -41.79 0.05 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.888 ' HB3' HD13 ' A' ' 23' ' ' LEU . 15.8 m-30 -52.84 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -1.11 . . . . 0.0 110.047 179.337 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.803 HG22 ' CG2' ' A' ' 58' ' ' ILE . 3.9 t -89.56 26.93 1.59 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.049 -1.032 . . . . 0.0 109.826 179.169 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 62' ' ' THR . . . -39.01 -29.96 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.485 -0.76 . . . . 0.0 109.269 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.635 HD11 ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -55.29 -25.15 32.39 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.678 0.751 . . . . 0.0 109.838 178.616 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -43.43 -22.1 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.718 -0.614 . . . . 0.0 110.569 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.594 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.255 179.889 . . . . . . . . 2 2 . 1 stop_ save_